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PREFACE
The Occupational Safety and health  Act of  19"J emphasizes the need for standards to p ro tec t the h ea l ta  -'tnd provide fcr  the safe ty  of workers 
occupationally exposed to an ever-'.acreasing runber cf p o ten tia l  hazards. The 
National I n s t i tu t e  for Occupational Saiery and L’ea i th  (NIOSH) «%-aluates a l l  ava ilab le  research data and c r i t e r i a  and recommends standards for occupational 
¿xyosure. The Secretary of Labor v i l i  weigh thes* recommendations along with 
other considera tions, such as f e a s i b i l i t y  and scans of implementation, in 
promulgating regula tory  standards.
NIOSH w i l l  p e r io d ica l ly  review the recommended standards to ensure 
continuing p ro tec tio n  of workers and w il l  make successive reports  as cev 
research and epidemiologic s tud ies  are completed and as sampling and a n a ly t ic a l  methods are  developed.
A permanent Federal standard e x is ts  for worker exposure fo v iny l ch loride . 
This curren t standard was promulgated ou October 4, 1974 (fe d e ra l  Register
39:25396), became e ffe c t iv e  January 1, 1975, and was included in the Code of 
Federal Regulations (29 CFR 1910.1017) in January 1976. As pa r t  of NIOSH's 
e f f o r t s  to ensure continuing p ro tec tio n  of vo-lters by pe rio d ica lly  reviewing 
c r i t e r i a  and standards , th is  c r i t e r i a  document presen ts recen tly  completed 
research  and epidemiologic s tud ies  as v e i l  as revised sampling and a n a ly t ic a l  aethods for v iny l ch lo r ide . In add it ion , th is  document presen ts  complete 
c r i t e r i a  and a recommended standard for fcur add it ion a l  v iny l ha lides .
The con tr ibu tions  to  th is  document on v iny l ha lides  by NIOSH s t a f f ,  o ther  Federal agencies o r  departments, the review consu ltan ts ,  the reviewers 
se lec ted  by the American Academy of Occupational Medicine, the American 
Academy of I n d u s t r ia l  Hygiene, and the Society of the P la s t ic s  Industry , and Robert B. O'Connor, M.D., NIOSH consu ltant in occupational medicine, are g ra te fu l ly  acknowledged.
ill
The views expressed end conclusions reeched In chls document, together 
with th'i recounendetlons fo r  e standard, a re  chose of MIOSH. They are  noc 
necessar i ly  chose of Cbe c o n su lta n ts , the reviewers se lec ted  by professional 
s o c ie t i e s ,  or ocher Federal agencies. However, a l l  connûmes, whether or noc 
Incorporated, were considered ca re fu l ly  and were sent with che c r i t e r i a  
docuaenc Co Che OccupaClonal Safety and Health Administration for consideration  in  s e t t in g  the standard. The review consu ltan ts  and the Federal 
agencies which received the docuaenc  J * ' -----  -- " 1 v i i .
Acting D irecto r , National I n s t i tu te  
fo r  Occupational Safety and Health
iv
The Division of C r i te r i a  Documentation and Standards Development, 
National I n s t i tu t e  fo r  Occupational Safety and Health, had
primary re s p o n s ib i l i ty  for the development of the c r i t e r i a  and 
recommended standard fo r  v iny l h a l id es .  Alfred S. M ilbert,
Ph.D., of th is  Division served as c r i t e r i a  manager. SRI In te rn a t io n a l  developed the basic  information for consideration 
by 3I0SH s t a f f  and consu ltan ts  under con trac t CDC-99-74-31.
The Division review of t h i s  document vas provided by Richard A. 
Rhoden, Ph.D. (Chairman), J .  Henry W ills, Ph.D., Paul E. C’plan, James L. Oser (Division of S u rve il lance , Hazard Evaluations, and 
P le ld  S tud ies) ,  Denis L. Foers t, Ph.D. (Division of Physical
Sciences and Engineering), Robert L. Roudabush, Ph.D. and Howard C. Spencer, Ph.D.
v
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I. RECOmENDATIONS FOR A V i m  HALIDES STANDARD
HIOSH recaaacnds th a t  employee exposure to vin^rl ha lides in the workplace 
be contro lled  by adherence to the provisions fo r  v inyl chloride in 29 CFR 
1910.1017, the contents of which are provided as Appendix I of th is  document, with the exception th a t  the r e s p ira to r  provisions la  29 CFR 1910-1017 
(g ) ( l ) ( i - iv >  and a lso  29 CFR 1910 (g) (6 )U i)  sh a l l  be replaced with those 
given below. All provisions sh a ll  be adhered to for each of the vinyl halides 
as defined below. The recommended occupational exposure l im its  are Measurable 
by cechn.Tuas that are v a l id ,  :»:roduc ib Le, .ind availab le  to Indus tr*» and ^overmaer.t agencies. S u ffic ien t te-.hnolcgy ex is ts  to permit cccipliance v i th  
the reconcended standard. Zaployers should 3>ake every e f fo r t  to lim it «anployee exposure to the vinyl halides to concentrations that are as low as 
possib le , with an eventual goal of zero exposure. Employee exposures sh a l l  be 
’nc.pt a t  or below the lim its  prescribed In 29 CFR 1910.1017. The c r i t e r i a  and standard w il l  be subject to review and rev is ion  as necessary.
These c r i t e r i a  and the recomended standard apply to workplace exposure of employees to the aonotaers v inyl chloride (CH2-CHC1), vinylidene chloride 
(CH2-CC12', v inyl bromide (CHI-CH3r) , v iny l f luoride  (C£2"CHF), and vinylidene 
fluo ride  (CH2-CF2), including any unreacfed monomer th a t  may remain in 
pol/mers of these h a lid es .  As used in th is  document, "vinyls" and "vinyl nalides" re fe r  only to these five  compounds unless the terms are otherwise q u a lif ied .
The b io log ic  e ffe c ts  of exposure to the v inyl ha lides  say Include changes 
in behavior, cardiovascular abnorm alities, degenerative changes In the l iv e r  
and bones, and the induction of malignant neoplasms, e spec ia l ly  angiosarcomas of the l iv e r .  A great deal of information is  availab le  concerning the e ffec ts  
of exposure of humans and animals :o vinyl chlorid'*, much of th is  is  r e la t iv e ly  new information having been developed sine* October 1974, when 29 
CFR 1910.1017 was promulgated. Am p e r t  of i t s  e f f o r t  to provide worker p ro tec tio n , NTOSH has extensively  reviewed the newly completed s tud ies  as well 
as the older l i t e r a tu r e  on v u y l  chloride and has considered th is  information in i t s  evaluation of the other v inyl h a l id es .  The data th a t  are availab le  
from s tud ies  of carc inogen ic ity , mutagenicity, and metabolism, and predic tions 
of b io log ic  r e a c t iv i ty  on the basis  of physical and chemical p ropert ie s  of the 
vinyl ha lides  suggest th a t  the other v inyl ha lides  have carcinogenic 
p o ten tia ls  s im ila r  to th a t  of v iny l ch lo ride . There Is strong evidence from animal s tud ies  of carc inogenicity  on the pare of vinylidene chloride and vinyl bromide. Although there  Is a lack of to x ic i ty  data  on v iay l f luo ride  and 
vinylidene f lu o r id e ,  u n t i l  some animal to x ic i ty  and/or metabolism data are av a i la b le ,  there  appears to be no reason to t r e a t  these two compounds 
d i f f e re n t ly  from the o ther v iny l ha ld les in  considerations of worker p ro tec tio n .
1
Procedures for the collection and analysis of workroom air samples for 
compliancc with this standard shall be as provided in Appendices II-VI or by 
any methods shown to be at l^ast equivalent in precision, sensitivity, and 
accuracy to the methods specified for vinyl chloride in 29 CFR 1910.1017 
(d)(4).
Continuous monitoring equipment with alarm capability has been developed 
for vir.yl chloride and vinvlidene chloride and should be used as specified for 
vinyl chloride in 29 CFR 1910.1017 (¿)(6)(ii).
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II. INTRODUCTION
This report presents the criteria and the recommended standard based 
thereon that were prepared to meet the need for preventing impairment of 
health from occupational exposure to vinyl halides. The criteria document 
fulfills the responsibility of the Secretary of Health, Education, and Welfare 
under Section 20 (a)(3) of the Occupational Safety and Health Act of 1S70 to 
"develop criteria dealing with toxic materials and harmful physical agents and 
substances which will describe exposure levels...at which no employee will 
suffer impaired health or functional capacities or diminished life expectancy 
as a result of his work, experience.”
After reviewing data and consulting with 'tl.ers, NIOSH formalized a system 
for the development of criteria on which standards can be established to 
protect the health and provide for the safety of employees exposed to 
hazardous chemical and physical agents. The criteria and recommended 
standards should enable management and labor to develop better engineering 
controls resulting in more healthful work environments. Simply complying with 
the recomaended standard should not be the final ¿oil.
These criteria for a recommended standard for vinyl halides are part of a 
continuing series of criteria developed by NI0S3. The recommended standard 
applies to the handling, processing, manufacture, use, or storage of the vinyl 
'halides. Ine standard was not designed for the population-at-large, and its 
application to situations other than occupational exposure is not warranted. 
The standard is Intended to: (1) protect against the development of short-
and long-term systemic effects from exposure to vinyl halides; (2) protect 
against local effects on the skin and eyes; (3) minimize the risk of Induction 
of cancer; (4) be measurable by techniques that are valid, reproducible, and 
available to industry and government agencies; and (5) be attainable with 
existing techrology.
Th» diagnosis of a rare liver cancer» angiosarcoma, la employees involved 
in polymerization processes Involving exposure to vinyl chloride has generated 
research on related compounds, Including vlnylldene chloride and vinyl 
bromide. The available data from studies with animals confirm the 
carcinogenic potential of vinyl chloride. The available information on 
vinylidene chloride and vinyl bromide suggests that these compounds also are 
carcinogenic and may Induce the same type of characteristic tumor that is 
associated with exposure to vinyl chloride.
Although no reports of animal experiments have been located in which the 
effects of long-term exposure to vlnrl fluoride or vlnylldene fluoride were 
investigated, these compounds have b^en found to be mutagenic In bacteria, and 
they may have metabolic products and pathways similar to those of the other 
vinyl halides. Examination of the chemical and physical properties of the
3
vinyl halides Indicates that all of them or their metabolites may have similar 
macromolecular binding potentials. The limited data on vinyl fluoride and 
vinylidene fluoride suggest that they probably exert nearly the »«me 
tuaorigenic propensities as vinyl chloride, vinylidene chloride, and vinyl 
bromide.
To permit accurate assessment of the health hazards associated with the vinyl halides, additional research is necessary. This research should Include 
attempts to : (1) develop le ss  toxic su b s t i tu te s ;  (2) develop improved control
technology; (3) develop re sp ira to ry  p ro tec tiv e  devices, espec ia l ly  those with e n d -o f-se rv ice - l i fe  in d ic a to rs ,  for the •»•inyl ha lides o ther than vinyl 
chloride; and (4) develop improved sampling and a n a ly t ic ? l  methods and 
continuous monitoring equipment.
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III. BIOLOGIC EFFECTS OF EXPOSURE
Vinyl halides ere of growing Industrial Importance, especially In the 
plastics Industry. The vinyl halides, vinyl chloride, vlnylldene chloride, 
vinyl bromide, vinyl fluoride, and vinylidene fluoride, are easily polymerized 
or copolymerized with various compounds, such as acrylonitrlie, vinyl acetate, 
and styrene, to form pliable, lightweight plastics or thermoplastic resins. 
Whereas there are many reports of epidemiologic, carcinogenic, mutagenic, and 
metabolic studies of vinyl chloride, there are few reports of studies of the 
biologic effects of any of the other vinyl halides. Because of the paucity of 
information on these latter compounds, NIOSH has undertaken evaluations of the 
structure-activity relationships, based on chemical and physical properties, 
of the compounds and has used these relationships, along with data from the 
vinyl chloride literature, as a basis for extrapolation from actual to 
potential hazards for substances about which direct information is inadequate. 
Pertinent physical and chemical properties of these vinyl halides are 
presented in Table XVII-1, and a list of some of the synonyms for these 
compounds is presented in Table XVTI-2.
The vinyl halides undergo metabolic conversions, presumably initiated by 
enzymatic oxidation, to the corresponding oxlranes (epoxides) f1—A]. 
Subsequently, the oxlranes are presumed to either bind covalently to cellular 
macromolecules or be spontaneously rearranged to the aldehyde or acyl halide, 
hydrolyzed to the dlol, conjugated with glutathione, or reduced back to the 
parent compound. The major adverse biologic effects of the vinyl halides or 
their metabolites may include carcinogenesis, mutagenesis, teratogenesis, and 
damage to the liver. Such effects may be associated with electrophlllc 
reactions (alkylation) with essential cellular components, whereas the 
rearrangements and other reactions (reduction, hydrolysis, conjugation) have 
often been considered to be detoxification mechanisms. It is realized that 
the rates of these possible reactions may vary »rid that the risk of adverse 
effaces ■ would be' a function o f  th* relative rates leading to, and
corresponding half-lives of, each metabolic intermediate. Therefore, toxicity 
of a different order of magnitude may be elicited by each of these compounds. 
Indeed, not all of these effects have been associated with each of the vinyl 
halides.
The absorption and subsequent metabolism of vinyl chloride have been 
described as concentration—dependent; a saturable enzyme system, predominantly 
responsible for its metabolism at low concentrations, and a secondary
oxidative system, predominant at higher concentrations, have been postulated 
[4-6]. The authors of these reports have further postulated that the oxlrane 
is formed predominantly at the higher concentrations, le, through the
secondary oxiditive pathway. The halogenated acetaldehyde is common to both 
pathways, however. Thus, even if the oxirane is not formed at low
concentrations, the potential for macromolecular alkylation exists through the 
aldehyde and subsequent intermediates.
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The covalent reactions of che vinyl halides and/or cheir metabolites with 
biologic materials may alter the chemical behavior and physical 
characteristics of the cellular constituents so as to prevent the altered 
molecules from functioning normally In physiologic processes. The formation 
of stable reaction products may account, in part, for the subsequent harmful 
effects observed in biologic systems exposed to the vinyl halidis. The
alkylatlon of the biologic materials controlling cellular metabolism by the 
vinyl halides and/or their metabolites Is the most plausible basis for the 
Induction of genetic and neoplastic alterations in cell populations exposed to 
these chemicals. Because of the long latent period before adverse effects 
such as neoplasia become manifest, measurable effects may not be observable 
until many year3 after exposure at low concentrations.
Ext ¿.it of Exposure
NIOSH has estimated that approximately 2.5 million US workers may be 
occupationally exposed to vinyl halide monomers. A more precise estimate is 
difficult to make because of the lack of Information on exposure tn monomer 
released in manufacturing processes involving the polymers or copolymers.
Some of occupations that involve exposure to the vinyl halides are listed In 
Table XVII-3.
(a) Vinyl Chloride
Vinyl chloride has the chemical formula CH2-CHC1. At room temperature, it 
is a gas with a sweet, pleasant odor, and It has a boiling point of -13.9 C 
and a solubility in water of 0.11 g/100 ml at 24 C (Table XV1I-1). It is 
easily liquified and is stored and used industrially in the liquid form [7,8]. 
Vinyl chloride was first prepared by Regnault in 1835 by reacting 
dlchloroethane with alcoholic potash [7]. An effective industrial method for 
preparing vinyl chloride was established in 1913 by Griesheim-Elektron, using 
hydrochlorination of acetylene, with mercuric chloride as a catalyst, as
described by Klatte and Rollett in 1911. It was not until World War II, 
however, that production of vinyl chloride for use in synthetic rubber was 
established on a large scale in the United States. Vinyl chloride is 
currently produced commercially by the oxychloriration of ethylene, by the 
liquid or gaseous reaction of acetylene with hydrochloric acid, and by the 
pyrolysis of ethylene dichloride [8].
Production of vinyl chloride in 1975 in the United States amounted to 
about 4,063 million pounds [9], and the annual growth rate In the vinyl 
chloride Industry is expected to be about 6Z up to 1980 [10]. Vinyl chloride 
is used principally to produce polyvinyl chloride and other resins, which are 
used in a vide variety of end products. It has also been used as a chemical 
intermediate, solvent, aerosol propellant, and refrigerant [7]. In 1974 NIOSH 
estimated that 2.2 million workers in the United States were potentially 
exposed to vinyl chloride.
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(b) Vinylidene Chloride
Vinylidene chloride has the chemical formula CH2**CC12. At room 
tenperature, it Is a clear, colorless liquid vlch a pleasant, sweet odor; its 
boiling point is 31.56 C and its solubility in water is 0.25 g/100 ml at 25 C 
(Table XVII-1). It was first prepared and described by Regnault, who obtained 
it by reacting 1,1,2-trichloroethane with alcoholic potash [11]. It is still 
prepared commercially by reacting 1,1,2-trichloroethane with lime or caustic, 
most often aqueous calcium hydroxide, 3t 90 C [12]. Other syntheses involve 
bromochloroethane, trichloroethyl acetate, tetrichloroethane, or catalytic 
cracking of trichioroethane [12].
The CS production of vinylidene chloride in 1974 was about 170 million 
pounds [13]. It is primarily used in the production of plastics, including 
copolymerization with vinyl chloride or acrylonitrile to form various 
thermoplastic resins [8]. In 1974 NIOSH estimated that 57,000 workers in the 
United States were potentially exposed to vinylidene chloride.
(c) Vinyl Bromide
Vinyl bromide, CH2*CHBr, is a colorless gas at room temperature and has a 
boiling point of 15.85 C ai.d a solubility in water of 0.565 g/100 ml at 25 C 
(Table XVII-1). It was first prepared and described by Regnault, who obtained 
it by reacting dibromoethaae with alcoholic potash [11]. In 1872, Reboul 
reported the preparation if vinyl bromide after reacting acetylene with 
hydrogen bromide. The major commercial method for producing vinyl bromide is 
the reaction of ethylene dlbromlde with sodium hydroxide [14].
Production of vinyl bromide in the United States amounted to over 5
million pounds in 1976 [14]. Currently, vinyl bromide is used primarily as a 
flame-retarding agent for acrylic fibers [8]. In 1974 NIOSH estimated that
26,000 workers in the United States were potentially exposed to vinyl bromide.
(d) Vinyl Fluoride
Vinyl fluoride, CH2-CHF, is a colorless gas at room temperature; It has a 
boiling point of -72.0 C and is essentially insoluble in water (Table XVII I). 
It was first prepared and described In 1901 by Swarts, who obtained it by 
reacting 1-fluoro-1,2-dibromoethane with zinc dust in the presence of alcohol 
[1J]. It is currently made by reacting acetylene with hydrogen fluoride [15].
Although Che amount of vinyl fluoride used each year has not been 
reported, an average of 0.6 pound of acetylene is required to produce 1 pound 
of vinyl fluoride by the current method. F.ach year about 2 million pounds of
acetylene are used in the United States for producing vinyl fluoride, which is
used for making various copolymers that are used In end products such as 
insulation for electrical wires and in protective paints and coatings [13], 
indicating that some 3.3 million pounds of vinyl fluoride are produced
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annually. The number of workers potentially exposed to vinyl fluoride has not
been estimated by NIOSH.
(e) Vlnylidene Fluoride
Vlnylidene fluoride, CH2-CF2, is a colorless gas at room temperature with
a faint, ethereal odor; it has a boiling point of -85.7 C and its solubility
in water is 0.018 g/100 ml at 25 C (Table XVII-1). It was first prepared by 
Swarts by reacting 2,2-difluoro-l-bromoethane with sodium amylate [11].
Vlnylidene fluoride is used in making polymers and copolymers t;hat are found
in such end products as insulation for high-temperature wire, protective
paints and coatings, and chemical tanks and tubing [8]. In 1974 NIOSH 
estimated that 32,000 workers in the United States were potentially exposed to 
vinylidene fluoride.
Historical Reports
The vinyl compounds assumed economic importance with the increased demand 
for synthetic rubber and the advent of the plastics industry. The first study 
[16] of the toxicity of vinyl chloride was conducted after its potential 
industrial Importance became apparent.
Patty et al [16], in 1930, exposed guinea pigs to vinyl chloride at
concentrations of 0.5-40Z (5,000-400,000 ppm; 12.8-1,024 g/cu m) in air.
Unsteadiness, staggering, and ataxia appeared within 2-5 minutes and lasted 
50-90 minutes at concentrations of 2.5 and 5Z. After 90 minutes of exposure
at these concentrations, the animals fell on their sides and remained in a
state of narcosis until death or termination of exposure. Within 1-2 minutes 
of exposure at 10-25Z, respiration became jerky and rapid, and the animals 
lapsed into a state of deep narcosis accompanied by convulsions and 
involuntary movements that terminated in death. At 40Z, the same signs
occurred within 15 seconds. Examination of the animals that died during
exposure showed,congestion ayd edema of the lungs and hyperemia of the kidneys 
and liver. On the basis of these findings and comparisons with other
experiments, the authors concluded that vinyl chloride was less harmful than 
benzene, gasoline, carbon tetrachloride, or chloroform. They further 
suggested that the comparatively low toxicity and the narcotic action of vinyl 
chloride might make it useful as a surgical anesthestlc.
The first two vinyl chlor^e-reJ.ated occupational deaths were reported in 
1960 by Danziger [17]. The first case involved a 21-year-old worker who
cleaned polymerization tanks. The man had entered a tank wearing an air- 
supplied mask after exploslometer tests had shown that the concentration or 
vinyl chloride in the tank was below the explosive limit (30,000 ppm; 76.8 
g/cu m). Ten minutes after he had last spoken to the worker, the foreman saw 
the man lying on the bottom of the tank. After an unspecified delay to get 
rescue equipment, the man was removed from the tank. He was not breathing, 
and he did not respond to artificial respiration. The rescue workers stated
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and he did not respond to artificial respiration. The rescue workers stated 
that they did not detect any odor of vinyl chloride in the tank or on the 
worker. At the post-mortem examination, no "remarkable" changes in the 
internal organs were observed that could have caused the sudden death. The 
heart was enlarged, the .blood failed to clot, and the spleen, kidneys, and 
liver were congested. Cyanosis of the fingernails and toenails was also 
observed. At the inquest, the presiding physician stated that the man died of 
asphyxia from an undetermined cause. The information suggests, however, that 
the death may have been due to respiratory depression caused by vinyl 
chloride.
The 3econd c a se  involved a 39—^ear-o?d worker who was bleeding condensed 
water out of a vinyl chloride s to r a g e  tank [17] . The worker had to turn a 
valve that was located In a 7-foot-deep p i t  Immediately adjacent to Che tank. 
Another vorker found the man lying unconscious in the pit about 20 minutes 
after he had entered it, and the second woncer climbed in to get him out. 
This worker reported that he shut '¿he open valve but then began to feel 
"giddy" and saw "circles" in front of his eyes. He went for assistance. 
After help was obtained, the first worker was removed from the pit, whereupon 
artlflcal respiration was attempted unsuccessfully. Autopsy revealed cyanotic 
fingernails, brown discolorations of the conjunctivas, acute hyperemia of the 
lungs, trachea, and bronchi, and failure of the blood to clot. Other findings 
were not remarkable, even though congestion oi: the kidneys waa again observed. 
Asphyxiation was again indicated as cause of death; however, in this case, it 
seems to have been more clearly attributable to exposure to vinyl chloride.
Information on the biologic effects of the other vinyl halides has begun 
to be published only recently. This information is discussed In the relevant 
sections in this chapter.
Effects on Humans
Prior to 1970, few industrial exposure studies had been conducted on vinyl 
compounds other than vinyl chloride. Two factors worked In conjunction to 
delay recognition of the potential health hazards from exposure to vinyl 
:ompounds. First, early acute exposure studies on volunteers [18] had 
indicated that the symptoms of exposure were relatively mild and that they 
were observed only at concentrations well above the odor thresholds, so that 
adequate warning of potential danger was assumed to be present. Second, these 
compounds had been of economic Importance for a relatively short time, and the 
correlation between adverse systemic effects and occupational exposure was not 
readily apparent. There are still comparatively f«*.* reports of effects on 
humans or epidemiologic studies of populations of workers handling vinyl 
compounds, and only those persons working with vinyl chloride and vioylldene 
chloride have been examined for chronic effects from exposure to these 
compounds. No reports of effects on workers from exposure to vinyl bromide, 
vinyl fluoride, or vinylidene fluoride have been located in the literature.
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(a) Vinyl Chlorid«
Lester et al [18], during 1961 and 1962, exposed six volunteers, three men 
(26, 35, 50 years of age; 86, 78, 73 kg, respectively) and three women (25, 
60, 55 years ot  age; 64, 52, 61 kg, respectively), to vinyl chloride gas at
concentrations of 0.3, 0.4, 0.8, 1.2, 1.6, or 2.0Z (0, 4,000, 8,000, 12,000,
16,000, or 20,000 ppm; 0-51.2 g/cu m). Exposures vere for 5 minutes twice 
each day, separated by a 6-hour Interval, on 3 successive days. Each subject 
was exposed at these six concentrations In a different order over the 3 days. 
Either the gas mixture or plain air was administered through a mask, at a
flovrate of 50 licers/mlnute, v i ch the subject seated in a chair. When the 
maak was removed, che subject was asked uo report his or her feelings in
comparison with chose just before putting on Che mask. .
When only air was presented, no differences were reported, except by 
subject 3, who felt "slightly dizzy" [18]. At a concentration of 0.42 vinyl 
chloride, no differences were reported by any subject. Similar results were 
obtained at 0.8Z, except that subject 3 felt "slightly heady." At 1.2Z, 
subjects 2 and 6 became dizzy, while the others reported no difference. At
1.6Z, subject 5 reported no effect, but the others reported various degrees of
dizziness, itausea, lightheadedness, and dulling of vision and hearing. These 
symptoms disappeared rapidly when the exposure ended. At 2.0Z vinyl chloride, 
all subjects reported symptoms more Intense than those at 1.6Z, and subject 1 
reported a headache chat persisted for 30 minutes.
The authors concluded that the maximum concentration of vinyl chloride 
causing no acute effects on humans after exposure for 5 minutes was between 
0.8 and 1.2Z [18]. The authors also stated that "vinyl chloride causes clear- 
cut intoxicating symptoms which can serve as adequate warning signs of its 
presence." While these conclusions were valid for the acute irritant and 
psychomotor effects caused by the 5-minute exposures to vinyl chloride, the 
possibility of adverse effects of vinyl chloride at concentrations lower than 
those necessary to produce these symptoms was not discussed.
Suclu ec al [19] described clinical manifestations of vinyl chloride 
poisoning in 168 workers at two vinyl chloride manufacturing plants in 
Rumania. Although workplace concentrations of vinyl chloride were given for 
each year from 1962 to 1972 (Table IIX-1), methods for these determinations 
were not reported.
The authors compared the workers' reports of symptoms indicative of 
effects on the nervous system in 1962 with those reported in 1966 [19]. For
these 2 years, the percentages of workers (n-168) reporting dizziness were 47 
and 10.2, drowsiness, 45 and 16.6, headache, 36.6 and 6.9, loss of memory, 13 
and 8, euphoria, 11 and 1.2, and nervousness, 9 and 0.6. These data indicate 
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Other sign." and symptoms of exposure to toxic materials were also reported 
Including Increased blood pressure, loss of appetite, hepatomegaly, Raynaud's 
syndrome, coughing and sneezing, bronchial rales, emphysema, pulmonary 
fibrosis, decreased respiratory function, abnormal liver function, abnormal 
serum enzyue activities. and anemias [19]. The frequency of these 
manifestations generally decreased with decreasing workplace concentration of 
vinyl chlorldc. The exception to this was the incidence of contact dermatitis 
which increased from 4.4Z in 1962 to 7.4Z in 1966, Indicating that contact 
dermatitis was not primarily dependent on the concentration of airborne vinyl 
chloride.
1 1
Th« authors stated that the frequency of adverse effects had diminished 
between 1962 and 1972 because of the institution of exposure-control and 
therapeutic measures [19]. Tbese measures included reduction of workplace 
concentrations of vinyl chloride, flushing vinyl chloride from the reactors 
before cleaning, wearing gloves (unspecified type) during manual cleaning 
operations, reduction of the workshlft to 6 hours, semiannual medical 
examinations coupled with transfer to another workplace If poisoning was
suspected, interdiction of smoking (presumably only at the workplace),
administration of vitamin C, vitamin B complex, and iron for 10 days a month,
and supplying ointments wiuj cortisone to prevent skin lesions. The authors
stated that these measures "reduced all symptoms by tv -thirds."
The importance of this paper [19] lies in its characterization of the wide 
range of adverse effects observed in a worker population exposed to vinyl 
chloride; however, which exposures n d  which workers were associated with 
particular effects is often unclear. The authors did not state in all cases 
whether or not the workers exmined in 1965 and In subsequent years were the 
same ones that were examined in 1962. The changes induced by the vitamin 
therapy and the changes caused by different engineering and administrative
controls and work practices are &lso impossible to evaluate independently.
Veltman et al [20] studied the effects of exposure to vinyl chloride in 70 
polyvinyl chloride workers who had been employed for from 6 months to 21.8 
years (average 7.7 years) in cleaning autoclaves and centrifuges, in drying 
and sifting processes, and in wrapping polyvinyl chloride as a dry end 
product. Exposure concentrations were not reported.
The workers complained of headache (12.9Z), pain in the calves (12.9Z) and 
joints (24.3^), potency problems (18.62), increased perspiration (27.1Z), 
sensation of cold in fingers or hands (25.7Z), numbness or tingling in fingers 
or toes (31.4Z), frequent dizziness (37.1Z) , fatigue (38.6Z), and upper
abdominal distress (60.0Z) [20]. On physical examination, 6 ot the 70 (8.6Z) 
had acroosteolysis, a softening or destruction of the distal phalanges of the 
hands or feet. Other abnormalities in th* workers included Raynaud's syndrome 
(8.6Z), scleroderma-like skin changes on the hands and forearms (11.4Z), 
varices In the esophagus or stomach (11.4Z), increased serum enzyme activities 
(14.3Z), reticulocytosis (41.0Z), increased sulfobromophthalein (BSP)
retention (67.2Z), leukopenia (7.1Z), slight to severe thrombocytopenia 
(81.0Z), and splenomegaly (57.4Z).
Arteries in the fingers were narrowed, and microscopic changes, notably 
fragmentation of elastic fibers, were found in the fingers of all workers with 
skin abnormalities and in 6 of 28 workers with apparently unchanged skin [20]. 
Thrombocytopenia was associated with enlargement of the spleen, but it was 
also found in patients whose spleens were not enlarged. Only 6 of 29 patients 
with thrombocytopenia showed Improvement in their platelet cotints 1-1.5 ’ years 
after having left their jobs; 20 had even lower platelet counts than those 
seen initially, and 3 showed no change. None of the most seriously affected
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workers showed improveaent in their platelet counts. All of the phalangeal 
lesions healed within 2 years after the workers left polyvinyl chloride 
production work, however.
The authors [20] stated that this study was significant because it showed 
that acroosteolysls was associated with employment in polyvinyl chloride 
production, it demonstrated that % vinyl chloride disease existed, and it 
Indicated that vinyl chloride disease might be detected by external signs 
(changes In fingers or skin) or blood tests (thrombocytopenia). The authors
also stated that thrombocytopenia was the earliest manifestation of vinyl 
chloride toxicity and chat placelet counts should be required of vinyl 
chloride workers. However, only 8.62 had club-like changes of the fingertips 
and only 11.42 had skin changes. Although 812 of the workers had 
thrombocytopenia, which in some cases persisted or worsened after exposure tj 
vinyl chloride ended, the nonspecific nature of thrombocytopenia and the 
possibility that It might signal damage that Is already irreversible casts 
doubt on the usefulness of this clinical sign for the early detection and 
diagnosis of vinyl chloride disease. It is apparent that the vinyl chloride 
syndrome is complex, Involving change* in Che skin, bones, blood and blood
vessels, liver, spleen, and possibly the nervous system. Until the disease 
process is better understood, a decision on which changes are true 
constituents of a syndrome and which are Independent events, coincidentally 
discovered by the same examination, is impractical. Frequent dizziness in 26 
of the 70 patients (37.12) In this study [20] supports the findings of Suciu
et al [19] and suggests that the CNS may be affected by exposure to vinyl
chloride, possibly indirectly by a vascular mechanism. Interference with CNS 
function might increase the risk of accidental injury to vinyl chloride 
workers.
Moulin and covorkers [21] observed four cases of scleroderma accompanying 
vinyl chloride-induced acroosteolysls in workers. Three of the four workers 
had scleroderma o.: the face, and each had shortening of the fingars,
thickening of the skin of the fingers with adhesion to the deep layers, palmar 
erythema and hyperhydrosis, difficulty In extending eh* fingers completely, 
and thickened skin on the palmar surface of the wrist and forearm with hard 
projecting nodules that were most prominent over the flexor tendons. 
Raynaud's syndrore had been experienced by two workers, one of whoa whose 
feet, face, and hands had slightly edematous, scleroderma-llke lesions.
One Individual’s condition was studied in detail and followed for 4 years 
[21]. The worker, aged 33 years, had for 4 years cleaned autoclaves used In 
vinyl chloride polymerization. There wafi no suggestion of a predisposition 
toward the development of acroosteolysls in the medical history of either the 
Individual or his family. The worker had a history of consuming 2 liters of
vine a day. Ha was hospitalized for malaise and was found to have slurred
speech, paralysis of the right arm and right side of the face, and loss of
skin sensations on the same side of the abdomen. Results of neurologic,
roentgenographlc, and electroencephalographic examinations showed mild 
deviations from normal. While the worker was hospitalized, marked
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abnormalities of his fingers were noted. The last phalanx of each finger 
itaud shortened enlarged, with the nail clubbed and wider than It was 
long. The patient had all the skin changes described previously as 
accompanying scleroderma. Microscopic examination of tvo nodules from his 
forearm showed a normal epidermis and a thickened, fibrous dermis vlth edema 
separating fragmented collagen fibers, but no signs of Inflammation. Elastic 
fibers vera few and segmented. No significant abnormalities of the blood 
vessels were reported. Roentgenograms of both hands shoved osteolysis of the 
last phalanx of each finger of both hands, Che distal three-fourths of each 
phalanx having disappeared. A complete roentgenographic examination of Che 
skeleton shoved beginning sacroiliac arthritis, but nortial phalanges in the 
tees. Arteriography showed normal circulation chrough the arm, but decreased 
circulation in che wrist and hand caused by extreme hypertonia of Che blood 
vessels of the fingers.
Three years after assignment to other work, the individual shoved 
regression of .he scleroderma, the fibrous nodules, and the circulatory 
disturbances [21]. The fingers remained hypothermic compared vlth the thumb, 
and painful paresthesia still affected the fingertips. Bone repair was seen 
in most of the phalanges.
Moulin and coworkers [21] concluded that Che incidence of acroosteolysls 
in vinyl chloridc polymerization workers could be considerably reduced by 
introduction of control measures to reduce exposure to vinyl chloride. They 
believed that the distal vasoconstriction they observed in these workers was 
not a true arteritis, although it was severe, and Chat the acroosteolysls and 
sclerodermatous changes in the skin were secondary complications of the 
peripheral vascular hypertonia. Because of the similarity of this disease to 
acrosclerotlc scleroderma, the authors suggested that dermatologists obtain an 
occupational nlstory from any patient: presenting the signs and symptoms
described in their paper.
Several other authors have reported CNS effects [ 2 2 ], acroosteolysls [2 3 -  
25J, and Raynaud's syndrome or scleroderma accompanying acroosteolysls [26-29]  
in workers exposed to vinyl chloride during its manufacture or polymerization. 
The information concerning signs and symptoms of vinyl chloride exposure in 
these reports is substantially the same as that in the reports previously 
discussed [1 9 - 2 1 ] .
Other studies have identified adverse liver effects on workers exposed to 
vinyl chloride. Marsteller et al [30] reported on 50 workers in a vinyl 
chloride polymerization plant, 45 cf whom underwent peritoneoscopy and 48 of 
whom had samples of liver taken for biopsy. All 50 underwent intravenous (lv) 
cholecystography and radiography of the upper gastrointestinal tract. 
Sclntography of the liver and spleen was oerformed for 48, using 197Hg. The 
llv*r was found by palpation to be enlarged in 31 cases and the spleen in 37 
by sclntography. The hepatic surface shoved conspicuously augmented 
vascularization and stellate, reticular, or nodular fibrosis and scarring of 
the capsule. The spleen was not well visualized ay peritoneoscopy except when
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lc was narlc«dly enlarged; then the crenaca margin waa sharply indented and 
shoved capsular flbroala and subcapsular hemorrhage*. Early signs of portal 
hypertension were noted, including ascites and dilatation and tortuosity of 
gastric and peritoneal veins.
Muller et al [31] deacribed microscopic changes ibserved in liver 
speciaens taken for biopsy from 50 polyvinyl chloride production workers. 
Liver cells shoved focal hydropic svelling, single-cell necrosis, fjcal 
granular disintegration of the cytoplasm, hyperplasia with enlargement and 
polymorphism of cell nuclei, and often the presence of several nucleoli. 
Periportal and centrilobular fibroses were described, without accompanying 
cellular activity or involvement of the portal vessels, and about one-half of 
the specimens of liver contained fatty degeneration. Changes in the cells 
lining the liver sinusoids were described as "most impressive,' and had begun 
to develop In the first few years of exposure. Proliferation of sinusal cells 
was the first change observed, and, after 6-10 years of exposure, sinusal cell 
nuclei had become markedly atypical. Three cases of hemangioendothellal 
sarcoma of the liver vere discovered. The authors reported that the regions 
around the sarcomas gave the impression that there was a transformation of 
atypical sinusal cells to tumor cells and that the cytologic atyplas of 
sinusal cells might be of prospective importance.
Thiess and Frentzel-Beyme [32] made a retrospective survey of diseases 
reported to be associated with industrial exposure to vinyl chloride in the 
Federal Republic of Germany. Insurance records listed ISO cases of "vinyl 
chloride disease," among then current employees of which 57 were recognized by 
the Occupational Medical Officer as being cases of true occupational Illness. 
Signs associated with vinyl chloride disease in the original 180 cases, in 
order of decreasing occurrence, were: thrombocytopenia (78), liver damage
(67), splenic abnormalities (47), Raynaud's syndrome (27), circulatory
disturbances (22), lung function disturbances (21), scleroderma (18),
acroosteolysis (16), and esophageal varices (13).
There vere five cases of "haemangioendothellosarcooa" in vorkers vho had 
been employed in vinyl chloride or polyvinyl chloride production areas for 11- 
17 years; four of the vorkers, aged 38-44 years, had died. Only 46Z of the 
vorkers exposed to vinyl chloride at one particular plant vere still vorklng 
in a polyvinyl chloride plant or were otherwise traceable; the rest vere lost 
to the statistical survey. The authors noted that there vere many
difficulties in retrospective surveys for occupational health hazards. They 
stated that: although mortality data vere accessary in identifying a new
disease, morbidity data vere even more important, because death certificates 
vere not alvays accurate. They also stated that prospective investigations 
vere preferable to retrospective ones, although the latter approach had 
received priority due to considerations of the time required in relations to 
the yield of information. Physicians representing the government, 
universities, and the vinyl chloride and polyvinyl chloride industries in the 
Federal Republic of Germany vere said to be cooperating in further 
epidemiologic studies. The authors pointed out that more data on vinyl
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chloride concentrations in Che workplace, periods of worker exposure, and 
control measures were needed before an association between exposure Co vinyl 
chloride and Che development of angiosarcoma and ocher disorders could be 
proven.
The authors stated that, with regard to the cause of death among employees 
at this plant, "a relatively large proportion of deaths occurring at ac early 
age, are due to unnatural causes of death I.e. accident at the work place or 
road accidents" [32]. This may suggest that the worker exposed to vinyl 
chloride could himself become an occupational and social health hazard because 
of behavior-modifying effects of the material, and may therefore support the 
inferences drawn from the work of Veltman et al [20] and Suciu et al [19] 
discussed previously.
Lange et al [33], in 1975, analyzed the medical ana work histories of 15 
workers employed In the polyvinyl chloride processing industry In the Federal 
Republic of Germany for an average of 5 years (range 1.5-13 years). Seven of 
the workers (472) complained of sensations of pressure or pain in the upp^r 
abdomen, three (201) of frequent dizziness, tvo (132) of cold hands and feet, 
and one (72) of increasing weakness in his legs. Medical investigations 
conducted on the workers consisted of a dermatologic examination and several 
laboratory t*sts. A BSP retention test was performed on 9 of the workers, a 
reticulocyte count on 10, roentgenograms of the chest, hands, and feet on 12, 
and a ilver-spleen scintigram, using 99 mTc-sulfur colloid on 11. Four of the 
workers also underwent laparoscopy and liver biopsy.
Dermatologic examination revealed no clinical signs of scleroderma or 
Raynaud's syndrome [33]. The results of the laboratory tests, however, showed 
slight to moderate thrombocytopenia (63,000-13S,000 cells/id.) in seven workers 
(472); increased BSP retention (5.2-15.12 at 45 minutes) in seven workers 
(472); reticulocytosls of 1.7-4.42 In six workers (402); and leukopenia (3,250 
cells/Ml) In one worker (72); more than one abnormality was found in some of 
the workers. One of the workers examined by llver-spleen scintigram had 
slight splenomegaly and one of the workers who underwent laparoscopy and liver 
biopsy showed changes, although less distinct, "of the kind observed in PVC- 
productlon workers." The authors concluded that, despite the small sample 
size, thrombocytopenia, Increased BSP retention, reticulocytosls, 
splenomegaly, and leukopenia were characteristic of vinyl chloride disease.
Lange et al [33] also presented case studies of tvo workers from the same 
polyvinyl chloride, plant who had died of malignant tumors. The fire:-;: case was 
that of a 38-year-old autoclave cleaner who was employed for 12 years in the 
plant. Physical examination in 1968 showed a large tumor in the upper abdomen 
la the area of the liver and spleen. Chest roentgenograms shoved destruction 
of the fourth rib, on the left side of the back. Laboratory findings included 
Increased erythrocyte sedimentation rate (22-67 mm/hour), considerable anemia, 
reticulocytosls of 62, a reduction of serum iron (25j*g/100 ml), an increased 
serum gamma-globulln (25 relative percent), an "Increased" alkaline 
phosphatase level (65 units/ml), and an Increased SGOT level (24 units/ml),
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all indicative of livar damage. Th« liver-spleen scintigram showed 
splenomegaly, hepatomegaly, and reduced storage in the liver
reticuloendothelial system. The patient then underwent a laparotomy, which 
revealed a generally enlarged liver with many palpable nodes on the surface. 
Microscopic examination of two of the liver biopsy specimens shoved 
hemangioendothelial sarcomas. After the laparotomy, the patienc was given 
cytostatic treatment, but his condition continued to deteriorat* and he died 
within a year after the initial diagnosis of the tumor.
The second case was that of a 39-year-old man who had worked for some 
portion of 11 years as an autoclave clearer in the plant and for 2 years in a 
machine-producing factory [33]. He had felt pain in the lowtr right quadrant 
of his thorax for some months and had experienced a painful hardening in the 
upper right portion of his abdomen several weeks before his medical
examination. Physical examination disclosed a tumor the size of an apple on 
the epigastric angle. Laboratory tests sh.^ed these values, which the authors 
considered abnormal: erythrocyte sedimentation rate (44-73 mm/hour), and the
"lactic" dehydrogenase (296 units/ml), aud alkaline phosphatr.se (80 units/ml) 
activities in the scrum. Normal differentiated blood counts and platelet 
counts were found. Laparotomy, performed rwice on this worker, showed a fist­
sized whitish-yellow tumor on the lower part of the left Lobe of tne liver
tnat extended to the posterior portion of the right lobe. Numerous other
nodules were palpable in the liver. A small degree of congestive spleen 
enlargement (not further defined) was also found. Microscopic examination of 
several biopsy specimens led to the diagnosis o f hemangioendothelial sarcoma 
of the liver. Although postoperative radiotherapy was given, the patient died 
about a year after the initial diagnosis.
Makk ct al [34], in 1974, reported that one of the authors, having noticed 
a diagnosis of angiosarcoma of the liver on a death certificate, recalled 
having performed a liver' biopsy 3 years earlier that led to the same 
diagnosis. An investigation shoved that both of these patients had worked in 
a. polyvinyl chloride plane la Kentucky,, and a search of plant and area 
hospital records showed autopsy reports of three other cases over a 10-year 
period; two additional cases were diagnosed by biopsy. A systematic program 
was therefore undertaken for detection of liver abnormalities in workers in a 
chemical plant producing polyvinyl chloride and synthetic rubber, using 
automated 12- or 18-factor blood analyses.
Screening profiles from the 12- or 18-factor analyses were obtained for
1,183 employees, of whom 75 (6.3Z) had either 2 liver-related abnormalities on
the Initial screening or 1 such abnormality that persisted [34]. Aa a result 
of further testing including exploratory laparotomy of these 75 workers, 2 
unsuspected cases of angiosarcoma and 3 cases of portal fibrosis were 
discovered. A biopsy of the liver was performed on two other workers who
requested it, but both samples proved to be normal. Abnormal test results
were reported for serum alkaline phosphatase.in 35/72 (48.6%), SGPT in 13/73 
(17.8Z), SGOT in 19/68 (27.9Z), sanjm lactic dehydrogenase (LDH) In 8/72
(11.1Z), serum bilirubin in 19/72 (26.4Z), serum isocitrate dehydrogenase in
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9/59 (15.32), and serum gamma-glutamyl transpeptidase in 31/70 (44.32). The
authors stated that, of the liver function tests, gamma-glutamyl 
transpeptidase seemed to have been the most useful for detecting abnormalities 
and reflecting the extent of liver damage. Fetoglobulln and carclnoembryonlc 
antigen tests gave results In the normal range.
The results of this study [34] have helped to provide a basis for 
Identifying clinical manifestations of vinyl chloride-induced liver damage. 
No single test was found to be pathognomonic ¿or this disease, and both false 
positives and false negatives were common. Sometimes the clue to Che presence 
o t  a n g i i3arcona of che liver was not the magnitude of elevation of an enzyme 
activity, eg, LDH, but the persistence a t chac elevation. Curiously, Che 
p'.-centage of workers with abnormal 12-factor test results was lower in 
polyvinyl chloride production workers (21.52) than in either synthetic-rubber 
production workers (28.62) or all other workers (26.72). However, abnormal 
results serious enough to warrant comprehensive examinations were present in 
9.82 of the polyvinyl chloride production workers, while only 6.92 of the 
synthetic-rubber workers and 4.92 of all other workers had such seriously 
abnormal results.
In a 1975 report, Creech and Makk [35] amplified C h i 5  early report of 
screening test results [34]. Specimens of the liver for biopsy were obtained 
from 16 employees of that same plant, 3 of whom had normal results on clinical 
screening tests [35]. The results of these three biopsies were normal, as 
were the results - from two other biopsies taken from employees with tainor 
abnormalities on the screening examinations. Two cases of angiosarcoma were 
detected, both with accompanying fibrosis. Periportal fibrosis was the most 
common biopsy diagnosis occurring in polyvinyl chloride workers and in two 
workers from other production areas. Two polyvinyl chloride production 
workers also had enlarged spleens, splenic vein thrombosis, and esophageal 
varices. Only one of seven workers with acroosteolysis had an abnormal 
battery of screening tests, and the test results returned to normal within 3 
veeics after the employee stopped drinking alcoholic beverages. Results of tlie 
clinical tests were essentially the same as had been previously reported [34]. 
The percentages of abnormal test results among 274 polyvinyl chloride 
production workers, compared with those of 411 other production workers, were: 
total bilirubin, 35.6 vs 29.6; alkaline phosphatase; 47.5 vs 50.9; LDH, 3.4 vs 
8.3; and SCOT, 33.9 vs 28.8. A further battery of liver function tests on 59 
polyvinyl chloride production workers and 132 other production workers who had 
exhibited serious abnormalities in the first screening tests showed the 
following percentages of abnormalities: SGOT, 46.9 vs 46.2; gamma-glutamyl
transpeptidase, 50.0 vs 33.3; SGPT, 34.4 vs 20.5; alkaline phosphatase, 59.4 
vs 61.5; LOB, 9.4 vs 28.2; and total bilirubin, 43.8 vs 41.0. As a result of 
the screening program, 59 employees were transferred to areas of minimal 
exposure to hepatic toxins.
Creech and Makk [35] concluded that no individual test was adequate to 
detect angiosarcoma or fibrosis, although the persistent 20-second "tumor 
blush" on angiography was useful for diagnosing angiosarcoma and venous
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pressure studies were useful for diagnosing fibrosis. Blood tests did not 
predict the results on liver scans, and scans did not always detect fibrosis. 
The authors stated that a combination of blood tests, liver scans, venous 
pressure studies, angiography, and biopsies would be necessary for the 
diagnosis of fibrosis and angiosarcoma. This study, like the earlier one 
[34], concentrated on attempting to assemble a diagnostic test profile and did 
not report workplace vinyl chloride concentrations or attempt to correlate 
examination results with extent or duration of exposure.
In 1974, Creech et al [36] reported oa fcur cases of angiosarcoma of the 
liver diagnosed in employees in one chemical plant between 1967 and 1973, that 
have been previously discussed [34]. The four workers, with a mean age of 
44.5 years (36, 41, 43, and 58), had each worked at least 4 continuous years 
in the vinyl chloride polymerization section of the plant prior to the onset 
of the disease and had been exposed to vinyl chloride for an average of 18 
years (14, 14, 17, and 27) [36]. Extensive, nonalcoholic-type cirrhosis, in
addition to the angiosarcoma, was found in all four workers. Gastrointestinal 
bleeding was found in two of the four; other effects observed in one or more 
wurkers Included portal hypertension, enlarged livers and spleens, weight 
loss, jaundice, an epigastric mass, and thrombocytopenia. Nons of the workers 
had a history of prolonged use of alcohol or exposure to hepatotoxins known to 
produce angiosarcoma, eg, uhorium dioxide or arsenic, either at work or 
elsewhere.
Falk et al [37], in conjunction with NIOSH, conducted an investigation at 
a vinyl chloride polymerization plant in Kentucky where seven cases of 
angiosarcoma of the liver had been discovered, including the four which had 
previously been reported by Makk et al [341 and Creech et al [36]. These 
seven cases were compared with four cases of portal fibrosis found in the same 
worker population. Factors in Che comparison were: age at diagnosis, initial
symptoms, physical examination findings, liver function studies, biopsy or 
autopsy findings, and work performed and overall duration of employment. The 
II • patient» were whit® males and were between the ages of 28 and 58. at the 
time of diagnosis.
The seven men with tumors had been employed at the plant for an average of
18.0 years; one had no complaints, but the authors reported fatigue, abdominal 
pain, chest pain, weight loss, black stools, bloody vomit, and weakness [37]. 
The four men with nonmallgnant liver disease (portal fibrosis) had been 
employed an average of 20.6 years; one reported chest pain and weight loss, 
one reported having had black stools on two occasions, one had been noted to 
be jaundiced when hospitalized for hernia repair, and one had been 
hospitalized for gallstones.
The physical examinations of these 11 men [37] disclosed enlarged livers 
or spleens in 4 of the 7 with angiosarcoma and in 3 of the 4 wxth portal 
fibrosis. In addition, one of the tumorous-patients had upper-rlght-quadrant 
tenderness. Two patients with angiosarcoma and 1 with portal fibrosis had no 




two groups were similar. In boch groups chere were elevations of the
concentrations of total bilirubin and the activities of alkaline phosphatase, 
SGOT, and LDH in serum, but no consistent pattern matched to the clinical 
B A n i f e s tations emerged. Of the seven workers with angiosarcoma, five had 
elevated SGOT activities, four had elevated activities of alkaline phosphatase 
or Increased concentrations of total bilirubin, three had heightened
activities of LDH, and one had a decreased platelet count. Liver-«spleen scans 
showed defects or other abnormalities in five. In the four workers with 
portal fibrosis, the concentration of total bilirubin and the activity of SGOT 
were each elevated in three, the activity of alkaline phosphatase was elevated 
in two, the activity of LDH was increased in one, and two had abnormal liver- 
spleen scans. Platelet counts were not reported for this group. Twelve
samples of liver for biopsy were obtained by opening the abdomen and only
three by puncturing the abdominal wall and the liver ¿’1th a Manghinl needle. 
In the seven men found to have angiosarcoma, liver biopsy findings included 
angiosarcoma In four, hepatitis in two, fibrosis in two, and cirrhosis in one. 
The biopsy sample from the four men without angiosarcoma revealed fibrosis of 
the liver; two of them had portal and subcapsular fibrosis, one had portal 
fibrosis, and one had chronic hepatitis with focal fibrosis. All five of the 
patlent3 who died of angiosarcoma had had biopsies, but angiosarcoma had been 
diagnosed In only two. Angiosarcoma had been diagnosed previously by biopsy 
in the two surviving patients, and fibrosis had been diagnosed previously by 
biopsy in the four without angiosarcoma.
Falk et al [37] stated that the development of angiosarcoma was related to 
exposure to vinyl chloride and that it was more closely related to the type of 
work performed than to the overall duration of employment. They suggested 
that a higher risk was associated with longer duration of employment as a 
helper (reaction vessel cleaners) than with work in which the monomer was 
handled in a closed system or in which only polymerized material was handled. 
The data presented, however, do not completely support this suggestion since 
several workers without angiosarcoma had actually had longer duration» of 
exposure as chemical helpers than those workers with angiosarcoma. Since 
conditions of exposure undoubtedly do not correlate exactly with job 
classifications, exposure concentrations and durations must be determined to 
permit assigning relative risk factors.
Whelan et al [381 described the angiographic characteristics typical of 
hepatic angiosarcomas found in the vinyl chloride workers previously discussed 
[34-37]. Liver scans were performed on all of the 1,180 workers at the vinyl 
chloride polymerization plant [38], using radioisotopes of gold, iodine, or 
most often technetium. On 50 of the workers, hepatic venograms, hepatic and 
celiac angiograms, and pressures in the right atrium, the inferior vena cava, 
and both free and wedged hepatic vein positions were recorded. Specimens of 
liver for biopsy were obtained also. Vinyl chloride concentrations in the 
workplace were not reported.
Four employees had angiosarcoma of the liver; their average age was 43 
years (range 37-49 years) and they had been employed in polymerization of
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vinyl chloride for 15 years (range 12-20 years) [38]. Although several tuners 
were found In some livers, no tumors of the spleen were found although 
splenomegaly waa present In some cases. No outstanding pathologic condition 
was found In either the venous or the arterial systems of the liver, but the 
centers of the tumors appeared to be less vascular than normal liver tissue.
Because the wedged venous pressure measurements resulted In hepatic 
Infarction in three patients, these tests were discontinued as part of the 
routine screening procedure [38]. The area of Infarction that resulted from 
measurement of wedged venous pressure caused one worker to appear erroneously 
to have angiosarcoma when he was examined angiographically. Spleen 
enlargement: occurred with and without portal hypertension; about 10Z of the 
1,180 employees had enlarged spleens without any evidence of tumor.
Whelan et al [38] concluded that lsotopic liver scans were the most useful 
procedures for detecting angiosarcoma. They also concluded that a peripheral 
tumor stain, puddling of the contrast agent from ths midarterlal phase up to 
34 seconds, and hypovascularlty of the central portions of the tumor were 
characteristic angiographic features of this tumor. Because hepatic Infarcts 
following measurements of wedged venous pressures may give a similar 
angiographic picture, the authors recommended that wedged venous pressure 
studies, when necessary, be done after angiography.
Popper and Thomas [39] studied surgical and autopsy samples from the 
livers of 11 vinyl chloride and polyvinyl chloride workers, in six of whom 
angiosarcoma of the liver had been diagnosed and five of whom had hepatic 
fibrosis. Two cases of primary hepatic carcinoma, one In a worker who had 
laminated polyvinyl chloride sheets for 17 year.« and the other in the 8-year- 
old daughter of a vinyl chloride polymerization worker, were described also, 
but no information on the concentrations and durations of exposure of these 
two persons was supplied.
In addition to angiosarcoma of the liver, typical lesions found in the 
liver» of the 11 patients Included subcapsular, portal, and perislnusoldal, 
fibrosis, Increased numbers of fibroblasts, formation of connective tissue 
¿epta, sinusoidal dilatation (without signs of passive congestion, such as 
compression of hepatocytes), Increased size and number of sinusoidal lining 
cells, and enlarged hepatocytes with hyperchromatic nuclei accompanied by bile 
stasis [39j. These lesions were usually more prominent in the group with 
angiosarcoma than In that with hepatic fibrosis.
Five patients (two with angiosarcoma and three with precursor signs) had 
enlarged spleens with "grossly visible and conspicuously enlarged Malpighian 
follicles separated by a meaty-appearlng homogeneous red pulp" [39]. The 
follicles had large germinal centers with phagocytic cells. The 
perlarterlolar lymphatic sheaths were markedly enlarged. Cells lining splenic 
sinusoids were enlarged but did not show phagocytosis; their elongated 
cuboldal shape made them resemble glandular cells. Perifollicular hemorrhages 
were noted, and in one case the presence of Gasma-Gandy bodies suggested old 
hemorrhages.
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Popper and Thcmaa proposed Chat hepatic fibrosis and hepatic and splenic 
cellular proliferation were precursor stages in the development of 
angiosarcoma [39]. Their evidence was insufficient, however, to prove that 
these changes -ere irreversible or progressive. Portal fibrosis was not found 
to be predictive of the development of angiosarcoma, and the focal 
Intralobular fibrosis in these subjects was similar to that in many elderly 
patients, particularly diabetics. Bepatic focal subcapsular fibrosis was 
characteristic of angiosarcoma, however, and could be seen by peritoneoscopy 
or during surgery. The authors noted that there were similarities between the 
development of portal fibrosis in workers exposed to vinyl chloride and 
diseases in European vineyard workers exposed to arsenical pesticides, 
patients in India with "Idiopathic portal hypertension" (Bantl's syndrome), 
and par.lents with psoriasis who were treated for prolonged periods with 
Fowler's solution (potassium arsenite). This report is valuable for its 
comprehensive description of vinyl chloride-induced visceral lesions and its 
comparison of these with other fibrotic lesions.
Thomas et al [40] extended the previous microscopic studies [39] of the 
livers and spleens of workers engaged In vinyl chloride polymerization. Among 
the 15 cases of angiosarcoma of the liver that the/ studied, the tumor had 
metastasized to the duodenum in one case, to the lung in a second, and to the 
lung, heart, kidney, and lymph nodes in a third. Specimens from 20 patients 
were reviewed microscopically.
These authors [40] again postulated that their observations sight have 
illustrated a developmental continuum in which fibrosis precedes the 
development of angiosarcoma of the liver. They also noted that a specimen of 
liver obtained for biopsy from one patient 2 years after his last exposure to 
vinyl chloride showed that both hepatocytes and sinusoidal lining cells had 
returned to normal, but the fibrous scars persisted.
The case for development of angiosarcoma of the liver from a fibrotic 
precursor stage would be compelling, if Che specimens presented were . obtained 
in a real-time sequence from an individual patient [40]. The authors' 
arrangement of specimens from 20 different patients is plausible, however, 
because fibrotic changes are seen throughout anglosarcomatous livers and the 
same changes in the spleen accompany bcth fibrosis and angiosarcoma of the 
liver. The disappearance of abnormal hepatocytes and sinusoidal lining cells 
from biopsy materials within 2 years after the worker was removed from 
exposure to vinyl chloride is additional evidence that this exposure caused 
the hepatic abnormalities.
Zlmmermann and Eck [41] reported a case of angiosarcoma of the liver In a 
38-year-old chemical laboratory assistant In Germany who was exposed to vinyl 
chloride at an unspecified concentration for 3 years and 5 months (1960-1963). 
Be was axposed for 3-4 hours two or three times a week and wore no protective 
mask. The worker was hospitalized with marked* abdominal distress about a year 
before his death in 1974. Tumors of the liver were suspected after
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l a p a r o s c o p y  but could not b« confirmed by microscopic examination of liver 
speclxnns at that time. An open-abdomen surgical sampling of the liver 6 
months later produced evidence of occlusion of the portal vein, necrosis, and 
interstitial fibrosis. The changes were originally attributed :o tertiary 
syphilis, but serologic examinations were negative, and the patient's work 
history showed exposure to vinyl chloride. The patient lived for another 6 
months and died from massive heniorrhage from esophageal v a r ice s .  Post-mortem 
examination showed a metastasizing m ulti locu la r  angiosarcoma or the l i v e r  with 
liver fibrosis. The tumor had spread to the diaphragm, the p leura , and the 
lymph nodes around the pancreas. Hepatomegaly, with Ic te ru s  and fibrosis, and 
splenomegaly were a lso  confirmed, and Che h ea r t  showed flaccid d i la ta t io n .  
Bronchitis was also ind ica ted .
Microscopic examination showed tumor cells bearing filaments and an 
abundance of connective tissue between atrophic liver-cell plates [41]. Liver 
structure was abnormal; lobular centers were often completely flbrotic, and 
branches of the portal vein were blocked by filamentary connective tissue and 
the diaphragm was bound to the liver by fibrous tissue. There were localized 
areas of recent necrosis. The spleen contained blood-forming centers for both 
red and white cell lines and had localized hemorrhages. The pancreas 
contained areas of fibrosis and of medlum-grade lipomatosis. The testes 
shoved a reduction of spermiogenesls and slight fibrosis. Purulent 
n/ocarditis was found. In the brain, there was localized atrophy of 
cerabellar Purkinje cells and necrosis of the frontoparietal cerebral cortex.
Zlmmermann and Eck [41] attributed the development of angiosarcoma in the 
patient, to his prior exposure to vinyl chloride, noting that primary 
angiosarcoma of the liver is extremely Infrequent. In addition to vinyl 
chloride, the patient had been exposed to methylene chloride, styrene, 
acrylonltrile, and other substances.
This 'paper [4IJJ showed some of the problems encountered In determining 
whether angiosarcoma of the liver was Induced by vinyl chloride. The short 
duration of work involving exposure to vinyl chloride (less than 3.5 years), 
the long Interval (7 0 years) before the onset of symptoms, the mixed 
exposures, and the infrequent occurrence of this tumor made the diagnosis and 
determination of cause difficult.
Christine et al [42], in 1974, noted six microscopically confirmed cases 
of hepatic angiosarcoma of the liver in Connecticut, five of the cases having 
been diagnosed after 1966. Two of the patients had apparently been 
occupationally exposed to polyvinyl chloride. A 47-year-old man had worked 
for the previous 10 years as an accountant in a factory producing vinyl sheet3 
and processing polyvinyl chloride resins and had frequently visited the 
plant's production areas. Another patient, a 61-year-old man, had spent 25 
years in an electrical plant operating a machine that applied polyvinyl 
chloride-containing plastic to wires. Two other patients, a 73-year-old man 
with a history of chvonic intake of alcohol and an 83-year-old woman, had had 
no known occupational exposure to polyvinyl chloride, but both had lived 35
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years or longer within 2 miles of the electric wire plant or within 0.5 mile 
of the vinyl products plant mentioned above. The other two patients, a 
housewife and an alcoholic nan, had neither occupational nor probable 
residential exposure to vinyl chloride. None of the six patients had a 
history of hepatitis or exposure to hepatotoxlc drugs, medications, or agents 
other than alcohol.
Many other reports are available in which cases of angiosarcoma in vinyl 
chloride workers are discussed [43-51]. Several other papers contain reports 
of scintigraphic investigations [52], histopathologic studies [39,53-56], ind 
clinical aspects [57-60] of liver damage in workers exposed Co vinyl chloride. 
The infc-nr^nion contained in chese papers is substantially the same as that 
which has been presented in this section and these reports often discuss the 
same cases.
NIOSH has compiled a listing as of August 1977 of the cases reported of 
angiosarcoma of the liver in vinyl chloride workers throughout the world [61]. 
These data are presented, in Table XVII-4; chey show that 64 cases of 
angiosarcoma of the liver had been reported and chat 50 of these had been 
confirmed microscopically. Two workers were still alive at the time of the 
communication, and no details were available for seven others. Calculations 
from these data indicate that che latent period from first exposure to vinyl
chloride to death averaged 20.5 ±6.0 years with a range of 9-38 years. The
average duration of exposure was 17.3 ±6.3 years with a range of 4-30 years. 
The first death was recorded in 1955. During the period 1955-1968, only 12 of 
che 57 deaths occurred. During the period 1974-1977, 27 (473!) of the deaths 
occurred, the largest number (11) occurring in 1975.
Because of the prolonged latent period calculated from these data and che 
unavailability of complete information on exposure conditions or numbers of 
workers exposed in the worldwide production of vinyl chloride, any estimate of 
expected future cases of angiosarcoma in Che workforce would be unreliable.
An estimation, of risk was performed by Kuzmack. and McGaughy [62] in. 1975.
They projected an incidence rate, using a linear dose-response model, of
angiosarcoma as 0.0052/person/year of exposure in highly exposed workers (350 
ppm or 896 mg/cu m, 7 hours/day, 5 days/week) from incidence rates in rats. 
Using data from epidemiologic studies of vinyl chloride workers and data on 
the exposure durations for the 14 US occupational cases of angiosarcoma that
were known as of 1974, a projected Incidence rate for angiosarcoma of
0.0031/person/year was calculaced. The authors concluded from their 
calculations that 7.5% of all highly exposed vinyl chloride workers would be 
expected to develop angiosarcoma and that 15Z would develop primary cancers at 
some site during their lifetimes. They also estimated that, as of 1974, only 
38Z of the predicted number of angiosarcoma caused by vinyl chloride had been 
diagnosed.
The authors [62] pointed out several possible sources of error in their
estimates. These Involved uncertainties in the numerical estimates of the
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functions «id conceptual inadequacies in the assumptions of the models. For 
example, the accuracy of the assumed exposure concentration of 350 ppm and the 
asauaed duration of 7 hours/day, j day:,/week, was uncertain. Also, biologic 
latency was not directly observable, ind the time of initiation of some 
unknown irreversible damage night not have been accurately represented by the 
duration of total exposure for the known cases. The predictions are based on 
the assumption that the set of stochastic variables, such as genetic 
conposltlors, previous medical histories, diets, etc, that might influence 
tumor formation Is homogeneous. If Is further assumed that the then current 
exposures will be continued with ac major change. These two assumptions 
cannot be supported since homogeneity in worker populations from various 
geographic areas Is highly unlikely and 3ince exposures have been decreasing 
In recent years.
Two maps prepared by Falk [63] describe the geographic distribution of 
deaths f:.*om angiosarcoma of the liver in vinyl chloride polymerization workers 
(Figux. i XVII-1) and in people not engaged in work with vinyl chloride (Figure 
XVII-2). A comparlsou of these figures shows that there Is no reason to 
believe that some unknown geographic or demographic feature would account for 
the clustering of angiosarcomas of the liver in the vinyl chloride worker 
population.
Casterline et al [641, in 1977, reported a unique case of squamous-cell 
carcinoma of the buccal mucosa associated with chronic oral exposure to 
polyvinyl chloride. The patient was a 22-year-old white male who had 
habitually chewed plastic insulation from wires and other plastic materials 
since he was 8 years old. He denied using any form of tobacco, alcoholic 
beverages, or illegal drugs. A pinhead-sized papule was found on the right 
anterior labial buccal sulcus a f t e r  an episode of aphthous stomatitis that 
lasted less than a week. In 3 month», the papule grew to about 1 centimeter 
in size a.id was excised by a dentist. Microscopic examination of the tissue 
resulted Ir. a diagnosis of Invasive squamous cell carcinoma. A wider 
resection shoved that the tissua margins appeared free of tumor. No 
recurrence.was noted in. the next 6 months. The patient's oral hyglen« 
appeared excellent, but his teeth were grooved as a result of his habit of 
stripping wire with them. He reported keeping plastic material in his mouth 
for 6-8 hours at a time. No abnormalities other than the buccal lesion were 
found, although a complete examination was made specifically to search for 
signs of vinyl chloride-induced functional aberrations.
Casterline et al [64] believed that the development jf this cancer In an 
area of the mouth where the Individual frequently stored polyvinyl chloride 
materials was more than coincidental. They cited as further support for their 
belief the high incidence of cancers of the buccal cavity and pharynx found by 
Tabershaw and Gaffey [65] to be associated with exposure to vinyl chloride. 
Casterline and coworkers urged that electronics workers be informed of the 
hazard of repeatedly holding plastic-covered materials in the mouth, ir the 
authors' conclusion Is correct, a little-suspected but significant route of 
exposure to vinyl chloride may exist. The possibility of coincidence, 
however, may be greater than the authors were willing to concede.
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(b) Vlnylldene Chloride
McBirney [66], In 1954, reported on a case of fatal poisoning In a worker 
exposed to the vapor from dlchlorethylene (Identified as vlnylldene chloride 
[67]) stabilized with 12 of a sodium .hydroxide solution. The worker was 35 
years old and had worked 8 hours/day, 5 days/week, for a "short" time 
extracting oil from fish livers using this mixture.
The worker first complained that the odor and vapors from the extraction 
kettles made him nauseous [66]. A day or two before he was suddenly taken 
ill, the worker had acted "strangely" and his covorkers at first had thought 
that he was drunk. He was hospitalized and died within 2 days. At autopsy, 
the brain, heart, lui:gs, spleen, liver, and kidneys were observed to be 
congested. The cause of death wa.s listed as bronchopneumonia.
Lack of exposure information in this report [66], the possibility of a 
preexisting condition, and the possibility that the vapor described as 
dlchloroethylene may have been 1,2-dichloroethylene (a substance known to have 
been used in extracting fish oil [68]) does not allow any conclusions to be 
draws.
Liver function tests and scans were performed on a group of 46 workers at 
a New Jersey plant in which the concentration of vlnylldene chloride in the 
air ranged from below the analytic limit o£ detection (O.QQ mg) to 1.45 ppm 
(about 5.6 mg/cu m) [69]. Previous company experience had established a 
typical range of 0-5 ppm (0-19.85 mg/cu m), with occasional peaks of 300 ppm 
(1,191 mg/cu m) associated with accidental spills or leaks and with removal of 
samples of product from the reactor. This plant used nearly 200 chemicals, 
including several known hepatotoxins, so that exposure to a single agent was 
net claimed. The cests Included measurements of SGGT, SGFT, and serum gamma- 
glutamyl transpeptidase, LDH, and alkaline phosphatase activities, total 
bilirubin, and indocyanine green clearance. None of the 46 employees was
found to have total bilirubin counts outside of normal limits, but 39Z had
abnormal LDH activity, 30Z had abnormal gamma-glutamyl transpeptidase 
activity, 28Z had abnormal SGOT activity, 21Z had abnormal SCPT activity, and 
13Z had abnormal alkaline phosphatase activity. Fourteen men had abnormal 
liver scans, but only five showed what the author defined as "definite
hepatomegaly." Six employees (13Z) had severe impairment of indocyanine green 
excretion (less than 10Z clearance), 25 (56%) had moderate impairment (10-17Z 
clearance), and 14 (30Z) were found to be normal (greater than 17Z clearance). 
Fifteen workers were retested for dye clearance; two had returned to normal, 
four had deteriorated, and the rest remained unchanged. On the basis of these 
tests, biopsy studies of the liver were recommended for 10 workers, but only 5 
agreed to undergo this kind of study.
All five employees on whom biopsy studies of the liver were performed 
exhibited abnormal clearances of indocyanine green [69]. Two had borderline 
or mild portal fibrosis on biopsy, one had mild nonspecific activation of
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hapatocytic nuclei and a borderline increase in fat, one had mild steatosis, 
and on« had moderataly saver« steatosis with stellate fibrosis that suggested 
an alcoholic llvar injury. Two of the five had enlarged livers. None of the
microscopic changes was attributed by the pathologist to the effects of
industrial toxins.
In a follovup study undertaken by NIOSH upon invitation by the company, 
256 employees were surveyed for serum total bilirubin, and alkaline 
phosphatase, GOT, GPT, and gamma-glutamyl transpeptidase activity [69]. Two 
criteria of abnormality were used. Criterion A was a deviation greater than 
two standard deviations from the normal population mean of the laboratory 
performing the analysis; criterion B was the occurrence of a value outside the 
normal range used by the laboratory performing the analysis. An abnormally 
high result by either criterion on any test was regarded as indicative of 
liver impairment. Duration of employment, work history, exposure conditions,
use of alcoholic beverages, current symptoms, history of liver disease, and
demograpt.lcs were also recorded. Of these, the only significant variable 
(?<0.001) related to abnormality, according to the more stringent criterion B, 
was duration of exposure at the site: 5.11 years for "cases" and 3.64 years
for "noncaaes."
A total of 75 employees (29Z) at the plant were classified a3 abnormal by 
criterion B on the basis of enzyme activity teats [69]. On the Individual 
teats, NIOSH found 46 employees (19Z) with abnormal elevations of SGPT 
activity, 42 (16Z) with abnormal serum gamma-glutamyl transpeptidase activity, 
31 (12Z) with abnormal SGOT activity, and 5 (22) with abnormally elevated
serum alkaline phosphatase activity. Only one employee (0.4Z) had an elevated 
serum total bilirubin value. Every area of the plant had at least one 
employee who was judged abnormal by one of the two criteria stated. The 
Incidence of abnormal alkaline phosphatase and bilirubin values in this study 
was lover than that reported previously [34] at a vinyl chloride plant.
The company had tested only a group of workers Involved in the 
p o ly m e riz a t io n  of vlnylldene chloride, who were exposed to this monomer at 
relatively high levels [69]. Whereas NIOSH had studied almost 88Z of the 
employees, nearly 5.6 times as many as the company had studied. The incidence 
of abnormal results on any test would be expected to be lower in NIOSH's 
study, therefore, as was the actual case. The substances or the relative 
concentrations responsible for producing adverse effects where exposures are 
mixed cannot be identified conclusively. The case for the existence of actual 
liver damage from exposure to vlnylldene chloride rests on the company's 
correlation of microscopic and dye-clearance data with the liver enzyme 
studies.
In 1970, Henschler et al [70] and Broser et al [71] each reported on the 
same two cases of poisoning from occupational exposure to vlnylldene chloride 
copolymers that had occurred in Germany in 1965. In both cases the workers 
had been transporting an aqueous suspension of vlnylldene chloride 
copolymerized with another unspecified vinyl compound. The authors stated
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chat eh« suspension contained about 0.42 of low molecular weight halogenated 
hydrocarbons, of which vlnylidene chloride comprised about one-half. Both 
workers developed symptoms of poisoning while manually cleaning the transport 
tank.
The first worker was 33 years old [71] . About 6 hours after he had worked 
in the tank for a "short," but indefinite time, he experienced fatigue, 
weakness, lack of appetite, and an "abnormal sense of taste." Nineteen hours 
after the initial exposure, he again entered the tank and remained for 45 
minutes. Five hours later, he experienced nausea, headache, dizziness, and 
eventually vomiting of blood. A "furry” feeling in the mouth and lips which 
he had noticed earlier now became more noticeable. He was admitted to a 
medical clinic 27-28 hours after his first exposure. Conjunctivitis, 
inflammation of the epipharnyx, herpes labialls, pains in the epigastrium, 
perception disorders of the face, and deflection of the tongue to the right 
were observed. Liver and kidney function tests were initially abnormal (low 
urine specific gravity, 3-6 leukocytes in the urine sediment, SGOT 20 mtJ, 82 
BSP retention, 602 prothrombin time, and what was described as decreased water 
excretion of 570 ml); however, all findings except the sensory effects 
returned to normal after 3 weeks.
An extensive neurologic examination performed 3 months later revealed 
analgesia and hypoesthesia In the total trigeminal area, including the nose 
and oral mucosa [71] . In addition, hypoesthesia and hypalgesia in the region 
of both ear muscles and under the angle of the jaw and absence cf the corneal 
reflexes were noted. Other findings were normal except for labile 
hypertension (blood pressure 170/90 mmHg). Followup examinations conducted 2 
and 4 years later showed the same types of findings, and the worker complained 
of the same symptoms.
The second worker, 53 years old, was exposed in the same way, but for a 
shorter time than the first [71]. His initial symptoms were essentially the
same as those of the other worker. On admission to the medical clinic, 5 days
after exposure, herpes labialls, hypertonic fundus, high blood pressure 
(170/115 mmHg), mild diabetes mellitus, and polycythemia (5.34 million 
erythrocytes, hemoglobin 17.2 g, color index 32.4, hematocrit 482) were 
observed. Kidney and liver functions were not abnormal. Perception disorders 
in the face and in the fingertips of both hands, paresis of the muscles of the 
cheeks and tongue, and bilateral double vision were also noted.
After 4 months, the subject complained of loss of the sense of taste, 
deficient saliva flow, and difficulties in opening his mouth, chewing, and 
eating [71]. Findings of a medical examination included hyposmia and 
hypogeusla and analgesia, thermoanesthesia, and hypoesthesia in the area of 
the trigeminal nerve, the skin of the face, the oral mucosa, the top of the
bead, th* tragus, the ear muscles, beneath the angle of the jaw, base of the
tongue, throat, and the external auditory, passages. Corneal, nasal, and 
vomiting reflexes were all absent. Followup examinations 2 and 4 years later 
revealed no Improvement.
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The authors [70,71] attempted to find mono- and dlchloroacetylene in the 
aqueous mixture, because of the close resemblance between the signs and 
symptoms of intoxication vith vinyl derivatives and with acetylene dlchlorlde, 
but were unsuccessful; however, they postulated that the toxic effects 
observed In these workers could have been caused by mono- or 
dlchloroacetylene. They suggested that caution be exercised where the 
potential existed for exposure to the Intermediate products of polyvinylidene 
chloride.
Krieger et al [72], In a 1971 report, discussed similar effects on a 32- 
y<iar-old worker exposed to off-gas from an aqueous dispersion of a vinylidene 
chloride copolymer. Several hour3 after receiving a jet of the gas in his 
face after opening a valve too soon and after manuaily cleaning a tank used to 
transport the copolymer, a job that lasted about 2 hour3, the worker developed 
pains in the upper lip, nose, and eyes, a frontal headache, and visual 
problems. Later he was bothered by a lack of sensation in his face and buccal 
mucous membraner, somnolence, anorexia, nausea, and difficulty in speaking and 
eating. Fourth a days after the incident, an examining physician noted 
bilateral facial anesthesia, corneal anesthesia, and hypoesthesla. The worker 
had neuralgia involving the anterior two-thirds of his tongue, but no 
trigeminal motor involvement or facial motor disorders. Krieger et al 
concluded that, because the clinical picture was similar to that described in 
previously published reports on the toxic effects of exposure to chlorinated 
acetylenes, these compounds probably were the toxic agents in Chls case.
Although none of these authors [70-72] suggested that vinylidene chloride 
itself was the cause of the "cranial polyneuritis" observed, each suggested 
that there is a potential hazard to workers exposed to intermediates or 
impurities of vinylidene chloride copolymerization processes.
(c) Vinyl Bromide, Vinyl Fluoride, and Vinylidene Fluoride
No reports of toxic effects on humans from exposure to vinyl brer,aide, 
vinyl fluoride, or vinylidene fluoride have been located.
(d) Summary
The human studies reported in this section do not permit comparisons of 
the modes of action of the various vinyl compounds. Only for vinyl chloride 
have reports of a full range of tests on a large population of workers been 
published. The adverse effects observed on humans exposed to vinyl chloride, 
eg, the serum enzyme aberrations, CNS effects, vascular abnormalities, and 
tumors, Indicate that such exposure is a serious hazard In the occupational 
environment. The other vinyl halides are also suspect because of their 
chemical similarity to vinyl chlorldc. The paucity of human data for the 
other vinyls should not be construed as an indication that they are Innocuous; 
the potential hazar < from occupational exposure to these compounds was only
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recently postulated. The hazards presented by thes? compounds nay vary only 
quantitatively rather Chan qualitatively, and the variations may be and are 
likely to be based on thalr relative bloreactlvlties.
Epidemiologic Studies
Although more than 30 epidemiologic studies of populations subject to 
occupational and environmental e:cpo3ure to vinyl chloride have been published 
since 1971, only one epidemiclogic study of workers exposed to vinylidene 
chloride [73] has been located, and no epidemiologic reports on the other 
vinyl halides were found.
(a) Vinyl Chloride
(1) Acroosteolysls
Tvo studies [74,75] of workers involved in various phases of the 
manufacture of vinyl chloride and polyvinyl chloride were published in 1971. 
Dinman et al [74] Investigated the Incidence of acroosteolysls and Raynaud's 
syndrome in employees potentially exposed to vinyl chloride at 32 plants in 
the United States and Canada. Cook et al [75] conducted industrial hygiene 
surveys at t’lese sane plants In an attempt to correlate the observed 
differences In health status with differences in work practices among the 
plants.
In the first study [74], the experimental population consisted of 5,011 
workers (96.4X male, 95.71 white, mean age 35.8 years). The control 
population was the adult male population of Tecumseh, Michigan: 2,407 men over 
the age of 18. Criteria for selection of the control population were not 
presented, and analyses comparing vinyl chloride workers with controls were 
not given. In assessing health status, Dinman et al had each worker complete 
a., questionnaire designed to probe for signs or symptoms related to Raynaud's 
syndrome or peripheral vascular insufficiency and related hand Injuries. 
Roentgenograms of both hands of each worker were made and were reviewed 
Independently by tvo radiologists for signs of acroosteolysls. Medical and 
occupational histories vere also obtained from each employee.
Twenty-five clear-cut cases of acroosteolysls were found in the worker 
population [74]. These cases met the following diagnostic crltarla: defects
along t&e shaft margin, sclerosis with recalcification, and shortening of the 
phalanges, or, marginal defects with residual fragments, transverse defects 
with or without distal fragmentation, and total resorption of the distal 
portion of the phalanx. Tventy-tvo of the 25 workers with abnormalities 
diagnosed by roentgenographic examination also indicated on the medical 
questionnaire that they had had symptoms characteristic of Raynaud's syndrome.
In only 7 of the 32 plants investigated were cases of acroosteolysls. 
diagnosed definitively by roentgenographic examination [74,75]. Three other
**v»
planes hod cases of possible acroosteolysls, 1«, cases ehat did not fully meet 
Che author»' confirmation criteria. A comparison of plant populations showed 
that the 25 cases of acroosteolysls were from a population of 1,673 workers. 
Each of Che workers with acroosteolysls had served as a reactor cleaner, 
although one of them had only cleaned a bench-scale reactor in a laboratory. 
Of the 5,011 workers surveyed, 1,047 (21Z) had had reactor cleaning
experience. The authors stated that in a few plants the concentrations cf 
airborne vinyl chloride had been measured inside the reactors during scraping 
operations, and that Che vinyl chloride concentrations had been generally 
below 100 ppm (256 mg/cu m) and usually about 50 ppm (128 mg/cu m) . Air 
samples taken close Co the hards of Che scrapers had contained concentrations 
of ’.'inyl chloride ranging between 600 »nd 1,000 ppm [75]; however, Che authors 
did not present details or identify Che plants where these measurements had 
been madt. .
DInman and coworkers [74] ard Cook et al [75] concluded Chat work 
practices rather chan any one specific substance or combination of nacerials 
used In the manufacturing process were determinant of whecher or aot 
acroosteolysls would occ.ur. They considered acroosteolysls to be a 
manifestation of a systemic intoxication rather than of local effects by a 
coxlc material, so that prevention of transpulmonarv, percutaneous, and 
gastrointestinal absorptions of materials scraped off the walls of the 
reactors was seen as the first line of defense of the health of the reactor 
cleaners, the group of employees in wLlch the greatest incidence of this 
disease was found. Bagger-packers also had a high incidence of acroosceolysls 
and were required to have protection against absoprtion of material from the 
polymerized produce from the reactors.
The authors [74,75] stated that, while gloves (unspecified type) were 
provided for reactor cleaners, the use of gloves was "Inconsistent" at those 
plants having workers with acroosteolysls. They also stated that the 
procedure for airing out reactors before cleaning was frequently "short-cut" 
in. these planes. They pointed oue that the complexity of the manufacturing 
processes, which involved - at least 227 different materials, including 
monomers, catalysts, ketones, and chlorinated hydrocarbon solvents, made 
conclusions about the hazard of any single ingrediert difficult. They also 
proposed that "idiosyncratic sensitization or susceptibility" be considered as 
a possible determinant of the development of acroosteolysls. The authors also 
stated that there were several problems with the consistency of the diagnostic 
procedures, eg, the radiologists seldom agreed on a specific diagnosis, and 
with the accuracy of the survey techniques. The authors' investigation of 
differences in ehe planes' work pracclces did not provide an explanation as to 
why there were definitive cases of acroosteolysls in only 7 of ehe 32 plants 
[74,75]. However, they did report that acroosteolysls was rare in plants 
using high-pressure water lances for cleaning the reactors and also In those 
that reduced the pressure within the reactor below the atmospheric pressure to 
the greatest extent and for the longest time before opening the reactor for 
cleaning. The authors' suggestion that work practices and engineering 
controls might not be followed in those plants having cases of acroosteolysls
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was not documented. The fact Chat all cases of acroosCeolysis were diagnosed 
In workers vb- had been employed at sometime as reactor cleaners, although 
only 21Z of the total worker population had been employed in this category, 
Indicates that employees performing this task . were at greater risk of 
developing acroosteolysis. Since this task also has been found to have the 
potential for the highest exposure to vinyl chloride, it is reasonable Co 
assume that exposure to this substance contributes to the induction of 
acroosteolysis.
(2) Clinical Tests
In 1972, Kramer and Mutchler [761 described a study in which 
environmental measurements were compared with clinical test results and 
meaical histories for 98 men who were occupationally exposed to vinyl chloride 
and to "small amounts" of vinylidene chloride in a polymerization facility.
Medical surveys and physical examinations had been conducted on 66 of 
these men during 1965 and 1-966, and the results were compared with results 
from a control group of 605 employees in other departments (not Identified) 
who were examined during the same period [76]. Ninety-five separate items 
were compared for the two groups by a test for differences between means 
assuming normal distributions. The only significant differences (?<0.05) 
between the medical histories of the vinyl chloride group and the control
group were in the prevalences of asthma (10.8 vs 2.62), stomach, liver, and
intestinal disturbances (6.2 vs 18.02), kidney stones and bloody uri.ie (9.2 vs 
3.02), nervous disturbances of any sort (4.6 vs 13.42), and, from occupational 
histories», work. , with, radioactive substances (1.5 vs 15.52). The number of 
significantly different items, 5, is about what would be expected by chance 
out of any 95 statistical tests.
Six of 20 clinical variables showed significant correlations (P<0.05) with
the cumulative TWA concentration and the cumulative dose of vinyl chloride 
when allowance was made for the effects of age and obesity [76]. Systolic 
blood pressure, diastolic blood pressure, BSP retention, icteric index, and 
serum beta-globulin concentration increased witn increasing TWA exposure 
concentration and total exposure dose (TWA concentration multiplied by cime on 
the job), while hemoglobin concentration decreased with increasing exposure. 
Although the authors did not present complete information on exposure 
concentrations, they stated that the mean TWA exposure concentration was 155 
ppm (397 mg/cu m) in 1950 and 30 ppm (77 mg/cu m) in 1965. The authors noted 
that recent (not further defined) measurements of the workplace concentrations 
of vinyl chloride had shown them to average about 10 ppm (25.6 mg/cu m) with 
vinylidene chloride present in "trace” amounts, virtually always less than 5 
ppm (19.8 mg/cu m). The authors also mentioned that data concerning exposures 
for each year since 1950 were available, but they did not present these data.
Kramer and Mutchler [76] also calculated the expected clinical values for 
these tests as functions of career TWA exposure concentrations, using the 
regression coefficients from estimated exposures for the study population.
Because blood pressure and Che concentration of hemoglobin in the blood did 
not move outside the normal range of values aud the significance of change in 
the concentration of beta protein vas not known, Kramer and Mutchler 
considered that the only dependent variables significantly linked to possible 
injury induced by prolonged exposure co vinyl chloride with trace amounts of 
vinylidene chloride were BSP retention and the icteric index. These measures 
indicate some interference with the normal liver function. The two persons 
with the greatest increases in BSP retention were reexamined in 1968, having 
been removed from further exposure in 1965. One individual, who had a M  story 
of hepatitis before exposure to vlr.yl chloride, retained high value? or BSP 
retention and icteric index; the other individual had essentially normal 
laboratory findings.
In 1975, Wyatt et al [77] published an epidemiologic study of the results 
of selected blood screening tests and medical histories of workers in a 
chemical plant In Kentucky where polyvinyl chloride was made. Since 
angiosarcoma had been diagnosed in seven workers in the unit where polyvinyl 
chloride was manufactured (unit 62) in this plant, results from workers in 
this unit were compared with other workers in the chemical plant who had never 
worked In unit 62. There were 413 employees with at least 1 month of 
experience in unit 62; they had means of 14 and 7 years of experience at the 
plant and In unit 62, respectively. They were compared with 469 employees who 
had never worked in unit 62 and who had a mean of 12 years of experience at 
the plant. All employees in the study were male, and less than 10Z in each 
group were nonwhite. The average age was 40 in the unit-62 workers and 41 in 
the other group. Height and_welght were similar in the two groups.
Blood tests were performed for several months, beginning in January 1974 
[77]. Blood was drawn in the early morning after an overnight fast and the 
serum was analyzed for total protein, albumin, calcium, inorganic phosphate, 
creatinine, uric acid, total bilirubin, alkaline phosphatase, LDH, GOT, CPK, 
creatinine phosphate, and cholesterol. Normal values for each test were based 
on the experience of the clinical laboratory performing the tests. Intergroup 
differences were determined for the means of each teat, and significance was 
tested by calculation of chi-square. The effects of age were analyzed by 
regression analysis of the mean values of each test plotted by 5-year age 
groups.
The mean values of each test were not significantly different for the two 
populations [7^]. However, when the results of each test were classified as 
normal, above normal, or below normal, albumin, alkaline phosphatase, and GOT 
In the blood serum were found to differ significantly (P<0.05) with regard to 
percentages In each range. Multiple regression analyses showed significant 
differences (P<0.03) in the albumin and cholesterol tests for the two 
populations. A comparison of the two populations by history of previous 
illness revealed significant differences (P<0.05) in the incidences of 
genitourinary disease, which was lower In the unit-62 workers, and "allergic" 
and "llver-spleen" illness, which were higher 'in the unlt-62 workers.
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Wyatt et al [77] made no attempt tc assess such factors as length of
employment, selective criteria for employment, age, or behavioral differences 
between the groups. They pointed out that many individuals in both groups had 
abnormal test results, but they stated that this oust be "interpreted
cautiously," particularly in the absence of a true control group. This study 
provides no information on exposure to potential chemical hazards for either 
of the groups. Without this information, the observations of differences
between the groups are of limited value.
In 1977, Waxweiler et al [78] described a cross-sectional medical survey 
d e 3 i g n e d  t o  compare the prevalence of liver a b n o r m a l i t i e s  a n d  liver d i s e a s e  i n  
vinyl chloride-exposed workers and appropriate controls a t  a  chemical p l a n t  in 
Pennsylvania and to identify the tests best suited to detect t h e s e  and other 
illnesses in vinyl chloride workers. Four groups of workers, each
representing a different estimated exposure to vinyl chloride, were used in
this study. The groups consisted of 134 rubber workers with "no" vinyl 
chloride exposure, 80 plastics workers vlth "light" vinyl chloride exposure, 
126 chemical workers designated as vinyl chloride "exposed," and 71 former 
chemical workers who had had "past" vinyl chloride exposure. Information 
concerning exposure concentrations was not presented. Subjects were
classified in one of the first three groups on the basis of their jobs at the 
time of the health survey. Basic blood screening tests and pulmonary function 
examinations were performed, and medical histories were obtained. All test
results were adjusted for age and the results of the pulmonary function tests 
and reports of respiratory symptoms were also adjusted for smoking. Alcohol 
consumption was analyzed, but no basis was found for adjustment o f  the data.
Of the total study population, there were 21Z abnormal SGOT, 5% abnormal 
total bilirubin, 13Z abnormal alkaline phosphatase, and 4Z abnormal LDH [78]. 
The prevalence of these abnormalities was similar in all four groups, except 
that abnormal LDH values were present in 11.8Z of the former chemical workers. 
The age-adjusted prevalence of hepatomegaly as diagnosed by palpation in 
current chemical workers (13.2Z) was almost twice that in rubber workers 
(7.1Z) and- plastics workers (7.32). A similar gradient was noted when 
diagnosis was by percussion alone or by percussion and palpation together. 
One former and three current chemical workers had both abnormal values for two 
or more of the four liver function tests and hepatomegaly as diagnosed by both 
percussion and palpation. Liver scintlgraphs, after injection of 99 Tc sulfur 
colloid, were made for 123 workers exposed to vinyl chloride and were read by 
three specialists in nuclear medicine. In no case did all three specialists 
agree on whether any single film was abnormal; of the 29 films read as 
abnormal, only 4 were read as abnormal by 2 reviewers.
No significant differences between the groups were reported for symptoms 
of Raynaud's syndrome [78]. Twenty-two of 207 roentgenograms of the hand were 
read as abnormal for some state of acroosteolysis by one of two radiologists. 
Severe, persistent headaches were reported more frequently by the chem.cal 
(13.7Z) and plastics (12.7Z) workers than by rubber (8.6%) and former chemical 
(6.4Z) workers, and loss of consciousness on the job was more common in
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chemical (6.3Z), plastic (5.22), and former chemical (5.8Z) workers chan in 
the rubber (2.1Z) workers. Neurologic examinacion revealed "slightly" 
diminished reflexes in Che chemical workers' group. The prevalence of angina 
pectoris, as measured by Che Rose Questionnaire for cardiovascular symptoms, 
was not noticeably different in the four groups. However, a much higher 
prevalence of systolic hypertension (>140 amHg) was noted in the former 
chemical workers. A significantly higher (P<0.05) prevalence of diastolic 
hypertention (>90 ¡nmHg) was seen in all three vinyl chloride-exposed groups 
compared with that in the group of rubber workers (39.4-41.0Z vs 24.3Z).
No differences between the four groups were found in tne prevalence of 
respiratory volume impairment (adjusted for smoking) or of respiratory flow 
impairment; volume impairment did n e t  differ between smoking and nonsmoking 
workers, although pulmonary function c e s t 3  made before and after the workshift 
showed results related to smoking rather than to job w-itegory [78]. Sputum 
cytologic and chest roentgenographic examinations revealed only "minor" 
intergroup differences. On the health questionnaire, the plastics workers and 
former chemical workeru reported prevalence? of chronic respiratory symptoms 
"substantially" higher than those In the rubber workers, while the current 
chemical workers reported prevalences only "slightly" higher than those in 
rubber workers.
Waxweiler et al [78] concluded that the striking increase in LDH 
abnormalities in the former chemical workers (12Z vs 2-4Z for the other three 
groups) might have been a function of self-selection out of the chemical area 
because of symptoms of associated abnormalities. They also stated that the 
"most impressive" difference between the groups was the prevalence and degree 
of hepatomegaly, which showed a "weak" dose-response relationship with vinyl 
chloride exposure as estimated from job categories. Finally, the authors 
pointed out that, because of differences between plants in work practices, 
production techniques, composition of the workforce, the presence cr absence 
of various associated toxins, and other factors, general conclusions about the 
hazards of vinyl chloride exposure should not be drawn from the results of 
this single study.
The types of data most valuable In comparisons of epidemiologic reports, 
such as dally exposures and total accumulated doses, were not available to 
these authors [78]. Exposures considered "light" in this plant might have 
been classified differently in another plant. The bias introduced by 
preselection for work and self-selection out of a hazardous environment is not 
quantifiable at present. The impact of these and other considerations, such 
as the latency of adverse effects on the estimation of the hazard of exposure 
to vinyl chloride remains to be determined. Waxweiler and coworkers did, 
however, draw some tentative conclusions that merit further evaluation. The 
suggestion o^ a dose-response gradient for hepatomegaly, the significant 
increase in the Incidence of diastolic hypertension in the vinyl chloride- 
exposed workers, and the severe headaches and loss of consciousness indicate 




la 1977, Fox and Collier [79] reported on the mortality of over 7,000 
man exposed to vinyl chloride at some time between 1940 and 1974 at 8 
polyvinyl chloride plants in Great Britain. TWA exposure concentrations were 
estimated by the companies (presumably on the basis of job description and 
area sampling data) and classified as high (>200 ppm or 512 mg/cu m), medium 
(25-200 ppm or 64-512 mg/cu m), or low «25 ppm or 64 mg/cu m), and as 
constant (most of the time) or intermittent (occasional).
The study Included a total population of 7,409 workers, 23Z of whom had 10 
or more years of exposure to vinyl chloride [79]. The Standard Mortality 
Ratio (SMR), 100 times the ratio of the number of observed deaths in the
population at risk and the number expected to occur from the same cause in a 
standard population of the same size on the basis of actual mortality figures, 
for this population was 75.4, using the sex- and age-standardized death rates 
for England and Wales for comparison. SMR's for all causes of death computed 
for eight factories revealed that at three of them there were significantly 
fewer deaths than expected, and that all had overall SMR's below 100. The SMR 
for cancer deaths was "marginally" higher than expected (101.4) in one plant. 
Four deaths from cancers of the liver were found, compared with 1.64 expected, 
for an SMR of 243.9. Two of these cancers were confirmed by microscopic 
examination as angiosarcoma, and two were confirmed as carcinomas rather than 
angiosarcoma. The two workers who died of angiosarcoma had had high constant 
exposures for 8 and 20 years. The two workers with carcinomas had had low, 
intermittent and medium, intermittent exposures for 6 and 18 years, 
respectively. Three of the deaths from cancer of the liver occurred in one 
factory after 1966. One of these was an angiosarcoma. This was significantly 
in excess of the 0.13 deaths expected In this factory (P<0.01).
Analysis of mortality by year of entry into the industry showed that 
longer employment was associated with higher SMR's for cancer and circulatory 
disease [79]. Data on cancer of the liver suggested a dose-response 
relationship» since both cases of angiosarcoma of the lives occurred is 
members of the highest exposure group. There was a general tendency for the 
age-adjusted SMR for all causes for those men alive 15 years after they began 
employment to increase with Increasing time on the job, from 100.6 (for men 
employed <* years or less) to 104.7 (5-9 years) and to 113.3 (10-14 years).
Approximately 75Z of the 7,409 workers had been employed for less than 10 
years, and more than half of those ever employed were still employed at the 
time of the study [79]. Since only about one-fourth of the workers had been 
exposed to vinyl chloride at high concentrations for a long time, and since 
most of them who had completed 20 years of service had done so only recently, 
Fox and Collier suggested that there had not been a sufficient followup period 
during which to evaluate the carcinogenic effect of vinyl chloride. They also 
pointed out the complicating factors cf the "healthy worker effect" and the 
"survivor effect" in analyzing these data. ' The healthy worker effect means
(3) Mortality and Morbidity Studies
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that most people accepted fo? employment are healthy, and, as a result, the 
workplace population tends to be In better health than the general population. 
The survivor effect stipulates that people experiencing adverse effects at the 
workplace tend to leave their jobs of their own volition; therefore, the 
remaining work population is composed of a larger percentage of people who are 
more resistant to the adverse effects of the Industry than the population of 
all people hired. The authors concluded that vinyl chloride was probably a 
carcinogen causing cancer of the liver in exposed workers; they noted however, 
that the cases of angiosarcoma observed were associated with exposure at "very 
high" concentrations. They added that no evidence was found that vinyl 
chloride caused cancers other than those of the liver, and that although the 
sy.R for cancers as a group was consistently higher than that for all deaths, 
cais was difficult to evaluate becauje of population selection factors.
These authors' conclusions [79] axe necessarily biased by the choice of a 
general population as the control group, and this fact is pointed out by the 
authors in their discussion of preselection and survivor effects. Thus, the 
relation of observed effect's in the worker population to expected effects on 
the general population may give a less than objective analysis of the 
potential hazard.
In another report, Fox and Collier [80] examined the effects of selection 
for work and survival in the industry on mortality in Industrial cohorts. 
They used the previously described worker population and data for these 
comparisons [79]; however, they compared the employees working at the time of 
their deaths with those who had left the industry [80]. For all causes of 
death, the SMS. for employees alive after 15 years is the industry was 74.0, 
while for former employees alive after 15 years, the SMR was 108.4. A 
comparison of SMR*3 for cancer of the lung between the two groups was 
particularly striking, 50 for current workers and 156 for former workers. 
Results of comparisons for other causes of death by 10-year age groups 
revealed similar differences in SMR's.
Observed and expected deaths categorized by cause of death and length of 
employment demonstrated increasing SMR's with Increasing length of time on the 
job [80]. The SMR for all causes of death for all workers progressed from 
37.4 (.for those employed for 0-4 years) to 62.9 (for those employed for 5-9 
years) to 75.1 (for those employed for 10-14 years) and to 94.2 (for those 
employed for more than 15 years).
The authors [80] concluded that the results of the analyses showed clearly 
that death rates for employees in the polyvinyl chloride Industry depended on 
preselection for employment, their continuing employment in the industry, and 
length of the time during which the workers continued to work in the industry, 
asd the length of time during which the cohort was studied. They suggested 
that mathematical models taking these factors into consideration might be 
productive alternative methods for analyzing mortality studies.
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Th««« studies [79,80] indicate the potential pitfalls of assessing an 
industrial hazard on th« basis of comparisons with the general population. 
Th« influences of pres«l«etion ard survival factors are demonstrated by the 
findings that SMR'» are lower both for workers with less experience and for 
current workers than for former workers. If these factors actually affect the 
results of an epidemiologic analysis, the assessment of hazard may be lower 
than is correct.
In 1974, the results of a retrospective study on 8,334 men with at least 1 
year of occupational exposure to vinyl caloride before December 31, 1972, were 
published by Tabershaw and Gaffey [65] and submitted as a report to th«; 
Manufacturing Chemists Association by Tabershaw/Cooper Associates Inc [81]. 
The study compared the mortality experience of the vinyl chloride workers with 
that of the general population and with that of other employee groups. The 
vinyl chloride workers were separated into subgroups on the basis of intensity 
and duration of exposure and of combinations of these two factors. These 
subgroups were compared on the basis of the SMR's for various causes of death.
Thirty-five plants in the United States that either produced vinyl 
chloride or used it in the production of polyvinyl chloride gave information 
from their employment records [81]. Quantitative exposure data were not 
available for each job, but relative exposures were estimated by plant
industrial hygiene and safety personnel. Actual concentrations were not 
estimated. The authors calculated an exposure index (El) for each worker on 
the basis of an average monthly exposure score ranging from 1 (low' exposure) 
to 3 (high exposure).
The median birth year of the 7,128 workers traced successfully was 1931, 
‘.he median duration of exposure was 80 months (6.7 years), the median El was 
1.44, and the median year in which exposure bega-> vas 1962 [81]. With the 
age-specific death rates as the standard of comparison, SMR's were calculated
for approximately 30 causes of death. No SMR for any cause of death was
significantly greater than. 100» and SMR's for several causes of death were
significantly below 100. For example, the SMR for "all causes'* was 75 (352
observed deaths vs 467 expected) and that for cardiovascular and renal
diseases was 80.
When the workers with vinyl chloride were subdivided according to El (more 
or less than 1.5) and duration of exposure (above and below 5 years), no 
remarkable findings emerged from these tabulations [81]. No SMR's were 
significantly above 100, although several were significantly below 100. 
Several trends were apparent, however, from the cross tabulations. SMR's for 
all malignant neoplasms Increased with increasing El and duration, reaching an 
SMR of 141 for an employment duration of 5 or more years and an El of 1.5 or 
greater. Cardiovascular and renal diseases showed a similar trend, although 
the SMR's generally remained below 100 for all causes of death except
hypertensive disease other than cardiac. There were slight, nonsignificant
excesses of observed deaths from respiratory system, digestive organ and
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peritoneum, and "other" cancers that increased in relation to increased 
duration of employment and estimated exposure. Cancers of the buccal cavity 
*nH pharynx also appeared in excess but had their highest rate of occurrence 
in the low, short-exposure group.
The authors [81] stated that the lower than expected overall mortality of 
the vinyl chlorxde workers was not a surprising finding because of the 
'healthy worker effect," even though vinyl chloride poses a significant risk 
of death from a particular cause, ie, angiosarcoma of the liver. Deaths from 
cancers of the digestive organs and peritoneum were further examined to study 
the role of angiosarcoma in overall mortality. Of the 19 deaths from cancers 
of the digestive organa and peritoneum, 7 were due to cancers of the liver, 2 
of which were identified on the death certificates as angiosarcoma. However, 
according to the authors, other investigators using the same study population 
Identified four other deaths from angiosarcoma; the death certificates stated 
the causes of death In three of these as cancer of the liver and in one as 
cirrhosis of the liver. Laennec’s cirrhosis was given as an alternative? cause 
of death on one death certificate identifying cancer of the liver as the
primary cause. If there had been no cases of angiosarcoma, the difference 
from the expected number of cancers of the digestive organs would have been 
insignificant.
The authors [81] concluded that the "consistent pattern of Increase" for 
particular causes of death with increasing exposure "appears" to relate 
mortality from cancer of the digestive syst:em or respiratory system, cancer of
other unspecified sites, and lymphosarcoma to vinyl chloride exposure. They
pointed out areas of possible bias In the studjr. The use of the US male 
population as a comparison group may have cauacd a slight overestimate of the 
SMR's, since the study population was from the eastern half of the United.
States, where expected mortality is higher; also, 15% of the workers could not 
be traced and the assumption that their mortality distribution was similar to 
that of those traced may have been incorrect. The data obtained on workers 
who could not be^traced showed that; on. the average/ they were born 10 years 
earlier than the study group and had much shorter exposures and slightly 
higher El’s. The effect that these differences may have had on mortality is 
uncertain. Also, 1,500 workers whose exposures had occurred up to 35 years 
earlier were located too late to be evaluated In the study. Information about
workers exposed for an extended period many years before might have more
clearly elucidated the effects of occupational exposure and been especially 
valuable because of the apparently long latent period for vinyl chloride- 
induced disorders. Although the authors did not demonstrate a statistically 
significantly increased risk from exposure to vinyl chloride in this worker 
population, the observation that the SMR's for various cancers increased with 
increasing duration ofzemployment and increasing estimated exposure suggests 
that exposure to vinyl chloride Indeed contributes to increased cancer
mortality risk-
A followup study [82] reported by Tabershaw/Cooper Associates Inc, in 
1975, extended the earlier investigation [81] by tracing through Social
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Security records chose workers who were lose Co followup and by including data 
on eligible workers noc previously Included. The addlclons co Che scudy 
group, which now totaled 8,714 workers, creaced only minor changes in the 
SMR's of observed deacb races Co chose expected based on Che US male 
populaCion. None of Chese differences changed Che major conclusions of Che 
prior sCudy. One more deaCh from angiosarcoma of Che liver was discovered.
A final report [83], which included che data from the above studies 
[81,82], was prepared by Equitable Environmental Health Inc in 1978. This 
report [83] increased the total worker group available for study to 10,173 
from 37 plants. Although the successive additions to the study population 
resulted in changes In the SMR's, these changes were not significant or 
compound-related and did not cause any change from the conclusions reported in 
previous studies.
Mbnson et al published two nearly identical reports in 1974 [84] and 1975 
[85]. They e v a l u a t e d  C h e  morcallcy of che accive and pensioned workers ac two 
planes in Kencucky, one of which was the polymerization plane where C h e  firsC
cases of angiosarcoma were seen, che other of which produced the vinyl
chloride used by the former. One hundred and sixty-one death records were 
analyzed for this study. Causes of death were taken from company abstracts of 
the death certificates, and the number of observed deaths from each cause, 
stratified into 5-year age- and time-specific groups, was compared with the 
number expected on the basis of age-, time-, and cause-specific proportional 
mortality ratios for US white males.
A 501 excess of deaths from cancer (41 observed vs 27.9 expecCed) was 
reported for the exposed populations (P<0.02) [84,85]. These cancers included 
angiosarcoma of the liver and cancers of the brain, lung, gallbladder, bile 
duct, thyroid, and nasopharynx. The trend was for the ratio of observed to 
expected deaths from cancer to increase with recency of death (before 1965, 
1.1; 1965-1969, 1.4; 1970 and after, 2.1). A 90Z excess of deaths from 
suicide (10 vs 5.3> was also reported. -
M o n s o n  e t  a l  [84,85] s t a t e d  t h a t  i t  " a p p e a r e d "  t h a t  t h e  r e l a t i v e  f r e q u e n c y  
o f  d e a c h s  f r o m  a l l  c a n c e r s  w a s  I n c r e a s i n g  w i c h  t i m e  a n d  s u g g e s t e d  t h a t
a d d i t i o n a l  e x c e s s  c a n c e r  a m o n g  v i n y l  c h l o r i d e  w o r k e r s  " w o u l d  s e e m  l i k e l y . "
They p o i n t e d  o u t  t h a t  a n  a n a l y s i s  u s i n g  p r o p o r t i o n a l  m o r t a l l e y  r a t i o s  d o e s  n o c  
t a k e  i n C o  a c c o u n t  C h e  a b s o l u C e  r i s k  o f  d e a c h  i n  C h e  p o p u l a C i o n  s c u d i e d ,  a n d  
C h aC  a  h i g h  r a e l o  o f  o b s e r v e d  C o e x p e c t e d  d e a t h s  m i g h t  r e s u l t  f r o m  " a n  e x c e s s  
o f  o n e  c a u s e  o f  d e a c h  o r  a  d e f i c i t  o f  a n o e h e r  c a u s e  o f  d e a c h . "
While the comparison did introduce an obvious bias in the seacisclcal 
treatment of results, the authors [84,85] adequately pointed Chls out in their 
discussion. The Crend in the raeios of observed to expected deaths from all 
cancers is a particular cause for concern since it indicated that the 
proportion of deachs caused by cancer was on che increase in this workforce. 
It must be remembered, however, that this was a study of workers at only two 
plants, and that che crend may noc have been relaCed to the vinyl chloride 
exposures alone.
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Ott et al [86] examined the mortality during 1942-1973 of 594 employees 
exposed to vinyl chloride between 1942 and I960« Several methods of sampling 
•nd analysis of airborne vinyl chloride had been used since 1950. Samples 
showed vinyl chloride concentrations before 1959 to have been generally welt 
below" 500 ppm (1,280 mg/cu m), with occasional excursions to 4,000 ppm 
(10,240 mg/cu m). In 1959, the company established a guideline of 50 ppm, 
(128 mg/cu m) as an 8-hour TWA exposure limit, and subsequent exposures were 
"generally found" to be below this concentration. Occupational histories were 
obtained from plant records, and exposures in the two largest units, which 
accounted for 466 of the workers, were classified as low (<25 ppm; <64 mg/cu 
m) , intermediate (25-200 ppm; 64-512 mg/cu m), or high >200 ppm; >512 mg/cu 
m), and each worker was assigned to one of these exposure groups on the basis 
of the highest estimated concentration at which he had been exposed for longer 
chan 1 month. The 128 workers from the three smaller production units, for 
which industrial hygiene data were not adequate to characterize exposures, 
were classified as having unmeasured exposures, which company industrial 
hyglenists estimated were, primarily in the low to intermediate range. For 
purposes of analysis, each exposure group was subdivided according to exposure 
at that concentration for less than 1 year or for 1 year or more. Exposures 
of workers to vinyl chloride at lower concentrations than their assigned 
category were not considered; for example, worker exposure at concentrations 
between 25 and 200 ppm for 6 months, and less than 25 ppm for 10 years, would 
be classified as intermediate exposure for less than 1 year.
All but one of the employees were traced through 1973 [86]. Causes of 
death were obtained from death certificates for all deceased workers except 
one who had been employed in a low-exposure job for less than 1 year.
Expected numbers of deaths for each exposure classification were calculated 
from OS death data for white males by determining the number of person-years 
in each exposure group over 5-year periods by 10-year age groups.
The total number of deaths in the study population was 89, compared with 
100.1 expected deaths [861. Malignancies accounted for 20 deaths vs 17;9 
expected, and none of these were cancers of the liver. There were three 
deaths from cirrhosis of the liver (3.1 expected), all in workers exposed to 
vinyl chloride for less than 1 year. Seventy-two of the vinyl chloride 
workers had also been employed in an arsenicals production facility where
workers previously had an increased cancer mortality risk, and these workers 
were therefore not Included in the population used for the vinyl chloride
s tudy.
With arsenicals workers excluded, total deaths in the population of 522 
vinyl chloride workers numbered 79, 91Z of the US death rate for white males, 
and the number of deaths due to malignancies was 13, compared with 16.0
expected deaths [86]. When the mortality data were stratified according to 
exposure concentration, 9 of these deaths from cancer were found to have 
occurred in the 163 workers with high exposure,* compared with 5.1 expected, 
and 6 of these were in workers exposed at high concentrations for longer than 
L year (2.9 expected). Statistical comparison of the ratio of observed to
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expected deaths from cancer in the high-expoaure group with that of all other 
groups combined, assuming a Poisson distribution for small sample sizes, 
showed a significant difference (P<0.025). When only deaths occurring 15 
years or more after the employee's initial exposure to vinyl chloride were 
included, eight of nine deaths from malignancies were in the high-exposure 
group (PCO.Ol). A survey of case histories of the 13 vinyl chloride workers 
who died from cancer showed that 2 had also had substantial exposure to 
benzene, 1 had a family history of malignancies that included 4 deaths in his 
imnediate family, and at least 3 of the 5 who died from lung cancer were 
smokers.
Ott et al [8 6 ] concluded that, although the number of deaths was small, 
the distribution of malignant neoplasms with respect to exposure categories 
suggested a possible dose-response relationship. No associations were noted 
for malignant effects in the lower-exposure categories where the estimated TWA 
exposure concentration ranged from 1 0 to 1 0 0 ppm.
In 1974, Nicholson et al [87] published a retrospective study of the 
mortality of a cohort of workers involved in the production of polyvinyl 
chloride at a plant In New York. From company and union records, 257 men were 
identified who had begun employment between 1946 and 1963 and who had worked 
for at least 5 years in the plant. The current health status of 255 workers 
was determined. More than half of the employees had worked primarily in 
polyvinyl chloride production, where reactor cleaning was routinely performed 
without respiratory protection, causing exposure to vinyl chloride. 
Approximately 25Z of the workers had been employed in maintenance, where 
exposures to vinyl chloride could be significant during repair work, and the 
remaining workers had been employed mainly in the shipping department and the 
laboratory. No records were kept of the vinyl chloride concentrations at 
which the workers were exposed. The only measurements made of environmental 
concentrations of vinyl chloride were those necessary to ensure that the 
explosive limit of 30,000 ppm (76.8 g/cu m) was not exceeded. The authors 
estimated that peak concentrations might often have exceeded 1,000 ppm (2,560 
mg/cu m) and nay occasionally have reached 10,000 ppm (25.6 g/cu m). This 
estimate was based on the results of medical examinations conducted in March 
1974 on a group of active and past workers, more than 50Z of whom reported 
symptoms of dizziness, headache, or euphoria, and 4Z of whom had lost 
consciousness on the job in comparison with the known development of these 
symptoms at high concentrations. The median age of the workers on the 10th 
anniversary of their employment was approximately 37 years, with 16Z under 30.
Of the 255 traceable workers, 82 had retired or were working elsewhere, 24 
had died, and 149 were still employed at the same plant [87]. Mortality among 
the workers was higher than expected based on death rates for New York State, 
excluding New York City, for deaths due to all causes and all cancers in 
groups exposed 10-15, 15-20, and 20-25 years, but not l a  the one exposed for 
25 or more years. These increases were not statistically significant, 
however. There were 10 deaths from all causes vs 6.1 expected in-the group 
exposed 10-15 years, 7 vs 6.6 in the group exposed 15-20 years, 7.0 vs 5.0 in
the group exposed 20-25 years, and 0 vs 1.3 in eke group exposed 25 years or 
more. The observed vs expected numbers of deaths from all cancers in these 
groups were 3 vs 1.2» 3 vs 1.4, 3 vs l.l, and 0 vs 0.3, respectively. There 
were chree deachs caused by angiosarcoma of Che liver and chree deaChs from 
other cancers (glioblascoma, reticulum cell sarcoma, and lymphosarcoma) that 
Che auChors suggesced might have been related Co exposure to vinyl chloride.
The authors [87] reported thaC Che three cases of angiosarcoma occurred in 
workers who had been exposed for the first time before 1951. They suggested 
that, as the time from first exposure increased, additional cases of 
occupational cancer might occur in this group of workers. The authors 
concluded that these data demonstrated the need to prevent exposure to vinyl 
chloride and to monitor, screen, and further study workers previously exposed 
to vinyl chloride.
In 1977, Chiazze et al [88] published a study of 4,341 deaths that 
occurred during 1964-1973 in a population of polyvinyl chloride production 
plant workers who had had exposure to vinyl chloride. A total o f 55 plants of 
17 companies supplied mortality data on employees who had died either while 
actively employed, after retiring from the company with retirement benefits, 
or after terminating employment but while still covered by a company-sponsored 
insurance program. A frequency distribution based on hospital and area was 
calculated for subjects whose cause of death was listed as cancer or liver 
disease. When one hospital or several hospitals in the same area appeared on 
several of these deaCh certificates, a Registered Records Administrator 
visited these hospitals and reviewed all of their pathology records to 
determine whether any cases of angiosarcoma of the liver had been diagnosed. 
Five cases of angiosarcoma were found in this manner, but none of these 
persons had ever been employed at any of the plants, in the study.
Over the 10-year study period, the size of many of the plants changed 
drastically [881. The number of employees at all plants under study was 
estimated to ha/e been between 65,000 and 70,000. However, the population at 
risk could not be accurately determined. Results were therefore reported in 
terms of proportional mortality ratios, rather than standardized mortality 
ratios, using race— and sex-specific OS mortality figures for comparison 
purposes.
The total number of deaths from cancer among males was 666 vs 562 
expected, for a PMR of 1.19 [88], Among females, 181 deaths from cancer 
occurred vs 138 expected, a PMR of 1.31. Approximately 312 of all deaths from 
cancer were due to cancers of the digestive system (PMR's of 1.29 for men and 
1.50 for women). Cancer of the liver was the cause of death for 6 men vs 4.2 
expected, for a PMR of 1.43. No deachs of women were attributed to cancer of 
the liver. PMR's also exceeded 1.0 for all other cancer categories except 
cancers of the buccal cavity and pharnyx and Che genital organs. The authors 
stated that "due to Che naCure of the data, formal significance tests and 
interprecacion in probabilistic terms are deemed inappropriate."
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Chiazze et al [88] concluded that there "appeared" to be excesses in 
cancer mortality for both men and women in this study and that these excesses 
"appeared" to be concentrated in cancers of the digestive system. ^They listed 
several factors that made definitive Interpretation of the data "difficult. 
Th* use of PMR's, they pointed out, does not take into account the absolute 
risk of death in a population. Also, the overall favorable mortality of 
working populations, which has been found in numerous Investigations, was not 
considered In this study. The authors did state, however, that their results 
"appeared to be consistent" with previously published studies [65,84], and 
that these results suggested a need for continued investigation. Definitive 
interpretation i3 difficult because special efforts were made to get 
supplementary hospital data for all deaths attributed to liver disease, 
malignant or not. The mthors do not 3tata whether this resulted in cnanring 
any death certificate causes from nonraaH^nant to malignant li\er disease, 
with consequent problems of comparability with US published data. The absence 
of cancer :'::e liver la women i3 not surprising, since the population was 
relatively small (601).
In 1976, Waxweiler et al [89] reported the results of a NIOSH 
retrospective mortality study of a cohort from four vinyl chloride 
polymerization plant0. In 1974, theiie plants had employed 250, 75, 250, and 
250 workers and t.ad been in the business of polymerizing vinyl chloride for 
28, 20, 2-*, ana 3.' vears, respectively. Only workers with at least 5 years of 
exposure to vinvl chloride and for whom 10 years had elapsed since the initial 
exposure were included in the cohort group of 1,294 workers (1,151 alive, 136 
deceased, and 7 lost to followup). The total person-years at risk was 12,720. 
The authors compared death rates among these workers to those among US white 
males, adjusted for age, calendar year, and cause, but not for smoking 
history. Mortality among the exposed workers was higher than expected for 
nonmalignant respiratory disease (6 observed vs 3.4 expected) and for all 
malignant neoplasms (35 observed vs 23.5 expected), and lower Chan expceced 
for cirrhosis of the liver and violent deaths. The number of deaths from all 
malignant neoplasms differed significantly (P<0.05) from that expected. 
Significant increases (P<0.01) were reported only for deaths from cancer c,f 
the biliary system aud liver among the workers for whom more chan 10 years had 
elapsed since initial exposure. Por the workers with more than 15 years since 
the Initial exposure, significant increases were reported for cancer of the 
brain, CNS, and respiratory system (P<0.05), and biliary svstem and li^er 
(P<0.01).
In each cancer mortality category, the calculated SMR. was higher for the 
15-year group than for the 10-year group [89]. The authors stated that this 
demonstrated Che importance of considering latency when looking for 
occupationally induced malignant neoplasms. They suggested that restricting 
the study to at least 10 years after initial worker exposure had minimized the 
"healthy worker effect," thereby eliminating the overall deficit of deaths In 
workers exposed to vinyl chloride often reported by other investigators. A
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similar pat-ern of latency had been reported previously by Nicholson et al
[87]. These results demonstrate an Increased risk of cancer for vinyl
chloride workers and show the essentiality of taking latency into account.
In 1975, Duck ec al [90] reported on the mortality experience of workers 
exposed to vinyl chloride in a plant in Great Brltian. A total of 2,120 male 
workers who had beeu exposed to vinyl chloride at some time since 1948 was 
identified from company records. Information from death certificates was 
compiled for these workers, and the mortality was compared with that of men in
England and Wales. Workers who died at more than 74 years of age or before
1955 were excluded from consideration in both populations.
SMR's were computed on the basis of cause of death, Job description,
duration of exposure, and year of first exposure [90]. No significant excess
mortality was found for the workers in any of the comparison categories. No 
cases of angiosarcoma of the liver were Identified in either population within 
the study period (1955-1975); however, the authors stated that one such death 
occurred ait^r the end of the study and before the paper was published.
The authors [90] pointed out that their comparisons did not allow for the 
selective effects of employment. They also noted that their findings 
conflicted with those of Monson et al [84]. The significance of these 
observations is difficult to determine, since the authors did not supply 
exposure information in this report. It is possible that, because of .unique 
work practices and engineering and administrative controls, the aortality of
workers from this plant may not be representative of workers from other plants
or from the Industry as a whole.
(4) Chromosomal Studies
Two studies from the United States [91,92] and one from West Germany 
[93] found no observed increases In lymphocytic chromosomal aberrations in 
vinyl chloride workers. Other reports [94-99] indicate that vinyl chloride 
may Increase the Incidence of lymphocytic chromosomal aberrations In exposed 
workers; however, the latter reports are based on results from relatively few 
workers.
In a preliminary report, Kilian et al [91] examined 2,291 lymphocytes from 
75 applicants for employment and 6,050 lymphocytes from 121 workers exposed to 
vinyl chloride and small concentrations of vinylidene chloride. The authors 
pointed out that the group of applicants contained only 2 persons over 50 
years old, whereas the exposed group included 30 persons over 50. During the 
previous 5 years, vinyl chloride concentrations in the workplace had been 
approximately 5 ppm (12.8 mg/cu m); 1 year prior to the study, concentrations 
of 1-2 ppm (2.56-5.12 mg/cu m) had been common; and 3 months before the study, 
vinyl chloride concentrations had been measured at less than 1 ppm (2.56 mg/cu 
m). The following results were obtained for .the applicants and the exposed 
workers, respectively: chromatid breaks, 6.72 and 2.942; chromosome breaks,
1.48 and 1.372; dicentrics, 0.17 and 0.462; rings, 0.00 and 0.022; exchanges, 
0.17 and 0.082; and abnormal cells, 6.07 and 4.262.
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Plcclaao et al [92] recently reviewed data from 209 workers In a plant 
manufacturing vinyl chloride, with an average length of employment of 48.3 
months (range 1-332 months); these were compared with data from preemployoent 
tests on 295 individuals. The average age of the workers was 39.5 years, and
that of the applicants vas 25.1 years. The proportion of lymphocytes with
chromatid breaks, chromosome breaks, rings, dlcentlcs, and exchange figures 
did not differ significantly between the two groups (exposed 3.72 vs controls 
4.52), nor did the occurrence of any single aberration. The authors also 
related the extent of vinyl chloride exposure to the number of chromatid and 
chromosomal aberrations. Workers were classified into estimated exposure 
categories of less than 1 ppm «2.56 mg/cu m), 1-5 ppm (2.56-12.8 mg/cu m), or 
greater than 5 ppm (>12.8 mg/cu m) on the basis of jot classification. In 
none of the groups was the percentage of aberrations found in workers 
significantly different from that found in controls. The authors stated that 
the difference In mean age between the exposed and preemployment groups was 
not considered to be a "confounding" factor in their analyses, since the 
cytogenetic change most often associated with aging was chromosomal loss 
rather than chromosomal breakage. The authors concluded that adverse
cytogenetic effects could be avoided in "controlled, minimal-exposure
environments," but they did not suggest a quan-itative exposure limit.
Fleig and Thiess [93] tested 10 vinyl chloride-exposed chemists and 
technicians for lymphocyte chromosomal aberrations. The 10 workers were 
exposed to vinyl chloride at concentrations of 1-25 ppm (2.56-64 mg/cu m) at 
the time of the study but bad previously been exposed at concentrations as 
high as 3,000 ppm (7,680 mg/cu m) for an average total o e. 13 years (range 4-34 
years). Four control subjects had frequencies of chromosomal aberrations In 
the range of 0-52. The 10 exposed workers also had frequencies of aberrations 
in the range of 0-52. The authors concluded that exposures in the plant had 
not increased the rate of chromosomal abnormalities, but they also mentioned
that the study group was small and that a realistic final conclusion could not
be drawn until all exposed workers had been tested.
Leonard et al [94] also examined vinyl chloride workers for lymphocytic 
chromosomal aberrations. Eleven polymerization workers, 7 vinyl chloride 
laboratory workers, and 10 controls selected from outside the factory 
environment were included in the study. Although vinyl chloride 
concentrations In the plant were not recorded, the authors assumed that the
concentrations must have exceeded 500 ppm (1,280 mg/cu m) several years prior
to the time of the study and had been reduced to less than 10 ppm (25.6 
mg/cu m) by 1376, when the study was made. They also assumed that laboratory 
concentrations of vinyl chloride were negligible. The laboratory workers had 
been employed an average of 9.3 years (range 2-15 years) and the 
polymerization workers an average of 6.5 years (range 1-17 years). Two 
hundred cells from each subject were examined. In controls, 2.62 of the cells 
had structural aberrations, In laboratory workers, 1.92, and in polymerization 
workers, 2.82. The Incidences of chromatid gaps and breaks and chromosomal 
gaps did not differ significantly between the three groups. The authors
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stated that polymerization workers had chromosomal fragments, translocations, 
rings, and dicentrics, whereas the control group did not; however, the authors 
noted that the vinyl chloride workers had had several roentgenographic 
examinations, which might have been responsible for the chromosomal 
aberrations.
In 1976, Szentesl et al [99] reported the occurrence of chromosomal 
aberrations in the lymphocytes from 45 polyvinyl chloride workers, 44 
industrial controls ( w o r k e r s  not exposed to polyvinyl chloride), and 49 
persons with no occupational exposure to chemicals. The mean ages of these 
groups were 27.3 years for the polyvinyl chloride workers, 43.9 for the 
industrial controls, and 29.1 for the nonexposed persons.
Aberrations of chromatids were observed In 165/1,600 cells (10.312) from 
the polyvinyl chloride workers, in 199/2,988 cells (6.662) from the industry 
controls, and in 149/2,523 cells (5.902) from the nonexposed persons [99]. 
The frequency of these aberrations was significantly higher (?<0.001) in the 
lymphocytes from polyvinyl chloride workers than in those from either control 
group. Unstable chromosomal aberrations were also significantly higher 
(P<0.001) in the polyvinyl chloride workers (25/1,600 cells; 1.562) than in 
the industry controls (17/2,988 cells; 0.562) or in the nonexposed persons 
(9/2,523 cells; 0.352). Data for each worker were scored individually and 
plotted against years of exposure to vinyl chloride. Seven polyvinyl chloride 
workers had values outside the confidence limit for the nonexposed control 
group. One of these workers had bean exposed to vinyl chloride for 6-7 years,
one for 10-11 years, and the other five for 12 or more years. These data may
indicate that increasing duration of exposure to vinyl chloride increases the
risk of lymphocytic chromosomal aberrations. The effecu of age was not
considered in this analysis, however.
In 1977, Heath et al [95] reported the results of cytogenetic analyses on 
the peripheral lymphocytes from 35 men employed for 10 years or longer In a 
large chemical/rubber plant and from 4 male controls who worked for the Center 
for Disease Control (CDC). Of the chemical/rubber plant employees, 14 worked 
in polyvinyl chloride polymerization (presumed high exposure to vinyl 
chloride), 4 in polyvinyl chloride processing (presumed low exposure to vinyl 
chloride), and 17 in rubber tire manufacture (Industry controls with presumed 
negligible exposure to vinyl chloride). The average group ages ^sre 49.4 
years for the high exposure group, 52.5 for the low exposure group, 48.5 for 
the industry controls, and 44.3 for the CDC controls.
Chromosome breakage was scored for each group [95]. The high exposure 
group had 6.72 breakage (74/1,105), the low exposure group had 7.82 breakage 
(14/180), the Industry controls had 5.92 breakage (77/1,306), and the CDC 
controls had 3.62 breakage (21/586). The frequency of breakage was 
significantly higher (P<0.05) in all three of the industry groups than in the 
CDC controls, but there were no significant differences between the Industry 
groups. The majority (862) of the aberrations observed in each group were 
chromatid gaps. Chromatid breaks and isochromatid gaps and breaks were also 
observed.
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The authors [95] also attempted to relate frequencies of breakage to 
duration of employment. No significant gradient was reported for the high and 
low exposure groups, but a signficant gradient (P<0.01) was observed for the 
industry controls (100-199 months, 0Z breaks, 2 subjects; 200-299 months, 1.3Z 
breaks, 2 subjects; 300-399 months, 6.7Z breaks, 13 subjects). The euthors 
stated that the interpretation of this gradient was "uncertain" because of the 
smell number of employees, and because the mean age Increased with employment 
duration (31.0, 44.5, and 51.8 years, respectively).
The authors [95] noted that their observations were not inconsistent with 
previous studies suggesting a twofold Increase in chromosome breakage 
frequency with occupational exposure co vinyl chloride; however, they 
concluded that the finding that the overall frequency of breakage did not 
differ significantly among high, low, and negligibly exposed industrial groups 
indicated that other agents in the chemical/rubber plant were capable of 
inducing the breaks, making it impossible to relate a particular agent to the 
abnormal effects observed. This difficulty does not diminish the concern 
warranted by the increased frequency of chromosome damage seen in chemical 
industry workers compared with that in workers outside the chemical industry.
Ducatman et al [96] compared the lymphocytic chromosomal aberrations in 11 
polyvinyl chloride workers (4-28 years of exposure, average 15 years) with 
those seen in 10 control subjects. Although no data were available on ambient 
concentrations of vinyl chloride, it was assumed, on the basis of reports of 
odor detection, dizziness, and headaches, that they must have exceeded 500 ppm 
(1,280 mg/cu m) at times. Fifty metaphases from lymphocyte cultures were 
examined for each individual. The results Indicated a slightly higher
incidence of chromosomal aberrations in the exposed workers. The mean numbers 
of aberrant cells and the standard deviations determined for exposed and 
control subjects were: breaks and gaps, 5.64 ±1.91 vs 4.40 £0.97
(0.1>P>0.05); unstable changes (fragments, dicentrics, and rings), 1.55 ±1.29 
vs 0.30 ±0.48 (P<0.01); and stable changes (monosomy, trisomy, deletions, and 
exchanges), 3.36 ±1.63 vs 2.90 ±2.18 (0.6>P>0.5),
Funes-Cravioto et al [97] compared chromosomal aberrations in cultured 
lymphocytes from seven male employees who had worked for 9-29 years in a vinyl 
chloride polymerization shop wifh those from three nonexposed workers. 
Exposure data were not given, but the authors estimated that the vinyl 
chloride concentrations in the polymerization department were 20"30 ppm (51-77 
mg/cu m). The exposed workers, none of whom had clinical signs of disturbed 
liver function, acroosteolysis, or abnormal hematologic changes, had an 
average of 9.52Z abnormal cells (138/1,450) compared with 1.941 (11/566) for
th* three control workers. The difference was statistically significant 
(P<0.001); however, the frequency of abnormal cells was highest in the 
employees who had been exposed to vinyl chloride for the shortest pariod.
Purchase et al [98] examined 100 lymphocyccs from each of 56 polyvinyl 
chloride workers and 24 workers with no exposure co vinyl chloride. Workers 




infections were excluded from the study* Exposed workers had 6.32 of cells 
with breaks and gaps, 1.45Z of cells with unstable changes, and 0.382 of cells 
with stable changes, Nonsxposed workers had 3.632, 0.462, and 0.09Z of cells 
in these respective categories. The authors stated that all group differences 
were statistically significant (P<0.05).
A secondary analysis was conducted by Dresch and Norwood [100] os the data 
from a number of studies of human lymphocytic chromosomal aberrations [94-99]. 
This analysis [100] made use of a binomial model, assuming a homogeneous 
group, and the Cochran model, a model t-rith provision for differences among 
clusters. The authors stated that the secondary analysis of each paper agreed 
with the authors' analysis, and that the cumulative data from all papers 
combined showed a statistically significant increase in the frequency of 
chromosomal aberrations with increasing exposure to vinyl chloride or 
polyvinyl chloride. They pointed out, however, that the frequencies of 
aberrations were small, only a "fraction" of background, and that, In view of 
tb ; inconsistency between laboratories, the positive statistical evidence 
should be "treated with caution."
(5) Reproduction Studies
Infante ,-r al [101], in 1976, reported on a study of pregnancy 
outcome in wives of workers exposed to vinyl chloride. Interviews were 
conducted with 95 vinyl chloride polymerization workers and a control group of 
158 rubber and polyvinyl chloride workers who were known to have had little or 
no exposure to vinyl chloride monomer. Paternal age, pregnancy outcome, and 
estimates of the date of conception for all pregnancies were obtained. Wives 
of the workers were not interviewed and maternal age and health status were 
not determined.
The fetal death rates in the families of the exposed workers were age- 
matched, for paternal age, with the control group, and the two groups were 
compared before and after exposure, ie, to vinyl chloride monomer for the 
exposed, group and to rubber and polyvinyl chloride fabrication emissions for 
controls [101]. Prior to exposure, there was no significant difference is 
fetal death rates between the offspring of vinyl chloride workers and those of 
the controls (6.1Z and 6.9Z). After exposure, however, this race was
significantly higher (P<0.05) for offspring of vinyl chloride monomer workers
(15.8Z vs 8.8Z). To determine the effect on the overall rate of fetal deaths 
of the data from women who chronically experienced abortions, workers' wives 
who had had more thas two abortions were excluded from the calculations. The 
results showed that prior to exposure the offspring of the controls had a
higher fetal death rate than those of vinyl chloride workers (6.92 vs 3.1Z),
but that after exposure of the fathers the rate for the offspring of the vinyl 
chloride workers was the higher (10.8Z vs 6.82).
Infante et al [101] postulated that germ-cell damage in the father was the 
leading possibility as the cause of fetal death. Unfortunately, this study
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relied on indirect knowledge of the key variable, fecal deaths, by 
interviewing only che fathers. Therefore, Che reliabilicy of this information 
muse be considered quescionable.
Infante [102] also compared che incidence of malformations among children 
born Co residencs of communities around polyvinyl chloride polymerization
planes in Ohio» He compared the raCe^ of producCion of malformed children
born in Chree cities with polyvinyl chlarlde plants with those in cities 
without such planes and with that of malformations in the entire state from 
1970-1973. Infante found a significant excess incidence (P<0.001) of
malformations in the three cities with polyvinyl chloride facilities above 
that in 10 cities without polyvinyl chloride plants. Although the  congenital
malformation rate in the cities with polyvinyl chloride plants was greater 
than the rate for the  3 t a t e ,  two cities without polyvinyl chloride plants had 
even ■ greater rates. Moreover, anomalies were not restricted to the cities 
with polyvinyl chloride exposures; for example, one clcy wlchout a plane had a 
higher race Chan two ciCies with plants. Infante conducted that these
preliminary findings did not link polyvinyl chloride production with an 
Increased occurrence of birth anomalies.
Edmonds et al [103] evaluated CNS birth defects recorded in Kanawha 
County, West Virginia, during 1970-1974 in an attempt to determine whether 
they were related to occupational or residential exposure of the parents to 
vinyl chloride from a local polyvinyl chloride plant. Kanawha was one of two 
counties, out of seven ÏÏS counties with polyvinyl chloride production plants, 
where CNS birth defects were significantly higher than the national rate for 
this 5-year period. Infants born with. CNS defects and whose parents were 
Kanawha County residencs were idencifled from Che register of the Center for 
Disease Control's Birth Defects Monitoring Program (BDMP) and records of the 
West Virginia Department of Vital Statistics. Infants without malformations 
born immediately before and after those born with CNS birth defects were used 
as controls. Families of 41 affected infants and of 1 of the 2 controls for 
each, selected randomly, were interviewed .to obtain histories ofprevior. 
pregnancies and residential and occupaClonal hisCories of che parencs for che 
5 years before the birth of the child.
BDMP and State records showed that the rate of CNS defecCs/10,000 births 
was higher in Kanawha County Chan in the United States as a whole for 1970, 
1971, and 1972 [103]. The Kanawha County rates for these years were 37.5,
39.7, and 34.9, respectively, compared with US rates of 21.8, 22.1, and 21.6. 
In 1973, however, che race of CNS birth defects in Kanawha County declined to
below the national average, and In 1974 the rate was only 3.0, compared with a
national race of 18.4. The Kanawha County rates differed significantly
(P<0.05) from the naeional races for 1970, 1971, and 1974.
The CNS birch defecC cases for Che 5-year period were closely macched wich 
controls for race, paternal education, maternal age, and socioeconomic status 
[103] as indicated by the Hollingshead Index. The groups did not differ
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significantly in maternal education or paternal age. All of the malformed 
Infanta were white and the majority were female C25:16). No seasonal 
variation in the rate of CNS birth defects was noted.
The reproductive histories of mothers in both groups were similar in the 
number of previous pregnancies and the percentage of live births and of other 
children with congenital anomalies [103]. However, a family history of birth 
defects was reported by 11 of the 41 families in the case group but by only 4 
of the 41 families in the control group. A family history of CNS birth 
defects wa5 reported in 5 of the case families but in none of the control 
families. Occupational histories showed that two fathers .... each group had 
been emp .oyed in the local polyvinyl chloride plant at the _ thel r infants
were cenceived, and that none of the mothers had ever worked in the polyvinyl
chloride plant.
In evaluating the distance from the polyvinyl chloride plant to both the 
place of work and the place of residence of the parents, Edmonds et al [103] 
found no significant differences between the birth defect and the control 
groups. However, multivariate analysis showed that, in families living within 
3 miles of the plant, CNS birth defect cases were concentrated in the area 
northeast of the plant (?<0.02). The authors attempted to determine whether 
this clustering was related to atmospheric vinyl chloride concentrations, but 
concluded that existing data on plant emissions and meteorologic conditions 
were insufficient to reconstruct vinyl chloride concentrations at the time of 
conception. Edmonds and his associates concluded that there was no evidence
Chat the high rate of CNS birth defects in Kanawha County for 1970-1974 was
related to vinyl chloride exposure.
(6) Summary
Although the results of the various vinyl chloride epidemiologic 
studies are sometimes contradictory, there is substantial evidence that 
workers in vinyl chloride plants may have an increased incidence of atypical 
liver function [76,78], increases in cancers' of the liver, brain, and 
respiratory systems [79,81,84-89], and increases in somatic chromosomal 
abnormalities [95,97-99]. One study [101] that suggested an increased fetal 
mortality due to exposure of the fathers to vinyl chloride has also been 
published; however, the method of data acquisition for this study was of 
questionable validity. Two reports [102,103] seem to indicate that birth 
defects and anomalies in offspring of parents living in the vicinities of 
vinyl chloride polymerization plants probably are not related to exposure to 
vinyl chloride.
Each of these studies has similar deficiencies, eg, the lack of exposure 
information for most cohorts, the relatively few workers for whom significant 
time has elapsed since first exposure, ie, >15 years, and the difficulties of 
assessing the "healthy worker" and "survivor" effects. Without this' 
information, it is impossible to quantitate the hazards from exposure to vinyl
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chloride. Although the results and conclusions of individual studies can be 
questioned on scientific grounds, chey justify an Increased concern about the 
hazard from increased exposure to vinyl chloride.
(b) Vinylidene Chloride
Ott et al [73] reported the mortality statistics and health examination 
findings on 138 workers exposed to vinylidene chloride containing small 
amounts (0.2Z) of vinyl chloride. Estimations of exposure were made on the 
basis of job descriptions and industrial hygiene data. Estimated career doses 
were then calculated based on duration of exposure and monthly average 
exposure concentrations. Mortality data for the cohort were compared with 
those for DS white males. Health examination data for the cohort were 
compared with data from controls paired as closely as possible ¿or age, 
smoking history, date of employment, and date of participation in the plant 
health Inventory program. Individuals in the control population were exposed 
to a variety of chemicals other than vinyl chloride used at the plant and 
therefore represented a background experience for chemical workers.
Comparison of the results of mortality experience of the total cohort, 
cohort with 15+ years of experience, and cohort with a total calculated dose 
exceeding 500 ppm-months (1,985 mg/cu m-monchs) showed no significant increase 
for any cause of death [73]. Comparison of the results of 17 clinical
laboratory parameters showed no significant differences between the matched
pairs of exposed and control workers. Regressions . of the individual pair 
differences on estimated cumulative dose and duration of exposure showed no 
positive correlations at the 0.05 level.
The authors [73] concluded that there were no findings "statistically
related or individually attributable to vinylidene chloride exposure" in the 
cohort studied. The study included few workers, however, and they were all
from a single plant. The authors recommended that additional epidemiologic 
studies be conducted to develop information on chronic exposure to vinylidene 
chloride. This study does not indicate that there is an occupational hazard 
from exposure to vinylidene chloride.
(c) Vinyl Bromide, Vinyl Fluoride, and Vinylidene Fluoride
No epidemiologic studies on workers exposed to vicryl bromide, vinyl 
fluoride, or vinylidene fluoride have been located.
Animal Toxicity
The results of experiments involving exposure of laboratory animals to 
vinyl halides show that some of these compounds can Induce the same toxic 
effects on rodents as on humans, Including the characteristic angiosarcoma of 
the liver. No lifetime animal experiments have been located that demonstrate 
a no-observable-adverse-effect concentration for any of the vinyl halides.
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(a) Vinyl Chlorid«
In 1975, Prodan et al [104] published estimates of LC50 values for a 2- 
hour exposure to vinyl chloride for several animal species* The values were 
27,419 ppm for mice, 47,640 ppm for rats, and 236,215 ppm for both guinea pigs 
and rabbits. However, there was an error in the authors' calculations, and 
thes« values should actually have been 117,500 ppm (300*8 g/cu m) for mice,
156.000 ppm (399.4 g/cu m) for rats, and 238,000 ppm (609.3 g/cu m) for guinea 
pigs and rabbits. The recalculated LC100 values were 150,000 ppm for mici,
210.000 ppm for rats, and 280,000 ppm for guinea pigs and rabbits. The 
authors reported that death was preceded by excitement, r.ontractioas and 
convulsions, and accelerated respirations. The excitement ph^se progressed to 
a state of "tranquility" characterized by Cheyne-Stoke i breathing and 
circulatory disturbances as Indicated by cyanosis and conjunctival congestion. 
This phase chen progressed into a state of deep narcosis chat was followed by 
respiratory failure and death.
Abreu and coworkers [105] surveyed the anesthetic effects of 18 
halogenated hydrocarbons, including vinyl chloride, on mice. The minimal 
certain anesthetic concentration (EC100 for anesthesia), highest tolerated 
concentration (LC0), 50Z anesthetic concentration (EC50 for anesthesia) and 
50Z lethal concentration (LC50) on inhalation were estimated. To establish 
each point on each substance’s effect-concentration of the curve, the authors 
exposed 10-40 mice to vinyl chloride for 10 minutes by inhalation. The ratio 
of the highest tolerated concentration to minimal certain anesthetic 
concentration was calculated as the "certain safety factor." The ratio of the 
50Z lethal concentration to the 50Z anesthetic concentration was calculated as 
the "50Z safety factor." Vinyl chloride had a minimal certain anesthetic 
concentration of 5.0 millimoles/liter (122,000 ppm; 312.3 g/cu m), a highest 
tolerated concentration of 9.0 millimoles/liter (220,000 ppm; 563.2 g/cu m), a 
"certain safety factor" of 1.8, a 501 anesthetic concentration of 4.1 
millimoles/liter (100,000 ppm; 256 g/cu m), a 50Z lethal concentration of 9.9 
millimoles/liter (242,000 ppm; 619.5 g/cu m), and a "50Z safety factor" of 
■2.4. _ '
Aviado and Smith [106] reported the results of studies on sodium 
phénobarbital anesthetized rhesus monkeys exposed to vinyl chloride at 
concentrations of 2.5, 5.0, or 10.0Z (25,000, 50,000, or 100,000 ppm; 64, 128, 
or 256 g/cu m). The vinyl chloride was administered to one animal at each 
concentration through a tracheal cannula for 5 minutes, alternating with 15 
minutes of room air. Pulmonary resistance and compliance were estimated from 
measurements of tracheal airflow and transpulmonary pressure. Although 
control procedures were not discussed, it is assumed that each animal served 
as its own control.
Pulmonary resistance increased and pulmonary compliance and respiratory 
minute volume decreased with increasing vinyl chloride concentrations [106]. 
The only values of the exposed animtls that were significantly different 
(P<0.05) from those of controls were pulmonary resistance (15.35Z higher than
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controls) and respiratory minute volume (12.302 lower than controls) at vinyl 
chloride concentrations o£ 102. No significant changes in heart rate or 
aortic blood pressure were observed in these animals.
Oster et al [107], in 1947, investigated the anesthetic effects on dogs of 
vinyl chloride gas mixed with oxygen. Two dogs were "momentarily" exposed to 
vinyl chloride at a 502 concentration (500,000 ppm; 1,280 g/cu m) which was 
then decreased to 72 (70,000 ppm; 179.2 g/cu m) by volume. During exposure, 
the dogs maintained good abdominal relaxation, but their legs became rigid and 
muscular movements became uncoordinated. A third dog, anesthetized with 252 
vinyl chloride, had signs similar to those in the first two dogs. After 
exposure the dogs continuously "crowed" and salivated heavily.
Four additional dogs received a local anesthetic, monocaine hydrochloride, 
and their blood pressures were checked by cannulation of the femoral artery 
[107]. After control blood pressure measurements were obtained, the animals 
were anesthetized with 102 vinyl chloride (100,000 ppm; 256 g/cu m) in oxygen. 
During the vinyl chloride' exposure, the dogs had normal blood pressures, but 
they showed such cardiac irregularities as Intermittent tachycardia, 
ventricular extrasystoles, and vagal beats.. Similar irregularities were 
detected with a stethoscope in noncannulated dogs on the same exposure 
regimen.
Six other dog3 were anesthetized wi'h 102 vinyl chloride (100,000 ppm) in 
oxygen [107]. Electrocardiographic (ECG) records (lead II) were obtained a^ 
exposures to vinyl chloride (not further defined) sufficient to produce light 
surgical anesthesia, surgical anesthesia, and threatened respiratory collapse. 
At exposures producing surgical anesthesia, several changes were noted In the 
cardiac rhythm, especially marked tachycardia followed by bradycardia. In 
addition, two of the six dogs showed R-wave inversions, and one dog showed 
incipient ventricular fibrillation. All six dogs showed abnormalities in the 
ECG record, ranging from sinus arrhythmia and transitory extreme left axis 
deviation, to atrioventricular (A.-V) . blocks ventricular tachycardia,, 
ventricular multifocal extrasystoles, and inversion of the T-wave with 
elevated ST segments. As ttie concentration of vinyl chloride was increased 
toward that necessary for respiratory failure, the ECG abnormalities 
disappeared except for the greatly reduced R-wave amplitude. The authors 
concluded that vinyl chloride caused muscular incoordination in the 
extremities and serious cardiac arrhythmias. They also concluded that vinyl 
chloride was not safe as an anesthetic and that its use in humans was not
warranted.
In 1974, Belej et al [108] reported the changes in cardiac function of
rhesus monkeys exposed to vinyl chloride at concentrations of 2.5, 5.0, and
10.02 (25,000, 50,000, and 100,000 ppm; 64, 128, and 256 g/cu m). Three
animals were exposed at each concentration. They were anesthetized with 
sodium phenobarbital, their tracheae were caanulated for artificial 
respiration, and their chests were opened by midstemal incisions to allow 
measurement of myocardial contractility, pulmonary arterial, aortic, and left
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atrial pressure. The vinyl chloride mixtures were administered for periods of 
5 minutes alternating vlth lQ-ttinute exposures to room air. The number of 
test periods for each animal was not specified. Control procedures were not 
reported, but each animal probably served as Its own control.
The heart rate and aortic, left atrial, and pulmonary arterial pressures 
were not significantly different between any of the experimental and control 
groups [108]. The force of myocardial contraction in animals exposed to 10Z 
vinyl chloride was significantly different (P<0.05) from control values, 
showing a decrease of 28.5Z. At 5Z vinyl chloride there was a 9.1Z decrease, 
and at 2.5Z vinyl chloride there was a 2.3Z decrease; however, these latter 
changes were not significant. Decreases in aortic blood pressure, while not 
significant, paralleled decreases in contractility.
Carr et al [109] demonstrated that inhalation of certain compounds 
increased the sensitivity of the canine heart to epinephrine. Lead II of the 
ECG was recorded from each of seven unanesthetized dogs in the experiment. 
Epinephrine hydrochloride Was injected iv at a dose of 0.01 mg/kg during 25-40 
seconds, and the ECG was again recorded. Subsequently, the animals were 
exposed to vinyl chloride at concentrations of from 15 to 90Z with oxygen. 
After the dogs had inhaled the vinyl chloride for 10-20 minutes, the ECG 
recording and epinephrine injection were repeated. Three of the seven dogs 
developed sensitization of the myocardium with multifocal ventricular ectopic 
tachycardia after vinyl chloride exposure. The authors concluded that viayl 
chloride produced sensitization of the myocardium, bu- is frequently than 
did its saturated analog, ethyl chloride. The total exp-..>^es used were too 
high to allow a conclusion about whether inhalation of vinyl chloride may pose 
an acute threat to workers in times of fear-provoking stress or to those who 
may take medication containing epinephrine for asthma control or other 
reasons.
Clark and Tinston [110] exposed beagle dogs to vinyl chloride at various 
concentrations by mask, for 5 minutes. During the final 10 seconds of 
exposure, a' 5-jxg/kg injection of adrenaline was administered iv. ECG's were 
recorded and analyzed for 3erious arrhythmias, such as multifocal ventricular 
ectopic beats or ventricular fibrillation. At each concentration., four to 
seven dogs were exposed. Vinyl chloride was calculated, by a moving average 
interpolation technique, to have induced cardiac sensitization in 50Z of the 
animals at a concentration of 5Z.
In 1970, Viola [111] reported on the effects on rats of exposure to vinyl 
chloride. Twenty-five male albino Wistar rats with an average weight of 150 g 
were exposed to vinyl chloride at a concentration of 3Z (30,000 ppm; 76.8 
g/cu m) for 4 hours/day, 5 days/week, for 1 year. Twenty-five similar rats 
served as controls. Throughout the exposure period, the general physical
appearance, behavior, and body weight of the animals were monitored. After 
the exposures, some of the exposure survivors and some of the controls were 
killed at 20-day intervals, and gross and microscopic changes in the paws,-
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brain, liver, kidneys, and thyroid were noted. The number of rats surviving, 
Che number of examinations conducted, and the number of rats killed at each 
interval wexe not specified.
Exposure to vinyl chloride did not slgnlflcartly affect growth but was 
slightly soporific to the animals during the first 10 months of exposure 
[111]. During the 11th month, the exposed rats had lower body weights and 
showed less aggressiveness and less reaction to external stimuli chan the 
controls; they also suffered disturbances In equilibrium. No details about 
Che observations made were presented. Of che rats exposed to vinyl chloride, 
13 died from cardiopulmonary complications and 2 died from hematoperltoneum. 
On microscopic examination, the authors observed chac most of che animals 
showed pathologic changes in the brain, liver, kidneys, and thyroid, and that 
six rats showed skeletal alteratious. He did not reporc whether these changes 
ware observed in the rats that died during exposure or in those that were 
killed after che exposure. The paws of che vinyl chloride-exposed racs had 
areas of hyperkeratosis, superficial chickening of the epidermis, and 
disappearance of che cucaneous "adnexa." In addition, vacuolizaCion and 
degeneradon of che basal layer, a modest increase in the papillar layer, and 
edema of the epidermis were noted. The connective tissue of the skin showed 
fragmentation and decreased elastic reclculum and dissociation of collagen 
bundles. The small arcerlal vessels of che paws showed signs of endothelial 
fibrosis, and some vessels were completely occluded by proliferation of 
connective tissue.
Extensive metaplastis proliferadon of cartilage-like material was found 
around the small metatarsal bones [111]. The edges of the material were 
Irregular, with differential growth chac resulced in outward bending of Coes» 
in areas of mature compact bone, che carcllaglnous elements were grouped 
around a cencral nucleus of the bone, giving che appearance of chondroid 
metaplasia. In small bones, this chondroid metaplasia was often extensive, 
and the bones appeared to be impregnated with a mucoid substance that 
obliterated the cement lines by altering the characteristic deposition of the 
bone tissue.
Microscopic examination of the brains of rats exposed l c  vinyl chloride 
showed diffuse degenerative lesions of the gray and white matter [111]. 
Flbrotic processes had often surrounded and Invaded the small nerve bundles of 
Che gray maCter. There was also evidence of neuronal phagokaryosis with 
satellltosls and deposition of neuroglial elements around the altered nerve 
cells of che whice matter. In the cerebellum, there were signs of atrophy of 
the granular layer and profound degenerative changes in some areas of the 
Purkinje cell layer.
“Animals exposed to vinyl chloride had enlarged livers [111]. Some livers 
appeared yellowish with smooth surfaces and were slightly more britcle chan 
normal. Microscopic examinacion revealed signs of diffuse interstitial 
hepatitis, functional degeneration or necrosis of the hepatic cells, and 
marked cytoplasmic and nuclear polymorphism. The Kupffer cells were often 
hypertrophic and showed evidence of abnormal proliferation. Numerous areas of
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partial necrosis and diffuse fatty degeneration often blocked the portal 
capillaries, centrllobular veins, and sinusoids. Intense fibrosclerocic 
reactions were also noted in the areas of degenerative change in the livers 
of a few exposed rats.
In contrast, the kidneys of the exposed animals were relatively 
unaltered except for signs of tubulonephrosis and occasional chronic 
interstitial nephritis [111]. The author also noted colloid goiters and a 
marked increase in parafollicular cells in the thyroids of several animals. 
Examination of the controls showed no alterations in any of the organs.
The author [111] concluded that his investigation confirmed that rats 
were sensitive to vinyl chloride and that the lesions of bone and 
connective tissue were similar to those described in workers affected by 
acroosteolysis of the hands and to those in experimental "osteolathyrism." 
This report is valuable for its characterization of the systemic toxic 
effects resulting from chronic exposure to vinyl chloride. An assessment 
of the hazard posed by exposure to vinyl chloride is not possible; however, 
because the information was not presented in sufficient detail to permit a 
statistical analysis. Observations on tumors produced in animals that were 
probably the same a& those in this paper were presented in a second paper 
by Viola et al [112] and are discussed in a subsequent section of this 
chapter.
In 1961, Torkelson et al [113] reported a three-part investigation on 
the effect of repeated exposure of rats, rabbits, dogj, and guinea pigs to 
vinyl chloride at 50, 100, 200, or 500 ppm (128, 256, 512, 1,280 mg/cu m ). 
In the first experiment, groups of 10 male and 10 female rats were placed 
in a 160-liter inhalation chamber containing vinyl chloride at a nominal 
concentration of 500 ppm for 7 hours/day, 5 days/week, for 4.5 months. The 
control group consisted of five male and five female rats.
Male rats exposed repeatedly at 500 ppm for 4.5 months showed at 
significantly higher (P<0.001) liver-to-body weight ratio than the controls 
[113]. Of the 20 exposed rats, 3 males and 1 female died during the 
exposure. Microscopic examination showed an increased centrllobular 
granular degeneration of the liver and interstitial and tubular changes in 
the kidneys.
In the second experiment, the animals exposed to vinyl chloride at 
nominal concentrations of 100 or 200 ppm (£152) for 7 hours/day, 5 
days/week, for 6 months, included 20-24 male and 24 female rats, 10 male 
and 8 female guinea pigs, 3 male and 3 female rabbits, and 1 male and 1 
female dog [113]. In addition, eight groups of five male r*ts each were 
exposed at nominal concentrations of 100 or 200 ppm (£152) for 0.5, 1, 2,
or 4 hours/day, 5 days/week, for 6 months. For each species and regimen, 
two control groups carefully matched on the basis of age, condition, and 
weight were used, one group of colony controls, and the other air-exposed 
in the chamber on a regimen similar to that of the experimental groups.
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Of the 24 rats exposed at 100 ppm for 7 hours/day, 5 males and 1 female
died [113]. All racs exposed repeatedly for 7 hours/day shewed slight but
significant; increases (?<0.05) in liver weight.
Repeated exposure to vinyl chloride at. 200 ppm for 7 hours/day for 6 
months resulted in the deaths of 3 of 12 rats [i. 13]. Of the five rata in each 
"short exposure" group, one, two, one, and one died after exposure for 0.5, 1, 
2, and 4 hours/day, respectively. Organ weights were normal In all species, 
except that liver weights Increased in rats exposed repeatedly for 7 
hours/day. At 8 weeks after exposure, male rats continued to have Increased 
liver weights, but the weights appeared to be returning to normal. Increases 
in liver weight of rats exposed for 2 or 4 hour3/day were not statistically 
significant. All the rats exposed for 0.5 or 1.0 hour/day had normal organ 
weights compared with those of control rats. Microscopic examination showed
liver changes characterized by centrilobular granular degeneration and
necrosis with some foamy vacuolization in male rabbits and periportal cellular 
infiltration in female rabbits.
In the third experiment, 24 male and 24 female rats, 12 male and 12 female 
guinea pigs, 3 male and 3 female rabbits, and 1 male and 1 female dog were
exposed to vinyl chloride at a concentration of 50 ppm for 7 hours/day, 5
days/week, for 6 months [113]. Three additional groups of 10 male rats each 
were exposed for 1, 2, or 4 hours/day, 5 days/wesk, for 6 months. Matched
groups of control animals were again used. Vinyl chloride concentrations in 
the chamber were determined by micro-Volhard titration. Repeated exposures to 
vinyl chloride at 50 ppm did not produce toxic signs in any of the animals. A 
decrease in the kidney weight was observed is the female rats, but it was not 
attributed to the exposure since it was not observed at higher concentrations.
Animals exposed repeatedly at 100, 200, or 500 ppm were found to have
normal biochemical and hematologic values and urinalysis tests [113]. Serum 
enzyme activities were normal is all dogs, rats, and rabbits. None of the 
organs examined had macroscopic tissue changes at. any exposure concentration. 
The authors concluded that repeated exposures f-»r 7 hours/day at 100 ppm could 
cause increased liver weight.
Lester et al [18] conducted four experiments witn Sherman strain rats. In 
the first experiment, an unspecified number of rats were exposed in pairs to 
vinyl chloride at various concentrations for up to 2 hours In an exposure 
chamber. No control animals were described. In the rats exposed to vinyl 
chloride at a concentration of 5Z (50,000 ppm; 128 g/cu m), the righting 
reflex was lost; at 6Z (60,000 ppm; 153.6 g/cu m), however, it was said to be 
still present, but it was absent in rats exposed at 7Z (70,000 ppm; 179.2 
g/cu m). The corneal reflex disappeared at a vinyl chloride concentration of 
10Z (100,000 ppm; 256 g/cu m). Tne animals rapidly returned to normal after
removal from the chamber. .One rat was killed after exposure to vinyl chloride 
at 10Z but showed no gross signs of adverse effects. Two rats exposed to 
vinyl chloride at 15Z were deeply anesthetized within 5 minutes. One rat had
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effusions of fluid from Che mouth and died cf asphyxia la 42 minutes; autopsy 
revealed edema and coogesclon of che lungs. The ocher ¡rat remained under deep 
anesthesia for 2 hours bue recovered promptly when removed from Che exposure.
In Chelr second experiment with rats, Lescer et al [18] randomly assigned 
18 male and 18 female rats co an experimental group and a control group. The 
experlmenCal animals were exposed Co vinyl chloride aC a concentration of 10Z 
(reduced co 8Z after 2 days) between 8:30 am and 4:30 pm. Two female raCs and 
an unspecified number of male rets in the experimental group died early in the 
experiment and were replaced, A total of three female rats died (days 2, 5, -
and 14) in the course of vinyl chloride exposure, and only two males survived 
all 15 day3 of exposure. In addition to mortality, exposure to vinyl chloride 
at a concentration of 3Z was associated with a failure to gain weight until 
day 9, followed by weight gain at a slower rate than the controls until the 
cessaClon of exposure, after which Che rates were equal. Neither grci'3 nor 
microscopic differences were noted becween experimencal and concrol livers and 
kidneys at necropsy. Some rats had parasitic liver cysts and focal 
necroclzlng pneumonia, buC kidneys were wlchln normal llmics of varlabillCy. 
Microscopic examination of the spleens of experimental rats showed a 
significantly higher incidence of severe abnormality than was found in 
controls, although some individual rats in the control group manifested 
equally severe splenic abnormalities.
Lester et al [18] performed anocher experimenc to ascertain whether vinyl 
chloride was a lung irritant. Three female and five male rats, matched with 
controls, were exposed as before for 8 hours daily for 19 consecutive days Co 
vinyl chloride at a concentration of 5Z in air. All animals were deprived of 
food and water while in the exposure chamber. Hemoglobin determinations were 
made during the exposure period. On the 20th day, all animals were 
anesthetized with ether, and blood was drawn by cardiac puncture. The animals 
were killed by an overdose of ether, and necropsies were performed. The 
terminal blood sample was tested for hemoglobin, prothrombin time, hematocrit, 
red cell, white cell, and differencial white cell counts, and unspecified 
serum transaminase activities. Prochrombin time, hematocrit, and the serum 
transaminase activities were normal for both groups. The experimencal group 
had a statistically significant increase (PC0.05) in red blood cells and a 
decrease (P<0.01) in white blood cells. The differential white cell counts of 
control and experimental groups were not significantly different. The ratio 
of the weight of the liver to the body weight was significantly elevated 
(males, P<0.01; females, P<0.001) In the experimental group. The five male 
experimental animals had thinner coats than normal and scaly calls; all other 
rats were normal In appearance. One of the experimental males had fibrous 
pleural adhesions, but these appeared to be old and unrelated to che 
experimental exposure. Microscopic examination of all organs and tissues 
failed to disclose abnormalities other than those in the liver in either 
group. There were no differences in intracellular or total fat in the liver, 
but livers in the experimental group had widespread swelling and vacuolization 
of cells with compression of the sinusoids. This difference was significant 
(P<0.001).
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In £ha last experiment of the aeries, rats were exposed to vinyl chloride 
ae a concentration of 2.0Z for 8 hours/day, 5 days/week, for 3 months [13]. 
Sixty rats weighing about 75 g were separated randomly into two groups, each 
consisting of 15 males and 15 females. In the week before the rats were 
exposed to vinyl chloride, they were observed and weighed and blood was taken 
for hemoglobin determinations. All rats were weighed weekly, and hemoglobin 
determinations were made monthly. Four control and one experimental animal 
died in the course of the experiment. After 3 months, all animals were killed 
for necropsy after blood samples were drawn. The livers and spleens were 
veighed before being fixed in formalin. No significant differences were noced 
between the experimental and control body weights, hemoglobin levels, 
hematocrits, prothrombin times, or white cell monocyte and eosinophil counts. 
The livers of the experimental animals were significantly heavier (P<0.001) 
and the spleens significantly lighter (males, P<0.02; females, P<0.05) than in 
the control group. The experimental rats also had a statistically significant 
decrease (?<0.01) in white blood cell and neutrophil counts and an increase 
(?<0.01) in lymphocyte counts, when compared to the controls. 
Microscopically, the experimental group had fewer signs of kldnr.y damage but 
more extensive liver damage, as indicated by swelling of cells and compression 
of sinusoids, than controls. No microscopic differences between the spleens 
of the two groups were noted.
In this 1963 paper, Lester and coworkers [18] concluded that the only
suggestion of a specific toxic action of vinyl chloride was the increase in 
liver weight; the Increase was not only statistically significant, but also of 
substantial magaitude (30Z heavier than controls). The authors stated that 
they did not know the significance of the increase in liver weight after 
exposure to vinyl chloride, nor whether the liver returned -o normal after 
exposure ceased. In addition, the authors pointed out the increasing 
neurologic deficits with increasing concentrations of vinyl chloride, finally 
terminating in death from respiratory insufficiency at concentrations of 15Z 
for a single exposure or of 10% for repeated exposures.
(t>) Vinylldene Chloride
In 1963, Irish [114], stated that there were at that time essentially ac 
published data on vinylldene chloride toxicity and summarized dat. from 
unpublished reports of the Dow Chemical Company. He presented no detailed
information on the animals exposed in these studies. "Brief" exposure Co 
vinylldene chloride at concentrations around 4,000 ppm (15.9 g/cu m) was said 
to have rapidly produced "drunkenness," which progressed to unconsciousness if 
the exposure was continued. The author stated that vinylldene chloride
irritated the eyes, and, in liquid form, Irritated the skin. Animals exposed
at concentrations of 25, 50, and 100 ppm (99.3, 198.5, and 397 mg/cu m) for 8 
hours/day, 5 days/week, for several months exhibited unspecified liver ana 
kidney damage. Irish concluded that vinylldene chloride produced adverse 
effects at concentrations below those necessary to produce irritation and 
below the odor threshold of 500-1,000 ppm.
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Jaeger et al [115] estimated Che LC50's for fed and faseed rats exposed Co 
vinylidene chloride. One group of male Holeroan racs weighing 250-400 g was 
allowed continuous access Co food; anocher group was fasced for 18 hours 
before exposure.
Eight groups of fasted racs and six groups of fed rats, each group 
consisting of five or six animals, were exposed to vinylidene chloride ac 
various concencracions for 4 hours [115]. The 4-hour LC50 ac 24 hours for the 
fasCed racs was 600 ppm (2,382 mg/cu m) and Che 24-hour minimum lethal 
concencracion was 200 ppm (794 mg/cu m). The estimated 4-hour LC50 at 24 
hours for Che fed rats was 15,000 ppm (59.6 g/cu m), and the minimum lethal 
concentration for these animals was 10,000 ppm (39.7 g/cu m).
The authors [115] suggested that decreases in glutathione concentration in 
the livers of fasted rats was a possible explanation for the differences in 
lethality. They pointed out that this could be of importance with regard to 
the occupational risk because of che known circadian pattern of glutathione 
concentrations in the liver.
Siegel ec al [116] published che results of experiments on several 
dichloroacetylene mixtures. For comparative purposes, they determined LC50's 
for vinylidene chloride and several other compounds. The 14-day LC50 of 
vinylidene chloride for male Sprague-Dawley rats was estimated to be 6,350 ppm 
(25.2 g/cu m) for a 4-hour exposure.
Short et al [117] reported the LC50 at 14 days and the 20-ppm LT50 for CD- 
1 mice exposed to vinylidene chloride for 22-23 hours. The LC50 for males was 
93 ppm (389 mg/cu m) (95Z confidence limits, 82-118 ppm), and for females it 
was 105 ppm (416.9 mg/cu m; 92-121 ppm). When the exposure periods were 
Increased to 2 days at 22-23 hours/day, the LC50 for male mice was 35 ppm (139 
mg/cu m). The LT50 for males was 4 days (3.6-4.4) at 20 ppm (79.4 mg/cu m). 
Concentrations of vinylidene chloride were measured by gas-liquid 
chromatography; other experimental details for these determinations were not 
given.
Carpenter et al [118] reported the effects of inhalation of vinylidene 
chloride on Sherman albino rats weighing 100-150 g. The authors reported that 
the concentration of vinylidene chloride sufficient to kill two to four of six 
tesc animals wlchin 14 days afcer a 4-hour exposure was 32,000 ppm.
Balmer et al [119] also performed a study to determine the inhalation 
toxicity of vinylidene chloride in rats. A group of 104 male and 104 female 
Sprague-Dawley rats was exposed to vinylidene chloride at a concentration of 
10 ppm (39.7 mg/cu m) for 6 hours/day, 5 days/week, for up to 18 months. A 
similar group was exposed at 40 ppm (158.8 mg/cu m) on the same schedule, and 
another group served as controls. After 30 days, four males and four females 
from each group were killed and examined. Because examination showed no 
effects, at the end of week 5 exposure concentrations wera increased to 25 and 




from each group were killed and examined, and after 7 months, four animals of 
each sex from each group were killed, and bone marrow cells were prepared for 
cytogenetic examination. After 12 months of exposure, five additional animals 
of each sex from each group were killed and examined. Exposure ended at 18 
months, and any animals remaining alive at 24 months were killed and examined.
Balmer ec al [119] stated that "no clinical signs of toxicity were seen at 
any time." There were no signs of cytogenetic effects, and no hematologic or 
clinical cherlcal changes were relatable to the vinylidene chloride exposure. 
No significant differences in mortality, tumor formation, or gross pathology 
o' the internal organs were observed. On microscopic examination, che livers 
of the animals exposed at both concentrations showed increased cytoplasmic 
vacuolatiou in the hepatocytes.
The authors [119] concluded that inhalatica of vinylidene chloride at 
concentrations of 25 or 75 ppm resulted in "minimal liver changes" and did not 
cause an increase in tumors in rats.
Gage r i 2 0 ] ,  in 1970, presented the result«? uf an inhalation study of 
several industrial chemicals, including vinylicfear, chloride, on Alderley Park 
specific-pathogen-free rats weighing an average of 200 g. Groups of four male 
and four female rats were exposed to vinylidene chloride vapor at
concentrations of 200 or 500 ppm (794 or 1,985 mg/cu m) for 6 hours/day, 5
days/week, for 4 weeks. Concentrations of vinylidene chloride in the exposure
chamber were monitored by gas chromatography. During the exposures, the 
animals were checked for any change in weight and activity. The rats were 
killed at the end of the exposures, and blood and organs were collected and 
tested. Macroscopic and microscopic examinations were performed on organs and 
fixed tissues. Rats exposed at 500 ppm developed nasal irritation (sneezing), 
did not gain weight normally, and suffered liver cell degeneration. Rats 
exposed at 200 ppm suffered only slight nasal irritation, and all organ.* were 
normal on necropsy. No further data were presented by the author.
Slletchnik and Carlson ri21J published the results of a study to determine 
Che cardiac sensitizing effects of vinylidene chloride. Adult male Charles 
Rivers rats weighing 250-400 g were lightly sedated with 25 mg of sodium 
pentobarbital/kg 4p, restrained, and then exposed to vinylidene chloride at 
25,600 ±700 ppm (101.6 ±2.8 g/cu m) for periods of 10 minutes or longer. The
rats were prêtre; ted with 4 Mg of epinephrine/kg, and the m-fn-fmum amount of 
epinephrine naces^ary to produce cardiac arrhythmias or demonstrate a
difference between pairs of animals was determined. The exfect of phéno­
barbital was determined using weight-matched pairs of animals. One animal of 
each pair was administered phenobarbita1, 50 mg/kg ip, daily for 4 days and 
exposed to vinylidene chloride 24 hours after che last dose. The pair mate in 
each case received injections of saline and was similarly exposed to 
vinylidene chloride.
In rats exposed to air alone, epinephrine at 4 ^g/kg did not elicit any 
cardiac arrhythmias [121]. The authors stated that vinylidene chloride alone
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caused sinus bradycardia and such arrhythmias as A-V-block, multiple 
continuous premature ventricular contractions, and ventricular fibrillation; 
they presented no further Information. Epinephrine at doses as low as 0.5 
Mg/kg elicited cardiac arrhythmias in 29 animals exposed to vinylldene 
chloride. Sensitivity to epinephrine Increased with increasing length of 
exposure to vinylldene chloride. The Increased sensitivity to epinephrine was 
reversible, since 5 minutes after removal from exposure the animals were again 
able to tolerate high doses of epinephrine without showing arrhythmias.
Premature ventricular contractions were seen in animals pretreated with 
phénobarbital, exposed to vinylldene chloride, and challenged with epinephrine 
[121]. No arrhythmias were seen in the saline-traated animals challenged with 
the same amount of epinephrine. Arrythmias were produced in the 
phenobarbital-created animals at a lower epinephrine dose and a shorter 
exposure to vlnylidene chloride.
The authors [121] concluded that the phénobarbital probably Induced 
vlnylidene chloride metabolizing hepatic enzymes and that a metabolite caused 
the cardlotoxlc effects. They further stated that, since the adrenal gland in 
humans may release up to 4 ;ig/kg/mlnute of adrenalin during stress, workers 
exposed to high concentrations of vinylldene chloride may be under a risk of 
these cardlotoxlc events.
Prendergast et al [122] conducted a series of Inhalation studies to 
determine the effects of vlnylidene chloride and other chlorinated 
hydrocarbons on Sprague-Dawley or Long-Evans rats, Hartley guinea pigs, New 
Zealand White rabbits, beagle dogs, or squirrel monkeys. The exposed anlmal3 
were subjected either to continuous 90-day exposures or to repeated 8-hour 
exposures, 5 days/week, for 6 weeks. The animals repeatedly exposed to 
vinylldene chloride Included 15 rats, 15 guinea pigs, 3 rabbits, 2 dogs, and 3 
monkeys. Continuous exposures involved groups of 15 or 45 rats, 15 or 45 
guinea pigs, 3 rabblesr 2 or 6 dogs, and 3, 9, or 21 monkeys. A control group 
consisted, of 304 rats, 314 guinea pigs» 48 rabbits, 34 dogs, and 57 monkeys« 
The concentrations of vlnylidene chloride were monitored by gas-liquid 
chromatography. The concentrations of vlnylidene chloride In the chamber 
during the continuous exposure were 20 ±2.1, 61 ±5.7, 101 ±4.4, or 189 ±6.2 
mg/cu m (5, 15.4, 25.5, or 47.6 ppm), and the concentration during the 
repeated exposure was 395 ±32 mg/cu u (99.5 ppm).
Immediately after each experiment, the animals were killed and necropsies 
were performed [122]. To estimate the effects of vinylldene chloride 
inhalation, the authors measured liver alkaline phosphatase, SGPT, serum urea 
nitrogen, and liver lipid content, and made hematologic determinations. In 
the control populations, 7/304 rats, 2/314 guinea pigs, 2/48 rabbits, and 1/57 
monkeys died prematurely.
Animals repeatedly exposed to vinylldene chloride at 395 mg/cu m (99.5 
ppm) showed no microscopic tissue changes relatable to the exposure when 
compared with control tissues [122]. Gross examination of tissues showed no
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changes la any anímala except for one rat that had a gelatinous substance on 
Its kidney and bloody urine In the bladder. The microscopic examination 
showed only nonspecific respiratory inflammation, which the authors considered 
not to be the result of vlnylldene chloride exposure. They did not give any 
reasons for this conclusion. None of the repeatedly exposed animals died 
during the exposure, and only rabbits and monkeys lost weight.
Of the animals exposed continuously at 189 mg/cu m (47.6 ppm), seven 
guinea pigs died between days 4 and 9, and three monkeys died, one each on 
days 26, 60, and 64 [122]. Gross examination showed mottled livers in a
majority of the experimental animals. Exposed rabbits, dogs, and monkeys lost 
weight, while rats and guinea pigs gained weight during the exposure. There 
were Increases in liver alkaline phosphatase and SGPT activity in rats and 
guinea pigs, but there were no significant changes in any other biochemical 
parameters. Two rats also showed Increases of 202 and 34.42 in liver lipid 
content. Serum urea nitrogen concentrations in exposed rats were comparable 
with those of control rats. Three of the 15 guinea pig3 that were exposed at 
101 mg/cu m '23.5 ppm) died between the 3^d and 6th exposure days, and 2 of 
the 3 monkeys exposed at 101 mg/cu m died, 1 on day 39 and the other on day 
47. White or bluish-gray spots and nodules were visible on the lungs of
several guinea pigs and rats. Serum urea nitrogen concentrations of exposed 
guinea pigs were comparable with those of the control group.
Continuous exposure: at 61 mg/cu m (15.4 ppm) resulted in the deaths of 3
of the 45 guinea pigs on days 3 and 4 of exposure [122]. The exposed monkeys 
lost weight, and exposed rats gained less weight than the controls. Several 
animals of all species had mottled livers and spleens.
Two of the 45 rats, 2 of the 45 guinea pigs, and 1 of the 21 monkeys 
exposed continuously at 20 mg/cu m (5 ppm) died [122]. The dogs lost weight, 
and the rats gained less than controls. Gross examination showed mottled 
livers in about one-third of the exposed animals. Microscopic changes were 
seen in the kidneys and liver of the exposed monkeys and nonspecific 
inflammatory changes in the- lungs of all animals exposed at 
concentration. The authors did not attribute the lung changes to the
vlnylldene chloride exposure. They did not give any reasons for this 
conclusion. Liver damage was noted in anl'nals exposed to vlnylldene chloride 
at 189 mg/cu m (47.6 ppm). Although animals exposed at 61 and 20 mg/cu m 
(15.4 and 5 ppm) also had signs of liver damage, the authors did not consider 
these attributable to the exposures to vinylidane chloride, since those 
exposed at 101 mg/cu m (25.5 ppm) did not exhibit these changes. Hematologic 
test results for exposed animals were similar to those for the controls.
In 1977, Humlston et al [123] and Rampy et al [124] reported the results 
of a study of the oral toxicity of vlnylldene chloride. Groups of 48 male and 
48 female Sprague-Dawley rats were given access to vlnylldene chloride in 
their drinking water at nominal concentrations of 50, 100, or 200 ppm
(equivalent ranges of daily intake: 5-12,'8-20, 16-40 mg/kg) for 730 days.
Eighty male and 80 female rats served as controls. The typical impurities of
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Che vlnylldene chloride used in this study was reported by Rampy et al [124] 
as: vinyl bromide, 4 ppm; vinyl chloride, 3-5 ppm; trana-l,2-dichloroethene,
138-1700 ppm; cis-I,2-dichloroethene, 24-680 ppm; 1,1,1-trichloroethane, 2-60 
ppm; 1,1,2-trichloroeChane, 48 ppm; hydrociuinone monouethyl ether, 2 ppm.
The appearance and demeanor of the rats ingesting vlnylldene chloride were 
not different from those of controls throughout- the atudy [123]. Body weight 
gains and food and water consumption were similar for experimental and control 
animals. No compound-related abnormalities were m  :ed In the results of 
hematologic studies, urinalyses, or serum chemistry analysas. No significant 
differences were noted in mean organ weights or organ *"o body weight ratios.
Gross and microscopic examinations revealed occasional statistical 
differences between exposed and control animals [123]. The differences 
considered compound-related were fatty changes or fatty degeneration of the 
liver in female rats in the 50, 100, and 200 ppm groups and in male rats ia 
the 200-ppm group. Although the incidence of these liver lesions in the males 
of the 100-ppm group was not significantly increased, it was higher than that 
in the controls. Centrllobular atrophy and periportal hypertrophy were also 
seen in the liver of the exposed animal«. No target organ was found that 
showed a tumorlgenic effect which was considered compound-related, and the 
total tumor incidence in male and female rats In the various exposure groups 
was not considered different from that in the controls.
Humiston et al [123] concluded chat the only compound-related deviations 
in these rats were the fatty changes or fatty degenerations of the liver. All 
other statistically significant deviations observed were considered to be 
within the normal variation encountered in lifetime studies with this strain 
of rat. They also concluded that these results did not indicate an "oncogenic 
effect for vlnylldene chloride ingested by rats." The data indicate that if a 
carcinogenic potential for rats exists for vinvlidene chloride, these 
cumulative doses muat be lower than that necessary to promote the expression 
of that potential.
Jaeger et al [125] gave single doses of vlnylldene chloride dissolved in 
corn oil by stomach tube to lightly ether-anesthetized male Holtzman rats 
weighing 250-350 g. The rats were fasted for 4 hours before they received the 
vlnylldene chloride. Anesthetized control rats received corn oil only. Some 
of the experimental rats were given ip injections of sodium phénobarbital (30 
mg/kg) to aid in measuring the time-response relationship for vlnylldene 
chloride. This was indicated by the time between loss and recovery of the 
righting reflex. Three spontaneous rlghtlngs within a minute was considered 
evidence that the reflex had returned. The liver glucose-6-phosphatase 
activity, serum alanine-alpha-ketoglutarate transaminase activity, liver 
triglyceride values, and the phénobarbital sleeping time were determined at 
different times after the animals received doses of vlnylldene chloride and 
were used as indices of liver damage. The rats were killed at intervals up to 
24 hours after they were given the vlnylldene chloride or corn oil, and their
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blood was collected for preparation of serum. The livers were removed and 
used Co make hoaogenates for biochemical assays.
The phenobarbital sleeping time increased significantly (P<0.05) within 2- 
4 hours in rats given 400 mg/kg of vinylidene chloride, and Che naxlnrnm 
increase was observed aC 12-16 hours, alchough there were no statistical 
differences between the sleeping times at 4-8, 12-16, and 20-24 hours [125]. 
Liver damage, as evidenced by either decreased hepatic glucose-6-phosphatase 
activity or increased rerum alanine-alpha-ketoglutarate transaminase activity, 
was marked at 8 and 16 hours after the vinylidene chi' ride ./as given to the 
rata. Serum alanine-alpha-ketoglutarate transaminase activity increased 
significantly (P<0.05)at 4, 8, 16, and 24 hours and the glucose-6-phospbatase 
activity decreased significantly (P<0.05) at 8 and 16 hours in animals given 
vinylidene chloride at 400 mg/kg. The serum enzyme activity began to decline 
after 8 hours. The liver triglyceride concentration increased with increasing 
doses of vinylidene chloride; at doses of 800 mg/kg, it was almost double the 
control concentration. None of the control animals showed a change In any of 
the indices of hepatic toxicity considered.
Jenkins et al [126] studied the effect of vinylidene chloride on
adrenalectomized male HoItman rats weighing 200-470 g. Sham-operated rats 
were used as controls. Both the adrenalectomized and control rats were fasted 
for 18 hours before being given single oral doses of 400 mg/kg of vinylidene 
chloride in corn cil, 2 ml/kg by volume. After 20 hours, more
adrenalectomized rats than control rats had died. Biochemical responses to 
vinyljidene chloride could not be measured as a result of the high mortality 
rate. The LD50 in adrenalectomized rats after 24 or 96 hours was 84 (64-111)
and 81 (70 94) mg/kg, respectively. However, with control rats, the LD50 was
1,550 (1,520-1,581) and 1,510 (1,445-1,578) mg/kg after 24 and 96 hours, 
respectively.
In the same study, Jenkins and associates [126] observed the effects of 
vinyiidene chloride on 9- co 11-week-old male and female rats given single 
oral doses of 400 mg/kg. They also studied the effects of vinylidene chloride 
on 21- to 24-week-old male and female rats given single oral doses of 200 
mg/kg. Liver and plasma enzyme activities were measured 20 hours after oral 
administration» The older female rats showed a greater increase in liver 
glucose-6-phosphatase activity than the older male rats, and both groups of 
females had increased liver alkaline phosphatase activity in comparison with 
their respective male counterparts. From these observations, the authors 
concluded that female racs were more susceptible to the hepatotoxlc effects of 
vinylidene chloride than male rats.
(c) Vinyl Bromide
Abreu et al [105] published the results of a study on the anesthetic 
properties of 18 halogenated hydrocarbons, including vinyl bromide. Groups of 
10-40 mice were exposed to vinyl bromide at several unspecified concentrations 
to determine the minimal certain anesthetic concentration (EC 100 for
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anesthesia), highest colerated concentration (LCO), and "certain safety 
factor" (highest tolerated concentration divided by minimal certain anesthetic 
concentration). Vinyl bromide showed a minimum certain anesthetic 
concentration of 3.5 mili-jnoles/liter (86,000 ppm; 376.7 g/cu m) and 9 Si_hest 
tolerated concentration of 7.0 millimoles/liter (171,000 ppm; 749 g/cu W , for 
a certain safety factor of 2.0 [105].
Leong and Torkelson [127] conducted two studies of the effects of inhaled 
vinyl bromide (99.72 pure) on various animal species, including rats, rabbits, 
and monkeys. The impurities in the vinyl bromide included a polymerization 
inhibitor (paramethoxy phenol, 0.1Z), ethylene oxide (0.12Z), vinyl chloride 
(0.06Z), and traces of ethyl bromide, methylene chloride, acetylene, and 
various aldehydes. The first study involved exposing four groups of five male 
Wistar rats each to vinyl bromide at 10,000 ppm (43.8 g/cu m) in a 160-liter 
stainless steel chamber for 7 hours/day, 5 days/week, for either 3 days or, ’,
2, or 4 weeks. Concentrations of vinyl bromide in the chamber were determined 
by infrared spectroscopy. Two control groups were exposed to room air. 
Immediately after the exposure, the surviving animals were killed, and 
macroscopic and microscopic examinations were performed on their organs and on 
fixed tissue specimens.
The rats exposed to vinyl bromide at 10,000 ppm became hypoactive during 
the 7-hour exposure period [127]. They seemed drowsy after 1 hour of the 
first exposure and looked "sluggish" by ¿he 13th exposure. The control 
animals remained active throughout the exposure period. Exposed animals 
showed a significantly lower (P<0.05) weigh: gain than controls between the 
15th and 20th days of exposure, and the differince was greater (?<0.01) after 
the 20th exposure. Gross examination of killed animals showed multifocal gray 
areas in the lungs, but the authors stated chat no "compound related" tissue 
changes were observed microscopically.
In Che second study, 2 groups of animals each consisting of 60 Charles 
River rats» 6 New Zealand white rabbits, and 6 cynomologus monkeys, all 
equally divided according to sex, were exposed to vinyl bromide at 25C or 500 
ppm (1,095 or 2,190 mg/cu m) for 6 hours/day, 5 days/week, for 6 months [127]. 
A third group of 30 male and 30 female rats, 3 male and 3 female rabbits, and 
4 female and 2 male monkeys was exposed to filtered room air. The experiments 
were conducted in the evening during the first 20 weeks of exposure and then 
were changed to dayClme. The auChor3 did noc state whether the concurrent 
control animals were also switched to a daytime schedule. Vinyl bromide 
concentrations In the chamber were monitored by gas chromatography. Gross and 
microscopic examinations were performed on organs and fixed tissue of exposed 
animals at the end of the experiment. The animals exposed for 6 months were 
observed for changes In activity, body weight, indications of respiratory 
distress, eye and nasal irritation, and skin condition. Hematologic tests 
were performed on rats, rabbles, and monkeys in the control and 500-ppm groups 
prior to exposure and after 2, 10, and 24 weeks of exposure. All monkeys were 
examined for nonvolatile bromide in whole blood at the end of weeks 1, 2, 4,
3, 16, and 26.
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AC the end of Che 6 monChs of exposure*, all Che animals exposed Co vinyl 
bromide ac 250 or 500 ppm showed weight increases aC rates comparable with 
controls [127], Only rats had a decrease in mean weight when the exposure 
schedule was changed from evening to daytime during the 20th week of exposure. 
Microscopic examination of major organs of all groups and species showed no 
changes that resulted from exposure to vinyl bromide. Analysis of blood 
showed elevated concentrations of bromide in all exposed animals, with monkeys 
chac had been exposed at 250 and 500 ppm having Che highesC levels. No 
statistically significant changes were observed in the ocher measurements.
In the same report, Leong and Torkelson [127] summarized the results from 
unpublished data on the effects of vinyl bromide on rats. An raspecified 
number of rats was exposed to vinyl bromide at nominal concentrations of
100.000 (437,600 mg/cu m), 50,000 (218,800 mg/cu m), or 25,000 ppm (109,400 
ng/cu m) for 1.5 and 7 hours. Two weeks after exposure to vinyl bromide at
25.000 or 50,000 ppm, the rats that survived were killed and examined for 
microscopic tissue changes.
Exposure at 100,000 ppm caused deep anesthesia and death within 15 minutes 
[127]. None of the rats exposed at 50,000 ppm for 1.5 hours died, but an 
unspecified number of deaths occurred during the 7-hour exposure. Within 25 
minutes, the rats became unconscious. Vinyl bromide at 25,000 ppm 
anesthetized the rats, but they recovered rapidly when removed from exposure. 
Microscopic examination of tissues showed slight to moderate liver and kidney 
damage in rats exposed aC 50,000 ppm. . Examination of tissues from rats 
exposed at 25,000 ppm showed no abnormalities.
Leong and Torkelson [127] also gave male rats a 5OS solution of vinyl 
bromide in corn oil by oral intubation to determine the LD50. They reported 
an LD50 of approximately 500 mg/kg but presented no supportive data. They 
also reported that vinyl bromide was irritating to the eyes but not to the 
skin of rabbits; data were not presented to support these findings.
'(d) Vinyl Fluoride
In a book on the toxicity of anesthetics [1281, Clayton reported that a 
mixture of 800,000 ppm (1,504 g/cu m) of vinyl fluoride in oxygen was not 
lethal for rats exposed Co ic for 12.5 hours. He also stated chac unpublished 
daca. of Limperos (no furcher identification given) showed chat male and female 
rats exposed to vinyl fluoride at concentrations of 100,000 ppm (188 g/cu m) 
for 7 hours/day, 5 days/week, for 6 weeks gained weight normally, exhibited no 
behavioral changes, had no fatalities, and had no cissue changes as evaluaced 
by microscopic examlnaCion. Claycon did not supply decails of Chese 
experiments.
In 1950, Lester and Greenberg [129] reported Che effeces of single 
exposures Co vinyl fluoride on adult white rats. Ra.Cs were exposed for 30 
minuces aC concenCraCions ranging from 20 co 80% (200,000 to 800,000 ppm; 376
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to 1,504 g/cu m) in an 11-liter glass chamber for 30 minutes. The rata were 
cesced for any abnormalities In Che poscural, righting, and corneal reflexes 
afcer Che exposure.
AC Che 30Z (300,000 ppm; 564 g/cu m) concentration, Che racs exhibited
"hindleg lnscabilicy" which Che auchors considered a sign of "slighc 
intoxication" [129]. Ac 80Z, Che raCs experienced difficulcy in breaching buC 
recovered afCer a 1-mtnuce exposure to room air. Postural and righting 
reflexes were lost between 50 and 60Z and beCween 60 and 70%, respeccively. 
Loss o f  Che poscural r e f l e x  was a l s o  evidenc in racs exposed Co vinyl fluoride 
ac  80Z f o r  12.5 hours, buC t h e s e  r a t s  a l s o  r e g a in e d  Che r e f l e x e s  soon a f t e r  
breathing room air.
Results of an investigation on repeated exposures of rats to v-'-ryl 
fluoride were summarized in a technical report from E I du Pont de Nemours and 
Company [130]. An unspecified number of rats were exposed to vinyl fluoride 
at a concentration of 100,000 ppm for 7 hours/day, 5 days/week, for a total of 
30 exposures. There were no differences in the rate of weight gain, in the 
results of necropsies, of microscopic examinations of fixed tissues, of organ 
weighcs, or of clinical observadons. It was concluded thac vinyl fluoride 
did noc conscitute "much of" an inhalation hazard. However, the technical 
report did not present any daca for evaluation.
(e) Vinylidene Fluoride
In a book on che toxicity of anesthetics [128]. Clayton reported thac a 
mixture of 800,000 ppm (2,096 g/cu m) '>->f vinylidene fluoride in oxygen was not 
lethal to rats exposed to it for 19 hours. No experimental details or data 
were offered Co support this statement.
Lester and Greenberg [129], in 1950, reported the effects of inhaled 
vinylidene fluoride on an unspecified number of adult white rats. The rats 
were exposed to vinylidene fluoride at concentrations.ranging from 10Z Co 80Z 
(100,000 Co 800,000 ppm; 262 Co 2,096 g/cu m) in an 11-liter glass chamber for 
30 minutes. After the rats were removed from the chamber, their postural, 
righting, and corneal reflexes were tested.
The rats exposed to vinylidene fluoride at 10Z-80Z for 30 minutes lost 
none of the reflexes tested, but those exposed at concentrations of 40Z 
(400,000 ppm; 1,048 g/cu m) or higher showed slight intoxication, which was 
manifested at 80Z by the development of an unsteady gait without loss of the 
postural reflex [129]. Rats exposed at 80Z for 19 hours showed no progressive 
signs of intoxication, and autopsies showed no evidence of pulmonary 
irritation.
Carpenter et al [1181 reporced che effeccs of short-Cerm scacic iuhalacion 
exposures of Sherman albino raCs weighing between 100 and 150 g Co vinylidene 
fluoride. The auchors reported that exposure to vinylidene fluoride at a 
concentration of 128,000 ppm (335.'+ g/cu m) for 4 hours was sufficient to kill
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two to four of the six test animals. From this observation, they concluded 
that vinylit'ene fluoride was slightly hazardous to rats. No further 
iaforaation w*s presented.
Burgison et al [131] studied the myocardial sensitizing properties of
viaylidene fluoride in eight dogs and tvo cats. The animals vere first 
injected with epinephrine and then exposed by inhalation to vinylidene
fluoride at 250,000-500,000 ppm (655-1,310 g/cu m) for 5-15 minute.- which 
time the epinephrine injection vas repeated. ECG's, lead II, of h animal 
were recorded. None of the animals developed myocardial sensitization to
epinephrine.
(f) Summary
The results of these studies show that each of the vinyl halides is
capable of causing CNS effects. Changes in liver function and structure were 
also observed in some experiments. The adverse effects noted after exposure 
were similar to Chose noted in worker populations exposed to Che vinyl 
halides.
T e ra C o g e n ic i ty  and E f f e c c s  on R e p ro d u c t io n
Only two experiments wich animals have been located in which the 
teracogenic, embryotoxic, and fetotoxic potentials of the vinyl halides were 
evaluated.
(a) Vinyl Chloride
John et a." [132] evaluaced Che effects of the inhalation of vinyl chloride 
on mouse, rat, and rabbic embryonal and fecal development. Female CF-1 mice 
(25-30 g) were exposed, at nominal concentrations of 50 or 500 ppo (128 or 
1,280 mg/cu m), and Sprague-D?wley rats (250 g) and New Zealand white rabbits 
(3.5-4.5 kg) were exposed at nominal concentrations of 500 or 2,500 ppm (6,400 
mg/cu m). Actual concentrations w»re determined by infrared 
spectrophotometry. Rats (20-35) and mice (30-40) were exposed on days 6-15 of 
gestation, and rabbits (15-20) were exposed on days 6-18 of gestation. 
Controls were matched to each exposure group and exposed in a similar manner 
to filtered room air. The authors examined the exposed dams for resorption 
sites in their uteri and the litters for the ratio of the sexes, body weights,
and other gross features of the fetuses. The authors also examined the
fetuses of each species for soft tissue and skeletal anomalies.
Maternal weight gain, food consumption, and final liver weighcs were
decreased in mice exposed aC 500 ppm (1,280 mg/cu m), buC these effects were
not observed at 50 ppm (128 mg/cu m) [132]. - Ethanol (152) in drinking water 
was also given to mice, rats, and rabbits exposed at 50 and 500 ppm, at 2,500 
ppm (6,400 mg/cu m), and at 2,500 ppm, respeccively. The auchors seated that
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ethanol altered the metabolism of vinyl chloride by blocking the primary and 
most rapid metabolic pathway. Ethanol with vinyl chloride at concentrations 
of 50 or 500 ppm decreased food consumption, weight gain, and liver weight In 
mice. In animals exposed to vinyl chloride at 50 and 500 ppm with 15Z
ethanol, weight gain and liver weight were lower than In those exposed to 
vinyl chloride alone. In rats exposed at 500 ppm, there was a significant 
decrease (P<0.05) in maternal weight gain during days 6—21 of gestation. At
2.500 ppm, the liver weight of the rats was increased significantly (P<0.05) 
at day 21 of gestation. There was also a significant difference in food 
consumption but no difference between exposed and control animals in weight 
gain. Rabbit3 showed a significantly decreased (P<0.05) food consumption ratt 
at 500 ppm, but no effects were noted at 2,500 ppm. Giving ethanol in 
addition to exposure to vinyl chloride at 2,500 ppm significantly increased 
the effects on rabbits and rats. Maternal mortality in mice exposed at 500 
ppm was significantly increased (P<0.05) over concurrent control mortality. 
Also, there was an increase (?<0.05) in the incidence of resorptions, a 
decrease (P<0.05) In fetal body weight, and a reduction (P<0.05) in litter 
sl2 e. No significant effects other than an Increase in crown-rump length
(P<0.05) were seen at 5C ppm. Fetuses from mice exposed to vln>. chloride at 
500 ppm differed significantly (P<0.05) from concurrent control fetuses in 
incidences of unfused sternebrae, delays in ossification of the sternebrae,
and delays in ossification of bones of the skull. The addition of 15Z ethanol
to the drinking water of the dams significantly increased (P<0.05) the 
incidence of skeletal anomalies In the fetuses of these mice, including 
anomalies in the sternebrae, vertebrae, and skull at 50 and 500 ppm, and In 
the ribs as well at 500 ppm.
There was only one maternal death In rats exposed to vinyl chloride at
2.500 ppm (6,400 mg/cu o) [132]. The only significant (P<0.05) fetal effects 
observed after exposure at 500 ppm (1,280 mg/cu m) were a reduction of the 
body weights, an increase in crown-rump length, and a significant increase 
(?<0.05) in the number of lumbar spur3 . Examination of the fetuses for soft 
tissue anomalies showed a significant increase (P< .05) in the incidence of 
dilated ureters at 2,500 ppm. Skeletal anomalies at 2,500 ppm included 
significant decreases (?<0.05) in the incidence of unfused sternebrae and 
delayed skull ossifications.
One of the seven rabbits exposed to vinyl chloride at 2,500 ppm died 
during the '¿xperiment [132]. A significant decrease (P<0.05) was seen in the 
number of live fetuses/litter at 5C0 ppm, but not at 2,500 ppm. No other 
gross differences were observed. The incidence of delayed ossification of the 
fifth sternebra was significantly increased (P<0.05) at 500 ppm. No other 
skeletal or soft tissue anomalies were seen in rabbits.
John et al [132] concluded that exposure to vinyl chloride at 
concentrations causing some maternal toxicity did not cause teratogenic 
effects on or embryonal or fetal toxicity in mice, rats, or rabbits. However, 
it is apparent that adverse effects did occur on the fetuses of the mice 
exposed at 500 ppm (1,280 mg/cu m) (sternebrae and skull anomalies) and in the
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f«tusea of rats exposed at 2,500 ppm (6,400 mg/cu m) (dilated ureters). The 
authors' determination that these effects did cot substantiate an embryotoxlc 
or fetotoxlc potential and were secondary to the maternal toxicity were not 
supported by clinical tests. The authors regarded the changes as minor 
skeletal and soft tissue variations and concluded that the incidence of
"major" skeletal or soft tissue malformations was not significantly greater in 
exposed animals than in the control groups. In mice exposed at 500 ppm, there 
were significant increases in the incidence of resorptions and decreases in 
the fetal body weight and in litter size. In rats exposed at 500 ppm, there 
was a significant decrease in the fetal body weight and an increase in crown- 
rump length, and, in rabbits exposed at 500 ppm. there was a significant 
decrease in the number of live fetuses/litter. In both rats and rabbits, 
however, there was not a corresponding adverse effect at the 2,500-ppm
exposure concentration. Ethanol at 15% in the drinking water enhanced the 
effects of inhaled vinyl chloride, but the authors concludcd that maternal 
toxicity was more enhanced than was fetotoxicity.
(b) Vinylidene Chloride
In 1977, Murray [133] reported the preliminary results of a jtudy of the 
effects of inhalation of vinylidene chloride on Sprague-Dawley rats and New 
Zealand white rabbits. Groups of 40, 28, and 26 pregnant rats were exposed 
for 7 hours/day to vinylidene chloride at 20, 80, and 160 ppm (79.4, 317.6,
and 635.2 mg/cu m), respectively, during days 6-15 of gestation. Eighteen and 
15 rabbits-were exposed to vinylidene chloride for 7 hours/day at 80 and 160 
ppm during days 6-18 of pregnancy. Controls for both species were exposed to 
filtered chamber air only. The animals were observed for changes in 
appearance and "demeanor," body weight gain, and food and water consumption. 
Fetuses were removed by cesarean section, the litter3 were counted, and the 
ratio of resorptions to implants, the sex ratio in the litters, and the body 
weights, crown-rump lengths, external abnormalities, and soft tissue and
skeletal alterations of the offspring were noted. The skeletal examinations
were performed on the skulls, vertebrae, and ribs.
After exposure at 80 or 160 ppm (317.6 or 635.2 mg/cu m), the rat3 showed
a decrease in their food consumption and body weight gain ^P<0.05) but an
increase in their water consumption (P<0.05) [133]. The only change noted in 
rats exposed at 20 ppm was an increase in water consumption (P<0.05). The 
appearance and demeanor, body weight gain, and food consumption of the exposed 
animals were comparable with those of controls. Fetuses of rats exposed at 80 
or 160 ppm had significantly increased numbers of skeletal abnormalities, but 
these were not seen in fetuses of rats exposed at 20 ppm (79.4 mg/cu m)
Skeletal examinations showed significant increases (P<0.05) in the incidences 
of delayed ossification of the parietal bone, "wavy" ribs, and lumbar spurs iu 
the 292 rats exposed to vinylidene chloride at 80 ppm. Exposures at 160 ppm 
caused significant increases (P<0.05) in delayed ossification of akull bones 
and cervical vertebrae and "wavy" ribs. No adverse effects were seen on rats 
exposed at 2 0  ppm.
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For the rabbits exposed to vinylidene chloride at 80 and 160 ppm (317.6 
and 635.2 mg/cu m), only those exposed at 160 ppm showed significant decreases 
(P<0.05) In body weight gain [133]. In addition, exposure at 160 ppm produced 
a significant Increase (P<0.05) in the racio of resorpcions co implants, from 
32 (4/115) in the concrols Co 312 (41/132) in Che exposed rabbles. The auChor 
sCaCed chac high racios of resorpcion-i Co implancs in particular females were 
correlaced wlch high loss of body welghc. No Increase in resorpcions was 
noced aC 80 ppm. Examination of feCuses from dams exposed at 160 ppm found 
significanC (P<0.05) skeletal abnormalities characterized by a decreased 
incidence of delayed ossificaCion of the fifth sCemebrae and by an increased 
incidence of 13 pairs of ribs. The invescigators concluded that only minor 
and "quesCionable" adverse effects resulced from exposure of rats and rabbi 
to vinylidene chloride ac concentrations above 20 ppm. They suggested that 20 
ppm should be considered ns a no-adverse-effeet concentration. They further 
noted that vinylidene chloride was embryotoxic by inhalation in both species, 
but chac Che embryotoxic effects were associaced wich exposure concenCradons 
chac were Coxlc Co Che mochers.
In anocher experiment, the investigators [133] gave 26 Sprague-Dawley rats 
access to vinylidene chloride at a concentration of 200 ppm (0.8 mg/liter) in 
drinking water during days 6-15 of pregnancy. Twenty-four control rats were 
given access to water alone. Similar observations to those noted in the 
inhalation exposures were reported. The only significant difference (P<0.05) 
reported was an increase in the fetal crown-rump length (controls 46.6 *2,4
mm; exposed 47.8 ±1.3 mm). The authors concluded that vinylidene chloride in 
the drinking water was not teratogenic in rats and did not cause adverse 
effects on rat embryos.
(c) Vinyl Bromide, Vinyl Fluoride, and Vinylidene Fluoride
No reports of studies that examined the teratogenic potential of vinyl 
bromide, vinyl fluoride, or vinylidene fluoride have been located.
Carcinogenicity
Angiosarcoma of the liver has been shown to be a characteristic tumor In 
workers exposed to vinyl chloride. Other cancers, of the lungs and brain, 
have also been linked to vinyl chloride exposure, but these latter types are 
more common than the former and may have been induced by a variety of other 
factors. Laboratory animals exposed to the vinyl halides have also shown a 
wide variety of tumors, especially angiosarcoma of the liver.
(a) Vinyl Chloride
In 1971, Viola et al [112] investigated tumor formation in rats exposed to 
vinyl chloride by inhalation. Twenty-five 3-month-old male albino Wistar rats 
were exposed to vinyl chloride at a concentration of 30,000 ppm (76.8 g/cu m)
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for 4 hours/day, 5 days/week, for 1 year; 25 similar rats served as controls.
Rats were killed at unspecified intervals, and their tissues were examined
microscopically. These exposed animals w«re apparently the same ones used in 
the study by Viola [111] that was discussed in Animal Toxicity.
Skin tumors, the most frequent types, were found in 65-70% of the animals 
after 10 months of exposure [112]. These tumors developed in the 
paraauricular region, and most were epidermoid carcinomas. The authors also 
found two mucoepidermoid carcinomas and one papilloma of the skin. In
addition to the tumors, they found warty subauricular grcwtns and papillary 
epithelial proliferation with progressive increases in the thickness of the 
epidermis in a few rats. In four rats, adenocarcinomas of the respiratory 
tract were found, and in one rat an epidermoid tumor was found. The authors
also found osteochondromas in the metacarpal and metatarsal regions of all
four limbs in five rats. None of the control rats developed any of the types
of tumors observed in the exposed animals.
In addition to the carcinomas, Viola et al [112] observed the same range 
of nontumorigenic adverse effects that Viola had reported previously [111]. 
They [1121 concluded that the tumorigenic potential of vinyl chloride was 
greatest for the "cutaneous system." They also suggested that the
mucoepidermoid carcinomas could have been caused by ingestion of vinyl 
chloride from the fur during cleansing, with subsequent concentration of it in 
“.he salivary glands. The authors did not analyze their data statistically, 
and they did not present thjm in terms of adverse changes/animal. Either of
t '.ese formats would have allowed a more accurate hazard assessment than is 
possible from the data as presented by the author*?.
In 1974, Caputo et al [134] extended the previous studies of Viola [111]
and Viola et al [112] by exposing 3-month-old Wistar rats of both sexes for 4
hours’/day, 5 days/week, for 12 months to vinyl chloride at concentrations of 
20,000, 10,000, 5,000, 2,000, 500, or 50 ppm [134j. A minimum of 150 animals 
was exposed at each concentration.
At 50 ppm (128 mg/cu m), no tumors were observed among 200 exposed animals 
[134]. At 500 ppm (1,280 mg/cu m) and above, a significantly greater (P<0.03) 
percentage of tumors wa3 seen in the exposed animals than was seen in a group 
of control animals. Tumors most frequently observed included squamous cell 
carcinoma of the skin, angiosarcoma of the liver and adenocarcinoma of the 
lung. The authors stated that rabbits exposed to vinyl chloride at 
concentrations of 10,000 ppm (25.6 g/cu m) also had significantly increased 
incidences (P<0.02) of acanthoma of the skin and adenocarcinoma of the lung 
appearing during the 9th through the 15th months of exposure. No further 
information concerning this experiment was reported.
The authors [134] concluded that these results clearly confirmed the 
carcinogenicity of vinyl chloride and that almost all tissues and organs were 
sensitive to it. Angiosarcoma of the liver appeared in 4/150 a n im a ls O X )  
exposed at 500 ppm, 10/200 (5%) at 2,000 ppm (5,120 mg/cu m), 12/200 (6Z) at
5,000 ppm (12.8 g/cu m), 16/200 (8 %) at 10,000 ppm (25.6 mg/cu o), and 18/150 
(12%) at 20,000 ppm (51.2 g/cu m). The prevalences of other tumors shovad 
similar Increases with increasing concentrations of vinyl chloride, indicating 
dos«-related responses.
In 1976, Maltoni [135] reported interim and final results of a series of 
17 experiments designed to evaluate the carcinogenic properties of vinyl 
chloride. A detailed plan for the conduct of these experiments [136] and 
preliminary results [137-139] had previously been published by Maltoni and 
coworkers. Tne experiments included inhalation exposure of Sprague-Dawl“.y and 
Wistar rats, Swiss mice, and golden hamsters to vinyl chloride at 
concentrations of up to 30,000 ppm (76.8 g/cu m) for 4 hours/day, 5 day/'week, 
for 30-52 weeks. Observation ^riods in some cases were as short as 46 weeks, 
because the experiments had not yet been concluded. Other experiments with 
Sprague-Dawley rats included inhalation exposures at concentrations of 6,000 
or 10,000 ppm (.15.4 or 25.6 g/cu m) for a total of 100 hours on various 
schedules; inhalation exposures of pregnant rats at 6 , 0 0 0  or 1 0 , 0 0 0  ppm for 4
hours/day during days 12-18 of gestation and subsequent examination of the
fetuses; and oral administration of vinyl chloride in olive oil at doses of
0.03-50 mg/kg.
The most common malignant tumors seen in Sprague-Dawley rats were Zymbal 
gland carcinoma (26%), angicsarcoma of the liver (2 2 %), and nephroblastoma
(9%), as indicated in Table III-2 [135]. It should be noted that most other
species do not have Zynbal glands. With increasing exposure, thts percentage 
of animals with tumors generally increased and the average latent period 
generally decreased. Angiosarcoma of the liver developed in 1 of 59 rats 
exposed at 50 ppm (128 mg/cu ra) for 52 weeks, with a mean .Latency of 135 
weeks, and in 18 of 60 rats (30%) exposed at 30,000 ppm (76.8 g/cu m) for 52 
weeks, with an average latency of 53 weeks. None of the 480 animals exposed 
at concentrations below 50 ppm had been observed for longer than 46 weeks at
the time of publication, and no tumors were seen in them. Preliminary
information [139] on tumor formation in the Wistar rats (Table III-3)
indicated that these animals might have been less susceptible to vinyl
chloride than the Sprague-Dawley rats: however, with the data presented, it
was not possible co determine this likelihood mathematically.
Decreased latency with increasing exposure was also observed in the Swiss 
mice (Table III-4); latency ranged from 51 weeks for lung tumors xn animals 
exposed for 30 weeks at 50 ppm (128 mg/cu m) to 36 weeks for animals exposed 
at 10,000 ppm (25.6 g/cu m' for the same period [135]. However, the
percentage of animals with each tumor reached a maximum concentrations that 
were different for each tumor. The majority of the tumors in mice were
adenomas of the lungs (45%). Angiosarcoma of the liver accounted for 12% of 
the tumors observed in these animals. The golden hamsters (Table III-5) did 
not show a dose-related response for tumor induction, and the latent periods
seen in this species were not reported.
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TABLE I I I - 2
TUMORS OLiSEKVED IN SPKAGUE-DAWLEY RATS
EXPOSED TO V 1NYL CHLORIDE BY INHALATION*
No . An i ma 1 s
Concentration Exposed** Aniinals with Tunors
(ppm) ________ _____________________________________________
Zymbal Gland Nephro- Liver All
Carcinomas blastomas Angiosarconas Tumors***




No . % La t ency 
(wk)
N o . %
30,000 60 35 58 k 3 0 0 - 18 3 0 53 5 » 85
10,000 61 16 26 50 8 59 9 1 5 64 38 62
6,000 60 7 1? 62 k 7 65 1 3 2 2 70 31 52
2,500 59 2 3 33 6 10 7<* 13 2 2 7 S 32 5<>
500 59 7 79 it 7 83 7 1 2 81 22 37
250 59 0 0 - 6 10 80 ¡i 7 7 * 16 27
50 59 0 0 0 1 2 135 1 2 1 35 10 17
Cont  r o l s 58 0 0 0 0 _ 0 C _ 6 10
•Result's afFer 135 wk in animals exposed k hrs/d, 5 d^wk, for 52 wk 
»•Number of animals surviving at 2 k wk, when first tumor was observed
•»»Includes angiosarcomas of other sites, angiomas, fibroangiomas, fibroadenomas, adenomas, 
carcinomas, papillomas, hepatomas, neuroblastomas, neurileinnomas, ependynomas, rhabdo­
myosarcomas, lymphomas; several animals had two or more tunors
A d a p t e d  f r o m M a l t o n i  [ 1 3 5 ]
T A ß L E  1 I 1 - 3
T U \D R S  O B SE R V E D  IN  W IS T A R  R A T S
EXPOSEI!) TO V I NYL CHLOR ID E  ßY IN H A L A T IO N *
Concent rat ion 
(ppm)
N o . An ima 1s 
Exposed No. An ima 1 s wi th T umo r s * *
Zymbal Gland  
Care inomas
Nepn r o- 
b 1 a s t oma s
Liver 
An g i o sa r comas
Al 1 
T umo r s * * *
10,000 30 1 (10/69) 1 (3/69) S (4/6^ ) 1 1 (20/69)
6,000 30 0 (3/72) 3 (3/72) 2 (3/72) 8 (13/72)
2, 500 30 0 (1/7 4) 0 ( 4 / 7 4 ) ■J (5/74) 4 ( U / 7 - )
500 30 0 (2/67) 0 (2/67) 3 (0/67) 4 (5/67)
250 30 0 (0/67) 0 (1/67) 1 (1/67) 3 (1/67)
50 30 0 ( 0 / 6 4 ) 0 (0/64) 0 (0/64) 1 (1/64)
Cont r o 1s 40 0 (0/68) 0 (0/68) 0 (0/6S) 2 (0/68)
•Results after 95 wk in animals exposed 4 h e j d ,  5 d7wk, for 5 2 wk
♦ ‘N u m b er s  in parentheses indicate p roportion of S p ra gue-Dawley rats at the same
exposures with tumors after 95 wk
• ••Includes angiosarcomas of other sites, adenomas, hepatomas, m es o th e l i om a s,  
f i b r o a n g i o m a s , carcinomas, lymphomas, pericyios arcoma s ; several animals had 
two or m o r e  tumors
A d a p t e d  f r o m  M a 1 1 o n i  [ 1 3 9 ]
TABLE III-4
ru\oiis oushrvtn in su-iss mice
EXPOSED TO VINYL CHLORIDE BY INHALATION*
No . An iina I s
C o n c e n t r a t i o n  E x p o s e d * *  A n i m a l s  w i t h  T u mo r s
( pp m)
Mu mn a r y  L i v e r  A l l
Lu n g  T u m o r s  C a r c i n o m a s  A n g i o s a r c o m a s  T u m o r s » » »
No . % L a t e n c y
( wk)
No . % L a t  e n c y  
( w k )
No . % No . %
1 0 , 0 0 0 50 35 70 36 1 3 4 7 31 8 16 36 72
6 , 0 0 0 54 38 70 38 8 28 33 5 9 39 72
2 ,  5 0 0 53 30 57 43 9 30 35 1 1 2 i 31 58
5 0 0 58 38 66 4 1 7 24 37 1 1 19 43 74
2 5 0 58 33 57 45 1 1 32 39 1 1 19 40 69
50 57 2 4 51 12 33 43 1 2 18 32
C o n t  r o 1s 141 8 6 44 0 0 - 0 0 1 3 9
• R e s u l t s  a f t e r  81 wk i n  a n i m a l s  e x p o s e d  4 h r / d ,  5 d / w k ,  f o r  3 0 wk 
• • N u m b e r  o f  a n i m a t s  s u r v i v i n g  a t  16 w k , w h e n  f i r s t  t u m o r  wa s  o b s e r v e d  
• » • I n c l u d e s  a n g i o s a r c o m a s  o f  o t h e r  s i t e s ,  a n g i o m a s ,  { i b r o a n g i o m a s , a d e n o m a s ,  c a r c i ­
n o m a s ,  p a p i l l o m a s ,  a c a n t h o m a s ,  a d e n o c a r c i n o m a s ,  b a s a l i o m a s ,  l e i o m y o s a r c o m a s ,  l y m p h ­
o m a s ;  s e v e r a l  a n i m a l s  h a d  t wo  o r  m o r e  t u m o r s
Adap ted f r on Ma 11 on i [13 5]
TABLE M I -  5
T U.\D RS O B S E R V E D  IN  GOLDEN HAMSTERS
E X P O S E D  TO V IN Y L  C H L O R ID E  BY IN H A L A T IO N *
C oncent rat ion 
(ppm)
No. A nimals 
E xposed No. Animals with Tumors
Liver 
Ang¡osar comas
Skin Tr i c ho - 
ep i the 1 iomas 
and Basa 1 iomas
Fores tonach 
E p i t h e l ia 1 
T unto r s
Al 1 
T umo r s * *
10,000 35 0 6 k it
6,000 32 1 2 7 10
2,500 33 0 1 1 0 12
500 33 2 3 7 12
250 32 0 3 2 6
50 33 0 6 i* 10
Cont rols 70 0 2 0 5
♦Results after 105 wk in animals e x posed 4 hrfd, 5 d^wk, ior~30 w k - -  ~~
»•Includes angiomas, f i b r o a n g i o m a s , adenocar ci n om a s,  melan o ma s , lymphomas, h e p a ­
tomas; several animals had two or mor e  tunoii
A d a p t e d  f r o m M a l t o n i  [ 1 3 5 ]
K►
The Sprague-Dawley r a t s  exposed a t  6,000 or 10,000 ppm (15.4 or  25.6 g/cu 
m) had been followed for  only 59 weeks a t  the time of t h i s  r epor t  [135].
Zymbal gland carcinoma was observed in some exposed animals,  but  no 
nephroblastoma or angiosarcoma of the l i v e r  was found. The prel iminary 
r e s u l t s  shown in  Table I I I - 6  suggest  tha t  exposure at  6,000 ppm for 100 hours during 25 weeks has a lower carcinogenic p o t e n t i a l  than exposure a t  10,000 ppm 
on the same schedule or at  6,000 ppm for 100 hours during 5 weeks. These 
f indings  ind ica te  t h a t  the severity cf exposure was :r.ore important than the t o t a l  mass to which the r a t s  were exposed 3nd suggest that metabolic and 
excre tory  processes may affect Lhe carcinogenic potential; however, more 
complete data  are needed to substantiate thij inference.
The o ffsp r ing  of pregnant  r a t s  exposed to v iny l  ch lo r ide  a t  concent ra t ions  
of 6,000 or 10,000 ppm (15.4 and 25.6 g/cu m) for 4 hours/day fror.i the 12th to 
the ISth day of g e s ta t io n  developed tumors [ 135] .  in 54 o f f sp r ing  from dams 
exposed a t  10,000 ppm, the fol lowing tumors developed: 3 Zymbal gland
carcinomas,  1 nephroblastoma, 1 subcutaneous angiosarcoma, 1 angiosarcoma of 
the leg ,  1 Zymbal gland fibrosarcoma, and 1 ovarian leiomyosarcoma. In the 32 o f f sp r ing  from dams exposed a t  6,00u ppm, 1 Zymbal gland carcinoma, 1 
subcutaneous angiosarcoma, 1 intraabdominal '  angiosarcoma, 1 Zymbal gland 
adenoma, 1 skin carcinoma, 1 subcutaneous fibrosarcoma, and 1 mammary 
carcinoma were observed following a 143-week observat ion  period.
Unfortunately,  d e t a i l s  of th i s  experiment, inc luding reproduction ind ices and 
signs of t o x i c i t y  to the dams, were not repor ted .  The a u th o r ’s suggest ion
tha t  the r e s u l t s  of t h i s  experiment i nd ica te  tha t  v iny l  chloride  has a
t ra ns p la ce n ta l  e f f e c t  i s  reasonable,  but i t  cannot be thoroughly evaluatedwithout  more d e t a i l e d  information chan was presented.
The experiments ou t l ined  by Maltoni and coworkers [135-139] were well  
designed.  The p re sen ta t io n  of data in these papers ,  however, was often  
confusing,  and the information contained in the t ab le s  fr equen t ly  disagreed 
with tha t  presented in the t ex t .  I t  was often  unc lear  whether they were 
present ing  the number of animals with tumors or simply the number of  tumors. 
Furthermore, pre l iminary  data on tumors when the followup period was l e s s  than 
the probable l a t e n t  period a re  of l i t t l e  value.  Maltoni 's  observa tions and 
data do show tha t  v inyl  ch lo r ide  induces various tumors in a v a r i e t y  of 
rodents,  and tha t  angiosarcoma of the l i v e r  i s  a c h a r a c t e r i s t i c  l e s io n  induced 
by v inyl  ch lo r ide .  The data  also  ind ica te  chat chere a re  s t r a i n  and species  d i f f e rences  in  the magnitude of the tumorigenic response e l i c i t e d  by exposure to v iny l  ch lo r ide .
Lee e t  a l  in  1977 [140] and in 1978 [141] repor ted  r e s u l t s  of i n h a la t io n  
s tud ie s  on 2-month-old alb ino  CD-I mice and CD r a t s  exposed to v iny l  ch lo r ide  (99.8% pure,  Matheson Gas Products) a t  50, 250, or  1,000 ppm (128, C40, or 
2,560 mg/cu m). Groups of 36 females and 36 males of each species were 
exposed fo r  6 hours/day,  5 days/week, fo r  12 months. Two s im i l a r  con t ro l  
groups were exposed to uncontaminated a i r .  Throughout the exposure per iod ,  
the animals were observed fo r  changes in weight gain ,  food consumption, and
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TABU; 111-6
TU\*ORS OBSERVED IN SWAGUE-DAWLEY RATS 
EXPOSED TO VINYL CHLORIDE BY INHALATION 
FOR 100 HOURS ON VARIOUS SCHEDULES*
E x p o s u r e  N o .  A n i m a l s  
C o n c e n t r a t i o n  S c h e d u l e  E x p o s e d  N o .  An inia 1 s wi  tit  T u mo r s
' p pm)
Z y mb a l  G l a n d  L i v e r  A l l
C a r c i n o m a s  Ang i o s a r c o i i u s  Tu mo r s *
10.000 4 hr/d, 5 d/wk 120 4 0 <*
x 5 wk
10.000 1 hr/d, 4 d/wk 120 4 G 4
x 2 5 wk
10.000 4 hr/d, 1 d/wk 120 2 0 3
x 25 wk
6.000 4 hr/d, 5 d/wk 120 3 0 4
x 5 wk
6.000 1 hr/d, 4 d/wk 120 0 0 l
x 25 wk
6.000 4 hr/d, 1 d/wk 120 0 0 1
x 25 wk
Controls - 249 0 0 0
•ResuTFs alter 59 wk
••Includes 1 a n g i o s a r c o m a ,  1 a n g i o p e r i c i to s a r c o m a , 2 l y mp h o ma s
Adapted fr cm Ma11oni [l35j
m o r t a l i t y .  Four animals of each spec ie s  and sex exposed a t  each c o n c e n t r a t io n  
were k i l l e d  a t  the  end of exposure months 1, 2, 3, and 9. Their  organs 
were examined g ross ly»  and t i s s u e s  were £ixed and examined m ic ro sc o p ica l ly .  
A dd i t iona l  l a b o ra to ry  d e t e rm in a t io n s ,  inc lud ing  hemato logic and blood 
chemis try  examinat ions,  c y to gen e t i c  ana lyses  of bone marrow c u l t u r e s ,  
pulmonary macrophage coun ts ,  DNA s y n th e s i s  a s say s ,  and u r in a ry  ana lyses  were 
performed a t  the  in t e r i m  examinations  and a t  the t e rm ina t io n  of the  experiment 
a t  12 months. Roentgenograms of the limbs of those animals exposed fo r  the  
lon g es t  pe r iods  were made a l s o .
Of the mice exposed a t  1,000 ppm (2,560 mg/cu tn), two males and one female 
died between the  3rd and 9th days of exposure [140].  Between the 6th and 9th 
months, 13 male and 21 female n ice  died or  wore removed from exposure because 
t h e i r  h e a l th  had d e t e r i o r a t e d .  By the end of the 9th month, a l l  animals had 
been removed from exposure.
By the 6th month, the most ev iden t  e f f e c t s  on exposed mice were rough h a i r  
coa t ,  l e t h a r g y ,  l o s s  of  a p p e t i t e ,  and rap id  weight  l o s s  [140].  A d d i t i o n a l l y ,  
abdominal d i s t e n t i o n  and e x t e rn a l  tumor masses,  such as mammary tumors in 
females,  were n o t i c e a b l e  between the  7th and 9 th  months, During the f i r s t  8 
months of the  experiment ,  exposed and nonexposed mice showed comparable weight  
gains ;  however, the  exposed group showed a d e c l in e  in weight  by the  9th month. 
Also,  by the  9th month of  exposure,  one female and most of  the male mice had 
e leva ted  pulmonary macrophage counts (from pulmonary washings) and had 
developed b ro n c h io lo a lv e o la r  adenomas.
Microscopic examinat ion  of  h e p a t i c  and r e n a l  t i s s u e s  from one female and 
two male mice t h a t  d ied  a f t e r  being exposed a t  1,000 ppm fo r  3-9 cays revea led  
a number of l e s io n s  c h a r a c t e r i z e d  by acu te  tox ic  h e p a t i t i s ,  f o c a l  to marked 
conges t ion ,  d i f f u s e  c oag u la t io n  n ec ro s i s  of hepa tocytes  in the c e n t r i l o b u l a r  
a rea ,  and t u b u la r  n ec ro s i s  in  the r e n a l  co r tex  [140].  During the 8th  and 9th 
months of exposure,  m i t o t i c  f i g u r e s  were observed in  mouse l i v e r s ,  but  were 
not  seen in  l i v e r s  of mice k i l l e d  a t  o th e r  t imes.
B ro nch io loa lveo la r  adenomas were observed in  48 of the 72 mice exposed a t
1,000 ppm, whereas only  1 of  the 72 c o n t ro l  mice developed t h i s  tumor [140]. 
These tumors were f i r s t  noted dur ing the 2nd month of  exposure to v in y l  
c h l o r i d e  and i n  the  9th month in  the c o n t r o l .  Mammary tumors . f i r s t  observed 
in  exposed female mice during  the 6th and 7th months,  inc luded adenocarcinoma 
and carcinoma of squamous c e l l s  and of a n a p l a s t i c  c e i l s ;  m e t a s t a s i s  wa3  
p re v a len t  to  the  lungs and p le u ra e .  None of the c o n t r o l  mice developed 
mammary tumors.  Angiosarcoma of the l i v e r  was found i n  31 exposed mice,  being 
observed f i r s t  dur ing  the  6 th  month of exposure.  In a d d i t i o n ,  angiosarcoma 
was o c c a s io n a l l y  seen i n  the mammary g lands ,  h e a r t ,  g a s t r o i n t e s t i n a l  t r a c t ,  
pancreas ,  k idneys ,  epid idymis ,  t e s t i s ,  mesen te r ic  lymph nodes,  and s k e l e t a l  
muscles.  Angiosarcoma of the  l i v e r  was more p re v a len t  i n  females than in  
males.  Two male and th r e e  female mice developed malignant  lymphoma between 
the 6 th  and 9 th  months of  exposure,  whereas none were seen i n  c o n t r o l s .
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A ll  female mice exposed to v in y l  c h lo r i d e  a t  250 ppn (640 mg/cu m) died  or  
had to  be removed from exposure by the 9th month because of morb idi ty  [140],  
Male mice were more r e s i s t a n t  to the  tox ic  a c t i o n s  o f  v in y l  c h lo r i d e  than 
female mice,  and some surv ived  the  12-month exposures .  No d i f f e r e n c e s  i n  body 
weight  between> the -  exposed and c o n t r o l  mice were noted.  One female mouse 
examined a f t e r  the  9th  month of  exposure showed an inc reased  pulmonary 
macrophage count.  B ronch io loa lveo la r  adenomas were f i r s t  d e tec ted  i n  exposed 
mice dur ing  the 2nd month; a t o t a l  of  48, 22, and 12 mice exposed a t  1,000,  
250, or  50 ppm, r e s p e c t i v e l y ,  developed t h i s  tumor. Only one c o n t r o l  male 
mouse developed b ro nch io a lv eo la r  adenoma dur ing  the  9th  month. Female mice 
a l s o  developed mammary tumors c o n s i s t i n g  of adenocarcinomas and squamous and 
a n a p l a s t i c  c e l l  carcinomas,  Of the mice exposed a t  250 ppm, 23 (16 females)
developed l i v e r  angiosarcomas,  which were f i r s t  ev iden t  a f t e r  the 6th  month of  
exposure. During the  9th month of exposure,  malignant  lymphomas developed in  
two female mice.
Between the 6th and 12th months of exposure to v in y l  c h lo r id e  a t  50 ppm 
(128 mg/cu m), 6 male and 14 female mice e i t h e r  died  or  were removed from 
exposure because of  d e t e r i o r a t i n g  h e a l th  [140].  Throughout the  exposure 
per iod ,  the body weights of  exposed mice were comparable w ith  those of  c o n t r o l  
mice. Microscopic examination a l so  showed m i t o t i c  f i g u r e s  in  the l i v e r  during  
the 8th and 3th months of exposure.  A s i g n i f i c a n t  inc rea se  in DNA s y n t h e s i s ,  
as measured by i n c o rp o ra t io n  of  14C-thymidine,  was d e t e c te d  in  the l i v e r s  of 
male mice exposed a t  50 ppm f o r  11 months. There was no inc re a se  in  the 
number of m i t o t i c  f i g u r e s  in  the  l i v e r s  of these  mice. During the 12th month 
of exposure,  one of  two su rv iv ing  male mice had an e leva ted  pulmonary macrophage count .
Bronch io loa lveo la r  adenomas were seen in  12 mice exposed a t  50 ppm (128 
mg/cu m) [140].  Three male mice developed angiosarcoma of the l i v e r .  Mammary 
tumors were observed in  n ine  of  the exposed mice, the f i r s t  a t  7 months. One 
female mouse developed a mal ignant  lymphoma dur ing  the 6th month and ano ther  
developed a hemangioma in  the mediast inum. Control  mice developed none of the 
tumors d i scu ssed .
From the e f f e c t s  observed in  n ic e  exposed to v in y l  c h l o r i d e  a t  1,000,  250, 
and 50 ppm (2,560,  640, and 128 mg/cu m), the  au thors  [140] concluded t h a t  
weight  l o s s ,  m o r t a l i t y ,  and tumor inc idence  were dependent  on the 
con c e n t r a t io n  of v in y l  c h l o r i d e  and the  d u r a t io n  of exposure.  Vinyl  c h lo r i d e  
inha led  a t  50-1,000 ppm fo r  6 hours /da^ ,  5 days/week,  was found to be h igh ly  
ca rc inogen ic  in  mice. The d u ra t ion  of exposure before  tumors were observed 
v a r ie d  from 2 months fo r  b ro n c h io lo a lv e o la r  adenomas to 6 months fo r  mammary 
gland tumors and f o r  angiosarcoma. The l a t t e r  tumors occurred  f i r s t  i n  the 
l i v e r  and then i n  o th e r  organs.  Angiosarcoma was more p r e v l e n t  in  female 
mice than in  male mice exposed a t  250 or 1,000 ppm. I t  was found mostly In 
the  l i v e r s  of mice exposed to v in y l  c h lo r id e  f o r  -7-9 months. Mammary gland 
tumors were cons ide red  to  be a complex type and were c h a r a c t e r i z e d  by 
a n a p la s t i c  and squamous c e l l  m e tap las ia  dur ing  the  e a r l y  s tages  of t h e i r  
development. M e ta s ta s i s  of a n a p l a s t i c  and squamous c e l l  carcinomas to the
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lungs was common, \ r o n c h lo a l v e o l a r  adenomas occurred  in  both  male and female 
mice a t  a very young age and a f t e r  a s h o r t  p e r iod  of exposure .  More dea ths  
and tumors were observed a t  250 and 1,000 ppm than a t  50 ppm. Other types of 
tumors observed i n  the  exposed mice were h e p a t i c  c e l l  ca rc inomas,  r e n a l  
adenomas, and k.eratoacanthomas of  the sk in .
In the  second p a r t  of the experiment,  Lee e t  a l  [140] exposed 72 a d u l t  
male and female r a t s  to v in y l  c h lo r i d e  a t  c o n c e n t r a t io n s  of  50, 250, o r  1,000 
ppm (128, 640, or 2,560 mg/cu m) fo r  up to 12 months, using  the  same exposure
schedule  p rev io us ly  re p o r te d .  During the  f i r s t  7 months of  exposure ,  no
remarkable adverse  e f f e c t s  were seen in any r a t s .  However, of the  r a t s  
.exposed a t  1,000 ppm, 8 male and 13 female r a t s  e i t h e r  died or  were removed 
from exposure dur ing  the 8 th -12 th  months. None of the c o n t r o l s  died during 
Che experiment.  A f te r  the 4 th  week of exposure,  female r a t s  had gained l e s s  
weight  tha r  the  c o n t r o l s .  During the 9 th  month, the f i r s t  cases of
angiosarcoma of the l i v e r  were observed in  four  r a t s .  By the end of the
s tudy ,  22 r a t s  had developed angiosarcoma of the  l i v e r ,  more females than 
males having the tumors.  Of the  22 r a t s  with  angiosarcoma of the l i v e r ,  13
a l s o  developed angiosarcoma of the lungs.  A dd i t ion a l  angiosarcoma was found
in  the  omentum of one r a t ,  and two r a t s  had hemangiomas in  the  ad rena l  g lands .
Four maie and 10 female r a t s  d ied  or  were removed from exposure dur ing  
months 8-12 of exposure to v in y l  c h lo r i d e  a t  250 ppm (640 mg/cu m) [140]. 
None of the c o n t ro l  r a t s  d ied  dur ing  the exposure p e r io d .  Body weight  gain  by 
exposed r a t s  was comparable with  t h a t  by the c o n t r o l s .  Two r a t s  developed
angiosarcoma of t he  l i v e r  dur ing  the 9th month of exposure.  By the end of the
12th month of  exposure,  13 r a t s ,  10 of  them females ,  had developed
angiosarcoma of the  l i v e r .  Of the  10 female r a t s ,  3 a l s o  had angiosarcoma of 
the lur.g3; angiosarcoma of the cmentum or mesentery was a l s o  found i n  two 
r a t s .  None of the  c o n t r o l  r a t s  had angiosarcoma.
During months 8-12 of exposure to v in y l  c h lo r i d e  a t  50 ppm (128 mg/cu m), 
two female r a t s  d ied  [140],  Exposed and c o n t ro l  r a t s  had comparable body 
weight  ga in .  Subcutaneous angiosarcoma was found in  two r a t s .  No
angiosarcoma of the  l i v e r ,  lungs ,  or  o th e r  organs was observed in  any of the 
r a t s  exposed a t  50 ppm, nor did any of the c o n t ro l  r a t s  develop angiosarcoma.
None of the l a b o ra to ry  t e s t s  performed on r a t s  exposed to  v i n y l  c h l o r i d e  
a t  1,000,  250, o r  50 ppm showed any p e r s i s t e n t  changes [140].  The au thors  
i n d i c a t e d  t h a t  female r a t s  were more s e n s i t i v e  to the t o x i c  a c t i o n  of  v in y l  
c h lo r id e  and t h a t  more females than  males died  between the 8 th  and 10th months 
of exposure.  In  g e n e ra l ,  r a t s  were considered  more r e s i s t a n t  to both  the 
c a rc inogen ic  and tox ic  a c t io n s  of  v in y l  c h lo r i d e  than  mice.
The experiments by Lee e t  a l  [140,141] i n d i c a t e  t h a t  v in y l  c h l o r i d e  i s  
ca rc inogen ic  i n  mice and r a t s ,  and t h a t  mice a re  more s u s c e p t i b l e  to i t s
ca rc inogen ic  e f f e c t s  than r a t s .  Since the  experiments were conducted a t  
va r io u s  exposure c o n c e n t r a t io n s ,  i t  can be concluded t h a t  the  d i f f e r e n t
responses probably  were a fu n c t io n  of s p e c i e s - s p e c i f i c  f a c t o r s  and were not
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caused by s t r u c t u r a l  d i f f e r e n c e s  between the  spec ie s  such as lung su r face  
a rea .  Since the re  a re  d i f f e r e n c e s  between s p e c i e s ,  the re  may be d i f f e r e n c e s  
between s t r a i n s  w i th in  a spec ie s  a l s o .  Such a s i t u a t i o n  would account fo r  the 
apparent  i n c o n s i s t e n c i e s  between the r e p o r t s  of var ious  authors  using 
d i f f e r e n t  ¿ t r a i n s  of the  same s p e c i e s .  This confounding f a c t o r  must be 
considered  i n  any a t tempt to e x t r a p o l a t e  the r e s u l t s  from animal experiments 
to human exposure s i t u a t i o n s .
Maltoni  e t  a l  [137],  in 1975, gave v in y l  ch lo r ide  by g a s t r i c  i n tu ba t io n  to 
13-week-old Sprague-Dawley r a t s .  Groups of 40 male and 40 female r a t s  were 
given 50.00,  16.65,  or 3.33 mg/kg of v in y l  c h lo r ide  d isso lved  in o l iv e  o i l  5
times/week fo r  52 weeks. A fou r th  group of r a t s ,  40 males and 40 females ,  was 
given o l iv e  o i l  without  v iny l  ch lo r ide  as the con t ro l  group. The number of 
tumors tha t  developed in the r a t s  of each group were recorded.
At 50 weeks, no tumors were apparent  in the r a t s  given the lowest  dose 
(3.33 mg/kg),  but  one of the male r a t s  given 16.65 mg/kg developed 
angiosarcoma of the l i v e r ,  which was i d e n t i f i e d  dur ing  the 49th »’eek of the 
experiment,  and a female r a t  given 5C mg/kg had angiosarcoma in  the thymus.
In an update of t h i s  s tudy [137],  Maltoni  [135] in 1976 repor ted  tha t  
a f t e r  34 weeks the r a t s  rece iv ing  the 50.00-mg/kg dose had developed e igh t  
cases of angiosarcoma of the l i v e r  and four o th e r  tumors.  At 16.65 mg,kg, 
angiosarcoma of the l i v e r  had developed in f iv e  r a t s ,  a Zymbal gland carcir .coa 
in one, and a nephroblastoma in one. No tumors were observed in  animals given 
3 . 33  mg/kg.
(b) Vinvlidene Chloride
Lee e t  a l  in 1976 [140] ana 1978 [141] descr ibed  the e f f e c t s  of inhaled  
v iny l idene  c h lo r ide  (99Z  pure,  Aldrich  Co.) o p  36 male and on 36 female 2- 
xonth-o ld  a lb ino  CD-I mice and 36 male and 36 female a lb ino  CD r a t s  exposed a t  
55 ppm (218.4 mg/cu m) fo r  6 hours /day ,  5 days/week,  f o r  12 months. Vapor 
c on cen t ra t io ns  were monitored by g a s - l i q u i d  chromatography dur ing  the 
exposures.  Control  animals were exposed to uncontaminated a i r .  Organs and 
t i s s u e s  from r a t s  and mice were examined fo r  microscopic changes a t  Che end of 
the 1 s t ,  2nd, 3rd ,  6 th ,  9 th ,  and 12th months of exposure.
Two male mice d ied  on the  13th day of exposure and were rep laced  in  the
study with h e a l th y  males [140].  Microscopic examination showed a number of
l e s io n s  in  the two dead male mice. They were c h a ra c t e r iz e d  by acute tox ic
h e p a t i t i s ,  f o c a l  to marked conges t ion ,  marked d i f f u s e  coagula t ion  nec ro s i s  of 
'nepatocytes,  and ¡narked tub u la r  n ec ro s i s  in  the re n a l  co r tex .  No a d d i t i o n a l  
deaths  occurred ,  nor d id  any c o n t ro l  animals d i e .  Six mice were observed to 
have smal l  nodules of b ronch io a lv eo la r  adenoma by the 12th month of exposure;  
only one c o n t ro l  male mouse developed a b ro nc h io a lv e o la r  adenoma. The mice 
removed from exposure a f t e r  the 9th month (two males) and 10th month (one
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female) had developed angiosarcoma in  the  l i v e r .  N ei the r  mammary tumors nor 
malignant  lymphomas were found.
A f ta r  exposures a t  55 ppm (218.4 mg/cu m), f a t t y  changes were seen i r  the  
l i v e r s  of r a t s  [140].  Two r a t s  had a l s o  developed e x t r a h e p a t i c  angiosarcoma 
(mesen ter ic  lymph node, subcutaneous) by the end of the exposure p er iod .  None 
of the  c o n t r o l  r a t s  developed l i v e r  tumors of  any type .
In 1977, Maltoni  e t  a l  [142] r ep o r ted  the re sea rch  p lan  and p re l im inary  
r e s u l t s  f o r  a s e r i e s  of experiments with  v in y l id en e  c h lo r i d e .  Groups of 60- 
120 Sprague-Dawley r a t3  were exposed by i n h a l a t i o n  to v in y l id en e  c h lo r id e  a t  
c o n c e n t r a t io n s  of 10, 25, 50, ICC, or 150 ppm (39-7, 99 .3 ,  198.5,  397, or
595.5 mg/cu m) f a r  4 nours /day ,  4-5 days/week,  for  12 aon th s .  An increased  
inc idence  of mammary tumors was noted in  the exposed animals ;  however, the re  
was no apparent  d o s e - r e l a t e d  e f f e c t .  One Zymbal gland carcinoma was found in  
an animal exposed a t  100 ppm.
Swiss mice were, exposed to v in y l id en e  c h lo r i d e  a t  10 and 25 ppm (39.7 and
99.3 mg/cu m) on the  same schedule  [142].  Exposure of  these  mice a t  
con c e n t ra t io ns  of  50 ppm or h igher  produced an unacceptably  high m o r t a l i t y  in  
the study popu la t ion  w i th in  4 days.  Adenocarcinoma of the  kidneys w?s 
observed in  two groups exposed a t  25 ppm with  an inc idence  of 8" and 4". Ncne 
of these  tumors were observed in  a r i n a l s  exposed a t  10 ppm or in  con t ro l  
a n im a ls .
Sprague-Dawley r a t s  were g iven v in y l id e n e  c h lo r i d e  in  o l i v e  o i l  by gavage 
a t  dose r a t e s  of  0 .5 ,  5, 10, and 20 mg/kg/day,  4-5 days/week fo r  52 weeks
[142]. No i n c re a s e  i n  mammary tumors was observed;  one r a t  developed a Zymbal
gland carcinoma a t  the 10-mg/kg dose.
Although Lee e t  a l  [140,141] had repor ted  t h a t  t h e i r  -lice were exposed a t  
55 ppm of v in y l id en e  c h lo r i d e ,  Maltoni  e t  a l  [142] found t h a t  exposure of h i s  
mice a t  c o n c e n t r a t io n s  of 50 ppm or more produced unaccep tab le  m o r t a l i t i e s  
w i th in  4 days.  M a l to n i ' s  mice exposed a t  25 ppm of v in y l id en e  c h lo r ide  fo r  12 
months d id  not  develop angiosarcoma of the l i v e r ,  whereas Lee e t  a l  s t a t e d
t h a t  3 of 72 mice exposed a t  55 ppm fo r  12 months did develop t h i s  tumor. The 
d i sc r ep a n c ie s  i n  the r e s u l t s  of  these  s t u d i e s  may be caused by d i f f e r e n c e s  in  
the s t r a i n s  of  animals used,  and has been d iscussed  p re v io us ly .  Maltoni  e t  a l  
[142] s t a t e d  t h a t  n e i t h e r  i n h a l a t i o n  exposures nor i n g e s t io n  experiments w i th  
r a t s  demonst ra ted  a s p e c i f i c  ca rc inogen ic  e f f e c t  from v in y l id en e  c h lo r id e  such 
as had been demonstrated f o r  v in y l  c h lo r i d e  (Zymbal gland carcinoma and 
angiosarcoma of the  l i v e r ) . I t  should be remembered t h a t  these  da ta  a r e
p re l im ina ry  f o r  r a t s ,  and t h a t  a longer  fol lowup per iod  may r e v ea l  t h a t  these
tumor types w i l l  be formed. The author« a l s o  s t a t e d  t h a t  mice were
s u s c e p t i b l e  to a s p e c i f i c  ca rc inogen ic  e f f e c t ,  adenocarcinoma of the  kidney,  
and t h a t  t h i s  s p e c i e s  d i f f e r e n c e  probably r e s u l t e d  from a more " favo rab le
m etabolic  c o n d i t io n  fo r  express ing  the  oncogenic p o t e n t i a l i t y . "  The au thors  
poin ted  out  t h a t  f u r t h e r  r e se a rc h  using d i f f e r e n t  spec ie s  was necessary  to 
e v a lua te  t h i s  hypo thes i s .
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(c) Vinyl Bromid«
In 1977, BL Van Duuren, in a written communication to NIOSH, reported 
unpublished results of bioassays with vinyl bromida. Thirty female ICR/Ha 
Swiss mice ware injected subcutaneously (sc) with 25 mg of vinyl bromide in 
0.05 ml of trioctanoin once a week for 420 days, and none of the mice 
developed tumors at the site of injection.
Van Duuren also tested the effect of vinyl bromide on mouse skin. Thirty 
female ICR/Ha Swiss mice had vinyl bromide in acetone (15.0 mg/0.1 ml) applied 
to their skin three times/week for 420 days. Control mice received no 
exposures. After 412 day3 of applications of vinyl bromide, one mouse 
developed a papilloma and another developed a subcutaneous fibrosarcoma. None 
of the control mice developed skin tumors. These data indicate that vinyl 
bromide is not carcinogenic by these routes of exposure.
Dorato et al [143], in 1978, submitted to NIOSH the-1-year interim results 
of a 2-year study on the inhalation toxicity of vinyl bromide. Rats were 
exposed to vinyl bromide at nominal concentrations of 1,250, 250, 50, and 10 
ppm (5,475, 2,095, 219, and 43.8 mg/cu m) for 6 hours/day, 5 days/week. 
Hematologic values did not show dose-related effects that were attributed by 
the authors to the vinyl bromide exposure, and the only clinical chemistry 
abnormalities considered significant were elevations in serum LDH and bromide 
in the rats exposed at 1,250 ppm. These rats also showed decreases in body 
weight beginning at week 16 for the females and week 45 for the males.
Increased liver weights were noted in the rats exposed to vinyl bromide at 
250 and 1,250 ppm, and increased spleen weights were noted In rats exposed at 
50, 250, and 1,250 ppm [143]. Angiosarcoma of the liver seen in 9/48 rats
exposed at 1,250 ppm and in 2/30 exposed at 250 ppm. Zymbal gland carcinoma 
was observed in 8/47 exposed at 1,250 ppm and in 2/30 exposed at 250 ppm. 
Lung, mammary, and brain tumors were also observed In these animals. 
Metastatic angiosarcoma was present in the lungs of four animal3 . The authors 
concluded that vinyl bromide after exposure for up to 52 weeks at 250 and 
1,250 ppm had a carcinogenic effect on rats.
A comparison of the frequencies of angiosarcomas at these exposure 
concentrations in this experiment [143] with the frequencies of angiosarcoma 
observed in rats exposed to vinyl chloride after a similar followup period 
[139] suggests that vinyl bromide may be more effective in inducing this tumor 
than vinyl chloride. Further comparison with the vinyl chloride data 
indicates that after a longer observation period, angiosarcoma will be seen in 
those rats exposed to vinyl bromide at lower concentrations.
(d) Vinyl Fluoride and Vinylidene Fluoride
No reports examining the carcinogenic potential of vinyl fluoride or 
vinylidene fluoride have been located.
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Each o£ the vtayl halides has been shown to be mutagenic in on« or another 
test aystea. The mutagenic activity of thcsa compounds increases with 
aacabolic activation by mammalian microsomal systems, showing that metabolites 
fcs wall as tha parent compounds have mutagenic potential.
(a) Vinyl Chloride
Because the reported carcinogenic action of vinyl chloride in workers 
attracted considerable attention, several investigators became interested la 
evaluating its mutagenicity and chat of its known or presumed metabolites. 
Ames et al [144] showed that many known carcinogens activated by mammalian 
liver enzymes produced back mutations in auxotrcphs of the bacterium 
Salmonella tynhiaurium. Studies of the genetic activities of vinyl chloride 
and some of its metabolites have been performed in several bacterial species, 
yeasts, Neurospora, Drosophila, mammalian cell cultures, and alee.
In 1974, Rannug et al [145] used the system described by Ames and his 
coworkers [1<*4] to Investigate the mutagenicity of vinyl chloride. Four 
histidine-requiring strains of Salmonella tvohiaurium were exposed to vinyl 
chloride under various experimental conditions ¿nd then cultured on histidine- 
deficient media to determine the frequency cf back mutations to histidine 
independence. Strain TA1535 reverts to histidine independence by a base-pair 
surstitution, while in the other strains used, TA1536, TA1537, and TA1538, 
reversion results from addition or deletion of a base pair (frameshift 
mutation). In addition to their Inability to synthesize histidine, these test 
strains Include a mutation that increases the permeability of the cell and 
anotner that decreases the repair of damaged DNA; these deletions enhance the 
sensitivity of the bacteria to certain mutagenic agents.
Because bacteria may not duplicate mammalian metabolic processes in 
activating potentially mutagenic substances, t’;e substances under test were 
incubated with a 9,000 x gravity (G) microsomal extract frcm the livers of 
Sprague-Dawley rats [145]. For some experiments, a microsomal system was 
produced by mixing the microsomal supernatant with a dihydronicotinaaide 
adenine dinucleotide phosphate (NADPH) generating system.
In preliminary tests with strain TA1535, Rannug and coworkers [145] 
bubbled vinyl chloride gas through either water or a suspension containing the 
microsomal 3 ystem, or they exposed the bacteria for 75 minutes to an 
atmosphere containing 1 1 2 (281.6 g/cu n) vinyl chloride. The vinyl chloride 
was analyzed by ga3 chromatography and mass spectroscopy and was reported to 
be of "very high" purity, containing only trace amounts of isopropanc*. In a 
subsequent experiment, strain TA1535 was exposed to an atmosphere of 202 vinyl 
chloride with cha microsomal system or with the aicrosomal supernatant with t o  
MADPH-generating system, and to vinyl chloride alone, for intervals of 30, 60, 
or 90 minutes. Controls were incubated with the aicrosomal system without 
vinyl chloride. Finally, all four strains were exposed for 90 ainutes under
Mutagenicity
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similar conditions. To evaluate the lethality of the vinyl chloride 
preparation*, identically treated bacteria were cultured on a medium 
containing hiatidine, and the nuaber of surviving cells was determined. To 
evaluate the cooperative mutagenicity of the vinyl chloride preparations,
histidine-independent mutant colonies were counted on five plates of minimal 
media for each test, and the number of mutants/ 1 0 0  million surviving cells was 
compared to the spontaneous mutation rate using the Student's t-test.
In the Initial tests, Rannug et al [145] found that vinyl chloride
dissolved in water or directly in the microsomal suspension had no effect on 
Che rate of back mutation Co histidine independence in strain TA1535.
However, exposure to an atmosphere of 112 vinyl chloride gas for 7 5 minutes 
-esulted in 17.6 £2.6 (SZ) autants/100 million surviving cells, compared with
5.3 *0.2 in controls, significant at the 12 level (?<Q.Q1). A mutation rate 
tvo to three times chat of controls was observed In strain TA1535 exposed to 
202 vinyl chloride in the presence of a microsomal system for Intervals of 30 
minutes (P<0.01) and 60 or 90 minutes (?<0.001). Bacteria exposed to vinyl 
chloride without the microsomal system showed no Increase in mutagenic 
response. Exposure of strain TA1535 to vinyl chloride and the microsomal
supernatant in the absence of the NADPH-geueratiag system also caused no 
significant change in the mutation rate. In the final experiment, involving 
all four test strains, only TA1535 showed a mutagenic response to. vinyl 
chloride. At the concentrations tesced, vinyl chloride with the microsomal 
3ystesj did not affect bacterial survival on a complete medium, although vinyl 
chloride alone- reduced the survival rate slightly.
Rannug et al [145] concluded that vinyl chloride was mutagenic in 
Salmonella only after metabolic activation by m^tanalian microsomal enrymes. 
They suggested that the most plausible primary metabolite from vinyl chloride 
would be chloroethylene oxide, which could be formed in the NADPH-dependent 
oxidation by microsomal enzymes. Since only strain TA1535 was affected, the 
mutagenically active metabolites of vinyl chloride appeared to be capable of 
causing base-pair substitutions but not frameshift mutations. The 
ineffectiveness of water solutions in inducing mutations was attributed to the 
low solubility and high volatility of vinyl chloride.
In 1975, Bartsch et al [146] reported tests of vinyl chloride on 
Salmonella, m  which they evaluated the mutagenic response as a function of 
dose and exposure duration and compared the effectiveness of several mammalian 
tissue fractions in manifesting the mutagenic potential of vinyl chloride. 
The Salmonella typhlamrlum strains used in this series of experiments were 
TA1535, TA1530, and G-46, which are reverted to histidine— independence by 
base-pair substitutions, and TA1538, which is reverted by a frameshift 
mutation. Bacteria were exposed to vinyl chloride (99.92 pure) at nominal 
concentrations of 0.2, 2.0, and 202 (5.1, 51.2, and 512 g/cu m) In air for up 
to 48 hours. Gas chromatography shoved that these nominal concentrations of 
vinyl chloride In air produced viryi chloride concentrations in the media of 
rj 04, 0.4, and 4 millimoles, respectively, after 6 hours, with no further 




Fractions of liver, kidney, and lung tissu« were prepared from BD-IV rats 
and 0F-1 mice, sooe of which had been pretreated with sodium phénobarbital to 
increase hepatic microsomal enzyme activity [146]. Microsomal supernatants 
were prepared by centrifuging homogenized tissue at 9,000 * C. For sooe
experiments, the microsomal supernatant was chan centrifuged at 100,000 x G to 
produce a purified aicrosoaal fraction and a supernatant containing aicrosomal 
protein. The 9,000 x G microsomal supernatants froir four human liver biopsy 
specimens were also tested.
In the presence of a aicrosomal fraction derived from aice treated with 
sodium phénobarbital, with an NADPH-generating system, the autation rate in 
TA1530, the aost sensitive of the strains tested, increased 6 , 12, and 2S 
tiaes over the spontaneous rate after -3 hours of exposure to vinyl chloride 
in air at 0.2, 2.0, and 20Ï [1¿6]. Sr.rains Til535 and G-46 showed similar
autagenic response, while ÎA1538 showed no significant Increase over control 
rates after exposure to 20Z vinyl chloride for ¿ 8  hours. Exposure of strain 
TA 1530 to 20* vinyl chloride without the aicrosomal system causad a linear 
increase in the mutation rate as a function of length of exposure, reaching 2 0  
times the spontaneous rate after 48 hours. ïhe prevalence of mutations in the 
presence of the aicrosomal system was seven times as high as wirh vinyl 
chloride alone after 1.5 hours, but only twice as high after 48 hours; the 
difference in the autation rata induced by vinyl chloride alone and in the 
presence of a aicrosooal system reached a plateau after about 9 hours of
exposure.
3artsch at al [146j attempted to characterize the enzymes involved in 
vinyl chloride mutagenicity by testing the activity of various mouse liver
fractions on strain TA1530. In the absence of the NADPH-generating system,
the 9,000 x G aicrosomal supernatant with 2Z vinyl chloride produced no
increase above the autation rates produced by exposure to vinyl chloride alone 
for periods of up to 48 hours. Purified aicrosomes with an NADPH-generating
system produced an increase in the vinyl chloride-induced mutation rate of
about half of that obtained with the 9,000 x G microsomal system after 48
hours. The 100,000 x G liver protein supernatant (cytosol) did not increase 
the mutagenic response compared to that induced by vinyl chloride alone. 
Addition of alcohol dehydrogenase and NAD+ to the microsomal systems did not
affect the mutation rate, although alcohol dehydrogenase would be expected to
convert any chloroethanol produced tc chloroacetaldehyde. This compound is 
known to be mutagenic to TA1530 [147].
Comparison of tissues from various sources showed that rat liver 
aicrosomal supernatant was comparable to that from aouse liver in activating 
the autagenic response to vinyl chloride [146]. Precreating the animals with 
phénobarbital increased the activity of the liver microsomal supernatant 15- 
402. _ Kidney and lung fractions from either pretreated or untreated animals 
increased the mutagenic activity of vinyl chloride only marginally over 
control values. One of the four human liver specimens tested was nearly twice 
as active as those of rat or mouse liver, while the remaining three were 
somewhat less active than liver tissue from phenobarbital-treated rats and
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ole*. Based oa data from pretreated animals, cha relative mutagenic 
activities of tissue fractions for strain TA1530 were: mouse liver 1002; rat
liver, 802; mouse kidney, 202; rat kidney, 162; mouse and rat lung« 72; and 
human liver, 170, 70, 64, and 4o2.
Bartsch et a.l [146] concluded that vinyl chloride was mutagenic to 
Salmonella in the absence of mammalian microsomal enzymes, probably through 
:he action of breakdown products produced either by bacterial enzymes or 
aonenzymatically. They pointed out that their findings strongly supported the 
enzymatic formation of mutagenic vinyl chloride metabolites- biuce the 9,000 
x G microsomal extract gave a stronger response chan purified microsomes, the 
authors concluded chat soluble liver proteins (cytosol) played a role l a  che 
metabolic activation of vinyl chloride, cither by involvement in a cwo-scep 
activation mechanism or by prolonging che viability of che microsomal enzymes.
In a subsequent review paper, Bartsch [148] noted that the wide variation 
in human liver enzymatic activity, which wa* confirmed in mutagenicity testing 
of N-nltrosomorphollne, indicated that some individuals are genetically liable 
to a higher risk from exposure to carcinogens. Bartsch suggested that those 
estimating acceptable envlronaencal levels of suc.i substances should consider 
che possible risk for the most susceptible individuals.
In 1976, Garro et al [149] reported studies of che modification of che 
mucagenic activity of viayl chloride on Salmonella tvphiaurium TA1530 by 
suspensions of untreated and Aroclor 1254-pretreated rat or mouse hepatic 
microsomes In che presence of an XADPH-generating system ami by a system 
generating free radicals from riboflavin and N,M,N',>T- 
tetramethylethylenediamlne (TMED) under irradiation from fluorescent lamps. 
They described TMED as an accelerator of vinyl chloride phocopolymerizacion. 
Alchough incubation of vinyl chloride with native microsomal suspensions 
Increased its mutagenic activity by about 652, incubation of chis chemical 
with similar suspensions that had been heated to destroy their enzvmatic 
activlcy also increased, but at a somewhat reduced level, its. mutagenic 
activity. Mutagenesis In the presence of liver extracts was not XADPE 
dependent. Incubation of vinyl chloride with the free-radical generating 
system apparently increased its mutagenic activity by nearly tenfold. The 
authors took these findings to indicate "that the stimulatory effect of liver 
extracts on the mutagenic activity of vinyl chloride in the Salmonella 
auxotroph reversion test cannot be ascribed to enzymatic activation by a 
microsomal mixed function oxidase and...that the mutagenic effect of vinyl 
chloride may involve a free radical mechanism."
Although Garro et al [149] found that riboflavin and che tertiary amine 
had an effect on the mutagenic activity of vinyl chloride for Salmonella 
typhimurium TA1530 only in the presence of light, they made no measurements 
that would confirm tha relationship of the presence of free radicals in thair 
photoactivated test system to increased mutagenic activity of vinyl chloride. 
Also, they did not rule out the possibility that the lighc itself altered the 
apparent mutagenic activity of vinyl chloride. These two uncertainties about
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ch« photochemical activation experiments makes ch« conclusion chac fr«« 
radicals may have a spacial importance in increasing ch« mutaganic activity of 
vinyl chlorid« quastionabl«.
In 1976, Andr«ws «t al [150] confirmed ch* earlier reports chat exposure 
to vinyl chloride increased th« mutagenic frequency in Salmonella TA 1535 in 
the absence of a microsomal enzyme system.
Greim ec al [151], Henschler [152], and Henschler ec al (153] reported a 
scudy of Che mutagenic effects of vinyl chloride and several related compounds 
on Escherichia coli K12. This bacterium, they suggesced, aighc be a more 
useful cest organism than Salaor.ella because it was aore resiscant co Che 
nongenecic toxic effects of some of the cesc compounds [152]. £. coli K12 can
be evaluated for aucagenic response ac four loci by placing on seleccive
aedla; back mucadons ac che gal+, arg+, and nad+ loci cause reversions co 
prototrophy, while forward mutations are measured at the gal+ and MTU loci 
[154], Vinyl chloride (99.92 pure) was bubbled through a medium containing 
the bacteria, a microsomal supernatant from mice procreated with 
phénobarbital, and an XADPH-generatlng system [152]. This produced a 
concentration of vinyl chloride in the medium of 1 0 . 6  millisoles, as
determined by pas chromatography. The aucagenic response at rhe four cest
loci, as a percerca^s of Che sponcaneous nutation frequency, was 231 ±20 (SD) 
for gal+, 663 *l4 i for arg+, 148 *24 for nad+, and 172 £35 for MTP.. Vinyl 
chloride was by far che mosc autagenlcally active of che compounds cesced.
lu 1975, Loprleno et al [155] reported on the genetic effects of vinyl 
chloride activated by mammalian enzymes both in vitro and in vivo (host-
mediated assays). Two species of yeasts were used as the test organisms. A 
haploid strain of Schizosaccharomvces ?ombe containing a ais-sense mutation in 
che ade6 locus and a aucaclon in che radio locus was used Co study forward 
autatlons at the five loci involved in the biosynthesis of adenine. A diploid 
strain of Saccharomyces cerevisiae with double heterozygotic alleles in the 
ade2 and trp5 loci vas used to studv the Induction of gene conversion at these 
loci. For the in vitro experimencs, vinyl chloride (about 99.9* pure) ac 
concentracions of 5 and 50? (128 and 1,280 g/cu m) in air was bubbled chrough 
a suspension containing che yeast cells for up co 4 hours, resulting in vinyl 
chlorid* '^ncentrations In the treatment flasks of 16 and 4a millimoles, 
respect: y. The vinyl chloride was activated vich a purified microsomal
fraction ^105,000 x C) from che livers of Swiss albino mice combined with an 
MADPH-generating system. For the host-mediated assays, Svlss albino mice
weighing 25 g each were administered orally 1 ml of olive oil containing 1.85Z
vinyl chloride, le, ac 740 mg/kg. Controls were given olive oil. Cells of
Schizosaccharomvces were Injected into the peritoneum of four to six mice and 
permitted to incubate for 3-12 hours before being placed to scudy mutation 
frequency.
Mutagenic activity was observed in the in vitro studies with 
Schizosaccharomvces only when a purified microsomal system was included in che 
preparaclon [155]. Maximum mutagenic activity was reached after 30-60 minutes
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of treatment, and tha activity lncreaaed with th« vinyl chloride concentration 
In tha medium. At a vinyl chlorld« concentration of 48 millimolar for 60 
minutes, tha mutation frequency at tha flv« loci vas 62.43/10,000 surviving 
call«, compared with a spontaneous mutation rata of 2.00/10,000. In scudies 
with Saccharomyces. treatment with 48 millimoles vinyl chloride for 300 
clnutas in tha praaanca of purlfiad mlcrosomcs producad a gene conversion 
fraquancy of 8.47/100,000/locus in tha ad«2 system and 4.36/iOO,000/locus in 
tha trp5 system; spontanaoua frequencies for these systems were 
0.49/100,000/locus and 0.85/100,000/locus.
In the host-mediated assay, Loprieno et al [155] found that 
Schizosaccharomyces showed a autagenic response after incubation for 12 hours 
in the peritoneum of mice given vinyl chloride orally at 740 ag/'<g. The 
observed mutation frequency was 6.89 (t0.60)/10,000 cells compared with a
concrol race of 1.33 (t0.19)/10,000 In yeast incubaced in racs not given vinyl 
chloride; regression analysis showed Che effecC Co be significant ac Che 1* 
level. Comparing Che mutagenic effectiveness of che 16 millimoles of vinyl 
chloride used in vitro with that of 11.2 millimoles of vinyl chloride 
administered to the mice for in vivo studies, the authors concluded chat in 
vicro creacaenc was more effective. They attribuced chis co Che fact chat, in 
Che hosc-medlaced assay, Che presence of an acclve concentration of Che 
purported autagenic metabolite was minimal as a consequence of its short half- 
Ufe.
In a later study with Saccharomyces cert vislae, Shahin [156] reported that 
vinyl chloride added directly Co che medium in concentrations of 0.275-0.552 
caused neither mutagenesis nor recombination (crossing-over) in the absence of 
a microsomal activating system. Be did not describe any experiments in which 
a microsomal system was used.
Drozdowicz and Huang [157] tested the xutagenic activity of vinyl chloride 
in the fungus Neurospora crassa. The test organisms were a wild-type scrain, 
which was scored for forward mucacion to acrlflavln resistance, and a 
nicotinic acid-deficient auxotrophic strain. Amounts of a 1.78 M ethanol 
solution of vinyl chJ-.ide (apparently up to 102) were added directly to the 
medium containing the fungal conidia for 3- to 4-hour exposures, or cultures 
were exposed to gaseous vinyl chloride at concentrations of up to 502 In 
oxygen for 3.5 or 24 hours.
Neurospora conidia were then plated on nonselective and selective media 
and Incubated for 5-7 days for scaring of survival and mutation frequencies. 
Activating systems used were a 9,000 x G hepatic microsomal supernatant from 
phenobarbltal-lnduced rats for the 3.5-hour exposures and a purified 
microsomal fraction from uninduced Buffalo rata for the 24-hour exposures, 
both mixed with an MADPH-generatlng system. Ultraviolet light and methyl 
methanasulfonata vara used as positive autagenic controls. Both of the latter 
treatments Induced dose-dependent Increases in mutation rates, but vinyl 
chloride shoved no mutagenic activity under any of the test conditions.
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Two possible explanations for this lack of vinyl chloride-induced 
mutagenicity in Neurospora were suggested by the authors [157]. Vinyl 
chloride or its mutagenic metabolites night have been unable to penetrate into 
the conl'la; however, the authors also noted that the Salmonella [146,150] and 
yeast tester strains [155] used carried mutations affecting genetic repair, 
while the Neurospora crassa strains used in this study [157] were not repair 
deficient and thus might not have been sensitive enough to indicate 
mutagenicity for vinyl chloride. Drozdovicz and Euang also mentioned 
unpublished data by Huang et al shoving that vinyl chloride was not mutagenic 
in Ea«nnphilus Influenzae when DNA from this bacterium was subjected to vinyl 
chloride treatment and used in transformation assays. No additional details 
were provided.
Bartsch and Montesano [158], la a 1975 review of the mutagenic and 
carcinogenic effects of vinyl chloride, mentioned a personal communication 
from F Verburgt reporting unpublished observations of positive results in a 
recessive lethal test on Drosophila. Verburgt exposed male Drosophila to 
vinyl chloride at 800 ppm for 4 or 17 days. He observed a significant 
Increase in the frequency of recessive lethals and noted that peak mutagenic 
activity was found in aetabolically active germ cells. No further information 
was provided. Magnusson and Ramel [159], in 1976, ’ also obtained positive 
results in recessive lethal tests with Drosophila. Male Drosophila were 
exposed to vinyl chloride at unspecified concentrations in air for 3 hours and 
then maced to Miller 5 females. The authors reported a significant increase 
of recessive lethals in both the first and second generations after trsatmenc, 
indicating that vinyl chloride Induced recessive lethal nosaics, but no 
quantitative data were given.
In 1977, Verburgt and Vogel [160] reported the results of recessive lethal 
tests on Drosophila males exposed to vinyl chloride at concentrations of 200, 
850, 10,000, 30,000, or 50,000 ppm for 2 days and to 30 or 850 ?pm for 17
days. At each concentration, chromosomes were tested and the number of 
lethals was scored during days 0 to 1 2 after exposure.
Vinyl chloride exposure for 2 days at concentrations of 0, 30, and 200 ppm 
produced 0.10, 0.18, and 0.09Z lethals, respectively [160]. Concentrations of 
850 ppm for 2 or 4 days produced 0.39 and 0.595! lethals, respectively, and 
concentrations of 10,000, 30,000, and 50,000 ppm for 2 days induced lethals In 
2.19, 2.22, and 2.30Z, respectively. After 17 days of exposure and
examination for 10 subsequent days, lethals were found in 0.19Z of those 
exposed at 0 ppm, 0.35Z of those exposed at 30 ppm, and 1.02.T of those exposed 
at 850 ppm.
Verburgt and Vogel [160] stated that the data, which demonstrated an 
increasing frequency of lethal effects between concentrations of 0 ind 1 0 , 0 0 0  
ppm, demonstrated that the mutagenic activity of vinyl chloride vas 
concentration dependent. Since exposure at 30,000 and .50,000 ppm did not 
significantly Increase the mutation frequency above that seen at 1 0 , 0 0 0  ppm,
they inferred that above a certain concantration (between 850 and 10,000 ppm) 
Drosophila was incapable of metabolically "activating" (for mutagenesis) 
further vinyl chloride, and that the enzymatic mechanism* were saturated.
Anderson et al [161] conducted a dominant lethality study with mice to 
determine whether vinyl chloride can induce genetic effects. Male CD-I mice 
were exposed in groups of 2 0  to vinyl chloride (purity not described) at 
concentrations of 3,000, 10,000, and 30,000 ppm (7.68, 25.6, and 76.8 g/cu m) 
6 hours/day for 5 days. A concentration of 30,000 ppm was the highest 
exposure level chosen because it had been shown in preliminary tests to be in 
tne "toxic range" and it was desired that the maximum tolerated dose or higher 
be included in the study protocol. Control mice were exposed tc air alone. 
Two positive control groups of 15 and 25 mice were given 200 ng/kg of ethyl 
aethanesulphonate orally for 5 days or one ip dose of 200 ¡ng/kg of 
cyclophosphamide on the 5th day. After the exposure period, each of the 
surviving males, then 1 0 - 1 2  weeks old, was mated with two 8- to 1 0-week-old 
females each week for 8 consecutive weeks. The females were killed 13 days 
after the asaumed date of mating, and their uteri were examined for live 
implantations, early fetal deaths, and late fetal deaths.
Of the male mice, only those exposed to vinyl chloride at 30,000 ppm 
showed significant mortality, with only 9 of 20 mice surviving 5-day exposures 
[161]. In females mated to vinyl chloride-exposed males, the frequency of 
pregnancy and the number of early and lat«» fetal deaths did not differ 
significantly from untreated control values. The number of 
implantations/pregnant female was not affected by vinyl chloride, except that 
it was significantly below the negative control value in females mated during 
the 4th week to mice that had been exposed at 30,000 ppm (10.00 vs 12.38, 
P<0.05); however, implantation frequency in this group was slightly above 
control values for 3 of the 8 week3 of mating. Both positive control groups 
were significantly higher than negative (air) controls in all the indicators 
of dominant lethality examined, attesting to the sensitivity of the system. 
The authors [161] concluded that vinyl chloride at the stated exposure 
concentrations was not mutagenic in mice as measured by the dominant lethal 
test. This suggests that the active mutagenic compound in the metabolism of 
vinyl chloride did not affect the germinal cells of these mice.
Several investigators have attempted to obtain information on the 
mechanism of mutagenic and carcinogenic activity of vinyl chloride by testing 
Its known or suspected metabolites for their ability to cause mutations in 
microorganisms. Malaveille et al [147] used Salmonella strain TA1530 to 
evaluate che mutagenic activity of three presumed metabolites, 
chloroacetaldehyde, chloroethanol, and chloroethylene oxide (chlorooxirane), 
and a known urinary metabolite, chloroacetic acid. The substances were 
tested, with and without a liver microsomal system from phenobarbital- 
pretreated mice, at concentrations of 40, 4.0, and 0.4 ¿uaol/ml of medium; 
chloroethylene oxide was also tested at 0.04 pool/ml.
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Chloroacetaldehyde was highly toxic to bacteria at each teat concantration 
used, reducing survival to laaa chan 0.00&Z of control levels [147]. 
Chloroacatic acid was toxic at concentration* of 4 and 40 ¿aol/ml and waa tha 
only substance taatad that showed no autagenic activity. Chloroacetaldehyde 
caused a sixfold increase over the spontaneous rate at a concentration of 4 
Mmol/ml in combination with the microsomal system; this substance also shoved 
direct mutagenic activity in the absence of mammalian nlcrosomes. At a 
concentration of 40 ^mol/ml, chloroethanol, which did  not  a f i e c t  b a c t e r i a l  
survival, Increased the  mutation frequency more chan 10 t imes in che presence  
of Che microsomal system and about 6 c iaes  in  i t s  absence;  a t  4 ¿¿mol/ml, 
ch lo roe thano l  approximate ly  doubled the a u t a t i o n  frequency of the  b a c t e r i a ,  
and i t s  mutagenic a c t i v i t y  was apparen t ly  una f fec ted  by the a i c r o s c n a l  system. 
Chloroethylene  oxide was t e s t e d  without  a ic rosomal  a c t i v a t i o n  o n l y . .  At a 
c on c e n t ra t io n  of  0 .4  ¿aaol/ml. I t  reduced b a c t e r i a l  s u rv iv a l  ta  11Z and 
produced a s i x f o l d  inc rea se  in the muta t ion  frequency;  a t  0.04 ( jaol/ml,  i t  
caused no increase over spontaneous mutat ion  f requency.  These findings 
indicate that chloroethylene oxide is a far more e f f e c t i v e  mutagen than 
chloroacetaldehyde, supporting the suggestion of Henschler and his colleagues 
[151-153] that the unstable oxirane was d i r e c t l y  involved in vinyl ch lo r ide  
au ta g e n e s i s .
McCann et al [162] compared the mutagenicity of vinyl chloride wlch that 
of its probable metabolites chloroacetaldehyde and chloroethanol, both with 
and without activation by a rat liver mlcrosGtaal system. They used Salmonella 
strains TA1535 ana TA100, the latter being identical with TA1535 except that 
it contains a factor that interferes with DMA repair, thus Increasing its 
sensitivity to many mutagens. Bacteria were exposed to 20Z vinyl chloride in 
air for 3-9 hours, while chloroacetaldehyde and chloroethanol were added 
directly to che media in concentrations of up to 30 /¿g/plate and 1-3 mg/plate, 
respectively.
The mutagenic responses ox strains TA1535 and TA100 to vinyl chloride were 
similar, and McCann et al [i62] observed very little activation by a 
aicrosomal system from phenobarbital-pretreaced rats with exposure periods of 
up to 9 hours. From the authors' graphs, the direct action of vinyl chloride 
on strain TA100 produced about 25 revertants/plate above spontaneous levels 
(which averaged 150 revertants/plate) with 3 hours of exposure and 200 at 9 
hours; the corresponding levels with the microsomal system added were 65 and 
225 revertants/plate above control levels. However, the authors added in a 
footnote that increasing the concentration of alcrosomes in the system had 
produced a tvofold increase over the direct activity of vinyl chloride in both 
TA100 and TA1535.
At the concentrations tested, chloroacetaldehyde, with no microsomal 
system, effectively reverted strain TA100 to histidine Independence but did 
not affect strain TA1535 [162]. The mutagenic activity in strain TA100
increased with the concentration of chloroacetaldehyde, reaching 235 
revertants/plate above the spontaneous rate at a concentration of 30 Mg/plate. 
Chloroethanol Increased the mutagenic reponse of strain TA100 to over twice
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th« spontaneous l e v e l s  and showed a t r a c e  of a c t i v i t y  with  s t r a i n  TA1535. 
However, a d d i t i o n  of the microsomal su pe rna tan t  caused a smal l  inc re a se  in  the 
mutagenic response  of s t r a i n  TA1535 and a much g r e a t e r  i nc re a se  in  t h a t  of 
s t r a i n  TA100; q u a n t i t a t i v e  d a t a  were not  given.  The au thors  noted t h a t  an 
MADPH-generating system was not  necessa ry  fo r  t h i s  a c t i v a t i o n .  Comparing the 
mutagenic a c t i v i t y  of the th r ee  subs tances  in s t r a i n  TA100 on an equimolar 
b a s i s ,  the  au thors  found t h a t  the number of rever tan ts /pono l ,  with  c on t ro l  
l e v e l s  s u b t r a c t e d ,  was 1.0 fo r  v in y l  c h l o r i d e ,  0.6 f o r  c h l o r o e th a n o l , and 746 
fo r  chloroace ta ldehyde .
Despi te the high mutagenic a c t i v i t y  of ch lo roace ta ldehyde  in  s t r a i n  TA100, 
McCann and coworkers [162] concluded t h a t  t h i s  subs, ance was probably not the 
a c t iv e  a s t a o o l i t e  involved in  v in y l  ch lo r ide  mutagen ic i ty .  Vinyl  c h lo r id e ,  
with or without  a ic rosom es , was about equa l ly  a c t i v e  in the two b a c t e r i a l  
s t r a i n s  t i s t e d ,  while ch loroace ta ldehyde  a f f e c t e d  only s t r a i n  TA100. By 
c o n t r a s t ,  a c t i v a t i o n  of ch lo roe thano l  by a microsomal system produced a 
r e l a t i v e l y  l a r g e  Increase  i n  the  muta t ion  r a t e  of TA100, i n d i c a t in g  t h a t  
ch lo roace ta ldehyde  might  be the mutagenica l ly  a c t i v e  m e tab o l i t e  of 
ch lo roe thano l .  The authors  suggested  t h a t  ch lo roe thy lene  oxide might be the 
metabolic  in te rm ed ia te  re sp o n s ib le  f o r  v in y l  ch lo r ide  mutagen ic i ty .  This 
conclusion i s  supported by the f in d in gs  of M alave i i le  e t  a l  [147] and of 
Sannug e t  a l  [163] chat  ch lo roe thy lene  oxide was s e v e ra l  t imes more a c t iv e  
than ch lo roace ta ldehyde  in  the n o n r e p a i r - d e f i c i e n t  s t r a i n s  TA1530 and TA1535.
In 1976, Rannug e t  a l  [162] compared the mutagen ic i ty  of ch lo roe th lyene  
oxide,  ch lo roace ta ldehyde ,  2 -c h lo ro e th an o l ,  and c h lo r o a c e t i c  acid  in 
Salmonella typhimurlum s t r a i n  TA1535. The t e s t  subs tances  were added to the 
b a c t e r i a  before  p l a t i n g ,  in  con c e n t ra t io ns  ranging from 0.1 to 1.5 m i l l im o la r ;  
2 -cn io roe thano l  and c h lo r o a c e t i c  acid  were a l so  s tud ied  a t  concen t ra t ions  of 
up to 1 M. Ethylene oxide,  descr ibed  as a "well  known mutagen," was used as a 
p o s i t i v e  c o n t ro l .  The authors  a l so  t e s t e d  v in y l  ch lo r ide  a t  a concen t ra t ion  
of 22 (51.2 g/cu  m) in  a i r  fo r  3 hours ,  using the procedure desc r ibed  in t h e i r  
e a r l i e r  s tudy [145].
Chloroethylene  oxide showed both a d e f i n i t e  t ox ic  e f f e c t  and s t rong  
mutagenic a c t i v i t y  [163].  At a c on c e n t ra t io n  of 0.75 m i l l im o l a r ,  i t  produced 
180 r e v e r t a n t s /1 0 0  m i l l i o n  su rv iv ing  c e l l s ,  60 c iaes  the spontaneous mutat ion 
r a t e .  Chloroacetaldehyde  a l so  showed a mutagenic e f f e c t  in  t h i s  c o n cen t ra t io n  
range but  was only about 52 as e f f e c t i v e  as ch lo roe thy lene  oxide on a molar 
b a s i s .  2-Chlo roe thanol  and c h lo ro a c e t i c  ac id  shoved no mutagenic e f f e c t  up to
1.5 millimolar and were therefore retested at higher concentrations. 2- 
Chloroetnanol produced a weak mutagenic response only at 1 molar. 
Chloroacetic acid was highly toxic to bacteria at concentrations up to 0.5 
molar, and no increase In mutagenic response could be detected. Ethylene 
oxide, the positive control substance, did not produce an increase in 
mutagenic response at concentrations below 5 millimolar, and ethylene oxide at
95.5 m i l l im o la r  produced an Inc rea se  In the muta t ion  r a t e  equ iva len t  to chat  
produced by ch lo roe thy lene  oxide a t  a c on c e n t ra t io n  of 0.15 m i l l im o la r .
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la their experiments with 22 (51.2 g/cu a) vinyl chlorid*, Rannug «t al 
[163] found that vinyl chlorida at this concentration in tha presence of a 
microsooal system produced 10.0 ¿0.9 (SE) revertants/100 million calls, |
significantly aora (P<0.001) than tha control rate of 3.8/100 million calls; 
naithar vinyl chloride alone nor the microsoaal system alone produced a
significant increase. Noting the difficulty of comparing vinyl chloride 
autagenlclty to that of the other compounds because of the difference in
experimental conditions, the authors estimated that only if all the vinyl 
chloride was converted t- 2-chlorcethanol would the concentration of this 
compound be great enough to account for the observed mutagenic activity of 
activated vinyl chloride.
Calculating that chloroethylene oxide was 10,000-15,000 times as mutagenic 
aa ethylene oxide, Rannug et al [163] concluded that this was in reasonable 
agreement with the ratio of the preliminary rate constants of the two
compounds for reaction with the appropriate nucleophiles. They considered
this to be an indication that chloroethylene oxide acts in the same '/ay as 
ethylene oxide, as a monofunctional alkylating agent. The authors concluded 
on the basis of interpretations by Hussain and Osterman-Golkar [164] that 
chloroacetaldehyde was far more active as a mutagen than would be expected 
from its reactivity as an alkylating agent.
In an addendum to the paper by Rannug et al [163], Hussain and Osterman- 
Golkar [164] analyzed the data of Rannug et al on a kinetic basis. They noted 
that the higher-than-expected mutagenic activity of chloroethylene oxide,
based on comparison of its rate constant for axK./lation with that of ethylene 
oxide, indicated "a certain role of the aldehyde groups.” Chloroacetaldehyde, 
however, was several orders of magnitude more effective than expected, 
indicating "a reaction mechanism different from simple alkylation."
In 1977, Loprleno et al [165] tested vinyl chloride metabolites for
mutagenic activity in yeasts. Chloroethylene oxide, 2-chloroacetaldehyde, and 
?-chloroethanol, added to the media in various concentrations, were tested in 
vitro; 2-chloroacetaldehyde was also tested in the host-mediated assay. Test 
organisms and experimental procedures were the same as those used in their 
previous study [155].
Chloroethylene oxide showed the highest mutagenic activity in all systems 
examined [165]. At a concentration of 0.1 millimole, the forward mutation 
frequency in pombe was 340 tlaes the control rate, and at 1 millimole the 
gene conversion rate in cerevlsiae was 40-50 times that in controls. 2- 
Chloroethanol in concentrations up to 50 millimoles showed no mutagenic 
activity in yeast cells, with or without microsomes. 2-Chloroacetaldehyde 
showed a weak mutagenic effect in vitro, increasing mutation rates 2-7 fold at 
concentrations up to 12.5 aillimoles. When administered to male Swiss albino 
mice (25 g) in oral doses of 250 mg/kg, 2-chloroacetaldehyde produced no 
increase in the mutation rate of pombe incubated in the peritoneum for 3 - 6  
hours.
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Elaore «c al [166] evaluated vinyl chloride and it* metabolite* in a study 
designed to pervic accurate comparison* of their mutagenic activity and to 
provide additional insight as to the mechanists of thi* activity. Since 
previous investigators had not ascertained the purity of the metabolites used, 
Elaore and coworkers tested pure fora* of chloroethanol, chloroacetic acid, 
chloroethylene oxide, and chloroacetaldehyde. The last compound can exist In 
coablnatlon* of four form*, depending on its preparation. The authors 
therefore tested pure preparations of the monomer, licer hydrate, and trimer, 
plus the 50:50 mixture of monomer and monomer hydrate formed when the monomer 
is dissolved in water or physiologic systems. They also tested a solution of 
0.0106 M vinyl chloride in nutrient broth.
lr mell.i tvnhlnurl'ia strain TA100 vaa osed for quantitative mutagr.nicity 
testing [lbfe]. The authors also tested DSA repair-deficient strains of 
Bacillus subtllis *n repair assays, as an indirect test for mutagenicity. 4- 
Nitroquinoline-N'-oxide was used as a positive mutagenic control. Hie number 
of replicate places used in these studies was not mentioned and tne authors 
did not lndicace Che scatlstlcal significance of their results.
Incubation of Salmonella for ¿ 8 hours in a medium containing initially
0.0106 M vinyl chloride produced no increase over the spontaneous mutation
rate [166]. Chloroethanol and chloroacetic acid at concentrations of 1 
millimole also showed no mutagenic activity. All forms cf chloroacetaldehyde
were mutagenic to Salmonella strain TA100. Chloroacetaldehyde monomer, the 
most active fora, caused a maximum mutagenic response of ¿04 rev«*rtants/plate 
above spontaneous levels at a concentration of 0.34 /uxnol. The mixture of 
monomer and monomer hydrate caused 512 revertants/plate at 14 ymol. The dimer 
hydrate at 120 /jmol and the triaer at 240 ¡̂mol produced 193 and 159
revertants/plate, respect!vely. Mutagenic response was linear up to these 
cor. ¿s. rations but became nonlinear at high concentrations for all four forms 
of chloroacetaldehyde.
Chloroethylene oxide, which decomposed rapidly to chloroacetaldehyde, with 
a half-life of 1.6 minutes under the 37 C incubation conditions, was 
prelacubated with the bacteria at 3 C for up to 6 hours before plating to 
ensure that the undecoaposed compound penetrated the cells [166]. With 4 
hour* of preincubacion, chloroethylene oxide at a concentration of 0.26 
miliiaole produced 114 revertants/plate above spontaneous levels.
The repair assay used by Elmore et al [166] involves incubating Bacillus 
sub tills strains on 6 -raa filter paper discs saturated with the test
substance*, as described by Kada et al [167], Lethality and mutagenic
potential were evaluated by comparing inhibition zones in the wild-type 
strain 168 wlch chose la strain* deficient In their ability to repair DNA
lesions due Co lack of eicher excision repair (her- or u v t - )  or
recoabioaelon repair (rec-) capability.
Vinyl chloride, chloroethanol, and chloroacetic acid did aot inhibit 
bacterial growth in the repair a**ay [166]. The various foras of
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chloroacetaldehyde affected growth of the wild type and excision repair- 
deficient •trains only slightly but had a much greater effect on the 
recoBbiaation-deficieot strain, with ths monomer sad monomer hydrate again 
being the aoat active Coras. Chloroethylene oxide also selectively inhibited 
growth of the recombination-deficieat strain.
Since the wild-type and excision repair-deficient strains of B. subtllls 
(both capabl* of recombination repair) were essentially unaffected by these 
substances, Elmore and colleagues [166] concluded chat recombination repair is 
induced to correct DNA lesions caused by vinyl chloride metabolites. They 
suggested Chat the post-replication repair of DNA in mammalian cells, which, 
like recombination repair in bacteria, is an error-prone process, nslghc be 
responsible for the production of human cancer by vinyl chJorlde. The 
ultimace carcinogenic metabolites of vinyl chloride, the authors considered, 
are chloroacetaldehyde monomer hydrates, known to react with DNA, and 
chloroethylene oxide, which rearianges co chlcroacetaldehyde or to a 
stabilized diradical intermediate also known to react with DNA. They 
suggested that the lower autsgenicity of chloroethylene oxide might result 
from it* being detoxified faster than chloroacetaldehyde.
Laumbach et al [168] extended the investigation of Elmore et al [166] by 
studying the effect of chloroacetaldehyde on transforming DNA extracted from 
Bacillus subtills. Previous studies [169,170] had shown that 
chloroacetaldehyde could bind tc DNA in vitro, modifying bases and causing 
mismatched base pairs; however, Laumbach et al [168] found thar. transforming 
DNA Isolated from wild-type subtllls and treated with chloroacetaldehyde 
did not affect the number of transforaanta in any of four auxotrophic E. 
subtllls strains used as recipients. When the wild-type strain was treated 
with chloroacetaldehyde for 15 minutes before the DNA was extracted, there was 
a major depression of biologic activity in the transforming DNA, as evidenced 
by a decrease of 50" cr more in the number of transformants produced. This 
depression showed genetic-marker specificity, reducing transformation ac seme 
loci by over 90Z. The authors noced that DNA segments that have previously 
been shown to be associated with macromolecular structures such as the cell 
wall or cell aeabrana appeared to be selectively protected froa attack by 
chloroacetaldehyde. The addition of a mammalian microsomal systea did not 
significantly alter the effect of chloroacetaldehyde on transformation 
efficiency.
Huberaan et al [171] evaluated the mutagenicity of chloroethylene oxide 
and 2-chloroacetaldehyde directly on mammalian cells, using cultures of V79 
cells derived froa the kidneys of Chinese hamsters; this cell system had been 
successfully used in detecting mutagenic activity of other carcinogenic 
substances. Cells were seeded on media containing 8 -azaguanine or ouabain and 
exposed to tit« test substances at concentrations of up to 25 ;<ar 1 for 3 hours. 
After an additional period of incubation, colonics r«sistaat to 8 -azaguanine 
w*r* scored for 1 0 - 1 2  plates at each concentration and ouabain-resistant 




Th« mutagenic response sc both loci Increased ss s function of the 
concentrations of chloroethylene oxide and 2-chloroecetaldehyde [171]. At a 
concentration of 6 ¿¿mol, chloroethylene oxide produced outatlon frequencies 4 
tines that of controls for 8 -azaguanlne resistance and 1 0 times the control 
frequency for ouabain resistance. The corresponding values for 2- 
chloroacetaldehyde at these concentrations were 13 and 2 times control 
frequencies. Chloroethylene oxide at 13 ¿anol produced mutation frequencies 
exceeding control frequencies by factors of 8 at the 8 -azaguanine locus and 23 
for ouabain. 2-Chloroacetaldehyde at this concentration was strongly 
cytotoxic, and no mutagenic effect could be detected.
(b) Vinylidene Chloride
In a 1975 study of vinyl chloride mutagenicity, Eartsch et al [146] stated 
that they had unpublished data showing chat vinylidene chloride mecabollcally 
activated by rat or mouse liver microsomal enzymes was a more active mutagen 
than vinyl chloride. A subsequent 1975 paper by Bartsch et al [172] presented 
data on the mutagenicity of vinylidene chloride in Salmonella cyyhiaurium. 
using histidine-deficient tester strains TA1530 and TA100. Plated bacteria, 
in a medium containing a microsomal system from the livers of phenobarbital- 
pretreated OF-) mice supplemented with an NADPH-generating system, vere 
exposed to vinylidene chloride, containing 0.32 4-methoxyphenol as an 
antioxidanc, at concentrations of 0.2, 2.0, or 20Z (7.94, 79.4, or 794 g/cu m) 
in air [172]. This produced respective vinylidene chloride concentrations of 
0.33, 3.3, and 33 millimoles in the media afcer 2 hours of exposure, as 
determined by gas chromatography. After exposure, the bacteria were cultured 
for up to 48 hours, and histidine-revertant colonies were counted on each 
plate. From one to four experiments were conducted at each concentration, 
each using a pool of four mouse livers; bacteria were plated in triplicate for 
each experiment. The authors also compared the efficiency of liver, kidney, 
and lung microsomal systems from male OF-1 mice and female BD-VI rats in 
inducing mutagenic response to vinylidene chloride in strain TA100.
Both Salmonella strains showed a positive mutagenic response to vinylidene 
chloride in the presence of a mammalian microsomal system [172]. Ho mutagenic 
activity was observed in the absence of the NADPH-generating system. In 
strain TA100, exposure to vinylidene chloride for 4 hours at 0.2Z produced an 
average of about 300 revertants/plate, compared with control levels of less 
chan 50. At 2Z vinylidene chloride, the number of revertants/plate In strain 
TA100 reached 500 £23 (SE) above control levels, while at 20Z vinylidene
chloride, the number was only 330 *29. Strain TA1530 followed che saae
pattern but was somewhat less sensitive. The authors suggested that the 
reduction in mutagenic response at the highest exposure concentration might 
have resulted from inhibition of the microsomal enzymes responsible for the 
metabolic activation of vinylidene chloride.
P »  mutagenic response of the bacteria to 2* vinylidene chloride increased 
linearly with time up to 4 hours, and this test period was therefore used in 




fraction* tasted inducad son* mutagenic response to vinylidene chloride, 
although tha livar fraction was the most active. Rat tissue fractions were 
ouch less accive than those of mice, and rat lung tissue showed ainimal
activity. Phenobarbital pretreataent, used only in aice, approximately 
doubled the mutagenic activity of vinylidene chloride. Exposure Co 2Z 
vinylidene chloride in the presence of microsomal systems from untreated mouse 
liver caused 330 £49 revertants/plate above control levels. Using this value 
as a standard (100Z), relative activities of the other tissue fractions from 
untreated animals were: mouse 'Kidney, 20Z; mouse lung, 6Z; rat liver, 30Z;
rat Itidney, 5Z; rat lung, less than 3Z. In a 1976 review paper, Bartsch [148] 
also noted that the relative activities of four human liver biopsy specimens,
under similar experimental conditions, were 38, 17, 15, and 11" of the
corresponding mouse liver values.
In another set of experiments, using Salmonella strain TA1530, Bartsch et 
al [172] attempted to explicate the mechanism whereby vinylidene chloride
exerted mutagenicity by adding sulfur-containing compounds to the media. With 
exposure to 2Z (79.4 g/cu m) vinylidene chloride, the addition of 12 (xmol/ml 
of N-acetyl cysteine and the .same amount of N-acety1-methionine to the medium, 
in the presence of a mouse liver microsomal system, caused an 80Z reduction in 
the number of revertants. 'the authors concluded that the mutagenic
metabolites of vinylidene chloride are trapped by m-.cleophilic sulfur groups, 
thus competing for binding to bacterial DNA.
In a review pubjished in 1976, 3artsch et al [173] again noted that 
vinylidene chloride was more mutagenically active than vinyl chloride, based 
on calculations from linear dose- and time-dependent response curves from
separate experiments. They indicated that vinyl chloride produced 3.7 
revertants/paol of substrate/hour of exposure/plate in strain TA1530 and 5.6 
in strain TA1Q0, while vinylidene chloride produced 9.5 and 14.6 
revertants/*nnol/hour/plate, respectively, in these test strains.
Grelm et al [151], Henschler [152], and Henschler et al [153] reported on 
the mutaganic activity of vinylidene chloride, as well as that of vinyl 
chloride and related compounds, in Escherichia coll strain K12. Analytical 
grade vinylidene chloride was injected into the incubation medium to produce a 
concentration of 2.5 millimoles, as determined by gas chromatography.
Like vinyl chloride, vinylidene chloride was most active in causing 
mutations at the arg+ locus, producing revertants at 229 £26Z of the
spontaneous mutation rate [151-153]. Revertants at the gal+ locus increased 
to 120 £14Z of the spontaneous rate in bacteria exposed to vinylidene 
chloride, while the MTR and nad+ loci werr not observably affected. No
mutagenic activity was observed in the absence of a microsomal system.
The authors [151-153] seated that the mutagenic activity of vinyl 
chloride, which caused a 563Z increase in mutations at Che arg+ locus, was 
"several times higher" than that of vinylidene chloride. It should be noted, 
however, that the measured concentration of vinyl chloride in the medium (10.6
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millimoles) was over four cimes ehac of vinylidene chlorid«. In addition, the 
difference in exposure technique required for the highly insoluble gaseous 
vinyl chloride necessitates that such comparisons be made with caution. Since 
Bartsch ec al [172] exposed bacteria to both vinyl chloride and vinylidene 
chloride in air, and thus determined the concentration in the medium under 
similar conditions, their comparisons of relative mutagenic activity are 
probably more accurate. Furthermore, Henschler et al [153] pointed out in 
cheir discussion that vinylidene chloride is che most polar of the chlorinated 
ethylenes they tested, and its oxirane, which has not been successfully 
synthesized, would be expected to be Che least stable. Thus, it should be 
expected to have a higher mutagenic activity than vinyl chloride.
(c) Vinyl Bromide
VF Simmon and R Maugham, in a written coinmunicaeion to NIOSH in August 
1977, reported the results of a study on the mutagenic effects of vinyl 
bromide on Salmonella typhimurium strains TA100 and TA1535. Plated bacteria, 
with and without a liver microsomal system from male rats pretreated with 
Aroclor 1254, were exposed for 12 hours to atmospheres containing 0-20" viayl 
bromide (source and purity noc described). After an additional 48-hour
incubation period, histidine tevertants were counted on three replicate plates 
for each concentration.
Vinyl bromide ac concentrations of 2-20" (87.6-876 g/cu m), in the absence 
of a microsomal activation system, increased the mutagenic response in both 
Salmonella test strains a3 compared with control activity according to Simon 
and Mangham. Addition of a microsomal system enhanced the mutagenic activity 
of vinyl bromide. At 20Z vinyl bromide in che presence of a microsomal 
system, there was an average of 1,129 revertanCs/plate in scrain TA100 and
959/plate in TA1535; wichout Che activating system, the mutation rates were
620/plate for TA100 and 721/plate for TA1535. Control rates of about
130/plate for TA100 and less than 20/plate for TA1535 were not significantly 
affecCed by che addicion of che microsomal system alone.
Although Simmon and Mangham did noc conduce simuleaneous scudies of vinyl 
chloride or measure che concencracion of vinyl bromide produced in che medium, 
chey postulated thac vinyl bromide was slighcly more mucagenic by chese 
procedures chan vinyl chloride. So data were offered in supporc of chis 
comparison. The auChors' findings do support a conclusion thac vinyl bromide 
induces mucacions in Salmonella scrain TA100 and TA1535 wichouc microsomal 
accivadon, alchough microsomes enhance ics mucagenic accivicy. The mucagenic 
responses of both strains were concencracion-dependent in a nearly scraighc- 
line relacionship, which showed a tendency to level out at the highest 
concentration tested (20Z). Since Simmon and Mangham did noc provide daca on 
baccerial survival, ic is not possible co determine whether this sacuration 
resulced from a coxic effecc of vinyl bromide at high concentracions.
In a 1976 review, Barcsch [148] mentioned unpublished daca on vinyl 
bromide mucagenicicy and noced chac microsomal syscems from chree human liver
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samples were 23-36Z as effective as a mouse liver microsomal system in 
inducing the mutagenic effects of vinyl bromide on Salmonella. No 
experimental data were presented, nor did Bartsch make any comparison of vinyl 
bromide mutagenicity with that of other vinyl compounds.
(d) Vinyl Fluoride and Vinylidene Fluoride
Putative mutants of Escherichia coli B and coli Sd-4 were isolated by 
Che penicillin method of Lederberg and Zinder and by plating in the absence of 
streptomycin, respectively [174]. The authors stated that the E. coll B
cultures exposed to vinyl fluoride and vinylidene fluoride mutated at about 
100 times the rate at which the control cultures mutated. They al30 noted a 
similar influence of vinylidene fluoride on the Sd-4 strain of coli.
Despite this apparent observation of extremely high mutation rates, the 
authors were unable to isolate any auxotrophic strains from the treated 
cultures [174]. They presented some evidence for the Induction of heritable 
changes in the fermentation patterns of certain carbohydrates, although it was 
not unequivocal.
While it is possible that qualitative changes in the mutation frequencies 
may have occurred, the failure to isolate auxotrophic strains from the treated 
cultures suggests that any such effects were minimal [174]. Also, the 
selection method used by these authors does not allow the direct measurement 
of either the spontaneous or induced mutation rates or frequencies of a
culture, although it may greatly enrich the ratio (frequency) of mutated cells 
to normal cells in the culture.
Vinylidene fluoride has been tested for mutagenic potential in the "Ames" 
Salmonella auxotroph reversion assay procedure, and Che "in vitro
transformation of BALB/3T3 cell assay (J Watson, written communication, April 
7, 1978). The "Ames" analysis was conducted with Salmonella typhimurium 
strains TA-1535, TA-1537, TA-1538, TA-100, and TA-98, with and without
activation by rat liver microsomes. Solvent and positive control plates were 
run concurrently with test plates. Test plates were exposed to vinylidene 
chloride gas for 1, 24, 48, or 72 hours and incubated at 37 C for 48 hours, 
after the 1-hour exposure, and 24 hours after the 24, 48, and 72-hour 
exposures.
Without activation, strain TA-1535 exposed for either 24 or 48 hours 
shoved a threefold increase in the number of revertants/plate and those 
exposed for 72 hours showed a sevenfold increase when compared with solvent 
controls according to Watson. Ten micrograms of methylnltrosoguanldlne/plate 
(positive control) Increased the number of revertants 43-fold. With
activation, the increases in revertants/plate were reported as sevenfold for
one 24-hour exposure, eightfold for one 48-hour exposure, and tenfold for a 
72-hour exposure. A positive control of 2-anthramine at 100 ^g/plate gave 
eightfold increases. Other Salmonella strains did not show substantial 
increases in revertants/plate vhen compared vlth solvent controls in either 
the activated or nonactlvaced systems.
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These results show that vinylidene fluoride induces a base-pair 
substitution, but no fraceshift mutations according to Watson. Although 
strain TA-100 should also identify any potential mutagen capable of inducing 
base-pair substitution, the results were negative for this strain in these 
tests. The most plausible explanation for this apparent discrepancy is that 
the presence of the resistance transfer factor on the TA-100 was in this case 
protective. The results also indicate that some product of the metabolism of 
vinylidene fluoride is more mutagenic than the parent compound.
Watson also tested the ability of vinylidene fluoride to transform 
BAL3/3T3 cells. Cells vere exposed for various periods ranging from 0 to 48 
hours, with and without tissue culture media. Only the cells exposed with 
culture media shoved an elevated number of transformations above background; 
however, these elevations were not significant.
Metabolism
Metabolic pathways have not been completely and convincingly delineated 
for any of the vinyl halides. That for vinyl chloride apparently is nearest 
to completion, but, even here, several key steps in the initial reactions *re 
only postulated and have not been conclusively proven by experimentation 
designed specifically to elucidate intermediate metabolic products in vivo. 
The proposed pathvays for vinylidene chloride are sketchy at best, while the 
determinations of pathvays for vinyl bromide, vinyl fluoride, and vinylidene 
fluoride have only just begun.
(a) Vinyl Chloride
Vinyl chloride metabolism has been studied extensively since the discovery 
of vinyl chloride**induced angiosarcoma in humans in early 197£. The major 
urinary excretion products of vinyl chloride have been characterized following 
both inhalation and oral exposures, and the compound has been shovn to be 
readily absorbed and videly distributed in body tissues and to be metabolized 
into several major and minor metabolites.
(1) Distribution and Elimination
Hefner et al [4], In 1975, found that the metabolism of vinyl 
chloride during the first 15 hours after exposure of three male rats to 14C- 
(l,2-)vinyl chloride at 49 ppm (125.4 mg/cu m; a total estimated Intake of 
0.49 mg/kg) for 65 minutes resulted in the formation of polar metabolites that 
were excreted predominantly in the urine (582 of the 14C activity). Lesser 
amounts of radioactivity vere excreted in the feces (2.72) and in the expired 
air as carbon dioxide (9.82). At 75 hours after administration, 67.12 of the 
radioactivity had been excreted in the urine, 3.82 in the feces, and 14.02 as 
expired carbon dioxide. Trace amounts of radioactivity (0.022 of that 
administered) vere eliminated in expired air as unchanged vinyl chloride. A 
small but significant amount of radioactivity (1.62) vas retained in the liver
105
These results show that vinylidene fluoride induces a base-pair 
substitution, but no frameshift mutations according to Watson. Although 
strain TA-100 should also identify any potential mutagen capable of inducing 
base-pair substitution, the results were negative for this strain in these 
tests. The most plausible explanation for this apparent discrepancy is chac 
the presence of Che resistance transfer factor on the TA-100 was ia this case 
protective. The resulcs also indicate thac some product of the metabolism of 
vinylidene fluoride is more mucagenic chan Che parent compound.
Watson also tesced the ability of vinylidene fluoride to transform 
BAL3/3T3 cells. Cells were exposed for various periods ranging from 0 to 48 
hours, with and without tissue culture media. Only the cells exposed with 
culture media shoved an elevaced number of cransforaacions above background; 
however, chese elevations were not significant.
Metabolism
Metabolic pathways have not beea completely aad conviacingly delineated 
for any of the vinyl halides. That for vinyl chloride apparently is nearest 
to completion, but, even here, several key seeps in the initial reactions *re 
only postulated and have noc been conclusively proven by experimentation 
designed specifically Co elucidace intermediate metabolic products in vivo. 
The proposed pathways for vinylidene chloride are sketchy at best, while the 
decerminations of pathways for vinyl bromide, vinyl fluoride, and vinylidene 
fluoride have oaly just begun.
(a) Vinyl Chloride
Vinyl chloride metabolism has been studied extensively since che discovery 
of vinyl chloride**induced angiosarcoma ia humans in early 197£. The aajor 
urinary excredon products of vinyl chloride have been characterized following 
both inhalation and oral exposures, aad the compound has been shown to be 
readily absorbed and widely distributed in body tissues and to be metabolized 
into several major and minor metabolites.
(1) Distribution and Elimination
Hefner et al [4], In 1975, found that the metabolism of vinyl 
chloride during the first 15 hours after exposure of three male rats to 14C- 
(l,2-)vinyl chloride at 49 ppm (125.4 mg/cu a; a total estimated Intake of 
0.49 mg/kg) for 65 minutes resulted in the formation of polar metabolites that 
were excreted predominantly in the urine (582 of the 14C activity). Lesser 
amounts of radioactivity were excreted in the feces (2.7Z) and in the expired 
air as carbon dioxide (9.8Z). At 75 hours after administration, 67.1Z of the 
radioactivity had been excreted in the urine, 3.8Z in the feces, and 14.0Z as 
expired carbon dioxide. Trace amounts of radioactivity (0.02Z of that 
administered) were eliminated in expired air as unchanged vinyl chloride. A 
small but significant amount of radioactivity (1.6Z) was retained in the liver
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for as long as 75 hours after exposure. The skin retained 3.6% of the 
radioactivity, 0.2Z was found in the kidneys, and 7.6Z was found in the 
remaining carcass.
Hefner et al [4] also reported that the in vivo kinetics of uptake 
(metabolism) of inhaled vinyl chloride, determined for four male rats exposed 
together in a chamber at initial concentrations ranging from 50.5 to 1,167.0 
ppm (129.3 to 2,987.5 mg/cu m) for 52.5-356.3 minutes, differed at different 
concentrations of vinyl chloride. For concentrations of 50-105 ppm, the 
apparent first-order rate constane derived after seven separate exposures was 
0.00804 :0.0034/minute, corresponding to a half-life of 86 minutes. After
five separate exposures to vinyl chloride at concentrations ranging from 220 
to 1,167 ppm, the first-order rate constant was determined to be 0.00265 
±0.00135/minute, a half-life of 261 minutes. Based on these results, Hefner 
et al concluded that there were differeut pathways for vinyl chloride 
metabolism and that at least one of them was readily saturated, so that the 
amounts of substrate degraded by the individual pathways were dependent on the 
concentration of vinyl chloride presented to the organism. However, these 
variations in apparent first-order constants are equally consistent with the 
existance of a single saturable process and do not provide any conclusive 
experimental evidence for the existence of multiple biochemical pathways.
Watanabe et al [175] reported chat the largest amounts of radioactivity in 
rats exposed Co 14C-(1,2-)vinyl chloride ac 10 or 1,000 ppm (25.6 or 2,560 
mg/cu m) for 6 hours remained, 11 hours afcer exposure, in Che liver and skin. 
For the liver, skin, carcass, muscle, lungs, and kidneys, ;xg equivalents of 
radioactivity per g of tissue were higher at 1,000 ppm than at 10 ppm. When 
the data were normalized for metabolized vinyl chloride, an apparent increase, 
although not a statistically significant one, was observed in the 14C activity 
of che liver and skin at 1,000 ppm.
In the rats exposed at 10 ppm, a greater percentage of the total recovered 
radioactivity was excreted in the urine and a smaller percentage in the 
expired air than in rats exposed at 1,000 ppm [175]. The apparent first-order 
rate constants for pulmonary excretion at 10 and 1,000 ppm were 0.034 ±0.002
and 0.031 iO.01/hour, respectively, equivalent to half-lives of 20.4 and 22.4 
minutes, respectively.
The urinary excr' .on of radioactivity as a function of time for both 
concentrations of airborne vinyl chloride was nonlinear [175]. This could 
indicate that elimination was occurring from at least two compartments [176]. 
From the initial linear portions of these data, apparent first-order rate 
constants were 0.151 £0.009 and 0.168 ±0.001/hour, corresponding to half-lives 
of 4.6 and 4.1 hours for 10 and 1,000 ppm, respectively. No kinetic analysis 
was performed on the slow phase, or second part, of the curve, since it 
represented less than 3Z of the cocal urinary radioactivity.
In 1976, Watanabe et al [177] reported' that, in male rats given 14C- 
(l,2-)vinyl chloride in single oral doses of 0.05, 1.0, or 100 mg/kg, the
p«rcentage of radioactivity in th« expired air varied in a dos«-dependent 
manner. At 100 mg/kg, 672 of the administered radioactivity was r«cov«r«d as 
unm«taboliz«d 14C-vinyl chlorid«, while at the lower doses, only 1—22 was 
recovered as 14C-vinyl chloride. The percentage of 14C activity detected as 
carbon dioxide was greater (132) at 1.0 mg/kg than at 0.05 (92) or at 100 
mg/kg (22). Urinary and fecal excretion of 14C activity was higher at 0.05 
and 1.0 mg/kg than at 100 mg/kg. The same trend was observed for the carcass 
and tissues. Analysis of tissues for 14C activity at 72 hours indicated that 
ehft liver contained three to six times as much radloactlvlty/g of tissue as 
Che ocher tissues. The proportion of che dose remaining in th« tissues after 
72 hours in the 0.05- and 1.0-mg/kg dose groups wai> greater chan thaC in the 
100-mg/kg group.
WaCanabe ec al [177] Indlcaced that che kirecics of che pulmonary 
elimination of oral doses of vinyl chloride at 0.05 and J mg/kg were 
essentially similar and aonophasic. The apparent first-order rate constants 
for the lower doses were 0.013 ±0.001 and 0.012 ±0.001/minute, corresponding
to half-lives of 53.3 and 57.8 minutes, respectively. The characteristics of 
excretion of a dose of 100 mg/kg, however, indicated a biphaslc response 
curing the first 4 hours after administration. Separation of the response 
into a rapid and a slow component gave apparenc first-order rate constants of 
0.048 ±0.005 and 0.017 ±0,008/minute, equivalent to half-lives of 14.4 and
40.8 minutes.
Urinary excretion curves after single oral doses of vinyl chloride 
indicated a multlphasic mode of elimination [177]. The linear portion of each 
curve extended from 12 to 36 hours after administration. The first-order rate 
constants were estimated to oe 0.155 ±0.006, 0.15 ±0.002, and 0.152
±0.011/hour, equivalent to half-lives of 4.5, 4.6, and 4.6 hours for doses of 
0.05, 1.0, and 100 mg/kg, respectively. Ninety-seven percent was excreted 
within 36 houra- After 36 hours, the excredon curves were qulce variable and 
represented less than 32 of che total urinary activity; hence, no estimates of 
rate constants were made.
Hefner et al [178], in 1975, reported that when the whole body (excluding 
the head) of a male rhesus monkey was exposed to 14C-(1,2-)vinyl chloride at
7,000 ppm (17.9 g/cu m) for 2 hours, and a second monkey was similarly exposed 
at 800 ppm (2.1 g/cu a) for 2.5 hours, radioactivity could be detected only in 
the liver, bile, and kidneys. They also reported that very little gaseous 
vinyl chloride was absorbed percutaneously, 0.023 and 0.0312 of the total 
available radioactivity at 7,000 and £00 ppm, respectively.
Gehrlng et al [179] reported that metabolism of vinyl chloride by rats did 
not Increase proportionately as the concentrations Increased from 1.4 to 4,600 
ppm (3.58 to 11,776 mg/cu m). Th« nonlincarlty of the amount of vinyl 
chloride metabolized during the 6 hours of exposure was reported to be in 
accordance with Mlchaells-Menten kinetics, rather chan with apparent first- 
order kinetics. From the Michaelis-Menten kinetic model, the authors
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estimated chat the theoretical maximum amount (Vm) of vinyl chloride chat 
could b« mecabolized In 6 hours was 8,558 ¿1,147 *ig and Che apparent Mlchaelis 
constant (Km) vas 860 ±159 Mg/liter of air.
Gehring ec al [6] analyzed the results obtained by Vatanabe et al [177] 
and concluded that vinyl chloride elimination tended to be dose dependent and 
that the primary pathways of vinyl chloride metabolism became saturated as the 
oral dose of vinyl chloride Increased, permitting elimination by another 
pathvay(s). From the urinary excretion curves of Vatanabe et al [177], 
Gehring et al [6] concluded chac, since Che slopes, and cherefore Che race of 
eliminación (half-lives of 4.5 hours), did not change, urinary excretion vas 
noc affecCed by dose. They also concluded that elimination kinetics cf vinyl 
chloride in expired air after a dose of 0.05 or 1.0 mg/kg indicaced a 
sonophasic process, whereas ac a higher do_e (100 mg/kg), blphasic eliminación 
kinecics vere indicaced. The half-life for eliminación for Che 100-mg/kg dose 
vas found co be 14 minutes, vhlch corresponded vlch che half-life for vinyl 
chloride in blood reported by Wlchey [180]. Cehrlng et al [6] interpreted 
these results to mean that "vinyl chloride Is bound reverslbly to same site in 
the body having a finite capacity. As the dose Increases, che availability of
Che binding sices decreases and Che chemical is free co find ics vay co ocher
sices as veil or Co be ellmlnaCed." The authors also concluded chac Che face 
of vinyl chloride vlchln Che body changed vlch dose, and chat pulmonary
excretion of vinyl chloride vas noc a race-limiting step in metabolism.
In 1975, Green and Bachvay [5] reported on a vhole-body autoradiographic 
study in vhlch rats vere given single oral doses of 30 mlcrocurles of 14C- 
(1,2-)vinyl chloride, vhlch s'ioved that, at 4 hours after administration, Che 
gastrointestinal tract vas free of radioactivity except for che largr
incestlne, vhic’i contained trace amounts. Afcer 2 hours, a disdncC
localizaCion of 14C vas noced vlthln sectioned tubules of Che paraauricular
region, vhlch Che authors thought might be localized in Che Zymbal glands.
Green and Hathvay [5] also fcund that excretion of radioactivity by four 
rats given single lv or ip doses of 250 or 450 mg/kg of 14C-(1,2-)vinyl 
chloride, containing 2 mlcrocurles of 14C, in a beta-hydroxyethyllactamlde
solution vas completed vlthln 72 hours. Rats given similar oral doses of 14C- 
vinyl chloride vere still excreting small amounts of 14C after 72 hours. The 
greatest percentage of the radioactive label In the lover oral dose vas 
excreted in the urine; only small amounts of radioactivity vere eliminated In 
expired air as unchanged vinyl chloride and [4,6,175,177,186,187] the high 
oral dose, approximately 92Z of che label, vas ellmlnaced In expired air as 
unchanged vinyl chloride and less chan 12 as carbon dioxide. The authors 
stated that, nevertheless, about 100 times more vinyl chloride vas metabolized 
at the higher oral dose than at the lover one.
At an lv dose of 250 Mg/kg, 99Z of the vinyl chloride vas excreted
unchanged In expired air vlthln an hour after injection, Including 80Z within 
2 minutes [5], The excretion profile of vinyl chloride after a single ip 
Injection at the low dose vas Intermediate betveen that occurring vlth oral or
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lv administration. The authors suggested that some of che vinyl chloride in 
blood vas excreted unchanged through the lungs and some was absorbed into Che 
hepatic-portal system and metabolized by the liver.
From these data, the authors [5] concluded that the change in excretion 
pattern between high and low doses was due to a "saturable drug metabolism and 
to a highly efficient arterial-alveolar transfer of unchanged vinyl chloride 
from systemic blood that leaves a relatively low concentration of material 
available for biotransformatior. 1=. ¿uctessive passes through the liver."
In another experiment by Green and Hathvay [5], three rats that received 
3, 30, or 300 mg/kg/day of nonradioactlve vinyl chloride by oral intubation 
for 60 days were given single oral doses of 14C-(1,2-)vinyl chloride (O.b 
mg/kg, containing 2 aicrocuries) on days 1 and 60. For the first 24 hours 
after administration of Che radiolabeled vinyl chloride, urine and expired air 
were monitored fir radioactivity. The auchors concluded Chat chronic exposure 
for 60 days did not affect the excretion rate for a single oral dose of 14C- 
vlnyl chloride. The authors also concluded that vinyl chloride did not Induce 
its own metabolism and that excretion data for a single dose also applied to 
Che chronic situation.
(2) Identification of. Metabolites
Gothe et al T3], .in 1974, analyzed the metaboliCes produced from 
vinyl chloride in vicro by a microsomal supernacanc from rat liver in Che 
presence of an NADPH-generacing system. Vinyl chloride was bubbled through 
che microsomal system, Co which 3,4-dichlorobenzeneChlol had been added as a 
crapping agenc for reaccive mecabolices, Afcer 2 hours of exposure, che 
produces idencified were consistent with the formation of chloroettiylene 
ox.\de, chloroacetaldehyde, or both.
A similar study by Barbin et al [2], using a mouse liver microsomal system 
and 4-(4-nicrobenzyl)pyridine, showed chac a volatile metabolic adduct of 
vinyl chloride was formed chac had an absorption spectrum ldenclcal Co chac of 
che adduce of chloroechylene oxide buc different from the adduce of 
chloroacecaldehyde. They concluded chac chloroechylene oxide was che primary 
mecabolice of vinyl chloride in their system.
Chloroechylene oxide was chemically syncheslzed by Zlef and Schramm [181] 
and Gross and Freiberg [182]. Upon standing, chloroechylene oxide was 
observed co readily rearrange to cnloroaceCaldehyde. In an aqueous soluelon 
at pH 7.4 and 37 C, chloroechylene oxide had a half-life of 1.6 minuces and 
ics rearrangement followed first-order kinetics [183].
Radwan and Henschler [184] reported chac small quantities of 
monochloroacetic acid could be dececced when vinyl chloride ac 100-2,000 ppm 
(256-5,120 ag/cu m) was perfused chrough isolated raC livers. They reporCed a 
slight Increase in th^ concentration of methemoglobin in the system, which 
they considered indicative of the formation of peroxide intermediaCes.
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Wacanabe ec al [175] reported that during the first 24 hours after 
exposure of rats to 14C-(1,2-)vinyl chloride 10 or 1,000 ppa (25.6 or 2,560 
ag/cu a) che nonvolatile urinary metabolites were N-acetyl-S-(2- 
hydroxyethyl)cysteine, thiodiglycolic acid, and a third metabolite that was 
not identified. They concluded that the proportion of 14C eliminated by 
various routes was concentration dependent. Moreover, the dominant route of 
excretion at both concentrations was in the urine and the metabolites were 
predominantly nonvolatile or polar. This finding supports Che earlier 
conclusions of Hefner et al [4] and Watanabe et al [177] that the elimination 
of vinyl chloride metabolites was dose dependent. The authors a'.so suggested 
that metabolism occurred at a reduced rate because body burden in terms of 
equivalents of radioactivity increased by only 27-fold as Che concentration of 
vinyl chloride was increased from 10 Co 1,000 ppm. They concluded thac chis 
also indicated that che primary mecabolic pathway for vinyl chloride was 
sacurable at high concencraclons, specifically ae 1,000 ppm. This work, in 
addition co the work of Hefner ec al [4], tends co support a hypothesis chac,
ac concencraclons of vinyl chloride above 220 ppm, aleernaCe metabolic
pathways *xist.
Hefner et al [4] reported that the urinary metabolites from rats exposed 
for 4, 5, or 7 w?eks to vinyl chloride at 5,000 ppm (12.8 g/cu m) were
similar. The polar metabolites in the urine appeared to be conjugated with 
glutathione or cysteine through covaler.t linkages to the sulfhydryl groups. 
Chromatographic analysis suggested the presence of S-(2-hydroxyethyl)cysteine. 
Two theoretically possible metabolites, S-(2-chloroethyl)cysteine and S-(2- 
carboxymethyl)cysteine, were noc dececced, buc Hefner ec al posculaced chac S- 
(2-carboxymethyl)cysteine might not have been adequately resolved from the 
urine bi.ckgrouad. When rats were exposed to vinyl chloride at 5,000 ppm for 
9 weeks, chromatographic analysis of their urine showed the additional
presence of monochloroacetic acid. Muller et al [185] exposed male rat3
continuously to vinyl chloride at 1,000 ppm fox 43 hours, and they found 
thiodiacetic acid as well as S"(carboxymechyl)cysteine in che urine.
To identify the probable urinary mecabollces of vinyl chloride afcer ics
administration by oral Intubation, Green and Hathway [5] gave each of four
rats three doses of 50 mg of 14C-(l,2-)vlnyl chloride/kg at 3-hour intervals, 
for a total dose of about 10 microcuries of 14C. Major metabolites of vinyl 
chloride were Identified by mass spectral analysis as thiodiglycolic acid, £»- 
(2-chloroethyl)cysteine, and N-acetyl-S-(2-chloroethyl)cysteine. Thiodif»ly- 
collc acid contained 472 of the excreted label, whereas S-(2- 
chloroethyl)cysteine and N-acetyl-S-(2-chloroethyl)cysteine each accounted for 
232 of the urinary label. Urea, glutamic acid, and monochloroacetic acid were 
responsible for 6, 0.5, and 0.52 of the urinary 14C, respectively.
Radiolabeled methionine and serine were present in trace aaouncs. The authors 
also stated chat chiodiglycolic acid is che major mecabolice (612) of
monochloroacedc acid in che rac.
Wacaoabe ec al [177] also found chree major and several minor high- 
pressure liquid chromacographic peaks thaC contained abouc 952 of the Cotal
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14C activity la urine samples from rats after oral doses of 0.05, 1.0, or 100 
mg of 14C-(1,2-)vlnyl chlorlde/kg. Two of the major peaks were identified as 
N-ac€Cyl-S-(2-hydroxyeehyl)cyscein« and ehlodlglycollc acid; the third major 
peak could noc be Identified.
(3) Proposed Pathways
Investigators have postulated that there are at least two pathways
for the metabolism of vinyl chloride, both leading to similar end products 
[4,6,175,177,186,187]. Some have stated that one pathway, suggested to be 
active at low levels of absorption, begins with a hydration reaction whose 
product is chloroethanol. A proposed second pathway, suggested to be 
predominant at high absorption levels. Involves the oxidation of vinyl 
chloride to chloroethyiene oxide by microsomal enzymes. These two pathways 
converge with the formation of chloroacetaldehyde as the second step in each. 
Investigators have also postulated that the metabolism of vinyl chloride 
Involves the formation of free radicals [5,157].
Reynolds et al [188], in 1976, proposed a scheme in which an epoxide 
(chloroethyiene oxide) was produced as a primary reactive metabolite of vinyl 
chloride. This would involve the hepatic mixed-funcCion oxidase system 
[189,190], particularly the cytochrome P-450 component [191,192]. A wide
variety of oxidative reactions, including epoxldatlon, can be mediated by
these enzymes, located in the membranes oJ the endoplasmic reticulum of liver 
cells, with n \DPH serving as an electron donor. Rearrangement of the epoxide 
could then occur, producing a beta-chlorinated acetaldehyde, a dlol, or a 
glutathione conjugate as a secondary metabolite. These products could be
formed by interaction of the epoxide with epoxide hydrase or with glutathione 
epoiJ.de transferase [188].
Vacanabe et al [177] reported that, at oral doses of 0.05 or 1 ag cf 14C- 
(1,2-)vinyl chloride/kg, 14C was consistently eliminated in the urine as 
nonvolatile, polar metabolites and in the expired air as carbon dioxide. At 
an oral dose of 100 mg/kg, however, the primary route of excretion was by 
expiration of unchanged viayl chloride. This indicated to the authors not 
only that metabolic pathways for vinyl chloride are dose dependent, but also 
that the process contains a saturable component. Comparing these results with 
their previous findings [175], the authors also concluded that the aetabolic 
fate of vinyl chloride is independent of the route of administration.
In both oral and inhalation exposures to vinyl chloride, N-acetyl-S-(2- 
hydroxyethyl)cyst«ine was a major urinary metabolite [175,177]. One study 
[193] has indicated chat this compound could be formed from 5-formylmeChyl 
cyscelne and S-formylaechyl glutathione, which ac one time were considered 
either not co be formed or to be metabolized to S-carboxymechyl cysteine 
[193]. Alchough Green and Hathvay [5] Identified (2-chloroechyl)cyscelne and 
M-acecyl-S-(2-chloroechyl;cysceine as urinary mecabolices of vinyl chloride in 
racs, Che formaclon of Chese produces may be an arclface [177,185] of Che
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acthod of separation (methanol derivacizacion produces the chloro-coopound, 
whereas dlazoaechane derlvatlzatlon produces che hydroxy-compound) [194,195].
Froo daca presented by other authors [5,175,177], showing the formation of 
14C-carbon dioxide after adminiseracion of 14C-vinyl chloride, Plugge and Safe 
[196] proposed two additional alternatives for its pulmonary metabolism. The 
first assumed chat the metabolism of vinyl chloride proceeded by che addicion 
and cransfer of a chloroacecyl group Co coenzyme A and by subsequenC
metabolism in che Krebs cycle. The second scheme assumed formation of
glycolate followed by oxidation Co glyoxylate, which entered the C-2 and C-l 
pools. By analogy with the metabolic pathway for chloroechylene oxide, the 
glycolate alternative seems to be the more feasible one [163].
Chloroechanol has been reported to be transformed in vivo and in vitro via 
rat liver enzymes to S-carboxymechyl glutathione, which can also be derived 
froo the Cwo compounds, S-fonnylmethyl glutathione and chloroacetate [193]. 
Chloroacetate has been detecCed as a metabolite of chloroechanol [197], 
Mecabollsm of eicher chloroechanol or chloroacetace yields S-carboxymechyl 
cysteine, chlodlacecate (thlodlglycolate), and small amounts of glycolate 
[197,198]. In another Investigation, thiodiacetate was detected as a product 
of the metabolism of S-carboxymethyl cysteine [199]; this conversion has been 
confirmed by Yllner [198].
Bonse and Henschler [1], in a 1976 review of the metabolism of chlorinated
ethylenes, concluded that their oxidation via moaooxygenases to corresponding
oxlranes (epoxides) conaltuted the Initial metabolic reaction. The authors 
suggesced chac eleccrophlllc reactions or alkylaeion of cellular components 
were essenclally responsible for che Coxlcity of che chlorinated ethylenes aud 
chac che ocher pachways were generally pare of a deCoxification mechanism. 
Afcer rearrangemenc, addicional mecabolic steps, including oxidacion of either 
aldehydic or alcoholic derivatives to carboxylic acids were suggested. The 
authors also suggested hydrolysis of acyl chlorides to acids as an alternate 
pathway.
Green and Hachway [5,195] speculaced that several routes might exist for 
vinyl chloride metabolism in rats. Their first suggestion was oxidative 
biocransformacion involving molecular oxygen and Che formaelon of 
chloroechylene oxide, which would Chen sponeaneously rearrange Co 
chloroacecaldehyde. Both chloroechylene oxide and chloroaceealdehyde can 
reacc wich glucachione Co fora S-(formylmechyl)glucachione, which in c u m  can 
be converc^d Co S-(2-hydroxyethyl)cysteine. Chloroacetic acid is also formed 
from chloroaceealdehyde and subsequendy metabolized via the Krebs cycle Co 
glucamlc acid. Formaldehyde would also be formed and metabolized Co carbon 
dioxide and urea. Since serine and mechlonine are syneheslzed in pare from 
formaldehyde, they also could be formed. The second suggested reacelon was 
the formaelon of che previously idenCified metabolites, S-(2-
chloroeehyl)cysceine and N-aeetyl“S-(2-chloroechyl)cysCeine. These reacelon 
produces were thought Co be che resulc of equilibrium inceraccions of S-(2-
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hydroxyethyl)cysteine and M-acetyl-S-(2-hydroxyechyl)cysteine through cyclic 
lnC«TMdl«ttt [1951. The third suggested reaction was conversion of S- 
(carboxvaachyl)cysteine, by oxidation and cranaaalnatlon, to chiodiglycol, and 
its subsequent oxidation to thiodiglycolic acid. The authors [195] concluded 
that chlorcacatic acid was not a part of tha major de^radative pathway for 
vinyl chlorida, but sinply a byproduct of chloroacetaldehyde matabolism, 
unless however, Cha glutathion* conjugation aechanism were Inhibited, 
whereupon the conversion of chloroacetaldehyr'e to cnloroacetlc acid would 
become an important detoxification alternative. They further supported this 
hypothesis bv administering leveral vinyi chloride aetabclites to rats and 
iticvl-.'.g that chlorcacetaldehvde -ind S-(carboxyaethy.)cystein«, but not 
chloroacetic acid, were In the direct pathway for the formation of 
thiodiglycolic acid. These authors [195] also identified small quantities of 
H-acety1-S-vlnylcysteine as » urinary metabolite of vinyl chloride in rats, 
thus li-ndiag credanca to ti a hypothasizad pathway of an equilibrium between 
tha chloro- and t(<« hydroxy-athyl glutathione derivatives, possibly through an 
aoi*ul;honlua ion Intermediate.
Plugge and Safe [196], in a 1977 review postulated that the metabolism of 
vinyl chlorida occurs both in vivo and in vitro via tha aixed-function oxidase 
system, primarily through the cytochrom* P--50 system, to an oxirane [153], In 
this case chloroethylana oxide. The oxirane (epoxide) formed from vinyl 
chlorida would ba a strong alectrophilic molecule, and it may be unstable 
becsuse of tha presenca of its asymmetric chlorine. This instability could 
result in intramolecular rearrangement of the chloroethylene oxide to 
chloroacacaldahyda. Tha authors considered that both chloroethylena oxide and 
chloroacataldahyda would bind either directly or enrymatlcally to glutathione, 
thereby forming S-formylmethyl glutathione. Via an NAIH-dependent aldehyde 
dehydrogenase, chlorocetaldehyde could also be oxidized to chloroacetate. 
This particular compound, if it was not. excreted, could bind with glutathione 
to form S-carboxymethy1 glutathione, which in turn could be hydrolyred to S- 
carboxymethy1 cysteine. S-carboxynetnyl cysteine could be either deaainated 
and decarboxylated to fora thiodiglycolace, N-acetylated, or excreted.
Van Duuren [200], in 1975, hypothesized that when rats were given large 
aaouncs of vinyl chloride, an epoxidatlon reaction would occur in which vinyl 
chloride was converted to chloroethylene oxide by the microsomal mixed- 
function oxldaae system. Chloroethylene oxide would subsequently be reacted 
or would spontaneously rearrange to chloracetaldehyde [201].
Hafnar at al [4] conjectured that, with exposures balow 100 ppa of *Tinyl 
chloride, its metabolisa would occur by hydration to 2-chloroechanol followed 
by oxidation to 2-chloroacetaldehyde by cha vary rapid alcohol dehydrogenase 
pathway. Sloe* chloroacataldahyda reacts rapidly wlch the sulfhydryl of 
glutathione, only a traca amount of aonochloroacetlc acid would be formed.
Ac higher concentrations of vinyl chloride, Hefner ec al [4] suggested 
that ch* alcohol dehydrogenaae pathway could easily be saturated. 
Compensatory mechanisms, in (.eras of alternate pathways, were suggested to
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these authors by the fact that two different rat* constants were obtained froa 
the results of their kinetic analyses. The rate constant was reduced, from 
0.0080A ±0.0034/minute (half-life of 86 minutes) for concentrations ranging 
fro« 30 to 105 pp« to 0.00265 ±0.00135 (half-life of 261 minutes) for
concentrations ranging from 220 to 1,167 ppm, suggesting that additional 
pathways were mobilized in conjunction vlth the alcohol dehydrogenase pathway. 
Hefner et al speculated that one of the mobilized metabolic paths may involve 
the oxidation of accumulated 2-chloro«thanol, and a second plausible
alternative appeared to involve direct epoxidation cf vinyl chloride. The
authors seated that their results were preliminary and inconclusive for
support of their hypotheses. Gehring et al [6] concluded that the reactive 
aetsbolitcs fonaed frco the first pathway should p o s s e s s a lower carcinogenic 
potential.
In 1977, Bolt et al [202] stated that vinyl chloride in the atmosphere of 
a closed system equilibrated with that in the tissues of rats within 15 
minutes at varioua concentrations below 250 ppm (the concentration at which 
tha authors stated that saturation of the vinyl chloride-metabolizing enzymes 
is achieved) when metabolism of vinyl chloride was blocked by 6-nltro-l,2,3- 
benzothiadiazole (an inhibitor of some cytochrome P-450-dependent oxidations). 
When rats not given the metabolic bio icing agent were tested, the 
concentration of vinyl chloride in the atmosphere declined exponentially with 
a half-life of about 1.1 hours.
Bolt et al [202] also reported that exposure of rats to vinyl chloride at 
concentrat'ons below 250 ppm (640 mg/cu m) produced a straight first-order 
decline of vinyl chloride in the exposure system indicating concentration 
dependence, while exposures at concentrations above 250 ppm produced decline 
curves best described by zero-order kinetics indicating no concentration 
dependence. Th«».y stated that vinyl chloride leaves the body rapidly due to
uri..ary excretion. They observed that approximately 502 of the dose from a 1- 
hour exposure at an initial concentration of 50 ppm appeared in the urine 
after 8 hours; approximately 702 appeared after 22 hours. Excretion via feces 
and via «xpiration of carbon dioxide was not taken into account. The authors 
also noted that the calculated rate constant for urinary excretion of
0.19/hour Is valid only In their system. They concluded that on continuous or
repeated exposure below 220 pptr, no appreciable accumulation of either 
unchanged vinyl chloride or its major metabolites should be expected. This Is 
consistent with the conclusions of ocher authors [146,200,203-205], who 
support the theory that a reactive, short-lived metabolice occurring in low
concencradons Is responsible for Che adverse effect.? of vinyl chloride, 
primarily liver damage and carcinogenesis.
Barrio et al [170], Sacrist et al [206], and Barbin et al [2] reported 
that chloroacetaldehyde reacts dlractly with adenosine or cytldlne at pH 3.5-
4.5 and 37 C to produce either 3-beta-D-ribofuranosyl-lmidazo-(2,l-i) purine 
or 5,6-dihydro-5-oxo-6-beta-D-ribofuranosyl-lmldazo-(I,2-c) pyrimidine. 
Baresch and Moncesano [156] posculaced chac covalent binding of
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chloroacecaldehyde directly Co DMA in Che cell could explain Che iaduccion of 
mutagenesis by base-pair subsdcucions In Salmonella Cyphimuriua TA1530.
An incegracive scheme of pucacivc mecabolic pachvays for vinyl chloride is 
presenced in Figure XVII-3.
(4) Mechanisms
Hefner ec al [A] evaluated che effects of pocencial inhibitors of 
vinyl chloride mecabolism. Pyrazole, an inhiblCor of alcohol dehydrogenase, 
xanChine oxidase, and ocher enzymes, adminiscered to racs 1 hour before 
exposure to vinyl chloride at 65 or 1,234 ppm (166.4 or 3,159 mg/cu m) 
inhibiced Che mecabolism of vinyl chloride by 71.2 and 86.92, respeccively. 
Ocher racs were precreated with ethanol 1.5 hours before exposure Co vinyl 
chloride aC 56 or 97 ppm (143.4 or 248.3 mg/cu m) Co compeCiCively inhibic 
alcohol dehydrogenase accivicy. This resulted in 96.0 and 82.92 inhibition of 
vinyl chloride mecabolism, respeccively. Exposure Co vinyl chloride ac 1,025 
or 1,035 ppm (2,624 or 2,649.6 mg/cu m) after precreacmenc with echanol 
produced inhibicion of vinyl chloride mecabolism by 46.5 and 35.72, 
respeccively. Racs pretreated with SKF-525A (a mixed funccion oxidase 
inhibitor) before being exposed Co vinyl chloride ac 65 ppm (166.4 mg/cu m) 
exhibited nc metabolic Inhibition. However, when SXF-525A precreaced rat« 
were exposed Co vinyl chloride at 1,038 ppm (2,657.3 mg/cu m), inhibicion of 
vinyl chloride mecabolism was 18.82.
Jaeger ec al [207,208], Conolly ec al [209], and Conolly and Jaeger [210] 
also evaluated che effects of various lnhibicors and promocers of vinyl 
chloride mecabolism in male and female racs. Female rats were noc susceptible 
co hepacoccxic effeccs of vinyl chloride in any of che experimencs. In 
polychlorinaced biphenyl (Aroclor 1254) or phenobarbical-precreaced male racs, 
pyrazole and SKF-525A proCecCed againsc acuce hepacotoxicicy, while disulfiram 
(an inhibitor of aceCaldehyde dehydrogenase) and echanol pocenciaced che toxic 
effects of vinyl chloride. The auchors speculated chac che proceccion 
afforded by SKF-525A was due to mixed-function oxidase inhibicion, indicacing 
a disrupCion in che mecabolism of vinyl chloride co an acCive mecabolice. 
Protection by pyrazole was probably due parcially co inhibicion of mixed- 
function oxidases and partially Co inhibicion of acecaidehyde dehydrogenase. 
The lack of coopedcive effeccs by echanol indicaCed Co the auchors chac che 
conversion of chloroechylene oxide co chloroeehanol was decreased, possibly 
because of Increased sponcaneous rearrangement of chloroechylene oxide co 
chloroacecaldehyde (bypassing che acecaidehyde dehydrogenase conversion seep) 
or because of caCalase conversion of chloroeehanol co a peroxide and 
subsequenc rearrangemenC co chloroacecaldehyde (again bypassing acecaidehyde 
dehydrogenase).
Hefner ec al [4] decermined the effeccs of vinyl chloride on liver 
sulfhydryl levels. Male racs were exposed for 7 hours/day co vinyl chloride 
ac concentrations of 15,000 ppm (38.4 g/cu m) for 5 days, 5,000 or 500 ppm 
(12.8 or 1.3 g/cu m) for 5 days/week for eicher 1, 3, or 7 weeks, or 50 ppm
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(128 mg/cu a) for either 1 hour, 7 hours, cr 5 days. No overt signs of 
toxicity were observed in rets exposed at any concentration. Significant 
reductions in nonprotein sulfhydryl levels were found in rats exposed to vinyl
chloride at 50 ppm for 7 hours, at 500 and 5,000 ppa for 1 and 3 weeks, and
15,000 ppm for 1 week. Although the reduction in nonprotein sulfhydryl levels 
could not be definitively correlated with exposure concentration, the authors 
concluded that there was a tendency for such reduction to become leas obvious 
with repeated exposures. Four rats treated with ethanol before exposura to 
vinyl chloride at 1,070 ppm (2.7 g/cu m) for 105 minutes had significant 
decreases in hepatic nonprotein sulfhydryl levels (77.0 *12.8%) as compared
with the controls (95,0 ±3.4%). The authors indicated that ethanol alone did 
not affect the liver nonprotein sulfhydryl levels.
Reynolds et al [211], in 1975, showed that male rats given drinking water 
containing 0.1% pentobarbital 7 days before either one or five consecutive 6- 
hour exposures to airborne vinyl chloride at a concentration of 5% (128 g/cu
m) exhibited a diffuse vacuolization of the cytop^sm of cells of the
centrllobular liver parenchyma and focal areas of necrosis of midzonal 
parenchyma after the exposure. In the livers of pratreated rata exposed to 
vinyl chloride for 5 consecutive days, the authors found broad tracts of 
stroma depleted of parenchymal cells that corresponded in distribution and 
extent to the areas of necrosis found 24 hours after a single exposure. Since 
pentobarbital, an inducer of mixed-function oxidase activity, appeared to 
increase the liver toxicity of vinyl chloride, the authors concluded that the 
endoplasmic reticulum was the primary site for generation of toxic vinyl 
chloride metabolites. Moreover, Reynolds and colleagues suggested that these 
metabolites, possioly epoxides, were presumably responsible for the observed 
cellular injury as well as the potential for tumorigenesis.
Several reports [202,204,205,212,213] have detailed the in vivo and in 
vitro requirements for covalent binding of vinyl chloride (or its metabolites) 
with cellular macromolecular constituents, including DMA, RNA, and protein. 
In addition, these reports have identified some effects cf various chemical 
inducers or inhibitors of cellular metabolic processes on the metabolism of 
vinyl chloride.
In 1975, Bolt et al [204] reported that rat liver microsomes metabolized 
vinyl chloride to more polar metabolites during a 90-minute incubation and 
that these metabolites became covalently bound to the microsomal proteins. In 
addition, vinyl chloride metabolices became covalently bound to other 
3ulfhydry1-containing proteins or to RNA when added to the incubation mixture. 
NADPH was reported eo be essential to the binding process, hence essential to 
this metabolic route for vinyl chloride. Similar results ^ere reported with 
microsomes from human liver, but the authors did not give experimental data.
Kappus et al [205], using the same incubation procedure as that used by 
Bolt et al [204], confirmed the essentiality of NADPH in the covalent binding 
process. In an additional paper, Kappus et al [212] reported that continued 
uptake of 14C-vinyl chloride by liver microsomes depended on NADPH. Without
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MADPH, uptake of 14C-(1,2-)vinyl chloride increased rapidly during the first 2 
minutes and reached saturation after 5 minutes. With NADPH, the uptake of 
vinyl chloride continued beyond the incubation time of 60 minur¿s and a 
tenfold increase in the uptake of 14C-vinyl chloride by the '•iicrosomal 
preparation was noted. The authors also showed that vinyl chloride could he 
taken up by both protein and lipid components of microsomal meabranes; the 
single difference noted was that the time course differed from that for uptake 
by microsomes. Their data also suggested a greater ability on the part of 
liposomes to bind vinyl chloride reversibly. Prom these studies, the authors 
inferred that the NADPH-independent part of microsomal vinyl chloride uptake 
was at least partially due to the reversible binding of vinyl chloride to the 
lipids and proteins of the microsomal membranes.
Kappus et al [212] also found that, of the total 14C-(1,2-)vinyl chloride 
taken up by the microsomes, about 1Z was bound irreversibly to the microsomal 
protein. Moreover, Irreversible binding of the vinyl chloride metabolites to 
the microsomal proteins appeared to depend on the presence of NADPH, the 
incubation time, and the concentration of the metabolites. In addition, the 
authors demonstrated that when atmospheric air was replaced by nitrogen in the 
presence of NADPH, vinyl chloride uptake was reduced. The amount of vinyl 
chloride metabolites irreversibly bound to protein also was lowered.
Kappus et al [205] reported that vinyl chloride metabolites were also 
bound to added albumin, but not to concanavalin A, which contains no 
sulfhydryl groups. They found that the addition of glutathione or 
glutathione-containing cytosol to the incubation medium caused a 30Z 
depression in covalent binding to cellular proteins ['*04,212], thus Indirectly 
supporting the concept that free sulfhydryl groups must be present for binding 
to proteins to occur or for detoxification to occur. In further support of 
this concept, they reported that inhibition of the microsomal cytochrome P- 
450-dependent mixed-function oxidases by 4-(l-naphthyl)imidazole inhibited 
covalent binding by about 85Z. Microsomal uptake of vinyl chloride was 
completely blocked by carbon monoxide, an inhibitor of cytochrome P-450 
oxidation reactions [212]. Irreversible binding of vinyl chloride metabolites 
to proteins was also blocked by carbon monoxide, whether NADPH was present or 
not. Boiling of the microsomes prior to incubation reduced vinyl chloride 
uptake in the presence of NADPH, and no irreversibly protein-bound vinyl 
chloride metabolites were detected. Addition of reduced glutathione to the 
microsomal incubation mixture with NADPH resulted in very little change in 
vinyl chloride uptake by the microsomes, but did result in a 25Z inhibition of 
irreversible protein binding.
Microsomal uptake of vinyl chloride was not affected by trichloropropene 
oxide, an Inhibitor of epoxide hydras« [212], However, irreversibly protein- 
bound vinyl chloride metabolites were increased twofold. No induction effect 
on vinyl chloride uptake could be demonstrated in microsomes from 
phenobarbital-pretreated rats. There also .were no changes in irreversible 
protein binding. Cytochrome P-450, however, was increased in the liver
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microsomes from racs precreated with phenobarbiCal. Vinyl chloride uptake was 
similar in liver microsomal preparations containing added glutathione and 
cytosol obtained from control and pretreated rats. From the data presented, 
the authors suggested that the initial step in vinyl chloride metabolism 
involved an oxygenation reaction catalyzed by an enzyme system containing 
cytochrome P-450. In addition, the arthors concluded that chloroethylene 
oxide was probably the initial reactive aecabolice.
Kappus et al [205] presented additional evidence for involvement of the 
epoxide in the covalent binding reaction by using the xanthine oxidase model 
system, which generates hydrogen peroxide and an oxygen-radical. They 
concluded chat demonstration of the binding of vinyl chloride metabolices Co 
albumin in Che presence of a complete xanthine oxidase syscem scrongly 
suggesced chac oxygen radicals, known Co be involved in epoxidacion by Che 
microsomal enzyme syscem, converc vinyl chloride Co a metabolite chac Chen 
binds covalencly to a protein, such as albumin.
Watanabe et al [214], in 1977, attempted to characterize the binding of 
vinyl chloride to hepatic macromolecules and nucleic acids by exposing male 
rats to 14C-(1,2-)vinyl chloride at nominal concentrations of 1, 10, 2 5, 50, 
100, 250, 500, 1,000, or 5,000 ppm (range 2.96-12,800 mg/cu m) . The results 
suggested that increases in exposure concentration did not proportionately 
Increase the total amounts of radioactivity bound to hepatic macromolecules. 
The percentage of total 14C activity bound to hepatic macromolecules ranged 
between 20 and 222, except in rats pretreated with phenobarbital where it 
reached 392. Both the metabolized and bound vinyl chloride increased with 
increasing nominal concentration, but the ratio of bound to metabolized vinyl 
chloride declined with Increasing nominal concentration.
In rats exposed at nominal concentrations of 1, 10, 25, or 50 ppm (range 
2.56-128 mg/cu m), Watanabe et al [214] found that the nonprotein sulfhydryl 
content of the liver was depleted, but not significantly s o . However, at 100 
ppm (256 mg/cu m) and above, a significant depletion (?<0.05) was noted. 
Since it seemed a reasonable assumption that Che major decoxificaclon of Che 
reacclve metabolites of vinyl chloride occurs by reaction with nonprotein 
sulfhydryl groups [186], Watanabe et al [214] considered it Important that at 
nominal concentraclons of 100 ppm and higher, h slgnflcanc dose-relaced 
deplecion of chac pool could be demonstraced. They also suggesced chat the 
carcinogenicicy of vinyl chloride was relaCed Co che decreased abilicy of 
exposed organisms Co decoxify che reacclve mecabolices of vinyl chloride.
WaCanabe et al [214] reported chac no evidence could be found chac would 
suggesc covalenC binding of 14C from vinyl chloride Co che isolaCed nucleic 
acids in cheir experimencs. The auchors concluded chac vinyl chloride did not 
preferentially react with incracellular nucleic acids. They mencioned, 
however, chac chis finding conflicced wich che findings of a previous sCudy by 
Bole eC al [215] which demonscraced chac covalenC binding Co RNA and DNA 
occurred afcer a scacic exposure Co 14C-vinyl chloride at 145 ppm (371.2 mg/cu 
m). Both Waeanabe ec al [214] and Bole ec al [215] concluded chac vinyl
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chloride does not preferentially react with hepatic nucleic acids. However, 
Watanab« et al [214] reported shat five rats pretreated with phénobarbital (80 
mg/kg/day) by ip injection 3 days before exposure to 14C-vinyl chloride at a 
nominal concentration of 100 ppm showed a markedly increased binding of 14C to 
hepatic oacromolecules when compared with nonpretreated animals, even chough 
there was no observable Increase in vinyl chloride metabolism.
W3tanabe et al [214] concluded that their findings did not associate the 
carcinogenicity of vinyl chloride with a disproportionate increase in binding 
of Its electrophilic metabolites to hepatic macromolecules as the exposure 
concentration was increased. Because there was no demonstrable evidence to 
support preferential binding of the electrophilic metabolites to nucleic acids 
of the hepatocytes, they raised the possibility that the carcinogenic 
potential of vinyl chloride could not be associated with this commonly 
accepted mechanism for carcinogenesis. The authors suggested, however, that 
before alkylation of nucleic acids was excluded as the carcinogenic mechanism, 
more studies to determine the absence of such alkylation activity in the 
target tissue rather than the hepatocytes are required. They suggested that 
the hepatocyte itself, since it is susceptible to the toxicity of vinyl 
chloride, may function as a detoxifier. This would imply that tissues having 
« lesser ability to detoxify the reactive metabolites of vinyl chloride ma" 
themselves become the victims of toxicity.
Gehrlng et al [6] stated that since "Toxicity, including carcinogenesis, 
is a dynamic process involving absorption of a chemical into the body,
distuiDution to various tissues, reversible or irreversible reactions with 
cellular components, and ultimately clearance from the tissues and the body 
via metabolism and/or excretion," it follows that "the predictability of
animal toxicological data for assessing the hazard of a chemical to man is 
enhanced if the fate of the chemical per se and/or its degradation products in 
animals is equated to the fate in man." They stated that under ordinary 
conditions and ov r a selected range of doses, chemical kinetics fit a linear 
differential equation, the implication being that a knowir increase in dose 
will result in a linear Increase in tissue levels. They added, however, that 
many metabolic and excretory processes were easily overwhelmed and saturated, 
thus leading to a situation in which nonlinear Michaelis-Menten
pharmacokinetics would prevail. The authors suggested that the results of
Hefner et al [4], in which the rate of metabolism of vinyl chloride at low 
concentrations was rapid and the primary metabolic pathways were overwhelmed 
at high concentrations, supported this theoretical model.
The data presented above suggest that alkylating metabolites of \-inyl 
chloride, such as chloroacetaldehyde ard chloroethylene oxide, are formed in 
vivo. Both chloroacetaldehyde and chloroethylene oxide can conjugate with 
glutathione and cysteine and subsequently form the vinyl chloride metabolites 
that have been identified in urine, such as N~acetyl-S-(2-chloroethyl)cysteine 
[195], which may itself be a potent alkylating agent by virtue of its half­
mustard forming ability. In terms of assessing the hazard of exposure to 
vinyl chloride, experimental data support the conclusion that the
carcinog«nicity of vinyl chloride is a function of the metabolic formation of 
alkylating metabolites. The urinary metabolites identified so far indicate 
that the primary deactivation mechanism is conjugation with glutathione, a 
nonprotein, free-sulfhydryl containing compounds. Experimental data have 
indicated that as the nonprotein, free-sulfhydryl groups are depleted as a 
sequel of the absorption and metabolism of vinyl chloride reaction of the 
alkylating metabolites with tissue macromolecules, such as DNA or RNA, may be 
more likely to occur. As a result, toxicity of a different order of magnitude 
may be elicited at higher exposure concentrations.
(b) Vinylidene Chloride
McKenna et al [216] showed that in rats exposed to airborne 14C(1,2-) 
vinylidene chloride at concentrations of 10 and 200 ppm (39.7 and 794 mg/cu m) 
for 6 hours covalent bonding occurred in the liver. At 10 ppm, 1-22 of the 
body burden was expired as unchanged vinylidene chloride, and at 200 ppm, 
between 4 and 82 was expired unchanged, ie, a twentyfold increase in the 
exposure concentration Increased the total body burdens of vinylidene chloride 
of both fasted (fasting depletes liver glutathione) and fed rats only 
fifteenfold.
The pulmonary elimination of vinylidene chloride at both 10 and 200 ppm 
(39.7 and 794 mg/cu m) was found to be biphaslc [216]. Firs;-order rate 
constants for the rapid and slow portions of the biphaslc curve were 0.0345 
£0.0095 and 0.0032 £0.0013/minute (half-lives of 20 and 217 minutes) at 10 ppm 
and 0.0324 £0.002 and 0.0052 £0.0042/minute (half-lives of 19 and 133 minutes) 
at 200 ppm. The largest amounts of radioactivity at both concentrations were 
found in the liver and kidneys. The fasted rats exposed at 10 ppm (39.7 
mg/cu m) had more radioactivity in the liver and plasma than the fed animals 
exposed at 10 ppm. The amount of covalently bound radioactivity in the liver, 
as compared with body burden of 14C and total metabolism of vinylidene 
chloride, increased about 26 times with a twentyfold increase in exposure 
concentrations for the fed rats. The percentage of covalently bound
radioactivity in the livers of fasted rats exposed at 200 ppm also was greater
than that in the fed animals, although the fasted rats metabolized less 
vinylidene chloride than the fed animals.
The elimination of radioactivity in rat urine at both 10 and 200 ppm was
also biphaslc [216]. First-order rate constants for the rapid and slow 
portions of the biphaslc curve were 0.226 £0.041 and 0.036 £0.005/hour, (half- 
lives of 3.1 and 19.3 hours) at 10 ppm and 0.155 £0.015 and 0.043 £0.007/hour, 
(half-lives of 4.5 and 16 hours) at 200 ppm. The urinary metabolites, at 24 
hours after exposure, were identified as N-acetyl-S-(2-hydroxyethyl)cysteine 
and thiodiglycolic acid, with two additional unidentified 14C-labeled 
fractions.
McKenna et al [217] reported that rats given single oral doses of 50 mg/kg 
of 14C-(1,2-)vinylidene chloride exhaled 19-292 of the radioactivity as- 
unchanged vinylidene chloride while rats receiving 1 mg/kg exhaled only 1-32
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of Che radioactivity as unchanged vlnylidene chloride. The increase in
pulmonary elimination of vlnylidene chloride at che higher dose was
accompanied by decreases in 14C carbon dioxide production and in urinary and 
fecal excretion of 14C. Fasted rats excrated less radioactivity In the urine 
(35Z) than fed animals (47Z) at 50 mg/kg. The pulmonary elimination of
radioactivity was Inconsistent after administration of vlnylidene chloride at 
a dose of 1 mg/kg, although these elimination curves also were blphasic. Rate 
constants were not calculated, but half-lives for the rapid and slow portions 
of the curves were estimated to be 25 and 117 minutes, respectively, for both 
fed and fasted rats. The pulmonary elimination curve at 50 mg/kg was
biphasic, with rate constants for the rapid and slow portions of the curve 
being 0.0332 ±0.0036 and 0.0105 ±0.001/minute (half-lives of 21 and 6 6
minutes). Elimination reached a peak at 30 minutes in fed rats and at 60 
minutes in fa3 ted rats.
The greatest tissue concentrations of 14C after 72 hours were found in the 
liver [217]. A fiftyfold increase in dose resulted in only a 35-fold Increase 
in nonvolatile radioactive compounds. There was a fiftyfold Increase in 
covalently bound radioactivity in the liver, however, which was greater than 
the observed Increase in metabolism. The urinary excretion profiles were 
biphasic, with apparent first-order rate constants for the rapid and slow 
phases of 0.116 and 0.042/hour (half-lives of 6 and L6.B hours) at both 1 and 
50 mg/kg. The major urinary metabolites were the same as those identified 
after inhalational exposure [216], ie, N-acetyl-S-(2-hydroxyethyl)cysteine and 
thiodigiycolic acid. McKenna et al [217] also reported that unchanged 
vlnylidene chloride wad eliminated only in expired air and was not retained in 
the tissues for longer than a few hours.
Madrid et al [218] identified two of the four aajor urinary metabolites 
isolated from rats exposed to 14C-vinylidene chloride by inhalation at 10 or 
200 ppm (39.7 or 794 mg/cu m) for 6 hours and by oral administration (1 or 50 
mg/kg) as N-acetyl-S-(2-hydroxyethyl)cysteine and thiodigiycolic acid. The 
former compound represented about 45Z of the total urinary radioactivity, 
whereas the latter accounted for 25Z. The authors concluded that the 
identification of these two compounds as urinary metabolites supported the
hypothesis that glutathione conjugation was a major step in the 
biotransformation of vlnylidene chloride.
Jaeger et al [219], in 1977, reported that fed and fasted male rats 
exposed to 14C-vinylidene chloride at 2,000 ppm (7.9 g/cu m) for 2 hours did 
not differ significantly in the rate of vlnylidene chloride uptake or of 
urinary excretion of 14C during che first 24 hours. Of the calculated dose,
36.7 and 36.5% were recovered within 24 hours in che urine of fed and fasted 
animals, respectively. Thirty minutes after a 2-hour exposure, the kidneys of 
fasted rats concalned both the greater amount of total radioactivity and the 
larger amount of metabolites that were soluble in trichloroacetic acid (hence, 
not bound). Fasted rats also had significantly greater amounts of total 
radioactivity in the spleen, heart, and serum than did fad rats. There was no
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significant difference between the 14C contents of the brain« of fad and 
fasted rats.
Th« livers of fastad rats contained substantial amounts of radioactivity 
that was trichloroacetic acid-insoluble [219]. This component represented 
either 14C that was tightly bound to microsomal or mitochondrial 
macromolecules or that had entered the metabolic pool. The rates of 
disappearance of the trichloroacetic acid-insoluble 14C from the microsomal 
and mitochondrial fractions of the liver in fed and fasted rats were similar, 
although the amounts differed significantly; both had estimated half-lives of 
less than 3 hours. Significantly sore radioactivity was found in the hepatic
cytoplasmic fractions of fasted r ’ts than in those of fad rats. The authors
suggested that on the basts of their data metabolism of vinylidene chloride 
was quite rapid, with trichloroacetic acid-soluble components being excreted 
by the kidney and trichloroacetic acid-insoluble components entering the 
metabolic pool. They concluded that since a rapid turnover of bound 14C
material occurred (half-life less than 3 hours), covalent binding to protein
or tissue constituents must have been minimal.
Jaeger et al [219] concluded that fasting had no effect on the rate or on 
the amount of in vivo metabolism, but that the in vivo metabolic pathway 
appeared to be significantly different la fasted rats than in fed rats. They 
also reported that pretreatment with trichloropropane epoxide (an epoxide 
hydrase inhibitor) significantly Increased the toxicity of vinylidene chloride 
in rats, and on this basis, suggested the possible formation of an epoxide 
Intermediate as a result of the hepatic metabolism of vinylidene chloride.
Several studies [115,220-224] have shown the hepatotoxic effects or 
inhaled vinylidene chloride on rats to be associated with decreased 
glutathione concentrations in the liver and liver mitochondria. Fasting of 
rats before exposure to vinylidene chloride at concentrations of 2 , 0 0 0  ppm 
(7.9 g/cu m) for 4 hours [115,221], 1,980 ppm (7.9 g/cu m) for 4 hours [220], 
250 ppm (992.5 mg/cu m) for 1-24 hours [223], or 200 ppm (794 mg/cu m) for 4 
hours [2 2 2 ] resulted in markedly enhanced hepatotoxicity as compared with that 
seen in fed control rats. Hepatic necrosis was reported in fasted but not in 
fed rats and was associated with glutathione depletion Elevation of serum 
alanine alpha-ketoglutarate transaminase activity levels (indicative of liver 
injury) occurred in fasted rats at 150-200 ppm but only at or above 2,000 ppm 
in fed rats [115,220]; this difference was also evident in an Isolated 
perfused rat liver system [115].
Diethylmaleate, a material that depletes glutathione, potentiated the 
hepatotoxic effects of vinylidene chloride on fed rats and on perfused livers 
from fed rats [115]. Surgical or chemical thyroidectomy (resulting in
increased liver glutathione) reduced the severity of hepatotoxic Injury in 
fasted rats exposed to vinylidene chloride at a concentration of 2 , 0 0 0  ppm for 
4 hours, whereas thyroxine (which Increases the general metabolic rate and 
decreases glutathione) enhanced the hepatotoxicity of vinylidene chloride 
[224], SKF-525A (an inhibitor of mixed-function oxidases) did not affect the
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response of fed rats exposed to vinylidene chloride nor did it protect fasted 
rats fro» the hepatotoxic effects of such exposure [222]. However, Reichert 
and Bashti [225] reported that SKF-525A in perfused rat liver preparations 
diminished the rate of metabolism of vinylidene chloride. These data support 
the hypothesis that a major pathway for the detoxification of vinylidene 
chloride involves conjugation with glutathione and that blockage of its 
conjugation with glutathione greatly enhances its hepatotoxicity.
Jaeger [2.23] noted that a significant elevation (P<0.05) of hepatic citric 
acid occurred after exposure of rats to vinylidene chloride at a concentration 
of 250 ppm. He concluded that vinylidene chloride probably affected the 
mitochondria, leading to inhibition of the Krebs, cycle and subsequent 
mitochondrial damage. Jaeger et ai [219], on the basis of prior work [5,152], 
hypothesized that chloroacetyl chloride, a metabolite of viaylidene chloride, 
was converted to monochloroacetic acid, which in turn was converted into 
chlorocitric acid, an inhibitor of the enzyme aconitase. Inhibition of this 
enzyme would result in an accumulation of citric acid. This hypothesis was 
predicated oy analogy on the hypothesis of lethal synthesis, which suggests 
that fluoracetic acid is converted to fluorocitric acid, which inhibits 
aconitase [226].
Short et al [117] reported that the lethality of vinylidene chloride in
male and female mice exposed at various concentrations for 22-23 hours was 
reduced substantially by pretreatment with disulfiram. When exposures were 
increased to 22-23 hours/day for 2 days, prefreatment with disulfiram, 
dlethyldithiocarbamate, or thiram reduced the lethality of vinylidene chloride 
in male mice. Pretreatment with methionine or cysteine also reduced the 
lethality of vinylidene chloride, but instead of protecting in terms of
increasing the acut® LC50 (as did the other three compounds), these compounds
protected by delaying the onset of mortality after exposure.
Short et al [117] also reported that disulfiram pretreatnent protected
male mice from the hepatotoxic effects of exposure to vinylidene chloride at 
60 ppm (238.2 mg/cu m) for 22-23 hours. However, after two consecutive 22- to 
23-hour exposures at 60 ppm, there was no protection frcm hepatotoxic!ty.
Short et al [117] showed that covalently bound radioactivity could be
detected in the macromolecule3 of the liver and kidneys of mice 4 and 24 hours 
after an ip injection of 3 mg of 14C-vinylidene chloride/kg. The kidneys
contained more bound 14C/mg of protein than did the liver at 4 and 24 hours 
after administration of vinylidene chloride. Pretreatment with'disulfiram 
greatly reduced the bcund 14C in both tissues at both time periods.
Bonse and Henschler [1] proposed in a 1976 review of polychlorinated 
aliphatic compound metabolism that an oxirane, a postulated metabolic 
intermediate of vinylidene chloride, spontaneously rearranged to chloroacetyl 
chloride and was then hydrolyzed to monochloroacetic acid. Since 
monochloroacetic acid is also a product of vinyl chloride metabolism, they 
speculated that its formation and fate in vinylidene chloride metabolism 
followed a similar scheme.
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Am  integrative schema for vlnylidene chloride metabolism is presented in 
Figure XVII-3.
(c) Vinyl Bromide
In 1940, Abreu and Emerson [227] reported that a slight increase 
(approximately 2.7 times control value, 0.016-0.043 mg/g vet liver) occurred 
la the amount cf total Inorganic bromide is the livers of mice exposed to
vinyl bromide vapor at a concentration of ?.5 millin.oles/liter (267,400 mg/cu
d ) for 60 minutes. The authors concluded that this Increase in liver brcmlde 
content was caused by the In vivo hydrolysis of vinyl bromide.
Barbln et al [2], in 1975, 3 hcved chat a volatile metabolite was formed 
when a 50? vinyl chloride-oxygen mixture was , assed through an incubación
medium containing phenobarbital-pretreated mouse liver microsomes and an 
NADPH-generating 3yscem. The voladle metabolite was ldenclfled as 
chlorechylene oxide. A 1:1 mixture of vinyl bromide and air, when passed 
chrough Che same microsomal syscem, produced a reaction product having an 
absorption spectrum identical to chat of the vinyl chloride/oxygen mixture. 
From these data, the authors coucl.ded that vinyl chloride and vinyl bromide 
were converted in vitro by microsomal enzymes to Che corresponding epoxides.
Conolly ec al [209] and Conolly and Jaeger 1210] reported that 
polychlorinaced biphenyl (Aroclor 1254)-treated male racs chat were then 
exposed to vinyl bromide at concentrations of 10,000-51,000 ppm (43.8-223.4 
g/cu m) for 4 hours developed acute hepatic injury as indicated by increases 
in serum sorbitol dehydrogenase activity. The auchors L209,210] concluded 
ehac chese daca, along wlch observations of Increased coxiclcy in fasced
animals and Chose CreaCed wlch an inhibicor of epoxide hydrase, suggesced chac 
Che acuCe hepaCoCoxiciCy of vinyl bromide was mediated chrough epoxide 
lncermedlaces. They felc that the similarity between che acuce effects of 
vinyl bromide and of ocher vinyl halides indicated chac hepacic mixed-funccion 
oxidase Inducción had occurred Co such an excenc that che race of epoxldaclon 
exceeded Che race of decoxificacion, so chac hepadc damage occurred. Conolly 
and Jaeger [210] concluded also chac boch glutathione and epoxide hydrase were 
involved in the detoxification of vinyl bromide metabolites in polychlorinated 
biphenyl-treated rats.
(d) Vinyl Fluoride and Vlnylidene Fluoride
Dllley et al [228] found that vinyl fluoride and vlnylidene fluoride could 
undergo biocransformacion and that the carbou-fluorine bond could be broken. 
Thsy reported that male rats exposed by Inhalation to vinyl fluoride or 
vinylidené fluoride for 30 minuees at concentrations of 3,000 and 2,200 ppm 
(6.64 and 5.76 g/cu m), respectively, excreted significantly lncreaaed 
(P<0.01) amounts of fluoride ion dally wh<an compared with the nonexposed 
control animals. The value for excreted fluoride ion 6 days after exposure to 
vinyl fluoride vas 3.77 £0.23 panol. There was a significant increase (P<0.05) 
in urinary output for vinyl fluoride-exposed animals that persisted for the 14
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days of measurement. The values for excreted fluoride 1,5, 6 , and 7 days
afcar exposure to vinylidene fluoride ranged from 3.02 ±0.14 co 4.30 ±0.49 
jiBol. Ho diuresis was observed la vinylidene fluoride-exposed animals.
The authors also noticed a cyclic excretion pattern for vinylidene 
fluoride in vhich ther* vas major excretion directly after exposure and again 
5 days after exposure [ 2 2 8 ] . The Authors proposed z h a t either the fluoride 
ion, the parent compound, or the fluorine-containing metabolites were stored 
in some biologic compartment and then released with a turnover rate of about 5 
days.
Conolly and Jaeger [210] reported that fasting had no effect on 
hepatoeoxicity in polychlorinated biphenyl-treated rats exposed to vinyl 
fluoride at 10,000 ppm (18.8 g/cu m) for 4 hours. Three consecutive daily 
doses of trichloropropane epoxide (an inhibitor of epoxide hydrase) before 
exposure to vinyl fiuoiicte produced Increased mortality in rats; however, 
fasting in addition to administration of trichloropropane epoxide did not 
exert a synergistic effect. This indicated to the authors chat glutathione 
may not be important in the detoxification of vinyl fluoride metabolites in 
polychlorinated biph.'.nyl-pre treated racs, but chat epoxida hydraie may be 
Involved in detoxifying fluoroethylene oxide.
Structure-Activity Considerations
Vinyl chloride has been shown to be a human and animal carcinogen, 
inducing characteristic angiosarcoma of the liver [79,84,87,134,135,140]. 
Vinylidene chloride [140,141] and vinyl bromide [143] have also been shown to 
induce this characteristic tumor in animals. No information is available 
concerning the induction of tumors by vinyl fluoride or vinylidene fluoride. 
An assessmenc of the carcinogenic potential of the vinyl halides as a group 
can be attempted by applying Che available carcinogenicity and mucagenlcicy 
data to nha structure-activity interrelationships of the five coapounds.
Such an assessment of the carcinogenic potential of the vinyl halides 
requires an understanding of their mechanisms of action. A review of the 
available metabolic data on vinyl chloride indicates that several reactive 
intermediates are produced (Figure XVXI-3). These intermediates are 
electrophiles, which have been shown to form covalent bonds with cellular 
macromolecules. A similar metabolic route may be operative for che ocher 
vinyl halides, producing similar intermediates that also may bind covalently 
to cellular constituents. The carcinogenic potential of each of the vinyl 
halides would therefore be the resultant potentials of these possible 
metabolites and of any unmetabolized compound.
One hypothesis for the mechanism by which vinyl chloride expresses its 
carcinogenic potential involves its metabolism, via the microsomal cytochrome 
P-450 mixed-function oxidase system, to the oxirane (epoxide), chloroethylene 
oxide [1,196,200,212]. One basis for predicting the carcinogenicity of
Inadequately tasted vinyl compounds Is Che assumption that metabolic 
epoxldation Is Involved in Chelr metabolism as veil, and that the epoxide is 
the major reactive intermediate. The relative carcinogenic potential would 
then be Influenced by the relative ease with which the epoxides are formed 
from the corresponding halo-olefins and the relative reactivity of a 
particular epoxide toward cellular nucleophiles.
The propensities of vinyl halides to undergo chemical transformation to 
epoxides are dependent on the electronegativities of the substituents on the 
olefinic nucleus [229]. Increasing electronegativity result3 in rarefaction 
of the electron density of the double bond, and thereby in a decrease in the 
susceptibility of the olefin to apoxidation. Thus, for the vinyl halides 
under consideration, the expected order of nou-enzymatic epoxldation would 
appear to be vinyl bromide > vinyl chloride > vinylidene chloride > vinyl 
fluoride > vinylidene fluoride. Bonse and Henschler [1] supported this scheme 
of epoxldation by showing that the order of the rate of ozonization of a 
series of olefins was ethylene > vinyl chloride > trlchloroethylene > 
tetrachloroethylene. Also, a study of the reaction rates of ozone, a strong 
oxidizing agent, vlth cnlorir.ated and conjugated olefins showed that the rate 
of ozone attack decreased strongly (1 ,0 0 0 -fold from vinyl chloride to 
tetrachloroethylene) as the number of chlorine atoms in the olefin molecule 
increased [230].
Hanzlik et al [231] found that a series of para-substituted styrenes 
(vinyl benzenes) underwent metabolism via the cytochrome P-450 system of rat- 
llver mlcrosomes at rates that were essentially substituent independent. From 
the kinetic data of these authors, RL Schowen (written communication, August 
1977) calculated a Hammett rho value (a measure of the sensitivity cf the 
reaction series to ring substitution) of around -0.2. Using this value and 
the Hammett equation, Schowen suggested that substituted vinyl compounds for 
which t.ie substituents have effective Hammett sigma values (measures of the 
substituents' abilities to attract or repel electrons by inductive and 
resonance effects) which differ by as much as 2 units, should differ in rates 
of oxidation by only a factor of 2.5. Since the sigma* values (measures of 
inductive effects alone) for the halogens are fluoride, 1.10; chloride, 1.05; 
and bromide, 1.02 [232], Schowen concluded that these vinyl compounds would be 
expected to generate epoxide metabolites at similar rates.
Schowen also addressed the problem of estimating the reactivity of the 
epoxide intermediates that ere assumed to be formed. He made two analyses, 
each dependent on an experimentally derived measure of reactivity for halide 
compounds. One analysis used Swain-Scott substrate factors, S, which reflect 
electrophiliclty [232]. Based on S values determined for other halide 
alkylating agents, eg, S ■ 1.00 for C1CH2C02-, 1.10 for BrCH2C02-, 1.33 for 
ICH2C02-, and Jor nonhalide agents, Schowen suggested that alkylating 
potentials of the vinyls relative to vinyl chloride would vary over a range of 
no more than 16. In a second analysis using a leaving group parameter, L, 
from the Swaln-Lohmann equation [233] for the halides (bromine, 0.0; chlorine, 
-1.61; fluorine, -3.60) and reaction constants determined from these L values
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for halld« coapounds, h« esciaaeed chat eh« ralaciva reaccion raeaa of chloro 
to fluoro coapounds would rang* froa 63 eo 1,583 and ehac choae of bromo co 
chloro would rang« froa 25 co 398. Thua, eh« tluoro drrlvaeiva« could b« 
roughly 1,500-fold laaa raacdve chan eh« chloro derivatives, whlla cha broao 
darivadvaa could ba roughly 400 Ciaes aora raacelva. Although eha sacond 
aaehod predlcca laaa alkylaelng pocancy for eha fluoro coapounds chan eha 
fltse aaehod, boch aachoda ¿ndlcaea chat ae lease cha chloro- and broao-vinyls 
would ba expeceed Co fora acelva alkylaelng inceraedlaces.
The available experimental evidence lends setae support co Che cheoreeical 
considerations regarding epoxidatlon, but the information is spotty, and 
comparative studies on tha relative rates of epoxidatlon of the five vinyl 
halides under consideration are not available. Besides the evidence for 
formation of tha epoxide of vinyl chloride, the production of epoxides in the 
metabolism of vinylldena chloride [1,173] and vinyl brjmide [2] has only been 
postulacad. No avldanca has baan located for tha metabolic epoxidatlon of 
vinyl fluorlda or vlnylidana fluoride. Ochar chlorinated olefins whose 
aacaboliaa via aa apoxlda has baan poaculaead are erlchlcroachylene and 
tetrachloroethylene. Evidence in support of the formation of tha 
corresponding epoxides has been reviewed [1 ].
Bonse and Her.schler [1] also attempted to estiaate the relative 
reactivities of vinyl intermediates. They noted that a common feature of 
those vinyl halides found Co ba mutagenic Is their potential for the formation 
of asymmetric oxirana intermediates. Asymmetrically substituted oxiranes have 
been found to ba lass stabla and, hence, presumably more reactive than the 
symmetrical ones such aa Chose Chat would ba expected to be formed from soma 
of Cha vinyl halides ehac ha-re baan eesCed and found Inactive aa mueagans, eg, 
els- and crans-1,2-dichloroethylene [151-153]. Tha auchors suggesCed Chat Che 
formation of an asymaecrlcal intermediate might be a useful criterion for 
predicting mutagenic and carcinogenic potentials of the vinyl halides.
Tha solubilities of tha vinyl halides in water Increase la the following 
ordar: fluoride, dlfluorlda, chloride, dichlorlda, and broaida. Tl.sir aolar
solubilities ara essentially zaro, 0.003, 0.018, 0.026, and 0.053,
reapacclvaly (saa Table XVII-I). Their solubilities In blood alghe wall 
follow this same order alehough lipid solublliey and various eypes of 
aacroaolecular 5lading cannot ba Ignored. That Is '.o say, the relative aaouae 
absorbed Chrough Cha lungs aay ba about 20 times greater for vinyl broaida 
chan for vlnylidana fluorlda.
Th« expe^iaantal avldanca and cheoreeical considerations ara coapacibla 
wlch cha hypcehasis Chat eha five vinyl halides ara capable of undergoing 
biochaaical apoxidacion buc ehac cha cvo fluoro olefins aay ba soaewhaC lass 
suseapclbl« Chan ch« ochcr vinyl halidaa co this raacclon. Exerapolaelon of 
Ch« estimates of Schowaa suggesCa ehac vinylidane chlorld«, and vlayl broaida, 
aay have a similar or graacar carcinogenic poceneial chan vinyl chloride, but 








on the basis of limited mutagenicity data, are likely to be less reactive 
(possibly up to 1,500 times less) than the other three.
The suggestion that the other vinyl halides resembl» vinyl chloride in 
theit effects and mechanism of action is debatable on the basis that normal 
mammalian biochemical constituents such as steroids and unsaturated fatty 
acids contain the vinyl moiety and are not suspected of carcinogenicity. It 
should be noted that variation either above or below a physiologically 
critical concentration range for many of these compounds may lead to toxic 
effects. NIOSH is unable to suggest any systematic relationship between the 
toxic?ties of all compounds containing the vinyl group, although vinyl halides 
are treated here as a group because of the similarities in chemical and 
physical properties. It may well be that it is the presence of the halide 
moiety which imparts a particular toxicity range to these agents by allowing 
them to be activated, epoxidated, or hydrated at sufficiently high rates, and, 
at the same time imparting to the metabolites a characteristic stab.'j.ity and 
inti^nsic activity that allows them to reach and interact with vital cellular 
constituents.
In the absence of additional toxicologic data on the vinyl halides under 
consideration, the relevance of th* theoretical considerations discussed above 
to estimation of the potential toxicity of these compounds might be tested by 
developing mathematical relationships between biologic activities and 
physicochemical parameters. These parameters could also consider any 
variations in steric interactions. Sufficient consistent biologic data are 
not yet available, however, to permit the development of such equations.
Correlation of Exposure and Effect
The vinyl halides have been shown to induce effects on the nervous, 
circulatory, respiratory, integumentary, skeletal, and digestive systems in 
humans and laboratory animals. These effects are summarized in Tables III-2 
to 111-10. The modes of action of the vinyl halides art not clearly 
understood, and there is little published information on any of them other 
than vinyl chloride. It has been proposed that expression of the tumorigenic 
and mutagenic potential of vinyls depends on metabolic intermediates; this 
possibility is discussed in the section on Carcinogenicity. Mutagenicity. 
Teratogenicity, and Effects on Reproduction.
Lethal concentrations of the vinyl halides have been determined. For 
vinyl chloride, the LC50 for mice exposed for 10 minutes and observed for an 
unspecified period was 239,580 ppm [105]. In another study, the LC50's for 2- 
hour exposures were calculated as 117,500 ppm for mice, 156,000 ppm for rats, 
and 238,000 ppm for guinea pigs and rabbits [104]. The LClOO’s were also
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determined In this experiment; they were 150,000 ppm for nice, 210,000 ppm for 
rats, and 280,000 ppm for guinea pigs and rabbles. The duration of the 
observation period was not reported.
For vlnylldene chloride, t! * 4-hour LC50 In rats has been reported as 
6,350 ppm with a 14-day observation period [116]. Other authors [118] 
reported that from two to four of six rats died within 14 days after one 4- 
hour exposure at a concentration of 32,000 ppm. A single 22- to 23-hour
exposure of rats produced LC50 values of 98 ppm for males and 105 ppm for
females [117]. Two exposures for 22-23 hours gave LC50 values of 35 ppm for 
male rats, and the LT50 for exposure at 20 ppm was reported as 4 days. Thl3  
experiment showed that mortality In rats exposed to vlnylldene chloride is in 
part a function of the total a 'cumulated dose. The 24-hour LC50 valae in rats 
after one 4-hour exposure was determines as 15,000 ppm for fed animals and 600 
ppm for animals fasted for 18 hours [115]. The oral LD50 has tlso been 
calculated for adrenalectomized rats as 84 mg/kg for 24 hours and 81 mg/kg for 
96 hours; In sham-operated controls, the LD50 was 1,550 mg/kg for 24 hours and 
1,510 mg/kg for 96 hours [126]. This Indicated that adrenal hormones provide 
some protection against the acute effects of vlnylldene chloride in rats.
Exposure to vinyl bromide at concentrations of 171,000 ppm has been
tolerated by rats for 10 minutes [105]. In another experiment 1127],
concentrations of 100,000 ppm were shown to be 1002 lethal in rats after 15 
minutes, and some rats died (percentage unspecified) at concentrations of
50.000 ppm for 7 hours. An oral LD50 of 500 mg/kg (given in c o m  oil) for 
vinyl bromide was also determined for rats [127].
Vinyl fluoride has been reported to be not lethal to rats exposed at a 
concentration of 802, with 202 oxygen, for 12.5 hours [128]. Vinyl fluoride 
at 100,000 ppm, 7 hours/day, 5 days/week, for 6 weeks caused no observed 
adverse effects on rata according to Lopieno, quoted by Carpenter [128]. 
However, Connoly et al [209] reported that four of seven rats pretreated with 
Aroclor 1254 and exposed to vinyl fluoride at concentrations of 102,000 ppm 
died after a 4-hour exposure.
Vlnylldene fluoride has been reported not to be lethal to rats exposed at 
a concentration of 802, with 202 oxygen, for 19 hours [128]. Another author 
[118], however, stated that a static exposure to vlnylldene fluoride at
128.000 ppm for 4 hours was sufficient to kill from two to four of six rats 
within 14 days, hot enough information was presented to evaluate whether or 
not the static exposure conditions, eg, decreased partial pressure of oxygen, 
were directly responsible for this difference in lethality.
These studies Indicate that vinyl chloride, vlnylldene chloride, and vinyl 
bromide present a low degree of acute toxic hazard in animals, and that, a* 
the duration of exposure increases, the concentration necessary to produce 
lethal effects decreases. One study [117] showed that «'xposure of male mice 
to vlnylldene chloride at concentrations as low as 2 0  ppm was lethal after 
dally exposures of 22-23 hours for 4 days. The information available suggests
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chat Che acute toxicity of these compounds is dependent in pare on Che races 
of metabolism and excretion and the subsequent total accumulated dose. The 
variability of the estimates of LC50 values, resulting in part from 
variability in the experimental protocols used, does not allow a ranking of 
the compounds according to acute toxicity, except that vinyl fluoride and 
vlnylldene fluoride are less toxic than the other vinyls and have not been 
found to have acute lethal actions on dynamic inhalation exposure in normal 
rats.
Cardiovascular effects have been reported for vinyl chloride, vinylidene 
chloride, and vinylidene fluoride. Twenty percent of 51 workers examined in 
1965, who were exposed to vinyl chloride at a TWA concentration of 49 ppm, and 
422 of 60 workers examined in 1969, exposed at a TWA concentrations of 43 ppm, 
showed elevated pulmonary arterial pressure [19]. Durations of exposure for 
these workers were not presented. In another report [78], workers who were 
currently exposed to vinyl chloride or who had been exposed In the past had a 
39.4-412 frequency of diastolic hypertension, while workers from the same 
plant with no known exposure to vinyl chloride had a frequency of diastolic 
hypertension of 24.32 (P<0.05). Symptoms of circulatory disturbances in
workers exposed to vinyl chloride have been reported in several studies. The 
symptoms included cold hands and feet (132) [33], cold fingers and hands
(25.72), numbness or tingling in fingers or toes (31.42), and other 
indications of Raynaud's syndrome (8.62) [20]. Raynaud's syndrome (155) and 
unspecified circulatory disturbances (1 2 2 ) appeared in another population also 
[32]. Cardiac sensitization to epinephrine has also been demonstrated in dogs 
exposed to vinyl chloride at 50,000 ppm for 5 minutes [110]. Changes, such as 
tachycardia, sinus arrhythmia, and ventricular multifocal extrasystoles, have 
been observed in the ECG records of dogs exposed to vinyl chloride at 100,000 
ppm without epinephrine stimulation [107]. A significant decrease (P<0.05) of 
28.52 in myocardial force of contraction has been observed in monkeys exposed 
to vinyl chloride at the same concentration for 5 minutes [108]. Monkeys 
exposed at 50,00C ppm showed a decrease of 9.12 in myocardial force of 
contraction, and those exposed at 25,000 ppm showed a 2.32 decrease in force 
of contraction. Decreases in aortic blood pressure followed a similar pattern 
in the monkeys. This experiment indicates that the cardiovascular effects of 
vinyl chloride are dose dependent.
Vinylidene chloride, inhaled at concentrations of 25,000 ppm for 10 
minutes, caused sinus bradycardia and such cardiac arrhythmias as AV-block and 
ventricular fibrillation in rats [121]. Vinylidene chloride also>enhanced the 
cardiac sensitivity to epinephrine, and this sensitivity increased with 
increasing duration of vinylidene chloride exposure.
No cardiac sensitization to epinephrine was noted in cats or dogs exposed 
Co vinylidene fluoride at concentrations of 250,000-500,000 ppm for 5-15 
minutes [131]. This suggests that vinylidene fluoride does not have the same 
mode of action on the cardiovascular system as vinyl and vinylidene chlorides. 
Similar information is aot available for vinyl bromide or vinyl fluoride.
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CNS effects have been observed on animals after exposure to each of ¿he 
vinyl halides. In some instances, these effects might have been secondary to 
systemic effects caused by cardiovascular changes. The authors of the reports 
did not address this possibility. Vinyl chloride caused "certain anesthesia" 
in mice after a 10-minute exposure at 122,000 ppm, and 50% anesthesia after 
exposure a 10-minute exposure at 100,000 ppm [105]. Exposures at LC50's 
caused excitement, convulsions, and contractions in mice, rats, and rabbits 
[104]. Exposure of dogs co vinyl chloride at 500,000 ppm momentarily, then at
70,000 ppm for an unspecified period, caused rigidity of the legs and 
uncoordinated muscular movements [107].
An experiment with human subjects showed that 5-minute exposures to vinyl 
chloride at 1 2 , 0 0 0  ppm caused dizziness in two, dizziness, nausea, 
lightheadedness, and dulling of vision and hearing at 16,000 ppm in five, and 
the same symptoms with more Intensity in all six, and a headache in one of 
them at 20,000 ppm [18]. Among 168 workers exposed to vinyl chloride at a TWA 
concentration of 899 ppm for up to a few months, 47% complained of dizziness, 
45% of somnolence, 36.6% of headache, 13% of loss of memory, 11% of euphoria, 
and 9% of nervousness [19]. Of 168 workers exposed to vinyl chloride at a TWA 
concentration of 9d ppm (prior exposure information not available), 10.2% 
reported dizziness, 16.6% somnolence, 6.9% headache, 8 % loss of memory, 1.2% 
euphoria, and 0.6% nervousness. Frequent dizziness and weakness in the legs 
were also reported by other workers exposed to vinyl chloride [20,33], as was 
fatigut in 38.6% and headache in 12.9% [20] and in 13.7% of another group, of 
workers [78]. These data Indicate that a decrease in the TWA concentration of 
vinyl chloride led to a decrease in the frequency of CNS symptoms, and that 
exposure at TWA concentrations as low as 38 ppm produced adverse effects.
Other findings that might be considered manifestations of CNS effect3 have 
included a "large proportion of accidents" occurring in a worker population 
[32] and an excess of suicides as the actual causes of death in another worker 
population (10 observed vs 5.3 expected) [84]. Effects on brain cells have 
also been observed, ie, a localized atrophy of cerebellar Purkinje cells and 
necrosis of the frontoparietal cerebral cortex in one worker [41]. Also, 
fibrotic processes surrounding and invading the small nerve bundles of the 
gray matter, neuronal phagokaryosis with satellitosis and deposition of 
neurologic elements around altered nerve cells of the white matter, and 
atrophy of the granular layer and degenerative changes in the Purkinje cell 
layer were observed in rats exposed at 30,000 ppm, 4 hours/day, 5 days/week, 
for 1 year [1 1 1 ].
Exposure to vinylidene chloride at about 4,000 ppm for a brief period 
caused "drunkenness" that progressed to unconsciousness in animals [114]. 
Workers exposed to a vinylidene chloride copolymer while cleaning tanks 
developed pains in the lips, nose, and eyes, headache, somnolence, facial 
anesthesia, corneal anesthesia, hypoesthesii, difficulty in speaking and 
eating [72], and fatigue, weakness, nausea, and dizziness [70,71]. Because of 
the composition of the copolymers to which these workers were exposed In
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aqueous suspension, it is not reasonable to assume that vinylidene chloride 
was the only causative agent of these CNS effects.
Vinyl bromide caused a ’’certain anesthesia" at a concentration of 86,000 
ppo for a 10-minute exposure in rats [105]. In another experiment, a 1.5-hour 
exposure at 25,000 ppm anesthetized all rats, and a 7-hour exposure at 10,000 
ppa caused drowsiness in rats [127].
Rats exposed for 30 minutes to vinyl fluoride at 300,000 ppm showed 
instability of the hindlegs; at 500,000 ppm there was loss of postural 
reflexes, and at 600,000 ppo there was loss of the righting reflex [129].
Rats exposed to vinylidene fluoride for 30 minutes at 400,000 ppm showed 
slight Intoxication, and at 800,000 ppm showed an unsteady gait without loss 
of the postural reflexes [129].
The available data indicate that vinyl chloride and vinylidene chloride 
can produce similar CNS' manifestations that may be secondary to the 
cardiovascular effects of these compounds. Human exposure information is not 
available concerning CNS symptoms for vinyl bromide, vinyl fluoride, or 
vinylidene fluoride, and anesthetic effects from vinyl fluoride and vinylidene 
fluoride have only been observed at very high concentrations.
Workers exposed to vinyl chloride have also experienced adverse 
respiratory effects ranging from coughing and sneezing to bronchial rales, 
pulmonary emphysema, decreased respiratory volume, decreased vital capacity, 
decreased maximum expiratory volume/second, and linear type pulmonary fibrosis 
[19]. Pulmonary function changes were also noted in 12 of 180 workers with 
"vinyl chloride disease" [32]. Monkeys exposed to vinyl chloride at 100,000 
ppm for 5 minutes have shown a significantly increased (P<0.05) pulmonary 
resistance (15.35%) and significantly lowered (?<0.05) respiratory minute 
volume (12.32) [106]. In addition, bronchioalveolar adenomas have been
observed in mice, exposed to vinyl chloride at 50 ppo, 6 hours/day, 5  
days/week, for up to 12 months [140].
Bronchioalveolar adsncmas have been found in mice exposed to vinylidene 
chloride at 55 ppm for 6 hours/day, 5 days/week, fo~ up to 12 months [140]. 
Respiratory irritation wa3 seen in rats, guinea pigs, rabbits, dogs, and 
monkeys when exposed to vinylidene chloride at 87.6 ppm . continuously for 90 
days or 1,730 ppm for 8 hours/day, 5 days/week, for 6 weeks [122]. Nasal 
irritation was seen in rats exposed to vinylidene chloride at . 2 0 0 ppo for 6  
hours/day, 5 days/week, for 4 weeks [1 2 0 ]. Inflasmatlon of & e^lpharynx was 
also noted in two workers exposed to the emanations from' an aqueous 
polyvinylidene chloride copolymer suspension [70,71]. Because of the mixed 
composition of this suspension, the authors did not attribute the effect to 
vinylidene chloride alone. No data were located on respiratory effects of 
vinyl bromide, vinyl fluoride, or vinylidene fluoride.
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Scleroderma of the hands and forearms was observed is 8 of 70 workers 
exposed to vinyl chloride at unspecified concentrations [20]. Fourteen of 36 
workers from whom samples of skin for biopsy were taken had fragmentation of
the elastic fibers of the skin of the fingers.. Dermatologlc complaints were
also elicited from 80% of 168 workers during the 1 st month of exposure to
vinyl chloride at a TWA concentration of 899 ppm [19]. These changes
progressed over a period of time from pruritus to contact dermatitis with 
papules to scleroderma. In the 1st yfear, 4.4Z of the workers developed 
contact dermatitis, and this frequency increased to 7.4Z during 7 years, even 
though the TWA concentration decreased from 899 to 43 ppm. Other possible 
routes of exposure of the akin were not evaluated by the authors. Scleroderma 
was diagnosed in 10% of 180 workers with "vinyl chloride disease" [32].
Another four workers found to have scleroderma ahowed thickening of the skin 
of the fingers, e.dhesions on the deep layers, palmar erythema, hyperhydrosis, 
and hard projecting nodules in the arees of the flexor tendons [21]. The paws 
of rats exposed to vinyl chloride at 30,000 ppm, 4 hours/day, S days/week, for 
1 year showed hyperkeratosis, superficial thickening of the epidermis, 
disappearance of the cutaneous adnexa, vacuolization and degeneration of the 
basal layer, a thickening of the papilliir layer, with edema, and a decrease in 
the elastic reticulum and dissociation of the collagen bundles [1 1 1 ].
Arterial vessels of the paws also showed endothelial fibrosis. The same rats 
also ahowed akin papillomas and warty aubauricular growths [112]. No reports 
were located of integumentary effects with exposure to vinylidene chloride, 
vinyl bromide, vinyl fluoride, or vinylidene fluoride.
Skeletal changes have also been observed in humans and animals exposed to 
vinyl chloride. Acroosteolysis has been observed in workers 
[*0,21,32,35,74,75,78]. In one study [78], exposures to vinyl chloride were 
estimated at 50-100 ppm in air and 600-1,000 ppm close to tne workers' hands 
during reactor cleaning operations. No information was available in any of 
these reports on the duration of employment or exposure for the workers with
acroosteolysir . It was noted that all workera with acrooateolyais had been
¿mployed in reactor cleaning, whereas only 21Z of the entire vinyl chloride-
exposed population had had experience as reactor cleaners [74,75]. In rats
exposed to vinyl chloride at 30,000 ppm for 4 hours/day, 5 days/week, for 1
ysar, observed effects included alteration in the characteristic bone
deposition in the small bones with a mucoid Impregnation [1 1 1 ] and
o.o-eochondcomas in the metacarpal and metatarsal regions of all of the limbs
of of 25 rats [112]. No information concerning skeletal abnormalities was 
locked for vinylidene chloride, vinyl bromid , vinyl fluoride, or vinylidene 
fluoride.
Liver a m  pleen abnormalities have been observed in humans and animals
exposed to vinyl chloride. Hepatomegaly was observed in 65Z of 48 workers
[30], in one worknr exposed 3-4 hours/day, 2-3 days/week, for 3 years and 5 
months [41], in 1 of 17 workers [33], in 64% of 11 workers [37], and ip 30.2% 
of 168 workers exposed at a TWA concentration of 899 ppm, and in 11.4Z of 168 
workers exposed at a TWA concentration cf 38 ppm [19] (durations of exposure 
not reported). Hepatomegaly wa3 also reported in 13.2Z of 126 workera
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estimated as having "moderate" exposures to vinyl chloride, while only 7.32 of 
80 workers estimated to havo "light" exposures and 7.1Z of 134 workers with 
"no" exposure showed hepatomegaly [78]. Degenerative changes found In the 
livers through biopsy Included single cell necrosis, hyperplasia, hydropic 
swelling of the cells, periportal and centrilobular fibrosis and fatty 
degeneration [31]; dilatation of sinusoids, formation of connective tissue 
septa, fibroblastic activation, and enlarged hepatocytes with hyperchromatic 
nuclei [39]; nonalcoholic-type cirrhosis [36]; and fibrosi3 [30,34,37,4C,41].
Several authors have reported clinical test results indicative of liver 
damage. Workers exposed to vinyl chloride showed abnormal SGOT values in 312 
of 277 [78], in 732 of 11 [37], in 502 of 36 [19], in 282 of 6 8  [34], and in
46.92 of 59 [35]. Results of BSP retention tests were found to be abnormal in 
472 of 15 workers [33], in 852 of 26 workers [19], in 92 of 11 workers [37], 
and in 67.22 of 70 workers [20] and to increase significantly (?<0.001) with 
increasing exposure to vinyl chloride [76]. LDH values were elevated in 362 
of 11 workers [37], in 11.12 of 72 workers [34], and In 9.42 of 59 workers 
[35]. Alkaline phosphatase values were also found to be abnormal in 132 of
277 workers [78], in 552 of 11 workers [37], in 49.42 of 72 workers [34], and
in 59.42 of 59 workers [35]. Other clinical values found to be abnormal in 
vinyl chloride-exposed workers in some of these reports included thrombocyte 
counts, leukocyte counts, reticulocyte counts, erythrocyte sedimentation 
rates, total bilirubin, albumin, cholesterol, icterus index, SGPT, isocitrate 
dehydrogenase, and gamma-glutamic transpeptidase activities, serum beta- 
globulin, and 17-ketosteroids [19,20,32-35,37,76-78]. Unfortunately, the 
authors of these studies did not supply information concerning exposure 
concentrations or durations that might facilitate a correlation of the 
exposures with the effects. It should also be noted that the frequencies of 
these abnormal test results were often not significantly different from those
in other cohorts of workers such as rubber workers.
Splenic abnormalities, Including enlargement, were observed in 57.42 of 70 
workers [20], 452 of 11 workers [39], 102 of 1,180 workers [38], 262 of 180
workers with "vinyl chloride disease" [32], and 772 of 48 workers [30] exposed
to vinyl chloride. No information is available on exposure concentrations or 
durations for these workers.
In 30 rats exposed to vinyl chloride at 20,000 ppm, 8 hours/day, 5
days/week, for 3 months, the livers were significantly heavier (P<0.001) than 
those of controls, there was widespread swelling and vacuolization of the 
liver cells and compression of the sinusoids; the spleens of the rats were 
significantly lighter (P<0.05) [18], Rats and guinea pigs exposed to vinyl
chloride at 100 ppm for 7 hours/day, 5 days/week, for 6 months also showed 
significantly increased liver weights (P<0.05) [113].
No abnormal clinical chemical values were noted either in mice or rats
exposed to vinyl chloride at 50, 250, or 1,000 ppm for 6 hours/day, 5
^ays/week, for up to 12 months [140] or in rats, guinea pigs, rabbits, or dogs 
exposed at 100 or 200 ppm for 7 hours/day, 5 days/week, for 6 months [113].
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In a group of 46 affected workers exposed to vlnylidene chloride at TWA 
concentrations of 0-5 ppm with occasional peaks of 300 ppm, 112 showed
hepatomegaly, 13Z showed abnormal serum alkaline phosphatase values, and 2 1 - 
392 showed abnormalities in serum LDH, GGTP, GOT, and GPT values [69]. Of 256 
additional workers tested, 292 had abnormal clinical values, and these workers 
averaged 5.11 years of exposure, whereas Che employees who showed normal 
value5 averaged 3.64 years of exposure. Serum alkaline phosphatase and GPT 
values were increased in rats and guinea pigs exposed to vlnylidene chloride 
at 47.6 ppm continuously for 90 days [122]. These animals also had mottled 
livers and spleens. In rats exposed to vlnylidene chloride at 25 or 75 ppm 6 
hours/day, 5 days/week, for 17 months, there was increased hepatocytic
cytoplasmic vacuolization [119]. Liver cell degeneration was also noted in 
rats exposed to vlnylidene chloride at 500 ppm for 6 hours/day, 5 days/week,
for 4 weeks, but not in animals exposed at 200 ppm for the same period [120].
Necrosis and fatty focal vacuolization was also seen in mice and rats exposed
at 55 ppm for 6 hours/day, 5 days/week, for up to 12 months [140]. Liver
damage has also been demonstrated in rats given vlnylidene chloride orally in 
corn oil in a single dose of 200 mg/kg [125,126], and in drinking water at 
normal concentrations of 50, 100, or 200 ppm for 730 days [123].
In a 1-year Interim report [143], vinyl bromide was stated to have caused 
Increased liver weights in rats exposed at 250 and 1,250 ppm and increased 
spleen weights in rats exposed at 50, 250, and 1,250 ppm. Gross examinations 
indicated mottled livers in a few of the animals exposed at these 
concentrations. • Significant elevations in serun LDH and bromide values were
also reported in those rats exposed at 1,250 ppm.
No information was located concerning the hepatotoxicity of vinyl fluoride 
or vlnylidene fluoride.
The systemic effects that reportedly resulted from exposure to vinyl 
halides suggest that the vinyls or their metabolites Interfere with cellular 
processes primarily in the liver and the cardiovascular system. Exposures to 
large quantities may also involve the skeletal, integumentary, and central 
nervous systems; however, these systems may also be affected secondarily by 
changes in the cardiovascular system, and the relative magnitudes of the 
effects resulting from primary action of the vinyl halides or their 
metabolites and from the suggested secondary ones are uncertain.
Carcinogenicity. Mutagenicity, Teratogenicity, and Effects on Reproduction
The vinyl halides produce reactive metabolic intermediates, possibly 
including asymmetric oxlranes. Several proposed intermediates in the 
metabolic pathways of the vinyl halides are capable of covalent binding with 
cellular macromolecules, and may therefore induce carcinogenesis and 
mutagenesis. Although few experiments have been reported in which the 
carcinogenic or mutagenic potentials of the vinyl halides other than vinyl
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chloride arc evaluated, the vinyl halides considered In this document, as 
suggested earlier In this chapter, may be qualitatively If not quantitatively 
similar In their Induction potentials.
One report has suggested that exposure of male workers to vinyl chloride
can Induce excess fetal deaths among their offspring [101]. However, as has
been previously discussed, the methods of data collection used in this report 
are considered inappropriate.
The fetuses of mice, rats, and rabbits from dams exposed to vinyl chloride
during pregnancy showed significant abnormalities, including increased crown-
rump length, in mice exposed at 50 ppm, and increased Incidence of 
resorptions, decreased fetal body weight, reduction in litter size, Increased 
numbers of unfused sternebrae, and delayed ossification of the bones of the 
skull In mice exposed at 500 ppm [132]. Fetuses from rats exposed at 500 ppm 
showed a significant reductiou in the fetal body weights and a significant 
increase in the number of lumbar spurs and In crown-rump length. Fetuses from 
rats exposed at 2,500 ppm showed a significant increase in th<5 Incidence of 
dilated ureters and significant decreases in the incidence of unfused 
sternebrae and delayed 3 kull ossifications. The only other significant 
difference noted was an increase in the incidence of delayed ossification of 
the fifth sternebra in rabbits exposed at 500 ppm. The authors of this study 
regarded these effects as due to maternal toxicity and not to direct toxicity 
to embryos and fetuses. However, the observation of characteristic cancers in 
progeny of dams exposed to vinyl chloride during their pregnancies [135] 
suggests that vinyl chloride or its metabolites cross the placental barrier 
and may have induced the abnormalities reported.
Pregnant rats exposed to vinylidene chloride at 80 ppm had significantly 
increased numbers of resorptions/implants and fetuses with significant 
increases in skeletal abnormalities such as delayed ossification of parietal 
bones, wavy ribs, and lumbar spurs [133]. Delayed ossification of skull bones 
and cervical vertebrae, along with wavy ribs, were also observed in fetuses of 
rats exposed at 160 ppm. No adverse effects were observed at 20 ppm. In the 
rabbits exposed at 160 ppm, there was a significant increase in the number of 
resorptions/implants and a significantly decreased Incidence of delayed 
ossification of the fifth sternebra, and an increased incidence of a 13th pair 
of ribs. No adverse effects were noted on the fetuses from dams exposed at 80 
ppm. In the fetuses of rats given access to drinking water containing 
vinylidene chloride at 2 0 0  ppm, the only significant difference from controls 
was an Increase in the fetal crown-rump length.
No reports have been located of studies in which the reproductive or 
teratogenic effects of vinyl bromide, vinyl fluoride, or vinylidene fluoride 
were investigated.
Covalent binding of the vinyl halides to cellular macromolecules such as 
DNA, RNA, and proteins may be a critical step in a genotoxic effect [1]. 
Vinyl chloride, after metabolic activation by microsomal enzymes, has been
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shown to enhance mutagenesis In Salmonella [151,152,155,156]. Similar 
metabolic enhancement has been shown for vlnylldene fluoride (J Watson, 
written communication, April 1978), vinyl bromide (VF Simmon and R Mangham, 
written communication, August 1977) and vlnylldene chloride [151,152,172]. 
The common molecular features of thes^ compounds, the formation of th«' 
asymmetrical ozlrane and the subsequent spontaneous rearrangement to the 
aldehyde or acyl halide, have been suggested as producing the most reactive 
intermediates [1-3,210], although the oxirane of vlnylldene chloride has not 
yet been synthesized In the laboratory [1]. Direct binding with proteins in 
vitro has been reported for chloroethylene oxide (the oxirane of vinyl 
chloride) [196,212] and for chloroacetaldehyde [170,206]. In vitro and in 
vivo binding of vinyl chloride or its metabolites to microsomal proteins has 
also been reported [204,205,212,214,215] as has macromolecular binding of 
vlnylldene chloride or its metabolites [117,219]. In addition to direct 
binding to proteins, metabolites of vinyl chloride have been reported to bind 
to RNA in vitro [170,204,205] and in vivo [215].
Even when the route of administration of the vinyl halides differ, the 
metabolic end products, and, presumably, the intermediates, with each route 
are the same [4,5,175,177]. Only unchanged vinyl chloride or vinyl chloride- 
derived carbon dioxide were exhaled after oral, lp, lv, or inhalation 
exposures [4,5,175,177]. Urinary metabolites from all routes of exposure 
Include cysteine-conjugated products and small amounts of monochloroacetate 
[5,175,177].
Absorption of vinyl chloride through the intact skin was reportedly 
minimal, amounting to less than 0.031* of the total available gaseous vinyl 
chloride in 2.5 hours [178]. Vinyl chloride concentrations in the air rapidly 
equilibrated (within 15 minutes) with vinyl chloride in the tissue when
metabolism was blocked [202]. Under these conditions, the half-life of vinyl 
chloride was 4.3 minutes. Absorption and subsequent metabolism of vinyl
chloride has been reported to be concentration dependent, with a saturable 
enzyme system responsible for metabolism at low concentrations and a secondary 
oxidative system predominant at higher concentrations [4-6]. It has been 
postulated that the oxirane is formed only at the higher concentrations 
through the secondary oxidative pathway, but that halogenated acetalydehyde is 
common to both pathways. Thus, even without the formation of the oxirane at 
low concentrations, the possibility of macromolecular alkylatlon exists
through the action of the aldehyde intermediate.
Vinyl chloride has been shown to produce a characteristic tumor,
angiosarcoma of the liver, in both humans [31,32,34,36,37,40,41] and animals 
[134,135,140]. The cases of angiosarcoma of the liver in workers exposed to 
vinyl chloride are summarized In Table XVI1-4 [61]. This summary shows that 
the average exposure of the affected workers was 17.3 ±6.3 years (range 4-30 
years) and the average latency for diagnosis of the tumor was 20.5 £ 6 years
(range 9-38 years). Accurate exposure information, to allow calculation of 
total accumulated dose, is not available for these workers. Kuzmack and 
McGaughy [62], using data derived from epidemiologic studies, calculated that
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the incidence rates of angiosarcomi in workers exposed at concentrations of 
350 ppm, 7 hours/day, for 5 days/week should be 0.0031/person/year of 
exposure. Ad incidence rate of 0.0052/person/year of exposure was also 
calculated from the incidence rate in rats.
Angiosarcoma of the liver was also observed in 1 of 59 rats exposed to 
vinyl chloride at 50 ppm, 4 hours/day, 5 days/week, for 52 weeks [135]. The 
percentage of animals with angiosarccma of the liver increased from 2% at 50 
ppm, to 71 at 250 ppm, 12% at 500 ppm, 22% at 2,500 ppm, 22% at 6,000 ppm, 15% 
at 10,000 ppm, and 30% at 30,000 ppm. Average latency increased with 
decreasing exposure concentration, from 53 weeks at 30,000 ppm to 135 weeks at 
50 rpm. In  another experiment [134], rats exposed at 50 ppm for 4 hours/day, 
5 days/vi?ek, for 12 months showed no tumors over an unspecified observation 
period. At 500 ppm., however, there was a significant increase (P<0.03) in the 
number of tumors seen, with 3% of the animals having angiosarcomas of the 
liver. Increasing exposure concentrations to 2,000, 5,000, 10,000, and 20,000 
ppm increased the frequency of all turners and of angiosarcoma of the liver to 
5, 6 , 8 , and 12%, respectively. Other tumors in rats, such as Zymbal gland
carcinoma and nephroblastoma, have been reported to have similar latencies 
[135]. Statistical estimates were nade by CR Norwood and FW Dresch (written 
communication, December 1977) using the data in these reports [134,135,140] 
and based on the assumptions that the background incidence of this tumor is 
zero and that the no-observable-effact concentration is that at which the 
probability of one tumor developing in 1 0 0 replications of the same experiment 
is less than 0.01. They found that conservative, no-observable-effeet 
concentrations for angiosarcoma of the liver could be calculated as any of 0 . 2  
ppm [140], 0.01 ppm [134], or 0.000004 ppm [135],
A variety of other tumors have been seen in workers exposed to vinyl 
chloride, such as cancer of the respiratory system [80,81,84], buccal cavity, 
pharynx, and peritoneum [64,81], brain [84,89], gall bladder [84], and 
glioblastoma, reticulum cell sarcoma, and lymphosarcoma [87]. Similar tumors 
have been seen in animals exposed to vinyl chloride [112,135,136,138,140]. 
These tumors are much more common than angiosarcoma of the liver, however, and 
can be induced by a wide variety of other carcinogens; they are therefore not 
considered pathognomonic of vinyl chloride exposure. The relatively long 
latent period for induction of angiosarcoma of the liver in both humans and 
animals, along with the lack of adequate followup information in most cases, 
makes a purely objective assessment of risk on the basis of the available data 
unwarranted.
No cases of cancer in humans have been reported to be related to 
occupational exposure to vinylidene chloride, and only three animal
experiments relative to its carcinogenicity have been located. In one
experiment [140], 3 of 72 CD-I mice exposed to vinylidene chloride at a
concentration of 55 ppm, 6 hours/day, 5 days/week, for up to 12 months
developed angiosarcoma of the liver. Two of 72 rats similarly exposed
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developed extrahepatlc angiosarcoma. In another experiment [119], 208 rats 
exposed at 40 ppm for 6 hours/day, 5 days/week, for 1 month and Chen exposed 
aC 75 ppm on Che same schedule for .17 more months developed no angiosarcoma. 
In addlclon, these racs did noc show Increased Incidences of ocher tumors 
compared wich Chose In concrols. A further experlmenc [142] showed an 
Increased Incidence of adenocarcinoma of Che '’Ldnay In Swiss mice exposed to 
vinylidene chloride aC 25 ppm for 4 hours/day, 4-5 days/week, for 12 months, 
but no increase in other tumors. The authors [142] stated that exposures at 
50 ppm and higher were lethal to these animals. Sprague-Dawley rats exposed 
on the same schedule at concentrations of from 10 to 150 ppm showed an 
increased incidence of mammary tumors; howevar, this increase was not dose 
dependent.
No cases of cancer in humans have been attributed to vinyl bromide 
exposure. The preliminary results of one animal experiment [143] Indicated 
chac vinyl bromide aC 1,250 or 250 ppm induced a significant Increase In 
angiosarcoma of the liver and other tumors in rats after 1 year of exposure. 
At 1,250 ppm, 9/48 rats developed angiosarcoma, and, at 250 ppm, 2/30 rats 
developed angiosarcoma. No Increase in tumor formation was observed in rats 
exposed at 10 and 50 ppm for 1 year.
No reports concerning the carcinogenicity of vinyl fluoride or vinylidene 
fluoride in humans or animals have been located.
Comparison of the limited animal data available on induction of 
angiosarcoma by the vinyl halides supports the postulations outlined in the 
Structure-Activity Considerations section of this chapter. The expected order 
of susceptibility of the olefins toward epoxidation, calculated from the sum 
of the electronegativities of the substituents, is vinyl bromide > vinyl 
chloride > vinylidene chloride > vinyl fluoride > vinylidene fluoride. The 
carcinogenicity data show that vinyl bromide at a concentration of 250 ppm 
induced angiosarcoma in 72 of Che animals after 1 year of exposure [143], and 
that vinyl chloride at a concentration of 250 ppm also induced angiosarcoma in 
71 of Che animals, buC after 2 years of exposure [135]. This indicates that, 
for this characteristic tumor, vinyl bromide has a stronger induction 
potential, since It is reasonable to assume that, within another year, more of
Che vinyl bromide exposed animals would develop the tumors. A comparison of
the induction potential of vinylidene chloride with that of vinyl chloride or 
vinyl bromide is more difficult. One experiment with vinylidene chloride 
showed 42 angiosarcoma of the liver In CD-I mice exposed at a concentration of 
55 ppm for 85,800 ppm-hcurs [140], another experiment showed no angiosarcoma 
in Swiss mice exposed to vinylidene chloride at 25 ppm for 23,000 ppm-hours 
[142], while an experiment with Swiss mice exposed Co vinyl chloride aC a 
concentration of 50 ppm for 30,000 ppm-hours showed a 22 Incidence of 
angiosarcoma of the liver [135]. These data are noC so easily compared as the
data from the vinyl bromide and vinyl chloride experiments, but they do
suggest that vinylidene chloride may be less active in Inducing angiosarcoma 
of the liver than vinyl chloride. Because the behaviors of these compounds 
appear to fit the expecCed scructure-activity relationship, it is reasonable
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to suppose Chat vinyl fluoride and vlnylldene fluoride might also fit Chls 
relationship. Because of the lack of Information concerning Che rinyl 
fluorides, ic Is noc possible eo substantiate chls hypothesis at Che present 
else.
No mutagenic effects on humans have been related Co exposure Co any of Che 
vinyl halides. Studies of chromosomal aberrations In the lymphocytes of 
workers exposed to vinyl chlo-ide [94-99] have indicated a significant 
increase In abnormalities; however, the combined frequency of abberations in 
these studies was only a fraction of the background frequency [1G0].
Each of the vinyl halides has been fcund to be mutagenic in some test 
system. Vinyl chloride has been shown to produce mutations in Salmonella, in 
the Ames test procedure [145,146,149,150,162,163], in E. coll [151-153], in 
yeasts, both in vitro and by host-mediated assay 1.155], and in Drosphila by 
the recessive lethal test [158,159]. Negative results have been obtained in 
Neurospora 1157],
Several investigators have shown that vinyl chloride has a direct 
mutagenic effect on Salmonella [149,150,162,163]. One study [¿46] reported a 
twentyfold Increase over the spontaneous mutation rate after 48 hours of 
exposure to a medium containing 4 millimoles of vinyl chloride. Activation by 
a 9,000 x G mammalian microsomal system increased the mutation rate to 28 
tices the spontaneous rate [146], and exposures of as short as 30 minutes at 
vinyl chloride concentrations of 2 0 0 , 0 0 0  ppm induced twice the spontaneous 
race of mutation [145]. Purified microsomal fractions (100,000 x G) have been 
shown to be less active than the 9,000 x G fraction [146], while the 
supernatant cytosol produced no increase in mutagenic activity above that 
found for vinyl chloride alone. Vinyl chloride has been shown to affect only 
loci at which mutation occurs by substitution [145,146]. One dominant lethal 
study [161] with male mice exposed to vinyl chloride at 30,000 ppm for 6  
hours/day for 5 days showed no mutations, which suggests that mammalian 
gametes may not be affected by exposure.
Vlnylldene chloride has been shown to be similarly mutagenic in bacterial 
systems [172,173]. Exposure of Salmonella for 2 hours, in media containing 
0.33-33 millimoles of vlnylldene chloride and a mammalian microscmal system, 
resulted in 6-10 clmes the spontaneous number of ravertants [172]. Bartsch et 
al [173] reported that vlnylldene chloride was about three times as active as 
a mutagen as vinyl chloride on an equimolar basis. In a study using E^ coli, 
Greim et al [151] concluded thac vinyl chloride was "several times" more 
mutagenically active than vlnylldene ' chloride; their data showed that 
vlnylldene chloride produced a onefold Increase over the spontaneous number of 
mutaclonj at a concentration of 2.5 mil.'.imolar, while vinyl chloride produced 
six Clmes the spontaneous number of mutations at the same locus at a 
concentration of 1 0 . 6  mlllimolar.
Vinyl bromide aC concentrations of 202 in air was shown to be mutagenic in 
Salmonella TA100 after a 12-hour exposure (VF Simmon and R Mangham, written
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coaaunicadon, Auguat 1977). This exposure produced revertants at 10 times 
cha spontaneous rata with microsoaal activation and at about 5 Claes tha 
spontaneous rata vlehouc activation.
Both vinyl fluoride and vlnylidene fluoride have been shown to produce 
direct mutagenic responses In coll at up to 1 0 0 times the spontaneous rate 
[174], However, no data were given on the exposure concentrations for these 
experiments and no auxotrophic mutants were isolated from the putative mutant 
colonies. Vinylidene fluoride has alao been reported to increase che 
frequency of nutations in Salmonella both with and without microcomal 
activation (J Watson, written coaaunication, April 1973).
Several investigators hav# tested knevn or presumed metabolites of vir.yl 
chloride in an attenpt to identify the mutagenically active agents. The most 
active compounds tested were chloroacetaldehyde and chloroethyiene oxide 
[166,147,163,165]. Chloroethanol shoved lower mutagenic activity [147,162, 
163], and chloroacetlc acid was not mutagenic in Salmonella [147,163,166]. 
The direct acti/ity of chloroethanol resembled that of vinyl chloride in that 
it affected Salaonella strain TA1535 and strain TA1C0 (identical to TA1535 
except that it is DN’A repair-deficient) about equally [162]. Chloroethanol, 
like vinyl chloride, was also further activated by the addition of mammalian 
aicrosomes [147,162].
McCann et al [162] suggested that, although chloroacetaldehyde was the 
most active of the metabolites of vinyl chloride that they tested, i<: was
probably not the major mutagenic metabolite of vinyl chloride, since 
chloroacataldahyde affected only tha repair-deficient Salmonella strain TA1C0. 
These authors suggested that chloroechylene oxide was the most likely 
mutagenic metabolite, although they did no; test its activity. However, the 
compound has been tested by other investigators on both repair-deficient [166] 
and nonrepair-deficient [147,163] strains, and it apocirj, like vinyl 
chloride, to be similarly active in each.
These studies show that each of tha vinyl halides is mutagenic in various 
Case systems and that Cha putaclva metabolites are more strongly mutagenic 
chaa che parenc compounds. The studies support the conclusions drawn from the 
limited carcinogenic data available and, further, raise a suspicion that the 
fluorides also may be carcinogens. The failure of vinyl chloride to be 
mutagenic in tha mouse dominant-lethal test may indicate that ~he mutagenic 
factor may not ba distributed to mammallan gametes in sufficient 
concencradonj co produce slgnlficanc changes; however, further research is 
necessary Co determine fully cha pocenelal of ehese compounds for mammalian 
mutagenicity.
Tha available evidence c seeming the vinyl halides indicates that e«eh 
produces similar biologic effects, albeic possibly ac different 
concencraclons. Indications from the experiments on mutagenicity suggest that 
chesa compounds are able Co exerc chair action directly but chat metabolism of 
Cha parenc compounds produces intermediates that are much more reactive.
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TABLE I I I - ?
o n c i i t r a t u n  I>-j t ,»t t <i n S i * n s  a n d  b ^ r p tO T j{ 3l»n)
i b S  * o  r k m
M Vo r k * r % 
60 Worker * 
1)7 t o r k e r  s 
I 61 Worker *
14,000






04 » o t h e r s *  0*3
( peaks  to 300)
7 )  Worker s *  •
111 Worker«*
avg S . 1 1 yr 
avg 3 . 4 *  yr
D i z : m p » i ,  nausea, I ^ h t h ea de dn es s,  
of viiion and f f j’ inj in
h e a d a c h e  »n 1
O i z z m e i t ,  I i g h t h * a d e d n e s s ,
d u l l i n g  o t  v i s i o n  and h e a r i ng  in 3
D i  x o  n t i  i  i n  2
No *1 f e e t *
D i z z i n e s s  ( a 7%) , sorrmolence (<»*%). 
f ' i j d a r n f  { )<».<>%),  i ^ o r e n a  ( 2 3 % ) ,
i r pa i t (16*>,  l o t s  of memory 
( I .**>) , i  l Of i oru  ( I ; "M , n e r v o us ne s s  (9%) ;
t otnegd i y M 0 .  2%); d e m i t o l o g i c  
c o mp l a in t s  I SCM&) ; Raynaud' s  syndrune (6%)
E l e v a t e d  pulmonary a r t e r i a l  p r e s s u r e  m 2?«
E l e v a t e d  pulmonary a r t e r i a l  p r e s s u r e
in *2%
D e c r eas e  in r e s p i r a t o r y  vot i me ,  FVC ,
FEV I
D i z z i n e s s  ( 10. 2** ) ,  sormolence ( 1 6 . 4 %) ,  
he. idache ( b . V K ) ,  a no r e x i a  ( 1 0 . 3 %) ,  
e p i g a s t r i c  pain (9%) ,  l o s s  oi  memory ( S%) ■ 
eupho r i a  (1.2%), n e r v o us n e ss  ( 0 . 6 % ) ;
“trpa t ome  ̂a I y ( 11 .  u%) ; d e r m a t i t i :  (7.<f%)j  
R aynaud’ s syndrome (2.9%)
A c r o o s t e o I y s i s  in 1%
Hepatomegaly (11%) ,  abnormal  a l k a l i n e  
phosphatase  (13%) ;  abnormal  LOH (39%) ,  
GGTP (3 0%),  SCOT (2 8%),  SCPT (21%)
Abnormal c l i n i c a l  bl ood v a l ue s











TABLE I I t . I
MXnjSOKIGfcNIC EFFECTS CN WIMALS FVCM EXPOSURE TO VINYL (>0.0«IDE 
LiY 1f*4ALATlCN
Species ConcentrAtion  
tppm)
E f f e ct s
Ref .
erence
Ret 2 1 0 , 0 0 0  
I 36,000 
)0,000






1 2 2 , 0 0 0  
11; ,>oo 
100 ,000  
300
30
<» hr  / d  , 3 d/wk* 1 yr
S “i r / d ,  3 d/wk\ ) ii'O
d 6 . ( 3  Of
ge * t a rI o n
7 hr/d,  5 d/wk x 6 mo





d 6 - I 5 o f  
ges tet i on
Guinee pig 230,000
LC100 106
LC50; c ont r ac t i ons ,  convuls ion* 10*
Serve '•elf c^anje*.  thickening of 111
s k m ,  papil loma:»,  warty growths
Liver  * i i<nt  increase ,  c e l l u l a r  IS
changes;  spleen «eight decrease
Di l a ted ureters  in of f spr i ng iJ2
Decreased l e t a l  weight,  increased 1J2
lisnber spurs in of fspr ing
'ncr tased l i v e r  weight 113
LC30 103
LC100 106
Anesthésie in 100% 103
LC50; cont r act i ons ,  convuls ions  10*
Anesthesia  in 50% 105
Decreased t i t t e r  s i z e ,  f e ta l  132
weight;  increasec  resorpt i ons ;
Increased crown-tump length in 132












1 0 0 .0 0 0
30.000
100-200
1 0 0 ,0 0 0
30.000
2 9 .0 0 0
7 hr/d,  3 d/wk 
x 6 mo
2 hr
d 6.  IS of 
gestet  ion
7 hr/d ,  3 d/wk 
K 6 mo
7 hr/d,  3 d/wk 
x  6 mo
LC30 106
L i ver  weight increase;  no blood 113
changes
LC100 106
LC30; c ont r ac t i ons ,  convuls ions  106
Death of 1/7; nc reproductive 1'*
e f f ec t s
Delayed o s s i f i c a t i o n ,  wavy r ibs  132
L i ver  weight increese;  no blood 113
changes
Car d i ac  i r r e g u l a r i t i e s  107
Cardi ac  s e n s i t i s a t i o n  to 110
ep inephr me
L i v e r  weight increase;  no blood 113
change*
Increased pulmonary r e s i s t a n c e ,  104
Myocardial  force decreased 21.3% 10S
Myoc . .d i a l  force decreased 9 .1 %  10S
M/ocardial  force decreased 2.9% 10S
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TABLE i I I -  9
N C N T U M D R I G EN  1C  EFFECTS CN  AN I.*MLS FKC M E X PO SU R E TO VINYL IDENE CHL OR I DE
BY IN HALATION
Species C o n c e n t r a t i o n  
( p pm )
Dur at i on Ef feet i





















10 m in  
» hr
6 hr/d, 5 d/wk 
x it wk
d 6-15 of 
ges tat ion
22-23 hr
8 hr/d, 5 d/wk 
x 6 wk
22-23 hr
d 6-15 of 
ges tation
6 hr/d, 5 d/wk 
x 17 mo
90 d
6 hr/d, 5 d/wk 
x 12 mo
22-23 hr x 2
* d
90 d
D eat h of 2 - i t of 6 in lu d 1 18
C ar d ia c  irregularities, sensi- 121
tization to e pi n eph rin e
LC50 (2<* hr) for fed animals 115
LC50 (1 » d) 116
LC50 (24 hr) for fasted animals 115
Liver cell deg ene ra t io n  120
Nose irritation; no liver effects 120
D e l a y e d  oss ification, wa v y  ribs 133
in offsp rin g
LC50--1*» d (females) 
Re sp i ra t or y  irritation
LC50--l<i d (males)
Increased fetal resorptions; 
skeletal abnorma lit ies
Liver cell deg ene ra t io n
M o t t l e d  livers; el ev at e d 
SCPT, al kal i ne  ph osp hatase
Fatty in fil tration of liver
LC50 (males)
LT50











TABLE I II -9 (CDNTINUED)




Dur at ion Ef feet s
Ref­
e r e n c e
Mouse 55 6 hr/d, 5 d/wk Necrosis of liver U O
Guinea pig 100 8 hr/d, 5 d/wk
x 6 wk









160 d 6-18 of
fees tat ion
100 8 hr/d, 5 d/wk
x 6 wk
5 90 d
100 8 hr/d. 5 d/wk
x 6 wk
5 90 d
100 8 hr/d, 5 d/wk
x 6 wk
Respiratory irritation 122
Increased fetal resorptions, 133 








SCNTIM3MIGENIC E FF E C TS  ON ANIMALS FKCM EXPOSURE TO VINYL  ftRCMIDE ftV INHALATION
Re I -
S p e c i e s  Co ncen t  r a t  ion  D u r a t i o n  E f f e c t s  e re n c e
( ppm)
Rat 1 7 1 , 00C 10 -mn Not l « t h « 4  109
1 0 0 ,0 0 0 15 mm Le t h a I  to 100% 127
« 6 ,0 0 0 cE
o
Anes t he j  j a m 1 0 i‘>*b 103
3 0 ,0 0 0 7 hr Death  at u n s p e c i f i e d  -tumbei 127
2 3 ,0 0 0 I . 5 hr A n e s t h e s i a  m  100% 127
1 0 ,0 0 0 7 hr Dr ows m e s s ,  s l u g g i s h n e s s 127
TABLE I I U 1 I
N3NTLM3RI GEN 1C EFFECT  j  CM ANIMALS FWCM EXPOSURE TO VINYL  FLUORIDE 
BY INHALATION
R e f .
S p e c i e s  C o nc en t  r a t  io n  f r j r a t i o n  E f f e c t »  e r e n c e
(ppm)
1 0 0 .0 0 0  1 2 . )  hr S o t  l e t h a l  129
in oxygen
1 0 0 .0 0 0  30 m m  B r e a t h i n g  d i f f i c u l t y ,  l o s t  o f  129
m  oxygen  p o s t u r a l  r e f l e x
6 0 0 . 0 0 0  " L o s s  of r i g h t i n g  r e f l e x  129
3 0 0 .0 0 0  " L o s s  of p o s t u r a l  r e l i e x  129
3 0 0 .0 0 0  " I n s t a b i l i t y  o f  h i n d l e g s  129
1 0 0 .0 0 0  '  h r / d ,  3 d/wk No e f f e c t s  128
x 6 wk
T A B LE 1 1 1 -1 2
S3 N TT > O R lG EN IC  E F F E C T S  CM ANIMALS FROM EXPOSURE TO V 1N YLID EN E FLU O R ID E
13Y ir^ tA L A T lC N
Re f -
S p e c ie s  C o n c e n t r a t io n  D u t a t io n  E f f e c t s  e r e n c e
(ppm)
8 0 0 .0 0 0  19 h r N ot l e t h a l  128
in  o iy g a n
8 0 0 .0 0 0  )0  ruin U n s te a d y  g a i t  129
* 0 0 ,0 0 0  “ S l i g h t  in t o x i c a t i o n  12*
1 2 8 .0 0 0  *  hr D e a th  o f  2 - *  o f t  in  1« d I I S
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~ J p
T A B L E  1 1 1 - 1 3
TU. VOK IGENIC  E F F E C T S  CN A N I M A L S  FHCM E XP O S U R E  TO 
V I N Y L  C H L O R I D E  UY I N H A L A T I O N
S pec  i e s C o n ee n  t r a t i o n
( p p»n)
D ur  t i o n Ef  f e c t  s Re 1e r ence
Ra t 30,0 00
2 0 , 0 0 0
1 0 , 0 0 0
6,0 00-
1 0 , 0 0 0
6,000
5 . 0 0 0  
2,  500




t* h r  I d , 5 d/wk 
x 1 2 mo
4 hr  / d 
d I 2 - I S  of  
g e s  t a t  i o n
4 h r / d  , 5 d/wk 
x 12 mo
T um o r s  i n  8 5% ;  l i v e r  135
a n g i o s a r c o m a s  m  30%,  
a v e r a g e  l a t e n c y  53 wk
L i v e r  a n g i o s a r c o m a s  i n  1 2%  134
T um or s  i n  6 2% ;  l i v e r  135
a n g i o s a r c o m a s  in 15%,  
a v e r a g e  l a t e n c y  64 wk
L i v e r  a n g i o s a r c o m a s  i n  3 %  134
Tumor  i n d u c t i o n  in  135
o f f s p r i n g
T um or s  i n  52%;  l i v e r  135
a n g i o s a r c o m a s  in 2 2%,  
a v e r a g e  l a t e n c y  70 wk
L i v e r  a n g i o s a r c o m a s  i n  6 %  134
T umor s  i n  54%;  l i v e r  a n g i o -  135
s a r c o m a s  i n  2 2% ,  a v e r a g e  
l a t e n c y  78  wk
L i v e r  a n g i o s a r c o m a s  in  5%  134
L i v e r  a n g i o s a r c o m a s  in  3 %  134
T umor s  i n  37%;  l i v e r  a n g i o -  135
s a r c o m a s  i n  12%,  a v e r a g e  
l a t e n c y  81 wk
T umor s  i n  2 7% ;  l i v e r  135
a n g i o s a r c o m a s  i n  7% ,  
a v e r a g e  l a t e n c y  73 wk
T um or s  i n  17%;  l i v e r  135
a n g i o s a r c o m a s  i n  2% ,  




TUMDRIGEN1C EFFECTS ON ANIMALS FROM EXPOSURE TO 
VINYL CHLORIDE BY INHALATION
Species Concent rat ion 
(ppm)









lQ, 0 0 0
10 , 000
4 hr/d, 5 d/wk 
x 30 wk
6 hr/d, 5 d/wk 
x 1 2 mo
<* hr/d, 5 d/wk 
x 30 wk
Tumors in 72%; liver 135
angiosarcomas in 16%
Tumors in 58%; liver 135
angiosarcomas in 2 1%
Tumors in 69%; liver 135
angiosarcomas in 19%
Tumors in 32%; liver 135
angiosarcomas in 2%
Bronchiolar adenomas 1<»0
Tumor induction; liver 135
angiosarcomas; not dose
related
Increase in skin acanthomas 131»
and lung adenocarcinanas
- ‘ ■— * 
'PPWI
TABLE I I I - 1 »
TUMDKIGENIC EFFECTS ON ANIMALS FRCM EXPOSURE TO 
VINYLIDENE CHLORIDE BY INHALATION
Spec i es Concent r? ‘ ion
(p:^-‘)
Du r a t i o n Ef feet s
Ra t s 10-150 hr/d, 4-5 d/wk Increase in mammary
x 12 mo turro r s
II 55 6 hr/d, 5 d/wk Extrahepatic angiosarcomas
x 1 2 mo in 3%
M •c* o « "•4 V* 6 hr/d, 5 d/wk No angiosarcomas* no
x IS mo increase in tumor»
Mi Ci 55 6 hr/d, 5 d/wk Liver angiosarcomas in
x 18 mo <*%; bronchiolar adenomas
25 4 hr/d, i * - 5 d/wk Increase in kidney




U O  
119 
U O  
U 2
TABLE I I 1-15
TUMORIGENIC EFFECTS ON ANIMALS FRCM EXPOSURE IO 
VINYL BRCM1DE BY INHALATION
Species
Rat







Ef feet s Referer,:
Liver cancer in 19%; signifi- 327 
cant increase
Liver cancer in 7%; signifi- 327 
cant increase in other tumors
No t umo r s 327
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IV. ENVIRONMENTAL DATA
Moat of the sampling and analytical procedures for airborne vinyls in 
occupational environments have been developed and tested for vinyl chloride. 
While these procedures may provide some guidance for choosing sampling and 
analytical conditions for the other vinyl halides, caution must be exercised 
in extrapolating or interpolating from vinyl chloride to vinylidene chloride, 
vinyl bromide, vinyl fluoride, and vinylidene fluoride. Certain physical and 
chemical properties of the latter compounds are quite different from those of 
vinyl chloride at ambient temperatures and pressures (see Table XVII-1). The 
collection media used for sampling the various vinyls should be selected to 
permit reproducible air sampling, adequate collection efficiency, storage 
stability, retention, and minimum breakthrough of the specific compounds.
(a) Sampling
(1) Vinyl Chloride
Denenberg and Miller [234] reported on several types of sampling 
equipment that can be used for the collection of workplace samples of vinyl 
chloride. These included evacuated glass flasks, glass syringes, and 
evacuated bottles for the collection of grab samples, and inflatable sampling 
bags (Saran, Mylar, or Teflon) and charcoal tubes for the collection of 
Integrated samples.
Murdoch and Hammond [235] used evacuated glass bottles to collect grab 
samples for the determination of vinyl chloride concentrations in polyvinyl 
chloride work areas. After the samples were collected, the bottles were 
sealed with silicone rubber septa. Aliquots were later removed by syringe for 
analysis by gas chromatography.
Williams et al 1236] also reported using evacuated stainless-steel 
containers equipped with critical orifices for collecting grab or integrated 
samples of air that contained mixtures of vinyl chloride,.vinylidene chloride, 
and other compounds under laboratory conditions. Identical results were 
obtained for samples collected in steel containers from a chamber and for 
samples taken directly from the chamber.
Stainless steel canisters and Tedlar bags have both been used for sampling 
for vinyl chloride. Losses of 0-10% vinyl chloride/day were reported for 
samples stored in Tedlar bags [10]. The losses were attributed either to 
leakage from the bags or to reactions of vinyl chloride with other air 
contaminants, such as nitrogen dioxide and ozone.
Sampling and Analytical Methods
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Levine et al [237] compared the storage stability of vinyl chloride 
collected in Teflon and aluminized Scotchpak gas sampling bags. The 
comparison showed the loss from Teflon bags to be about 20%/day, but it was 
not determined whether the loss resulted from the permeability of thé Teflon, 
from chemical reaction, or from mechanical problems. No detectable loss 
occurred during a 1-week period from aluminized Scotchpak bags that contained 
samples of vinyl chloride at concentrations of 0.1-1.1 ppm (0.256-2.8 
mg/cu m).
Ketterer [238] found Teflon bags to be satisfactory for holding samples 
that would be analyzed for vinyl chloride soon after collection but did not 
repoct the time between sample collection and analysis. The relative standard 
deviations for seven samples of vinyl chloride at a concentration of 25 ppm 
(64 mg/cu tu) and for eight samples at a concentration of 52.2 ppm (133.6 og/cu 
m) were 2.24 ard 1.772, respectively, and the reported accuracy at both 
concentrations was 95Z. The author concluded that this degree of accuracy and 
reproducibility should be readily attainable in field use, since fluctuations 
in temperature and hunidity and the presence of other volatile organic 
materials had little effect. [238].
The major advantage of bag sampling is that it permits direct analysis of 
the sampled air, ie, without the adsorption and desorption steps required for 
collection on solid sorbents [239]. Its disadvantages include the bulky 
equipment required for personal sampling and the relatively high detection 
limit, approximately 50 ppb (0.13 mg/cu m) tuat results from the sample not 
being concentrated. Another disadvantage of bag sampling is that the sample 
volume is limited.
The most widely used sampling technique involves adsorption on solid 
sorbents such as Tenax-GC resin and activated charcoal. The major sampling
problem in collecting vinyls on solid media is that vinyls have appreciable
vapor pressures, which can result in sample migration or loss.
Tenax-GC resin was used by Ives [240] to concentrate grab samples of 
contaminated air. Average recoveries of 90Z for vinyl chloride at 6 ppb 
(0.015 mg/cu m) and 1002 at 60 ppb (0.15 mg/cu m) were reported when 
contaminated air in a 500-ml gas sampling tube was flushed with nitrogen 
through the Tenax-GC resin trap at a flowrate of 85 ml/minute for 35 minutes. 
The crap was cooled in dry ice. Ahlstrom et al [241] reported that Tenax-GC 
resin did not quantitatively adsorb vinyl chloride from the atmosphere, but 
they presented no data supporting thi3 conclusion. Zado and Rasmuson [242] 
reported that the breakthrough volume for vinyl chloride on Tenax-GC resin was 
170 ml at a flowrate of 30 ml/minute, but they did not specify the
concentration sampled nor the dimensions of th*s resin bed. They stated that
Tenax-GC resin had the next to the poorest breakthrough performance of 10 
absorbents tested.
Nelms et al [243] described a permeation sampling technique using a 
charcoal badge, 41 x 48 mm and 7 mm thick, pinned to the worker’s clothing for
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monitoring 8 -hour exposures of vinyl chloride at concentrations of 5 ppb to 50 
ppm (0.01-128 mg/cu m). Vinyl chloride passed through a permeable membrane 
and was adsorbed on activated charcoal. The vinyl chloride concentration was 
later determined by gas chromatography. The authors stated that temperature 
and humidity had no measurable effect on the determination of vinyl chloride. 
Of the compounds tested (including sulfur dioxide, nitrogen dioxide, and 
ozone) only ethylene chloride was reported to cause positive interference 
during analysis.
Hill et al 1244] evaluated breakthrough volumes for vinyl chloride on 20 
sorbents, 6 activated charcoals and 14 gas-chromatographic column packings, 
each contained in 1.5-cm sections of glass tubing with inner diameters of 4 
mm. Breakthrough volume was defined as the air volume sampled when 5% of the 
synthetic atmospheric concentration of vinyl chloride was detected in the tube 
effluent. Vinyl chloride was measured using a portable gas chromatograph with 
a flame ionization detector. The results are shown In Table XVTI-5. 
Breakthrough volume for Dow carbon XF 4175 L and MSA- 6  coconut charcoal 
increased with decreasing flowrate, and the amount of vinyl chloride adsorbed 
increased with increasing concentrations of vinyl chloride in the air. The 
authors concluded that the MSA- 6  coconut charcoal was suitable for collecting 
vinyl chloride at concentrations of about 1 ppm (2.56 mg/cu m) or lower, at 
flowrates of 50-100 ml/minute. High humidity or high concentrations of other 
organic contaminants could reduce the breakthrough volume, but this was not 
investigated [244]. The authors suggested that maximum sample volumes of 5 
liters at a flowrate of 50 ml/minute would not result in significant
breakthrough. These suggested values have been adopted for the NIOSH-accepted 
method [245].
Cuddeback - al [246] tested commercially available charcoal tubes from 
two manufacturers. By examining the packings of the front sections of the 
tubes, they determined that MSA tubes averaged 99.7 mg of charcoal (±62) for 
three samples in 16.5 mm (±10.9%) tubes, and SKC tubes averaged 86.2 mg 
(±3.1%) for six samples in 15.9 mm (±7.8%) tubes. Breakthrough volumes,
defined as those at which the effluent concentration of vinyl chloride was 1 0 %
of the inlet concentration, were measured using the front sections of the MSA
tubes. As shown in Table XVII-6 , there was no consistent correlation between 
breakthrough volume and sampling rate.
Several activated charcoals were evaluated for vinyl chloride collection
and breakthrough by Severs and Skory [247]. They concluded that the 
Pittsburgh PCB had superior breakthrough characteristics for vinyl chloride 
sampling. Breakthrough volumes for commercial tubes with different packings 
were also compared. Tubes packed with 600 mg of SKC (Lot 105) charcoal or 700 
mg of Pittsburgh PCB carbon had a breakthrough of less than 2% for vinyl 
chloride at 25 ppm (64 mg/cu m) at a flowrate of 1 liter/minute for 30
minutes. The same tubes packed with 150 mg of the SKC charcoal had
breakthrough of 2 % within 2 minutes for vinyl chloride at 1 ppm (2.56 mg/cu m) 
sampled at 1 liter/minute.
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(2) Vinylidene Chloride
Severs and Skory [247] used charcoal tubes for collecting vinylidene 
chloride in workplace samples. No data on collection efficiency or storage 
stability were reported. Tubes packed with 600 mg of SKC charcoal had "good" 
retention capacity for vinylidene chloride. At 31 ppm (123 mg/cu m) of 
vinylidene chloride, samples collected at a flowrate of 1 liter/minute had a 
breakthrough below 0.08% after 75 minutes. Russell [248] reported that the 
breakthrough volume of vinylidene chloride on Carbosieve B was greater than 10 
liters of air.
(3) Vinyl Bromide
Russell [248] collected vinyl bromide on Porapak N porous polymer in 
a 4-inch by 0.19-inch inner diameter stainless steel sampling The
breakthrough volume was 1 liter at a sampling flowrate of 1 0 0 ml/mlnute of air 
that was nearly saturated with water and that contained 1-5 ppm (4.38-21.9 
mg/cu m) of vinyl bromide.- Bales [249] used a charcoal tube tu collect vinyl 
bromide in a production facility. No data on breakthrough volume, collection 
efficiency, or storage stability were reported.
(4) Vinyl Fluoride
Bales [250] used Teflon bags for collecting air samples to be 
analyzed for vinyl fluoride. DW Yeager (written communication, August 1977) 
stated that there was no measurable leakage of vinyl fluoride from Teflon bags 
in a 4-day period; however, within 2 weeks a 50% loss had occurred. Only a 
limited number of samples were analyzed for this study.
(5) Vinylidene Fluoride
Pennwalt Corporation [251] recommended that charcoal tubes be used to 
collect vinylidene fluoride. No data regarding efficiency and stability were 
reported.
NIOSH recommends using the sampling methods as outlined in Appendices II- 
V. Charcoal tubes are recommended for sampling vinyl chloride in the NIOSH- 
accepted method (Appendix II) and for sampling vinylidene chloride in the 
NIOSH-proposed method (Appendix III). There are no validated methods for 
vinyl bromide, vinyl fluoride, or vinylidene fluoride; however, NIOSH 
recommends that charcoal tubes be used for vinyl bromide (Appendix IV) and 
vinylidene fluoride (Appendix VI). Teflon air bags, as used by Bales [250], 
are recommended for sampling vinyl fluoride in the proposed method (Appendix
(b) Analysis
The available methods for determination of'vinyls in the workplace include 
gas-chromatographic and infrared techniques, among others, but vinyl chloride
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has most oftan been analyzed by gas chromatography. This method has the 
advantages of being more specific and less expensive than infrared analysis.
(1) Gas Chromatography
Analysis by gas chromatography generally involves direct injection of
a portion of. the air sample taken from a sampling bag or canister or injection
of an aliquot of sample desorbed from a suitable adsorption material through 
which ambient air has been drawn. Ives [240) used both procedures in series 
to sample and analyze for vinyl chloride. Grab samples in a 500-nl gas 
sampling tube were flushed with nitrogen through a Tenax-GC cold trap. Vinyl 
chloride wa3 subsequently thermally desorbed directly onto a gas
chromatographic column. Severs and Skory [247], on the other hand, thermally 
desorbed vinyl chloride from charcoal into a gas sampling bag. While the 
injection of contaminated air obtained from a bag or canister is
straightforward, samples from activated carbon or gas-chromatographic packings 
must be desorbed before analysis.
(A) Desorption
Desorption from sampling tubes Is accomplished thsrmally cr by
solvent extraction. A variety of operating conditions, for these tvo
techniques have been investigated.
Three variations of thermal desorption have been applied to vinyl
chloride. The first variation Involved heating charcoal in a flow of
prepurified nitrogen and collecting the vinyl chloride containing effluent in 
a bag [247]. Heating the charcoal to 430 C eliminated low and erratic 
recoveries. The nitrogen flow was maintained at 500-800 ml/minute.
In the second variation [239,241,248], activated charcoal or gas- 
chromatographlc packing was heated, and the vinyl chloride-laden effluent was
flushed directly onto the analytical column with carrier gas. Purcell [239]
maintained the desorption chamber at 260-300 C and the column at 25 C for 4 
minutes during desorption. After desorption, the column temperature was 
raised to 70 C, and the vinyl chloride was eluted. When this technique was 
used to analyze the front section ( 1 0 0  mg) of the charcoal tube, an overall
recovery of 901 was determined for a 278-ml sample spiked with vinyl chloride 
at 1 ppm (2.56 mg/cu m). Good reproducibility was demonstrated by obtaining a  
relative standard deviation of 4.12 in the analysis of 11 sampling tubes, each 
containing a 278-ml sample spiked with vinyl chloride at 1 ppm.
Ahlstrom et a l  [241] also thermally desorbed vinyl chloride directly onto 
a  gas-chromatographic column. The sample, collected on 150 mg of petroleum- 
derived charcoal (SKC Lot 104) packed in a 5- x 3/16-inch U-shaped stainless
steel tube, was desorbed by pulse heating the tube for 2 minutes at 400 C. 
The desorbed vinyl chloride was swept by the helium carrier gas onto the 
column, which was maintained at 90 C. The carrier gas flow was 20 ml/mlnute. 
Recovery of a 45-ppm vinyl chloride synthetic atmosphere sampled at 50
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ml/alnut* for 1, 2, «ad 3 «invita* averaged 99 ±2Z. For four runa of a 1-ppm 
vlr>l chloride standard, the relativa standard deviation was 1 .2 X.
Russell [248] thermally desorbed vinyl broolde from Porapak M and vinyl 
chloride and vlnylldene chloride from Carbosleve B adsorbents. In each case, 
the recovery was 100 ¿3!. Samples were collected at a flowrate of 100
al/minute, but specific concentrations and sample volumes were not reported. 
Desorption from Porapak N was performed by heating for 5 minutes at 200 C, and 
desorption from Carbosleve B was accomplished by heating for 5 minu 2S at T.70 
C. The aii3orb*;nt column was tiaincained at 60 C for desorption from Porapak N 
end at SO C for desorption from Carbosleve 3.
The third thermal desorption variation [240,252] Í3 similar to that of 
Ahlstrom et al [241]. It differs from that of Russell [248] in that the 
sample 1s Injected Into the analytical column only after desorption is 
complete, rather than being continuously flushed Into the column during 
desorption while elutriatlon is retarded by a relatively low column 
temperature.
Ives [240] used Tenax-GC sorbent cooled to dry ice temperature to 
concentrate air bag samples, virh thermal desorption directly onto the 
chromatography column. Ives heated the Tenax for 5 minutes at 150-180 C 
before flashing It with carrier gas through the gas-chromatographic column. 
Recovery was 100" for a 579-ul sample spiked with vinyl chloride at 60 ppb and 
90" for a similar sample spiked with vinyl chloride at 6 ppb.
Myers et al [252] collected vinyl chloride on activated charcoal (GC 
grade, 60/80 mesh, Coa.it Engineering Laboratory) packed in glass columns 6.5 
cm long and 5-tnn outside diameter. For desorption, the tubes were heated for 
30 seconds at 300 C. The analytical column, 6-feet x 1/8-inch Chromosorb ’.01, 
was maintained at 100 C. Replicate analysis of 13 samples of a standar¿ 
atmosphere containing vinyl chloride at approximately 1 ppm indicated an 
average of 1.25 ±0.037 ppm (3.2 ±0.09 mg/cu m). The authors concluded that
vinyl chlorida could b« detected at 100 ppb (0.256 mg/cu a), in a 1-llter 
sample and at 20 ppb (0.05 mg/cu a) in a 5-liter sample. They speculated that 
1 ppb (0.003 ag/cu m) could be detected by increasing the instrument's 
operating sensitivity.
The advantages of the thermal technique for desorption of vinyl chloride, 
according to Zado and Pascuson [242], are that It is simple to handle, free of 
Interferences, and highly sensitive. The authors noted that Its disadvantages 
Include the requirement of expensive equipment and the inability to make 
repeated injections of the sample. They suggested using the less expensive 
Porapak N instead of Carbosleve B. However, the disadvantage of Porapak X Is 
its low breakthrough volume of 976 al, compared with greater than 2,000 ml for 
Carbosleve B, at a flowrate of 50 ml/mlnute.
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For solvent d«sorption of vinyl chloride and other vinyls, carbon 
disulfide has generally been used. However, tetrahydrofluran and a bromine- 
hexane mixture have also been used.
Hill et al [244] reported using a 2-ml vial containing 0.5 or 1.0 ml of 
carbon disulfide for desorption of vinyl chloride fvom the front section of a 
charcoal tube (100 mg of charcoal). The 13-Mg samples were analyzed after 
desorption periods of 10-30 minutes at ambient temperature. The authors found 
that desorption efficiencies were generally in the 80-902 range. Hill et al 
also determined that the addition of the charcoal to the carbon disulfide 
enabled more precise analyses at ambient temperatures than If the solvent were 
added to the ch.ircoal. They concluded that solvent temperature and volume had 
little effect on precision, although only one set of tests was performed at 
other than ambient temperature (0 C). Studies of the stability of vinyl 
chloride samples by the same authors [244] demonstrated that vinyl chloride 
was stable on charcoal for periods of over 2 weeks, but that migration from 
the front to the back section occurred when the tubes were stored at ambient 
temperatures. Cooling to ^20 C retarded this effect. The authors suggested 
using two tubes in series as the front and backup sections to obviate the need 
for storage at low temperatures.
Severs and Skory [247] studied a desorption technique by which 1 g of PCB 
12/30 charcoal was added slowly to 10 ml of carbon disulfide, the mixture was 
cooled in a dry ice/acetone slurry and agitated for 30 minutes. Samples were 
stored under refrigeration and held In a wet ice bath while they were 
analyzed. An average recovery of 982 (93-1012) was reported. When the same 
procedure was applied to the desorption of vinylidene chloride, recovery 
ranged from 95 to 1002. In neither case was sample loading specified.
Lao et al [253] added 15 al of carbon disulfide, cooled to -15 C, to 1-g 
aliquots of 20/50 carbon in a 25-ml flask fitted with mini-inert valves. The 
system was allowed to equilibrate for 15 minutes at 15 C before samples were 
withdrawn for analysis. Recovery was 882 for 2.7 ng of vinyl chloride, 952 
for 14.1 ng, 982 for 54 ng, and 972 for 126 ng. The concentration of vinyl 
chloride In the headspace of the flasks never exceeded 2 2  of its concentration 
in the liquid.
i
Still another desorption technique was used by Cuddsback et al [254]. The 
charcoal ( 1 0 0  mg) was placed in a 2-ml glass vial, which was sealed with a 
silicone rubber septum. The vial was cooled to dry ice temperature, and 0.5 
ml of carbon disulfide at room temperature was Injected through the septum. 
When bubbling produced by the mixing ceased, the vial was removed from the dry 
ice and allowed to stand at room temperature for 5 minutes before samples were 
withdrawn for analysis. Recoveries from a 2.55-jig sample were 852 for 
Immediate analysis, 832 after 7 days, and 712 after 14 days. For a 31.9-Mg 
sample, respective recoveries for these intervals were 89, 79, and 812.
Hoffmann et al [255] used a mixture of 0.5 ml of bromine and 1 1 ml of n- 
hexane, cooled to -30 C in a Reacti-flask, to desorb vinyl chloride from 1 g
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of charcoal. After the charcoal was added, the flask was sealed and covered 
with dark paper, and the contents were stirred magnetically for 7 minutes. 
During this procedure, vinyl chloride is converted to 1,2-dibromo-l-
chloroethane, which has a much greater sensitivity to electron-capture 
detection than vinyl chloride. For samples enriched by column chromatography 
and determined by gas chromatography using an electron-capture detector, the 
authors reported a recovery of at least 35%.
Desorption of vinyl chloride with tetrahydrofuran was reported in an 
Environmental Protection Agency (EPA) publication [10]. Recovery was 8 8 %, and 
there was le«.. diffusion into the heaaspace than was evident with carbon 
disulfide d«3orp:ion; however, the solvent volume and the desorption 
conditions were not reported.
Ethyl Corporation [14] reported that a carbon disulfide-pentane .xture 
was used to desorb vinyl bromide from about 14 g of Pittsburgh 20x50 activated 
carbon.
No data were located on the desorbing agent for vinyl fluoride and 
vinylldene fluoride samples.
(B) Chromatographic Columns
The choice of column materials and operating parameters for
analysis of vinyls will cspend on the interfering compounds that may. be
present and their relative retention times. For vinyl chloride analysis.,
potential Interferences Include light hydrocarbons, other halocarbons, Freons, 
«3rd sulfur dioxide [240,247,256,257]. Contaminants often found du-ing 
analyses for vinyl chloride include acetylene, methyl chloride, 1,3-butadiene, 
and vinylldene chloride [253]. Table XVTI-7 shovs the retention times 
relative to vinyl chloride for a number of interfering compounds or. various 
column materials. Foris and Lehman [253] listed the Kovats retention indices 
for four vinyl halides on Poropak Q.
Severs and Skory [247] separated vinyl chloride and vinylldene chloride on 
a 20-foot x 1/8-inch stainless steel column containing Carbowax 4,000 on 
80/100-mesh Supelcoport and with a 6 -foot x 1/8-inch column of 20% DC 200 on 
80/100-mesh Chromosorb W.
For vinylldene chloride separation, the NIOSH-proposed method [259] 
recommends that a silanized glass column (10-foot x 1/4-inch outer diameter) 
packed with 100/120-mesh Durapak 0PN be used. The Manufacturing Chemists’ 
Association (MCA) reported use of a stainless-steel column (10 feet x 1/8 
inch) packed with 100/120-mesh Durapak OPN chemically bonded to Porasll C 
[260].
Rein et al [261] reported using a 50-foot x 1/4-inch column packed with 
33.5% DC-200 oil on 30/60-mesh Chromosorb P to analyze for vinyl fluoride and 
vinylldene fluoride at about 30 C. The packed column was conditioned for 8-12
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hours In the inscruaent under operating conditions. The authors noted that 
the column vas excellent for separating compounds with lov boiling points at 
ambient temperatures. The retention times for vinyl fluoride and vlnylldene 
fluoride were 16'.4 and 12.4 minutes, respectively. Rein et al [261] also 
reported analyzing for vinyl fluoride and vlnylldene fluoride on combined 6 - 
foot and 12-foot columns packed with 33.52 DC-200 oil on 30/60-mesh Chromosorb 
P, but they found that resolution of any low-boiling fractions that were 
present was poor at ambient temperatures.
The Ethyl Corporation [14] has analyzed for vinyl bromide using a 25-foot 
x 1/8-inch stainless stael column packed with 302 SE-52 on 80/100-mesh Gas
Chrom Q conditioned for 16 hours at 200 C; Lao et al [253] have used a 6-foot
x 1/8-inch column of Chromosorb 102, similarly conditioned. The Ethyl 
Corporation report [14] noted that isopentane Interfered with the 
determination of vinyl bromide on an SE-52 column, and suggested that a 
combined column of 12 feet of SE-52 and 6 feet of 102 Carbovax 20M gave a good 
separation of vinyl bromide from Isopentane. The SE-52 on Gas Chrom Q column 
was used to determine vinyl bromide ac concentrations of less chan 1 ppm.
(C) Chromatographic Detectors
Detection methods used in gas chromatography to quantitate 
vinyls, particularly vinyl chloride, include electron capture [10,255], 
microcoulometry and electroconductivity [256], chemiluminescence [262], mass 
spectroscopy [257,263], and flame-ionization [238,239,242,247,253,264], Table 
XVII- 8  shows the specificity and approximate detection limit of each of these
detectors for vinyl chloride.
Electron-capture detectors belong to the general class of direct-current 
ion chambers. Nitrogen or argon is used as the carrier gas, and 3H or 63N1 is 
used as the radioactive source to excite the gas. As compounds are eluted 
from the gas chromatographic column, they become ionized by the excited 
carrier gas and produce an increased current flow across parallel electrodes. 
The current flow is proportional to the amount of compound present. Electron- 
capture detection is more selective than flame-ionization detection, but it is 
less reliable and has a smaller dynamic range [10]. A further disadvantage of 
electron-capture detection with respect to vinyl chloride analysis is that 
response to aromatic halides and polychlorinated hydrocarbons is relatively 
low [264]. %}ffmann et al [255] have extended the electron-capture detection 
limit for vinyl chloride by brominating vinyl chloride to produce 1 ,2 -dibromo- 
1-chloroethane. The detection limit for this compound was 15 pg/injection, 
and the response was linear between 50 and 300 pg [255].
Mlcrocoulometrlc detection is highly sensitive and accurate for chloride 
ions [10]. As chlorinated hydrocarbons are eluted from the gas chromatograph 
column, they are pyrolyzed to form hydrogen chloride gas. The hydrogen 
chloride causes silver chloride to precipitate, and to disturb the electrical 
balance at the positive silver electrode. The couxometer regenerates silver 
ions until the electrical balance is restored, and the current generated to
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restore th« balance is proportional to the number of chloride ions generated. 
Ernst and Van Lierop [256] used a Hall detector (microcoulometer) for the 
analysis of vinyl chloride; the vinyl chloride was pyrolyzed in a quartz tube 
in the presence of hydrogen and the hydrogen chloride formed was detected as a 
function of the increased conductivity of an aqueous reservoir. A detection 
limit of 0.07 ng, slightly better than the flame-ionization detection limit, 
has been reported [264], The major advantage of nicrocoulometry is its 
sensitivity to organohalides [264]. Its disadvantage is its electrical power 
requirements, which make the detector impractical for field use [1 0 ].
Chemiluminescence detection of vinyl chloride has been used by McClenny et 
al [262]. Thij method is baseJ on light emission from the products of the ¿as 
phase reaction of vinyl chloride with ozone. The authors determined the lower 
detection limit co be 50 ppb (0.13 mg/cu m), and response was linear from 50 
ppb to 10 ppm (0.13-25.6 mg/cu m).
Mass spectroscopy specific ion monitoring is a highly sensitive and 
selective detection method-, but it is relatively expensive to install. 
According to Rosen et al [257], it offers a detection limit for vinyl chloride 
of 8.7 pg/10 al injection. Detection depends on the response of the
instrument to the vinyl chloride molecular ion (m/e 62) and the 37C1 ion (m/e 
64) [257,263]. For qualitative confirmation cf vinyl chloride, the ratio of 
the o/e 62 and m/e 64 peaks should be about 3:1, conforming to the natural 
abundance ratio of 35C1 and 37C1 1253,257].
The flame-ionization detector is perhaps the most commonly used instrument 
for the analysis of vinyls. This detector responds to most organic compounds 
and is insensitive to almost all inorganic compounds [10]. It has a wide 
linear range covering several orders of magnitude, aud it can detect vinyls in 
the ppb range. According to reports of t;ie NIOSH-acceptad method for the 
analysis of vinyl chloride [245], and the MCA uethod for vinylidene chloride 
[260], a sample of 0 . 2  ng/injection of vinyl chloride and vinylidene chloride, 
respectively, can be detected by flame-ionization. However, the conditions 
under which the MCA method was tested were not specified. For vinylidene 
chloride analysis, the NIOSH-proposed method [259] reports that a sample 
loading of 7 ¿ig (about 35 ng/injection) had * desorption efficiency of greater 
than 802. Detector response is generally a function of the number of carbon 
atoms in a molecule of a compound, although a reduced response or no response 
may occur when the carbon atom is attached to atoms other than hydrogen, such 
as chlorine, oxygen, or sulfur. A lower detection limit of 0.01 ppm (0.03 
mg/cu m) for vinyl chloride in a 1 0—ml sample of air has been reported for the 
flame-ionization detector [10]. The major disadvantage of the flame- 
ionization detector is its relatively nonselective response [264].
(2) Infrared and Other Analytical Methods
According to a personal communication by Keenan cited in an EPA 
publication [ 1 0 ] , the analysis for vinyl chloride by infrared 
spectrophotometry has one major problem: several substances that are present
? « *
in ambient air act as interferences, and thus the method is not specific for 
vinyl chloride. The EPA report [10] noted chat vinyl chloride is detectable 
at an absorption frequency of 941 or 917 1/an. The authors pointed out that 
these major problems could be circumvented by additional instrumentation, but 
they cautioned that the cost would be high. Effective optical paths of 20 
meters are required in order for infrared analyzers to achieve a detection 
limit of 1 ppm (2.56 mg/cu m).
Other methods that have been used to determine vinyl chloride 
concentrations Include colorimetry and polarography [10]. The sensitivities 
of the colorimetric methods are very much affected by such interferences as 
ethylene and methanol, and the sensitivity of the polarographic method is 
affected by any other volatile materials that may be present.
Gronsberg [265] used a photometric method to determine concentrations of 
vlnylldene chloride in air. Bis method is based on the reaction of vinylidene 
chloride with pyridine and on subsequent condensation of the reaction products 
with aniline or barbituric acid. After the reaction, a polymethine dye 
complex is formed. The method has a sensitivity of 2 ¿tg/photometric cuvette 
volume and is capable of determining vlnylldene chloride in air at 
concentrations of 10 mg/cu m (2.5 ppm). . The author reported that vinyl 
chloride, acrylonltrile, dichloroethane, and hydrogen chloride had no effect 
on the analysis for vlnylldene chloride but noted that trichloroethylene and 
1 ,1 ,2-trichloroethane produced analogous reactions.
Color-specific detector tubes are available fcr the determination of vinyl 
chloride or vlnylldene chloride in the work environment. Two types of color 
reactions, one using chromate and bromophenol blue, and the other using 
permanganate and o-tolidine, were used for analyzing for vinyl chloride [266]. 
Their ranges of linearity were 0.5-3 ppm (1.28-7.68 mg/cu m) and 1-50 ppm 
(2.55-128 og/cu m), respectively. Vinylidene chloride can be determined with 
twice the sensitivity with which vinyl chloride can be determined. No 
detector tubes for vinyl bromide? vinyl fluoride, or vinylidene fluoride are 
known to be available.
Murdoch and Hammond [235] reported using detector tubes to determine 
concentrations of vinyl chloride in polyvinyl resin production environments. 
Vinyl chloride was determined at concentrations of 0-3 ppm (0-7.68 mg/cu m). 
The tubes had a lower detection limit of 0.5 ppm (1.28 mg/cu m).
Detector tubes have the advantages of being simple and inexpensive, and do 
. not require that samples be transported for analysis. Their major 
disadvantages are their susceptibility to interferences and lack of 
sensitivity.
(3) Continuous Monitors
Continuous monitoring systems can. be used to warn employees of 
overexposure to vinyl chloride at high concentrations, permit reduction of
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emissions by locating sources of leaks« and produce permanent reccrJa for 
areas where employees have been exposed to vinyl chloride.
Continuous systems with multiple sampling points have been reported to be 
effective for monitoring concentrations of vinyls in work area atmospheres 
[239,267-270]. The air samples were analyzed by infrared spectrometry or gas 
chromatography. Other continuous-analysis methods that have been used for 
vinyl chloride include impregnated paper tape [234,271], Stark spectroscopy 
with a c.rbon mcnoxide or carbon dioxide laser [272], and an ultraviolet (UV) 
conductivity system [273].
Portable infrared analyzers with 20- to 25-meter folded-path absorption 
cells have been used to detect vinyl chloride at a working lower detection 
limit of about 1 ppm (2.5G ag/cu m) [267,274]. Also, portable gas 
chromatographs with flaae-ionization or electron-capture detectors have been 
used for "''ontinuous" monitoring for vinyl chloride, and a sensitivity of 0 . 1  
ppm has been reported for such systems [10]. Purcell [239] found lover 
detection limits for vinyl chloride of 50 ppb with gas-liquid chromatography
and 1 ppm with infrared spectrometry.
Baker and Reiter [275] described an automatic monitoring system, based on
a gas chromatograph equipped with a flame-lonization detector and an alarm 
device that has been used for the determination of vinyl chloride in workplace 
atmospheres. Each analyzer in the system could monitor 20 sample points, and 
each analysis required 2 minutes from collection to readout. An analytic 
range of 0.1-25 ppm (0.256-64 mg/cu m) vas reported. The compounds found co 
interfere with the analysis of vinyl chloride included methyl chloride, 
isobutylene, n-butyl acrylate, and toluene, and the int*rferance from the last 
two compounds occurred after approximately 40 minutes. The authors concluded 
that the monitoring system had the advantages of being ‘very sensitive, very 
accurate, and relatively maintenance free.
Denenberg et al [234,271] reported the use of impregnated paper tape for
monitoring vinyl chloride. With this method the intensity of light reflected 
from the tape surface is theoretically proportional to the concentration of 
analyte. The double bond in the vinyl chloride molecule Is broken by means of 
an oxidant converter, releasing free chlorine. The chlorine reacts to darken 
the paper tape. A lower detection limit of between 0.05 and 0.1 ppm (0.13 and 
0.256 mg/cu m) is claimed, and performance and sensitivity are unaffected over 
ranges of 0-100% relative humidity and 0-40 C [234]. Trichloroethylene, which 
produces a response three times as great as vinyl chloride, will interfere, 
and vinylidene chloride, with a double bond and two chlorine atoms, will 
produce twice as great a response as vinyl chloride [271],
Stark spectroscopy was used by Freund and Sweger [272] for the measurement 
of vinyl chloride concentrations. Carbon monoxide and carbon dioxide lasers 
were Investigated and the extracavity absorption cell contained two 40-cm 
stainless steel Stark electrodes spaced 1 mm apart. The method is capable of 
detecting vinyl chloride at 1 ppm (2.56 ag/cu m).
*
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A UV method for measuring vinyl chloride in air has been developed by 
Confer [273], in which vinyl chloride exposed to UV light decomposes to 
produce chlorine, hydrogen chloride, phosgene, and other products, and the 
concentrations of the decomposition materials are measured by changes in 
conductivity of deionized water. A 6 -inch UV lamp with an output of 2.5 
watts, 902 of which is at a wavelength of 253.7 nm, was positioned in a 600-ml 
gas washing flask directly upstream from the sensor of a conductivity 
analyzer. Air was passed over the lamp at 2 liters/minute, and the deionized- 
water absorber was set at a flowrate of 6 ml/minute. Degradation efficiency 
was 802, and, with a 2.5-minute holdup time in the conductivity cell, response 
reached 902 of the final reading. A lower detection limit of 0.05 ppm (0.13 
mg/cu m) was found. Response was linear for concentrations up to 25 •jpm (64 
mg/cu m). Interferences by sulfur dioxide, chlorine, and hydrogen sulfide can 
be removed by scrubbing in a 1 0 0 -ml gas-washing bottle equipped with a fritted 
bubbler and containing 20 ml of deionized water. Interferences by nitric 
oxide, carbon disulfide, and trlchloroethylene, however, are not removed by 
this scrubbing method.
(4) Recommendations
The analytical methods described in detail in Appendices II-VI offer 
the necessary quantitative sensitivity and precision. Their accuracy, 
technical requirements, and cost requirements are easily within the range of 
most analytical laboratories.
For the analysis of vinyl chloride and vinylidene chloride, NIOSH
recommends desorption of samples with carbon disulfide and analysis by gas 
chromatography vlth flame-ionization detection. A stainless steel column (20 
feet x 1/8 inch) packed with 102 SE 30 on 80/100-mesh Chromosorb W is 
recommended for vinyl chloride [245]. For analysis of vinylidene chloride, a 
silanized glass column- (10 feet x 1/4 inch) packed with Durapak OPN 
(oxypropionitrile) chemically bonded to 100/120-mesh Porasil C is recommended 
[259].
There are no NIOSH-validated methods for the sampling and analysis of 
vinyl bromide, vinyl fluoride, or vinylidene fluoride. However, NIOSH
recommends that samples of vinyl bromide and vinylidene fluoride, collected on 
charcoal tubes, be desorbed with carbon disulfide and that samples of vinyl 
fluoride, collected in Teflon bags, be injected directly into the 
chromatograph. For analysis of these compounds, gas chromatography with 
flame-ionization detection is recommended. The column recommended for vinyl 
bromide analysis is an SE-30 (20-ft) column, the column recommended for vinyl 
fluoride is also a 20-foot, SE-30 column (DW Yeager, written communication, 
February 1978), and the recommended column for vinylidene fluoride is a 
stainless steel ( 6  feet x 1/8 inch) column packed with 80/100-mesh Chromosorb 
102 (JL Sadenwasser, written communication, March 1978). However, other
columns with high separation efficiencies can.also be used. All work with the 
desorbing agent should be performed in an exhaust hood because of the high 




NIOSH a lso  recommends th a t  a continuous monitoring system with alarm- 
in d ica to r  devices be In s ta l le d  to monitor area concentrations of v iny l 
ch loride  or vlnylldene ch loride  In accordance with 29 CFR 1910.1017(g)(6)11. 
Continuous monitors should be In s ta l le d  to monitor v iny l bromide, v iny l 
f lu o r id e ,  or vlnylide.ie f lu o r id e  as soon as systems se n s i t iv e  enough become av a i la b le .  The system Idea lly  should be highly s e n s i t iv e  and sp e c if ic  to the 
v iny l ha lides  sampled and f re e  of In te rfe rences .
Environmental Levels
In 1975, Barnhart e t  a l  [276] reported the r e s u l t s  of NIOSH In d u s tr ia l  
hygiene surveys of v iny l ch loride  monomer producers and polyvinyl ch loride  
processers . Three v iny l ch loride  manufacturing p lan ts  and seven polyvinyl
ch loride  processlr% p lan ts  were included in  the study. Workplace a i r  samples 
were co llec ted  on charcoal tubes and analyzed by gas chromatograph a f t e r
desorption with carbon d is u l f id e .  The survey found concentrations in  the 
range of 0 .1-9.20 ppm (0.256-23.55 mg/cu m) in  the monomer p lan ts  and 0.01- 
0.35 ppm (0.03-2.18 mg/cu m) in  the polyvinyl ch loride  processing p lan ts .  The 
authors concluded from these data th a t  polyvinyl ch loride  processors were ra re ly  exposed to v iny l ch loride  a t  concentrations g rea te r  than 0.5 ppm (1.28 
mg/cu m), which was the Federal ac t ion  lev e l  a t  th a t  time. Monomer production
workers, on the o ther hand, had a g re a te r  r i s k  of v iny l  ch loride  exposure.
Polyvinyl chloride producers were not included in  th is  study.
Results of o ther v iny l ch loride  monitoring surveys have a lso  been reported 
[277-280] and the data are  presented in  Tables IV-1 and IV-2.
B aretta  e t  a l  [269] monitored the concentrations of v iny l ch loride  in av iny l ch loride  polymerization p la n t ,  apparently before and during 1967, 
continuously with an in fra red  spectrometer. Five sampling probes were placed 
in  the work area fo r  each of four job c l a s s i f i c a t io n s ,  and mean v inyl chloride concentrations were ca lcu la ted  weekly. Mean area concentrations fo r  the 
coagulator operator, dryer operator, blender-packager, and polymer operator 
declined s te a d i ly  during the 7 months of the study. The authors a t t r ib u te d
the decline  to undescrlbed "actions undertaken to reduce the atmospheric
concentration" of v iny l ch loride . Weekly average v iny l ch loride  
concentrations decreased from 205 to 40 ppm (524.8 to 102.4 mg/cu m) fo r  
coagulator operators and from 90 to 20 ppm (230 to 51 mg/cu m) fo r  dryer 
opera to rs . Blender-packagers and polymer operators were co n s is te n t ly  exposed 
a t  concentrations below the ta rg e t  concentration of 50 ppm (128 mg/cu m) used 
in  the p lan t  a t  th a t  time.
Kramer and Mutchler [76], in  1972, reported 8-hour TWA concentrations fo r  v iny l ch loride  of from 0 to 300 ppm (0 to 768 mg/cu o) in  a v iny l  ch loride  
polymerization p la n t .  They s ta te d  th a t  the mean TWA concentration  was 155 ppm 
(396.8 mg/cu m) in  1950 and 30 ppm (76.8 mg/cu m) in  1965. Concentrations were estimated on the b t s i s  of area sampling data .
TABLE I V - 1
SUMMARY-VINYL CHLORIDE MONITORING
Mean Concentration














Loading area 1975 
(TWA concentrations)
1976
Production u n i t  
(TWA conc-u trations) 
3/8 .«»«jnnles 1975
3 0 4  s a m p le s 1976
2.7 ppm 
(6.9 mg/cu m)
2.3 ppm (5.9 mg/cu m)
1.6 ppm (4.1 mg/cu m)
1.7 ppm 
(4.4 mg/cu m)
1.6 ppm (4.1 mg/cu m)
1.4 ppm 
(3.6 mg/cu m)
1.3 ppm (3.3 mg/cu m)
0.5 ppm 0.1 -  6.2 i-pm
(1.28 mg/cu m) (0.256- 15.87 mg/cu m)
0.3 ppm 0.1 -  0.6 ppm
(0.77 mg/cu m) (0.256- 1.54 mg/cu m)









0.3 ppm 0.1 -173 ppm 280
(0.77 mg/cu a) (0.256-443 mg/cu m)
28Q
{,0.77 mg/cu m) (0.256- 74.24 mg/cu m)
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TABLE I V - 1 (CONTINUED)
SUMMARY-VINYL CHLORIDE MONITORING
Mean Concentration
Operation Year Concentration Range Reference
Reactor operator(TWA concentrations)No. 1 1976-197? 0.8 ppm - 280(2.0 mg/cu m) -
No. 2 1976-1977 0.2 ppm - 280(0.5 mg/cu m) -
F ir s t  operators 1976-1977 0.3 ppm nd - 1.2 ppm 280(0.77 mg/cu m) (nd - 3.1 mg/cu m)
U ti l i ty  1976-1977 0.3 ppm 0.1 - 0.5 ppm 280operators (0.77 mg/cu m) (0.256 1.28 mg/cu m)
Union Carbide Corp
Solvent Process AreaPersonal samples 1974 - 0.6 - 8.1 ppm 277
- (1.5 - 20.7 mg/cu m)
Area samples 1974 - 0.7 - 6.8 ppm 277(1.8 - 17.4 mg/cu m)
Dynel Process Area o rPersonal samples 1974 - 0.2 - 2.7 ppm 277
— (0.5 - 6.9 mg/cu m)
Area samples 1974 1.4 p p m 277Control room (3.58 mg/cu m) -
Dispersion Process Area
Personal samples 1974 - 3.0 - 43.7 ppm 277— (7.68 - 111.87 mg/cu m)



































































































Utility man 3.2 ppm 8.7 ppm nd- 23.6 ppm
(21.0 mg/cu m) (22.3 mg/cu m) (nd- 60.4 mg/cu m)
Bagger 0.2 ppm 0.4 ppm nd- 0.9 ppm
(0.5 mg/cu m) (1.0 mg/cu m) (nd- 2.30 tag/cu m)
Adapted from Jones [278]
Cook et al [75], in 1971, reported that concentrations of airborne vinyl 
chloride inside a reactor during scraping operations tended to be below 100
ppm (256 mg/cu m) and were usually about 50 ppm (128 mg/cu m). These
estimates were developed from information supplied by a "small number" of 
unspecified plants, and the dates of the analyses were not reported.
In 1975, Ott et al [86] summarized 8-hour TWA concentrations of vinyl 
chloride measured by area sampling techniques from 1950 to 1966 in a 
polymerization facility. From 1950 to 1959, TWA concentrations ranged from 5 
to 825 ppm (12.8 to 2,112 mg/cum) with excursions to 4,000 ppm (10,240 
mg/cu m). Large variations in the TWA concentrations were reported for 
different job classifications, and even within a single job classification, 
eg, dry end packer, 5-10 ppm (12.8-25.6 mg/cu m) and coagulator, 135-825 ppm
(345.6-2112 mg/cu m). From 1960 to 1966, TWA concentrations ranged from 5 to
240 ppm with excursions to 500 ppm. The TWA concentration for the dry end 
packer during this period was listed as 5 ppm and that for the coagulator was 
30-240 ppm (75.8-614 mg/cu m).
Ott et al [73], in 1976, also estimated TWA concentrations of vlnylldene 
chloride from data gathered by area monitoring In production and 
polymerization facilities from 1956 through 1965. Estimated concentrations 
ranged from 5 to 70 ppm (19.85-277.9 mg/cu m) with excursions to 1,900 ppm 
(7,543 mg/cu m).
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Dow Chemical USA (230] has provided NIOSH with v inylidene ch loride  
monitoring data . These data are  summarized in  Table IV-3.
Bales [250], in  1977, provided NIOSH with the r e s u l t s  of two in d u s t r i a l  
hygiene surveys conducted a t  a v iny l f lu o r id e  polymerization and monomer 
production p lan t .  Samples were co llec ted  in 7 . 7 - l i t e r  Teflon bags and were analyzed fo r  v iny l f lu o r id e  by gas chromatography. TWA concentrations of 
v iny l f lu o r id e  ranged from 1 to 5 ppm (1.88 to 9.4 mg/cu a) for 11 samples 
co llec ted  from employees' breathing zones. Both personal and area samples 
co llec ted  in the monomer p lan t showed tha t concentrations of v iny l f luo r ide  
were le ss  than 2 ppm (3.76 mg/cu m) fo r  a l l  but one (21 ppm or 39.5 mg/cu m) 
sample taken a t  the s t a r t  of the operation .
Bales [249] a lso  reported re s u l t s  from an in d u s t r i a l  hygiene survey in a 
v inyl bromide monomer p la n t .  The data are shown in Table IV-4.
Engineering Controls
Engineering con tro ls  should be used to elim inate  the p o te n t ia l  fo r  
exposure to v iny l ha lides  in  the workplace and to prevent f i r e  and explosion. 
These goals can be achieved with properly constructed and maintained closed- 
syscem operations and appropria te  sa fe ty  precautions.
Closed-system operations provide the best means for elim inating  employee 
exposures to v iny l ha lides .  Closed-system operations are e f fe c t iv e  only when 
t l i  in te g r i ty  of the system is  maintained by frequent in spection  and by prompt 
re p a ir  of any leaks th a t  are  found. Closed-system operations should be performed under negative pressure .
Where closed systems cannot be adequately designed and e f fe c t iv e ly  used, 
loca l exhaust v e n t i la t io n  systems should be provided to d i re c t  vapors and 
gases away from employe.es and to prevent the r e c i rc u la t io n  of contaminated 
exhaust a i r .  Contaminated a i r  should be d irec ted  to an in c in e ra to r  equipped 
with scrubbers to remove any toxic  combustion products. Exhaust v e n t i la t io n  
systems fo r  q u a li ty  con tro l la b o ra to r ie s  or laboratory  hoods where samples a re  prepared fo r  analysis  should be equipped with so rbers . Guidance fo r  designing 
a lo ca l  exhaust v e n t i la t io n  system can be found in  Recommended In d u s t r ia l  
V en ti la t ion  Guidelines [281], I n d u s t r ia l  V en ti la t ion—A Manual of Recommended 
P rac tice  [282], or more recent rev is io n s ,  and in Fundamentals Governing the 
Design and Operation of Local Exhaust Syst »ms, ANSI Z9.2-1971 [283].
V en ti la t ion  systems of th is  type requ ire  regu la r  in spection  and maintenance 
for e f fe c t iv e  operation . These Inspections should include face—veloc ity  
measurements of the co llec t in g  hood or duct, inspection  of the a i r  mover and 
c o l le c to r ,  and measurements of v iny l concentrations in  workroom a i r .  Continuous a irflow  in d ic a to rs ,  such as o i l  or water manometers, are 
recommended and should be properly mounted on c o llec t io n  hoods, ductwork, or 
labora tory  hoods and marked to in d ica te  the appropria te  a irflow .
TABLE IV -3
SUMMAR Y- VINfLIPENE CHLO RI DE M O N ITORING
O per.it ion Year
Mean TWA
C e n o 'n t r a t  Ion
Mean TWA 
C o n c e n tra t io n  ?ançe
Ar<M s.i"p li*s 
L o u is ia n a  D iv is io n
L oading  a re a  




0.1- 1 .7  
(0.4- 6 .7 5
ppm
m g/cu a)
7 sam ples 1976 0 .6  
C. 38
ppm
a g /c u m)
0 .1 -  2 .2  
( 0 . - -  3 .7
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P ro d u c tio n  u n i t
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(5 .9 6
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(7 .5
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Adav-ed from Bales [249]
Although ic  may be unnecessary to v e n t i la te  monomer production equipment, 
since i t  is  usually  located outdoors, proper v e n t i la t io n  must be provided for
Che building from which Che process is con tro lled  [276]. The con tro l building
should be maintained under p o s i t iv e  p ressure , and i t s  a i r  in take should be positioned so as to provide clean fresh  a i r .
The procedures developed fo r  v inyl ch loride  as discussed in  the following
paragraphs can also be used to con tro l exposure to the ocher v iny l compounds.
Vinyl ch loride  monomer is  manufactured in closed systems. The maintenance 
of the in te g r i ty  of such systems is  dependent on care fu l  inspection  of s e a ls ,  
e spec ia l ly  a t  j o in t s ,  va lves , and pumps. Generally , where sea ls  are  c lose ly  
inspected and maintained, escape of vinyl ch loride  can be prevented during 
monomer production. Several rep o r ts ,  however, have mentioned processes,
periods, or areas of p o te n t ia l  exposure [279,280,284,285]. These include qua li ty  con tro l sampling po in ts  [284], tank car loading [286], tank car 
gauging [285], storage and t ra n s fe r  systems [286], d i s t i l l a t i o n  areas [230], 
and leaks from other equipment [297,284]. These p o te n t ia l  sources of exposure 
in  monomer production should be avoided by the use of a l te rn a t iv e  methods of
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tank car gauging [284] (s l ip - tu b e  gauging has been a source of exposure and 
should be con tro lled  and monitored [285]), by the use of purge gas in  loading 
and storage operations , p r io r  to maintenance en try , and in  q u a l i ty -c o n tro l  
sample c o l lec t io n  [284], by the ca re fu l c o l lec t io n  and p u r i f ic a t io n  of purge 
gas, by the use of closed-loop systems for tank car loading and qua li ty  
con tro l sampling [276], and by the use of properly maintained laboratory hoods 
for qua li ty  con tro l laboratory procedures.
Most of the cases of angiosarcoma of the l iv e r  found in v inyl ch loride  
workers have occurred among employees of vinyl chloride polymerization p lan ts .  
Controls are needed to reduce worker exposure to v iny l chloride during the 
opening and cleaning of reac tion  v e sse ls ,  a t  discharge points from r e l i e f  
valves and piping jo in t s ,  while monomer i s  being stripped  from the polymer, 
and while tank cars are  being loaded or unloaded. A reduction in the 
frequency of manual cleaning of reac to r  v e s s e ls - i s  abso lu te ly  necessary. The 
c ru s t  on the vesse l can contain up to 3-52 monomer, and 30-502 of th is  may be l ib e ra ted  during cleaning [287]. Automatic high-pressure water, steam, or
organic so lvent vesse l-c lean ing  systems can reduce the frequency of worker 
entry in to  reac to r  vesselsf [286,288,289]. Organic so lvents are also toxic  to 
varying degrees, however, and t h e i j  use should therefo re  be ca re fu l lycon tro lled . A proposed p roprie ta ry  system for l in ing  reactc  e sse ls  is  
claimed to e lim inate  re s in  buildup on the reac to r  vesse l surfaces 1286].
Because v iny l ch loride  polymerization reac tions do not go to completion, 
polyvinyl ch loride  res in s  should be s tr ipped  of unreacted monomer. Stripping 
v e sse ls ,  s lu r ry  tanks, cen tr i fuges ,  and dryers must be enclosed and exhaust- 
v e n t i la te d  [286].
I f  amount of re s id u a l  monomers in polymers is  reduced, the exposure of fab rica tin g  workers to v iny l ch loride  w il l  be su b s ta n t ia l ly  reduced. The 
quantity  of res idua l  monomer th a t  is  released from a re s in  depends on the 
process temperature, the su rface  area of the re s in ,  and the quantity  of 
unreacted monomer in  the re s in  [290]. Manufacturers should contro l th e i r  
process to reduce these fac to rs  to the g re a te s t  extent consis ten t with the 
demands of the process. F abrica to rs  should know the re s id u a l  monomer content of the polyvinyl ch loride  res in s  th a t  they use. Methods are av a i la b le ,  eg, 
a sp ira t io n  and a i r  s t r ip p in g  [291], fo r  reducing the re s id u a l  monomer content 
of res ins early  in the fab rica tin g  cycle, p referab ly  during the compounding 
and dry-blending s tages . Oberg [292] found v iny l ch loride  concentrations of0.04-1.5 ppm during labora tory  blending opera tions.
Unless adequate v e n t i la t io n  is  provided, the escape of res idua l v iny l 
ch loride  from bagged or boxed res in  can r e s u l t  in  buildup of the v iny l chloride concentration in  warehouses and storerooms [293]. According to Oberg 
[292], v inyl ch loride  concentrations of 0 .8-1 .5  ppm have been found in  s torage 
areas. A manufacturer of vinylidene ch loride  reported th a t  a la te x  containing 2,000 ppm of unreacted vinylidene ch loride  released  1,000 ppm of vinylidene 
ch loride  in  1 week of storage [294]. High storage or processing temperatures
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aay also  a cce le ra te  Che re lea se  of unreacted monomer. Oberg found ranges of 
vinyl ch loride  concentracions of 1.5-2.2 ppm aC 46-68 C and 60-120 ppm a t  71- 
110 C.
In v iny l production a reas , employers should i n s t a l l  automatic, m ultipoin t 
continuous monitoring systems with alarm devices s e n s i t iv e  to a irborne vinyls 
a t  the recommended exposure l im i ts .  Baker and R eite r  [275] reported on a 
highly s e n s i t iv e  automatic monitoring system using a gas chromatograph 
equipped with a f lam e-ion ization  de tec to r  and an alarm device th a t  ac t iva ted  
when e i th e r  the v iny l ch loride  concentration exceeded a preselec ted  le v e l ,  the 
check 3ample analysis  was out of rar-ge, or the sample flow was in s u f f ic ie n t .  
The system required 2 minutes for an an a ly s is ,  and each analyzer could monitor 
up to 20 lo ca tio n s .  Areas in  which high v iny l concentrations a re  detected 
should immediately be monitored fo r  gas leaks with a portab le  organic vapor 
analyzer. Also, en try  in to  such areas should be lim ited  to authorized 
personnel with proper p ro tec tiv e  c lo th ing and equipment. As soon as a leak is  
located, properly equipped maintenance personnel fam il ia r  with emergency 
procedures should try  to rep a ir  i t .
E ffo rts  should be made to minimize the extent to which v iny l vapors mix 
with a i r  in  confined or regula ted  areas and to prevent vapors from being 
exposed to any ig n i t io n  source. A f le x ib le  hose v e n t i la t io n  u n i t  and recovery 
system which can be moved to the source of the leakage should be ava i lab le  to contro l leaks which are  not read ily  repa ired .
Unloading v iny ls  from ra i l ro a d  tank cars Is  e spec ia l ly  hazardous while 
l in e s  and hoses are  being coupled and uncoupled. Vinyl ch loride  vapor and 
vapor from o ther v inyl ha lides  a lso  remain in tank cars a f t e r  the l iq u id  is 
removed. I f  compressors and pumps are used to remove the vapor, care should 
be taken fo avoid leaks from th is  equipment. I t  has been suggested th a t  tank 
cars be emptied down to only the vinyl ch loride  vapor pressure , which
elim inates the need to purge the car and reduces the use of pumps andcompressors [286].
Storage and process areas where v iny l ha lides a re  stored  as l iq u id s  shouJd 
be diked to prevent the uncontrolled spread of any sp i l l e d  m ate r ia l .  The 
diked areas should be designed with drainage systems to carry  s p i l l e d  m ate r ia l 
in to  holding ponds or o ther areas where the product can be recovered or disposed of in  a sa fe  manner.
The f laam ab ili ty  of some of thes* compounds mandates c a re fu l  design and 
operation of a l l  spark- or heat-producing equipment in  v iny l ha lide  work 
a reas . E le c tr ic  systems and motors must be spark- and explosion—proof. Sump pumps in  diked areas must a lso  be explosion-proof.
Achievement and maintenance of reduced concentrations of airborne vinyls
In the workplace are  dependent on the implementation of the engineering
contro l recommendations. According to an unpublished rep o rt [295] submitted
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to NIOSH, Che av a i la b le  data suggest thac a combination of many con tro l 
measures Is required to keep v iny l ch loride  concentrations a t  or below the 
curren t Federal occupational l im i t  of 1 ppm (2.56 mg/cu o ) . Since the 
promulgation of the v iny l ch loride  standard in 1974, many d i f f e re n t  types of 
contro l techniques have been employed I d work a reas ,  and employee viny l 
chlorides to v iny l  ch loride  have been g rea tly  reduced. Table 17-5 shows the 
apparent reductions in  v inyl ch loride  concentrations tha t have been achieved 




8-HOUR TWA EXPOSURE OF WORKERS TO VINYL CHLORIDE, 1974-1977
Process-Year
Average D is tr ib u t io n  of Vinyl Chloride Concentrations
<1 1-5 >5 ppm
PVC Mass Polymerization No. 1
1974 2 2 522 462
1975 43% 452 122
1976 732 202 72
PVC Mass Polymerization No. 2
1974-1975 OZ 452 5521977 80Z 202 02
PVC Suspension Polymerization
1975 17Z 662 1721976 83Z 172 02
PVC Dispersion Polymerization
1975 50 2 502 02
1976 672 332 02
PVC Dispersion and Suspension 
Polymerization
1974 OZ 382 622
1975 422 442 1421976 552 362 92
197 7(f irs t
h a lf ) 652 302
52
Adapted from refe rence  295
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V. WORK PRACTICES
In a l l  workplaces where the vinyl halides are produced, handled, u s e d o r  stored, employers should supplement engineering and adm inistrative controls with appropriate work p ractice  programs. Work practice  programs 3hould be oriented toward methods for handling vinyl ha lides , procedures for cleaning up s p i l l s  and responding to emergencies, and use and care of personal protective clothing and equipment. In addition, a regular program of in s truc tion  should be established to ensure that a l l  po ten tia lly  exposed employees are fam iliar with the spec ific  hazards of each vinyl halide and with appropriate procedures for handling them. Employers should inform employees of any adverse effects  that could be caused by inhalation of decomposition products. If  contractors are employed for maintenance and repair  a c t iv i t i e s  or cleaning of vinyl contaminated equipment, employers should ensure that the contractor personnel are also fam iliar with the hazards of the compounds and with precautions to be taken when performing th e ir  duties. Employers may use the Material Safety Data Sheet presented in Appendix XVI as a guide in providing employees with the necessary information.
The vinyl halides vary In th e ir  to x ic i t ie s  (Chapter I I I )  and th e ir  chemical and physical properties (see Table XVII-1). Although th is  chapter 
and the l i t e r a tu re  c ited  in i t  deal mainly with vinyl chloride, a l l  of the vinyl halides are s im ilarly  produced, handled, s tored, and transported. Similar practices and engineering controls w il l  usually be applicable, therefore, to a l l  v inyl halides; those spec if ic  for each halide a te  discussed separately . The control procedures outlined in Chapter IV for spec if ic  processes involving vinyl chloride are not a su b s ti tu te  for good general work p ractices.
Since the promulgation of the 1974 Federal occupational exposure lim it of 1 ppm (2.56 mg/cu m) for v inyl chloride, many papers have been published on various ways to reduce workar exposure to th is  compound. Although some practices are applicable to work with vinyl chloride a t  any time, most controls and practices  can be separated into those that apply to monomer production, those tha t apply during polymer production, and those that apply during polymer fab rica tion  or processing.
Although closed loop systems may be used for quality -con tro l sampling, the proximity of the employee to the sample cylinder connections greatly  Increases the likelihood of exposure in the event of leaks [280]. Therefore, caution 
should be used in  co llec ting  qua lity-contro l samples even where closed loops are used.
All work areas in  which exposure to vinylidene chloride or v inyl bromide may occur should be posted with warnings tha t a po ten tia l  human carcinogen is
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present. For po ten tia l  exposure to vinyl chloride, the area should be posted 
to warn that a human carcinogen i s  present.
Entry into regulated areas, as defined in Appendix I (29 CFR 1919.1017
(e)) , or confined or enclosed spaces should be carefu lly  controlled by a permit system or the equivalent. A confined or enclosed space is  usually 
thought of as any reactor, autoclave, tank, chamber, va t,  p i t ,  pipe, f lue ,  duct, bunker, or undergrade room and only properly protected personnel trained in emergency procedures should be permitted to enter such areas [305,297]. Unauthorized personnel and those not properly protected should not be permitted to enter regulated areas oi confined or enclosed spaces. Records of those who enter these spaces should be kept by means of a daily  log, employment records, or the equivalent. Properly f i t t e d  pro tective  clothing and equipment should be worn by anyone entering such areas, and su itab le  respira tory  equipment should be worn i f  vinyl concentrations exceed the permissible exposure l im its .
Whenever airborne vinyl halide concentrations exceed the recoranended environmental l im its ,  resp ira to rs  must be used in accordance with Table 1-1. The current Federal standard for vinyl chloride allows the use of a chemical cartridge resp ira to r  or a gas mask, f ro n t-  or back-mounted c an is te r ,  a t  concentrations of vinyl chloride not exceeding 10 ppm or 25 ppm, respectively . Service l i f e  requirements, 1 hour for a cartridge and 4 hours for a can is te r ,  are also l i s te d  (29 CFR 1910.1017 (g)). NI0SH, however, has also requited that end-o f-serv lce- life  indicators be used with cartr idge  and can is te r  a i r -  purifying resp ira to rs .  In December 1974, NI0SH and MSHA published therequirements for a canxster or cartr idge  resp ira to r  with end-o f-serv ice - life  indicators for use in vinyl chloiride atmospheres (30 CFR 11.200-11.208). NIOSH has recently approved the 3M No. 8716 vinyl chloride cartr idge  resp ira to r ,  which has an end-o f-serv ice- life  ind icator , for use in vinyl chloride a t concentrations up to 10 ppm (DP Wilmes, w ritten  communication, 
February 1978). E nd-of-se rv ice- life indicators for can is te r  gas masks forvinyl halides have yet to he developed. To prevent exposure through leakage, NIOSH recommends that each employee be provided ar* appropriate individually- f i t t e d  resp ira to r  in good, clean condition, and that employees be d r i l le d  In the use of these resp ira to rs  and In testing  them for leakage, proper f i t ,  and proper operation.
Since vinyl chloride, vinyl bromide, vinyl f luo ride , and vinylidene fluoride are gases a t ambient conditions and are liqu ids only under pressure, 
a hazard from splashes rare ly  ex is ts  under normal working conditions. These compounds can nevertheless cause eye and skin i r r i t a t i o n ,  and contact withthem should be avoided. Vinylidene chloride is  a l iqu id  a t  ambient conditions. Bccause the pressurized m aterials evaporate rapidly on re lease , 
excessive exposure to undiluted liqu id  vinyls could cause a " f ro s tb i te"  type of "burn" [298,299,300]. Warnings against skin i r r i t a t i o n  and burns from 
contact with liqu id  vinylidene chloride and vinyl chloride have been published 
[299,301]. Phenolic in h ib i to rs  of polymerization, formerly used widely, have been implicated in  the causation of burns by contact with surfaces from which
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Che inhibiced vinyl monomer had evaporated, leaving a film of Che inhibicor [301]. I f  a v inyl halide is  splashed on the skin, the affected areas should 
•immediately be washed v’i th  soap and water. I f  eye exposure occurs, the affected eye should be rinsed with water for a t  le a s t  15 mir.utes, and medical a tten tion  should be obtained as soon as possible [297], Eyewash fountains and emergency showers should be located near a l l  vinyl exposure areas and should 
be readily accessib le .
Employees who handle vinyl'1 or enter vinyl exposure areas should be 
provided with appropriate clothing. P rotective  clothing should be provided clean and dry for each use. To prevent contamination of otheir work areas, employees should not wear protec tive  clothing outside exposure areas. In most 
vinyl operations, employees should use coveralls made of any nonsparking material [305]. Employees should also wear safety  goggles or glasses with side sh ie ld s ,  hardhats, resp ira tory  pro tec tive  equipment, rubber gloves, and 
boots whenever they enter confined or regulated areas [297]. One vinylbromide manufacturer has recommended that neoprene gloves and boots be worn byemployees opening process lines and repairing pumps and that a one-piece nylon su i t ,  vinyl-coated on both sides , with attached neoprene boots and gloves be worn by employees entering a reactor vessel or tank [14]. Employers should warn employees that heat stroke may re s u l t  from the wearing of impervious clothing.
Vinyl-contaminated work clothing should be kept separate from s t re e t  clothing and should not be removed from the work area. Employers should 
provide shower and change rooms with locker room f a c i l i t i e s  tha t allow for complete separation of work and s t r e e t  clothing. Employers should encourage a l l  employees working in areas where exposure to vinyls might occur to shower before changing from work clothes in to  s t r e e t  c lo thes. Employers should be responsible for the laundering of contaminated or soiled clothing, and no 
employee should be allowed to take or wear home any work clothing. All work clothing should be adequately cleaned a f te r  each wearing. Employers should inform laundry personnel of the possible hazard from vinyl contaminants on work clothing. Although the vinyl halides 3re a t  most only s l ig h t ly  soluble
in  water, clothing contaminated with liqu id  vinyls should be allowed to drybefor® being laundered. This should be done in a vacuum or other enclosed system provided with a i r  v en t i la t io n  devices in  order to prevent vinyl halide re lease  into the laundry or work area. Waste water should be handled in accordance with a l l  applicable Federal, s t a t e ,  and local regulations.
The vinyl halides addressed in  th is  document are flammable over wide ranges of concentrations in a i r ,  and contact with ig n ition  source- should therefore be avoided. Vinyl chloride, vinylidene chloride, vinyl f luoride , and vinylidene f luoride  have been reported to be explosive a t  concenCrations 
of 3.6-33.0, 7-16.0, 2.6-21.7, and 5.5-21.32 by volume in a i r ,  respectively[302,303]. A producer of vinyl bromide reported that vinyl bromide a t  
concentrations of 6.0-152 by volume in  a i r  may- ig n ite  in the presence of high- 
energy ign ition  sources and suggested that vinyl bromide be handled as a moderately flammable m aterial [304] .
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Since the vinyl halides are so readily  flammable, i t  i s  important to 
prohibit smoking, carrying of uncovered smoking m aterials such as matches and l ig h te r s ,  open flames, and use of m aterials that can cause sparks in areas where vinyls are present. Smoking I f  allowed at a l l  on the plant s i t e  should be r e s t r ic te d  to designated areas. Signs warning of a danger of f i r e  or explosion should be posted in areas where vinyls are produced, handled, or 
stored, and transport, containers should have warning labe ls . Warning 3igns 
should also be prominently posted in areas where s p i l l s  and leaks are l ike ly  to occur. °rocess equipment, 3uch as tanks, p ipelines, pumps, and compressors, should be grounded to prevent tne build up of s t a t i c  e le c t r i c i ty  [299]. F irefigh ting  and resp ira tory  protective equipment should be readily  availab le  for use in case of emergency. Employers should inform f ire f ig h t in g  
personnel of the possible combustion products of the vinyl halides. Vinyl chloride combustion products include phosgene, hydrogen chloride, carbon monoxide, carbon dioxide, and water. Hydrogen chloride is  also a major 
combustion product of vlnylidene chloride. Employers should therefore provide f i re f ig h te rs  with pro tec tive  equipment to prevent injury from inhalation  or contact with the combustion products. Vandervort and Brooks [305] reported that the major thermal decomposition products of polyvinyl chloride films were di-2-ethylhexyl adipate and hydrogen chloride. The authors found no vinyl chloride emissions during hot-wire cutting of the film , but warned against inhalation of aerosol p a r t ic le s  from di-2-ethylhexyl adipate and hydrogen chloride.
To ensure tne effectiveness of recommended work practices  in protecting the employees' health , employers should require tha t a l l  employees p a r t ic ip a te  in an o r ien ta tion  program when they ara hired and in periodic Information seminars led by personnel qualified  by experience or tra in ing . During o rien ta tion , employees should be informed of the hazards associated with handling of the vinyl halides and of the precautions that should be taken to prevent in jury or i l ln e s s .  Employers should also inform employees that vinyl chloride is  a known human carcinogen and that the other vinyls are po ten tia l  human carcinogens. Employees should be made thoroughly fam iliar with emergency and evacuation procedures.
Periodic tra in ing of employees should include opportunities for employees to meet with management personnel to discuss or review safety  procedures and new toxicologic findings. New Information an the vinyl halides should be posted in designated areas accessible to employees. I t  i s  e sse n t ia l  to s tre ss  the Importance of the employees' cooperation with management in  preventing adverse e ffec ts  of exposure to v iny ls , and employees should be encouraged to report a l l  circumstances tha t might crea te  the po ten tia l  for such exposure.
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V I . DEVELOPMENT OF STANDARD
(a) Vinyl Chloride
Standards for regulation of exposure to vinyl chloride in the United States were f i r s t  reported in 1945 in Cook's review [306] of maximum allowable 
concantrations (MAC's) of in d u s tr ia l  atmospheric contaminants. A Utah State Department of Health recommendation of 500 ppm (1,280 mg/cu m) was c ited . A 1930 report by Patty e t  a l  [16] indicated that guinea pigs exposed to vinyl chloride a t  5,000 or 10,000 ppm (12,800 or 25,600 mg/cu m) for as long as 500 minutes "showed no symptoms." Cook [306] recommended an MAC of 1,000 ppm for prolonged exposure. Citing the lack of long-term animal experimentation data and of data on in d u s t r ia l  exposure a t  known concentrations, Cook recommended medical observation of workers exposed to vinyl chloride a t concentrations near the suggested l im it .
In 1946, the American Conference of Governmental Indus tr ia l  Hygienists (ACGIH) [307] recommended an MAC of 500 ppm (1,280 mg/cu m) for vinyl chloride. When the ACGIH changed i t s  terminology in 1949 [308], th is  lim it became the Threshold Limit .Value (TLV) for vinyl chloride. According to the1962 Documentation of Threshold Limit Values [309], the ACGIH TLV was also
based on the study by Patty e t a l  [16]. The 1962 documentation [309] noted that narcosis was the most important e ffec t of exposure to vinyl chloride, and that the TLV of 500 ppm (approximately 1,300 mg/cu m) "appears to be su ff ic ie n t ly  low to prevent s ign if ican t  narcosis ."
In the Threshold Limit Values for 1963 [310], i t  was noted that a TLV in the form of a time-weighted average (TWA) concentration lim it might not provide a su ff ic ie n t  safety  fac to r  for acutely acting substances. Consequently, a "C" or "ceiling" designation was appended to the value for vinyl chloride, indicating that the TLV, which remained a t  500 ppm, was a lim it that should not be exceeded.
Although the TLV had not changed, the 1966 Documentation of Threshold • Limit Values [311] c ited  several studies that presented conflic ting  data. Torkelson e t a l  [113] found l iv e r  damage in rabb its  exposed repeatedly for 7 hours to vinyl chloride a t  200 ppm (512 mg/cu m) and s l ig h t  increases in l iv e r  weights of ra ts  exposed a t  100 ppm. Other animals were unaffected a t  100 ppm. The authors suggested tha t worker exposure be controlled so tha t re su l ts  for p rac tica lly  a l l  ana ly tica l measurements were less than 100 ppm (256 mg/cu m) and that the TWA concentration for a l l  exposures be limited to 50 ppm (128 mg/cu m). Lester e t al [18] found some increase in the re la t iv e  weights of 
the l iv e r  apd spleen in  ra ts  exposed repeatedly to vinyl chloride a tconcentrations of 20,000 ppm (51,200 mg/cu m) for 92 days and 50,000 ppm(128,000- mg/cu m) for 19 days. They did not consider these changes
B a s is  f o r  P r e v io u s  S ta n d a r d s
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s ign if ican tly  pathologic, and they concluded that the accepted TLV for vinyl 
chloride of 500 ppm (1,300 mg/cu m) was adequate to protect workers. The 1966 documentation [311] concluded tha t ,  "although the available  data are conflic ting , the preponderance ind ica te j  a compound of re la t iv e ly  low tox ic ity  
with which a threshold l im it  of 500 ppm is consis ten t ."
In 1970, the ACGIH [312] announced i t s  in ten tiou  to reduce the TLV for vinyl chloride to 200 ppm. In 1972, the ACGIH [313] reduced the TLV for vinyl chloride to 200 ppm (770 mg/cu m [ s ic ] ,  actually  equivalent to 512 mg/cu m) as an 8-hour TWA concentration. Several studies supporting r.his action were cited in the 1971 Documentation of Threshold Limit Values for Substances in Workroom Air [314], including the 1961 study by Torkelson e t a l [113] and the 1963 study by Lester e t a l  [18]. The documentation alsc  c ited  a study, conducted between 1950 and 1967 and presented in 1968 by Mutchler and Kramer [315], of exposure of chemical plant workers. Workers exposed to vinyl chloride (with about 5 ppm of vinylidene chloride) a t  a mean concentration of 160 ppm (410 mg/cu m) did not have s ig n if ican t changes in blood pressure, concentration of hemoglobin in the blood, or ECG's, and acroosteolysis was not found. Howevar, changes of possible physiologic significance were acted in 
serum beta-lipopro te in , I c te r ic  index, and sulfobromophthalein re ten tion . Based on analysis of these data, the authors suggested that some l iv e r  dysfunction might re su l t  from exposure to vinyl chloride (combined with 5 ppm of vinylidene chloride) at a TWA concentration of 300 ppm (768 mg/cu m) over a working life tim e. The 1971 documentation [314] concluded that a TWA environmental l im it of 200 ppm (770 mg/cu m) for vinyl chloride (with a few 
ppm of vinylidene chloride) "seems appropriate to prevent adverse systemic e ffec ts  from long-continued daily  exposure.”
In 1974, the ACGIH [316] published a notice tha t the TLV for vinylchloride would be reassigned as a re su l t  of i t s  newly discovered carcinogenicp o ten tia l.  No spec if ic  studies were citfid in support of th is  action. As of 1977, the TLV for vinyl chloride s t i l l  awaited reassignment pending the acqu isition  of more d e f in it iv e  data [317].
According to a 1968 jo in t  report of the In ternational Labour Office andthe World Health Organization [318], permissible l im its  se t  by foreigncountries for vinyl chloride In the working environment include 30 mg/cu m for Bulgaria and 1 mg/cu m for the United Arab Republic and the Syrian ArabRepublic. The German Democratic Republic has a lim it of 500 mg/cu m for vinylchloride in  the work environment [319].
Limits adopted in foreign countries since 1974 r e f le c t  the accumulatingevidence of the carcinogenic po ten tia l  of vinyl chloride. The United Kingdom has se t  25 ppm (64 mg/cu m) a s  a  TWA l im i t ,  with a 50 ppm (128 mg/cu m) ce i ling  lim it [305], u n t i l  more d e f in it iv e  information is  availab le . In 1976, the Federal Republic of Germany established Technical Guideline Concentrations for vinyl chloride of 10 ppm (26 mg/cu m) in .ex is t in g  polymerization plants and 5 ppm (13 mg/cu m) elsewhere u n t i l  such time as an MAC value could be assigned [320]. Sweden established an 8-hour TWA lim it of 1 ppm (2.5 mg/cu m)
and a ca ll ing  lim it of 5 ppm (13 mg/cu a) for exposura to vinyl chlorida [321]. The Swedish document notad th a t  v inyl chlorida has carcinoganic properties and tha t I t  may be absorbed to a considerable extant through the 
skin.
The In te rna tional Labour Office [322] recently  published the following national occupational exposure l im its  for vinyl chloride: Yugloslavla, 75 ppm(300 mg/cu m [s ic ] ,  ac tually  equivalent to 195 mg/cu m); Rumania, 100 mg/cu m 
as a TWA lim it and 200 mg/cu m as a ce l l ing  l im it ;  A ustra lia , 25 ppm (95 mg/cu m [ s ic ] ,  actually  equivalent to 64 mg/cu m); Hungary, 50 mg/cu m; Poland and USSR, 30 mg/cu m; Netherlands, 10 ppm (26 mg/cu m) as a ce iling  l im it;  
Finland, 10 ppm (26 mg/cu m); and Japan, 2.5 mg/cu m. In I ta ly ,  vinyl chloride is  regarded as a human carcinogen, and an exposure lim it of 5 ppm (13 mg/cu m) has been recommended. However, the exposure l im it is  intended as a 
guideline, as are those of A ustralia , Japan, and tne Netherlands, and is  not 
legally  blading. In Cvltzerland, vinyl chloride is  regarded as a probable human carcinogen also, and a provisional exposure lim it of 10 ppm (26.5 mg/cu m) has been established. Switzerland also requires tha t the best available  technical and medical pro tec tive  measures be applied to ensure maximum reduction o£ r i sk  froiu exposure to vinyl chloride.
The 1971 US Federal standard for workplace exposure to v inyl chloride (29 CFR 1910.93) was a ce iling  lim it of 500 ppm (1,280 mg/cu m), based on the 1968 TLV [323]. Cn January 22, 1974, NIOSH informed the Occupational Safety and Health Administration. (OSHA) th a t  the BF Goodrich Chemical Company had reported the deaths of several or i t s  employees from angiosarcoma of the l iv e r ,  and tha t the deaths may have been occupationally re la ted .  A f a c t ­finding hearing began on February 15, 1974 (reported in the Federal Register 39:35890, October 4, 1974), a f te r  consultation with NIOSH and a jo in t
inspection of the BF Goodrich plant by OSHA, NIOSH, and Kentucky Department oi Labor personnel. Preliminary reports of experiments conducted by Cesare Maltoni of the In s t i tu to  d i Oncologia, Bologna, I ta ly ,  and other information disclosed a t  th is  hearing indicated that vinyl chloride could induce angiosarcoma in  the l iv e r  of ra ts  a t exposure concentrations as low as 250 ppm (640 mg/cu m). OSHA concluded from the Information presented a t  the hearing and in posthearing comments th a t  occupational exposure to vinyl chloride was probably the cause of angiosarcoma of the l iv e rs  observed in workers in the industry. An Emergency Temporary Standard (ETS) was promulgated on April 5, 
1974 (Federal Register 39:12342), as 29 CFR 1910.93(q ) . This standard reduced the permissible exposure level to 50 ppm (128 mg/cu m), as a ce i l ing  l im it ,  and established other requirements, Including monitoring and resp ira to ry  protection.
OSHA published a proposed permanent standard (Federal Register 39:16896, May 10, 1974) for the regulation of exposure to vinyl chloride. The proposed standard specified  that employee exposure be limited to "no detectable  level" as determined by a sampling and analy tica l method sens itive  to 1 ppm with an accuracy of 1 ppm 4502. The proposal also called for monitoring employee exposures and Implementing engineering control and work practice  programs when
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necessary. Hearings on th is  proposal were conducted from June 25 through June 28 and from July 8 through July 11, 1974. The carcinogenicity of vinyl
chloride in  three animal species was documented in  the record of th is  proceeding by the studies of Maltoni and of In d u s tr ia l  Bio-Test Laboratories (Federal Register 39:35891, October 4, 1974). These studies demonstrated the induction of angiosarcoma of the l iv e r  in ra ts  and mice exposed to vinyl chloride a t  concentrations as lov as 50 ppm (128 mg/cu m) and in hamsters exposed a t  higher concentrations. Evidence presented by these and other investigators also Indicated additional tumorlgenic and toxicologic properries 
of vinyl chloride. CSHA concluded from these findings of angiosarcoma of the liver  in experimental animals and employees exposed ,:o vinyl chloride chat vinyl chloride "must be regarded as a human carcinogen, and the probable causal agenc of angiosarcoma of Che l iv e r ,  and chat exposure of employees to 
vinyl chloride muse be contro lled ."
The current permanent standard for worker exposure to vinyl chloride was 
promulgated on October 4, 1974 (Federal Register 39:35896) and becameeffec tive  Januarry 1, 1975. The standard (29 CFR 1910.1017), presented asAppendix I of th is  document, Includes an 8~uur TWA exposure lim it of 1 ppm and a ce il ing  lim it of 5 ppm, averaged over any period not exceeding 15minutes. The standard spec if ies  that no employee may be exposed to d irec t contact with liqu id  vinyl chloride. The standard also establishesrequirements for monitoring employee exposure, providing resp ira tory  protection , and in s t i tu t in g  medical surveillance programs. A TWA action level of 0.5 ppm (1.3 mg/cu m) also i s  specified in the standard. Where the re su l ts  of monitoring show tha t no employee is  exposed in excess of the action level, employers are exempted from certa in  provisions of the standard.
(b) Vinylidene Chloride
In 1975, the ACGIH adopted a TLV of 10 ppm (40 mg/cu m) for vinylidene chloride [324]. Several studies were c ited  in the 1971 Documentation of Threshold Limit Values for Substances in Workroom Air [314] in support of th is  l im it .  Increased m ortality  in r a t s ,  rab b its ,  guinea pigs, and monkeys exposed to vinylidene chloride a t  concentrations as low as 61 mg/cu m (15.4 ppm) for 90 days was reported by Prendergast e t  a l  [122], Gage [120] found that a f te r  vinylidene chloride inhalation 6 hours/day for 20 days a t  500 ppm (1,985 mg/cu m) there was nasal i r r i t a t i o n ,  retarded weight gain, and l iv e r  c e l ldegeneration in  r a t s .  At 200 ppm (794 mg/cu m), there was only s l ig h t  nasali r r i t a t i o n ,  and no l iv e r  c e l l  abnormalities were observed. I r i sh  [114]reported l iv e r  and kidney damage in r a t s ,  rab b its ,  guinea pigs, and dogsexposed to vinylidene chloride for 6 months a t concentrations as low as 25 ppm (99 mg/cu m), and he suggested that concentrations In workplace* be maintained b-'low 25 ppm.




froa in to le rab le  i r r i t a t i o n ,  chronic or ir rev e rs ib le  t issu e  changa, or narcosis su f f ic ie n t  to increase accident proneness, impair se lf-re scuc , or reduce work eff ic iency . I t  should be noted that the 1976 STEL's were not deterained on the basis of occupational or experimental data; ra th e r ,  they were se t e ap ir lca l ly .  A provision lim iting  the number of 20-ppm excursions to no acre than four each day, with a t  le a s t  60'minutes between exposure periods, was also Included.
According to the 1968 jo in t  report of the In ternational Labour Office and the World Health Organization [318], national permissible H a l t s  for vinylidene chloride in the working environment include the following: Yugoslavia, 200 ppm (794 mg/cu m), l i s te d  as "dichloroethylene," and Bulgaria and Hungary, 50 mg/cu m, l i s te d  as "dlchloroethvlene." A 1977 publication of the In ternational Labour Office [322] l i s t s  the following occupational 
exposure lim its  for vinylidene chloride in foreign countries: Rumania, 500mg/cu a as a TWA lim it and 700 mg/cu m as a ce lling  l im it ;  Poland and USSR, 50 ag/cu a as a ce ll ing  lim it;  and Belgiom. Federal Republic of Germany, Netherlands, and Switzerland, 10 ppm (40 mg/cu m). A ustralia  has established a provisional exposure lim it of 10 ppm (40 mg/cu m) for vinylidene chloride. The exposure l im its  shown for A ustralia  and the Netherlands are intended as guidelines and are not lega lly  binding.
No US F---eral standard for workplace exposure to vinylidene chloride currently ex is ts .
(c) Vinyl Bromide
In 1971, the ACGIH [326] recommended a TLV for vinyl bromide of 250 ppm (1,095 mg/cu m). This TLV was adopted in 1972 [313].
Two studies were included in the 1971 Documentation of Threshold LimitValues for Substances in Workroom Air [314] as bases for th is  TLV. In an unpublished study cited by ACGIH, Torkelson determined an ora l LD50 of 500 mg/kg in male r a t s .  In acute inhalation s tud ies , Torkelson observed no tissue  changes in r a t s  exposed to vinyl bromide a t concentrations as high as 25,000ppm (109,500 mg/cum). Leong and Torkelson [127] reported no s ign if ican tpathologic changes in ra ts  exposed for 20 days to vinyl bromide a t  10,000 ppm (43,800 mg/cu m). In a chronic inhalation study, they found no s ign if ican t changes in growth ra te ,  hematology, organ-to-body weight r a t io ,  or gross and microscopic tissue  findings as a re su l t  of exposure to vinyl bromide a t  250 or 500 ppm (1,095 or 2,190 mg/cu m). The ACGIH concluded that "a TLV of 250 ppm should protect against bromide in toxication  and organic in jury , and .. . excursions even to 500 ppm would be acceptable provided the time- weighted average does not exceed 250 ppm.”
In 1976, in  addition to the TWA exposure l im it  of 250 ppm (1,095 mg/cu m) for vinyl bromide, the ACGIH [325] adopted a ten ta t iv e  TLV-STEL of 250 ppm (1,100 mg/cu m). In 1977, the ACGIH [317] proposed a reduction of the TLV to 5 ppm (22 mg/cu m).
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According to a 1977 publication of the International Labour Offica [322],axposura lim its  of 250 ppm (1,095 mg/cu m) for vinyl bromide hava baan sa t byAustralia , Balgiua, Finland, and tha Netherlands. Tha Australian and Dutch l i a l t s  ara intandad as guidalinas and ara not legally binding.
»No US Federal standard for workplace exposure to vinyl bromide currently 
ex is ts .
(d) Vinyl Fluoride
The ACC1H has not adopted a TLV for vinyl fluoride. No US Federal standard for exposure to vinyl fluoride currently ex is ts .  No foreignstandard3 have been located.
(e) Vinylidene Fluoride
The ACGIH has not adopted a TLV for vinylidene fluoride. No US Federal standard for exposure to vinylidene fluoride currently ex is ts .  No foreignstandards have been located.
Basis for the Recommended Standard
(a) Permissible Exposure Limits
Among the vinyl halides discussed in th is  document, only vinyl cr.lorlde is regarded as a known human carcinogen chat can induce a characteris tic  tumor, angiosarcoma of the l ive r  [31,32,34,36,37,40,41]. Animal studies have shown that vinyl chloride [134,135,140], vinyl bromide [327], and vinylidene chloride [140] are capable of inducing angiosarcoma of the l iv e r  and other tumors. In these experiments, erp<- rure to vinyl chloride at 50 ppm for 4 hours/day, 5 days/week, for 52 weeks induced angiosarcoma of the liver  in 1/59 ra ts  a f te r  135 weeks [135]; vinyl, bromide at 250 ppm caused angiosarcoma of the l ive r  in 2/30 ra ts  a f te r  52 weeks [327]; vinylidene chloride at 55 ppm for 6 hours/day, 5 days/week, for up to 12 months caused angiosarcoma of the liver in 3/72 mice [140]. Exposure a t higher concentrations induced a greater incidence of tumors and shortened the latency ior th e ir  development, indicating that there was a dose-response relationship for tumor Induction.
No reports in regard to the carcinogenicity of vinyl fluoride or vinylidene fluoride have been located. However, th is  lack of information cannot be construed as an indication that these compounds have no carcinogenic poten tia l. Each of the vinyl halides may form reactive intermediates that can bind to ce llu la r  macromolecules [1-3,210]. Putative metabolic pathways and reactive Intermediates are shown in Figure XVII-3. The metabolic studies referenced with the figure, along with Information from reports on structure- a c t iv ity  relationships [229, RL Schowen, written eooaunication, September 1977], indicate that both vinyl fluoride and vinylidene fluoride may have the capacity to fora intermediates capable of alkylating DNA, RNA, or proteins.
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The hazard potential of these compounds In a biologic system Is difficult to 
determine, however, because of detoxication mechanisms (reduction, hydrolysis, 
and conjugation) that compete with alkylation, as well as repair, mechanisms.
Each of the vinyl halides has been found to be mutagenic in some test 
system. Vinyl chloride has been shown to have a direct mutagenic effect on 
Salmonella [146,149,150,162,163J; metabolic activation by microsomal er.zyme 
systems has been shown to increase its mutagenic activity [146,145]. 
Vinylidene chloride [151,162,173], vinyl bromide (VT Simoon and R Nangham, 
written communication, August 1977), and vinyl and vinylidene fluorides [174] 
have also been shown to be mutagenic in bacterial test systems. Since many 
mutagenic compounds are known to also be carcinogenic, these findings suggest 
that all the vinyl halides might be potential caicinogens.
No studies have demonstrated teratogenic or other affects on human 
reproduction from exposure to any of the vinyl halides. Structural
abnormalities, including Increased numbers of unfused sternebrae, delayed 
ossification of skull bones, and an increase in the number of lumbar spurs in 
mice whose dams were exposed to vinyl chloride at 500 ppm during days 6-15 of 
gestation [132] and in ra^s exposed in utero to vinylidene chloride at 80 ppm 
during the same period [133], have been observed. Other reproductive effects 
included increased resorptions/implants, decreased numbers of live 
fetuses/litter, and increased fetal crown-rump length [132,133]. The authors 
of these studies suggested that the abnormalities observed wer- seccndary to 
the maternal toxicity of the compounds. Although tnese changes are not 
generally considered to be evidence of teratogenicity, they do indicate
fetotoxic effects from maternal exposure to vinyl chloride.
Other adverse health effects attributed to exposure to vinyl halides 
include CNS [18-20,33,78,114,127,129], cardiovascular [19,20,32,33,78,107, 
110,121], respiratory [19,32,106,120,122,140], skin [19-21,32,111,112], and 
skeletal effects [20,21,32,35,74,78,111,112], as well as liver and spleen 
abnormalities [18-20,30-32,36-39,78,113].
The risk to the health of employees exposed to the vinyl halides is a 
combination of the risks of moplastic and other systemic effects from their
inhalation or ingestion and of their subsequent metabolism to reactive
intermediates.
The observation of neoplasms in humans and animals exposed to vinyl 
chloride and in animals exposed to vinylidene chloride and vinyl bromide, the 
similarities in the excreted metabolic products of the vinyl halides, and the 
calculations of relative reactivity of these compounds on the basis of their 
physical and chemical properties suggest that each of the five may have a 
neoplastic potential.
Concern for employee health requires that risk of carcinogenesis as a 
result of workplace exposure to these compounds be minimized. NIOSH believes 
that sufficient information does not exist to warrant changing the present 
Federal Standard for vinyl chloride as stated in 29 CFR 1910.1017. Further,
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NIOSH believes that the available information on vinylideie chloride and vinyl brooid« indicates that they are at least  as toxic as vinyl chloride. Although su ffic ien t biologic information is  not available concerning vinyl fluoride and vinylidene fluoride, chemical information suggests that these compounds may also exhibit to x ic i t ie s  similar to that of vinyl chloride, ie, until better animal toxicity  and metabolism data are available, there appears to be no reason to t rea t  the fluorides differently from the other vinyl halides. 
Therefore, NIOSH recommends that workplace exposure to each of the five vinyl 
halides be controlled by adherence to the provisions of 29 CFR 1910.1017, and 
on the basis of animal carcinogenicity date:, NIOSH suggests that employers 
make every effort to limit employee exposures t o the lowest feasible levels 
with an eventual goal of zero exposure. As pointed out in Chapter IV there 
has been a steady decline in workplace environmental concentrations of vinyl 
chloride since 1974. The lower limits of reliable detectability (see 
Appendices II—III) are 0.003 ppm for vinyl chloride and 0.5 ppm for vinylidene 
chloride. Workplace concentrations of vinyl bromide have been measured as low as 0.01 ppm [249]. Vinyl fluoride and vinylidene fluoride in air samples have been measured at concentrations as low as 1 ppm and 2 ppm respectively (see 
Appendices V-VI).
Since the promulgation cf the vinyl chloride standard in 29 CF3 1910.1017 
in October, 1974, several advances in respirator technology have taken place. 
Table 1-1 reflects the latest developments in respiratory protection, and 
NIOSH recommends the substitution of these provisions and requirements for 
those contained in 29 CFR 1910.1017, paragraph (g).
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V I I .  COMPATIBILITY WITH OTHLR STANDARDS
The Environmental Protection A^ancy (EPA), the Department of Transportation (DOT), the Food and Drug A daia lstratlon  (FDA), and other Federal agencies have proposed or enacted standards regulating the use orrelease of several vinyl compounds. The standard recommended by NIOSH in th is  document for the vinyl halides 13 compatible with the standards promulgated and proposed by other Federal agencies. Standards proposed by other government agencies chat are direct'.y applicable to the standard proposed by 
NIOSH are reviewed below.
(a) Vinyl Chloride
In 1976, CPA established a national emission standard for vinyl chloride 
(40 CFR 61.60-71) because vinyl chloride had been implicated in the development of angiosarcoma and other serious disorders in occupationally exposed persons and in experimentally exposed animals. Vinyl chloride emissions from ethylene dichlori^e and vinyl chloride production andpurif ica tion  processes were thereby limited to 10 ppm. For the oxychlorlnatlon process, vinyl chloride emissions were re s t r ic te d  to 0.2 g/kg of ethylene dichloride product. Vinyl chloride emissions from polymerization plants were limited to 10 ppm through the stripping stage and to 0.02 g/kg of polyvinyl chloride product when reactors were opened. Emissions of vinyl chloride were required to be controlled a f te r  s tripping operations byreduction of res idual monomer in the polymer to below 400 ppm (2,000 ppm for dispersion re s in s ) .  Where control devices rather than stripp ing  technology were used to l im it emissions, dispersion resins were required to be controlled to 2 g/kg of polyvinyl chloride product and a l l  other resins to 0.1 g/kg of polyvinyl chloride product. EPA assumed that adherence to these lim its  would reduce hazards to the health of the estimated i .6  million people who live within 5 miles of controlled plants so that '-he incidence of new primarycancers as a re su l t  of exposure to vinyl chloride in th is  group of peoplewould not exceed 1/year of exposure (Federal Register 41:46560, October 21, 1976). EPA sta ted  that a complete ban on vinyl chloride emissions was not desirable because (1) vinyl chloride has benefic ia l uses for which su bsti tu tes  
are not available , (2) po ten tia l  substi tu tes  may have unknown health  e ffe c ts ,  (3) unemployment would re s u l t ,  and (4) control technology is  available  to greatly reduce vinyl chloride emissions.
On June 2, 1977, EPA proposed amendments to the national emission standard (Federal Register 42:28154-28159). Sources currently  subject to a 10-ppm 
emission lim it and new sources of th is  type would be required to lim it emissions to 5 ppm. Emissions fron oxychlorlnatlon reactors la  ethylene dichlorlde-vlnyl chloride plants would also be limited to 5 ppm. The 
amendments would d ire c t  that residual monomer .in the polymer a f te r  stripping be limited to 500 ppm in new dispersion resins and 100 ppm in a l l  other new res ins . Where control devices ra ther than stripping technology would be used
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co l ió le  m iss ion« , a«w dispersion resins would have to be controlled Co 0.5 
*/*g of polyvinyl chloride produce and a l l  ochar new resins co 0.1 g/kg of polyvinyl chlorida produce. The proposed amendments also would prohibit any 
Increase in ealsslons due co che conseruccion of new sources wlchln 8 km • of ex lsd ng  sources. EPA proposed chese amendments in an e f fo r t  co conciaue tu approach the rero-em^ssions level for vinyl chloride with available  technology because of I t s  determination that th is  is  the only level absolutely procectivs of health- These H a l t s  and proposed amendments are not d irec t ly  comparable with those proposed by MlOS'i, since they do not specify breathing zone sampling. They do, however, re f le c t  the same philosophy espoused by NIOSH; chit i s ,  chat the f in a l  goal is zero exposure.
Aeroscl drug products containing vinyl chloride as an Ingredient or propellant are considered to be nsw drugs by FDA and are regulated «s such (21 CFR 310.506). EPA (Federal Register 39:14753, April 26, 1974), FDA (21 C7R 700.14), and Che Consumer Product Safety Commission (16 CFR 1500.17(a ) (10)) have banned Che use of vinyl chloride as an lngredienc or propellanc in aerosol produces, including pes tic ides , cosmetics, and foods, intended for consumer use. These standards are more conservative than that proposed by NIOSH; however, they re la te  primarily to use of the product and only secondarily to occupational exposure.
FDA proposed rules for regulating the use of vinyl chloride polymers in contacC wich food on SepCember 3, 1975 (Federal Register 40:40529-37). FDA 
stated  that the use of vinyl chloride polymers and copolymers should be prohibited where there was a reasonable expectation of migration of vinyl chloride monomer into food. FDA proposed a ban on the use of vinyl chloride polymers and copolymers in food-contact a r t ic le s  except where sp ec if ica l ly  permitted in the FDA regulations. Exceptions to th is  ban included coatings, gaskets, cap l in e rs ,  f lex ib le  tubing, and p lastic ized  films. Use of polyvinyl chloride in water pipe was also permitted on an Interim basis pending the outcome of studies to determine whether vinyl chloride could be extracted by water passing through such pipes. FDA has subsequently published regulations concerning the formulations and amounts of ex tractable  monomer allowable in / iny l chloride copolymer components of paper and paperboard in contact with 
foods (21 CFR 176). Similar regulations for vinyl chloride copolymers used as basic components of single and repeated use food concacc surfaces have also been promulgated (21 CFR 177). These are compaclble, alchough noc d irec t ly  comparable, wlch the provisions of the NIOSH standard specifying that no food 3hall be stored, dispensed, prepared, or consumed in vinyl halide exposure areas.




over any 8-hour period, or 5 ppm (13 ag/cu o ) , averaged jver any period noc exceeding 15 miautes, for personnel Involved in vinyl chloride transfer operations. Continuous nonltorlng oust be conducted during such operations, using a method with an accuracy of not less  than t502 from 0.25 through 0.5 ppo, t35Z from 0.5 ppm through 1 ppm, and *252 over 1.0 ppm. The US Coast Guard [328] has also developed a cargo compatibility guide for bulk liquid chemicals indicating combinations of chemicals chat re su l t  In dangerous chemical reactions when accidentally mixed inside a cargo tank or pipe. Vinyl chloride Is l i s te d  as incompatible with n i t r ic  acid and caprolactao solution. Regulations for unmanned barges carrying certa in  dangerous bulk cargoes, including vinyl chloride, also nave been established by Che US Coast Guard (46 CFR 151). The Coasc Guard stai.iard for occupational exposure is less s tringent than chat proposed by NIOSH.
(b) Vlnylldene Chloride
FDA has published regulations concerning the formulations and amounts of extrac table  monomer allowable in vlnylldene chloride copolymer components of paper and paperboard that come into contact with foods (21 CFR 176). Similar regulations for vlnylldene chloride copolymers used as basic components of single and repeated use food contact surfaces have also been established (21 CFK 177).
The Materials T ran sp o s it io n  Bureau of DOT has designated vlnylldene chloride as a hazardous material for purposes of cransportatlon in commerce and has established requirements pertaining to les labeling, packaging, and transportation  (49 CFR 172.101). In i t s  cargo compatibility guide for bulk liquid chemicals, the DS Coast Guard [328] has l i s te d  vinylidir.e chloride as incompatible with n i t r i c  acid and caprolactam so lution. Regulations for unmanned barges carrying certa in  dar~erous bulk cargoes, including vlnylldene chloride, nave been established by the US Coast Guard (46 CFR 151).
NFPA [329] provides a compilation of information on the hazardous properties and f ire f ig h t in g  aspects of vlnylldene chloride. This compound is  very flammable and readily  forms explosive mixtures in a i r .  Polymerization may occur at elevated temperatures, possibly rupturing containers. A readily explosive peroxide may be formed during long-term storage. In the 1975 Manual of Hazardous Reactions [330], NFPA notes that vlnylldene c.iloride polymer is  se lf - reac t iv e  and may explode under appropriate conditions. I t  also reports that mixtures of vlnylldene chloride and chlorosulfonic acid, n i t r i c  acid , or oleum (fuming su lfu r ic  acid) in closed containers cause increased temperature and pressure. In f i re f ig h t in g  operations, NFPA recommended tha t the gas flow be stopped and that dry chemical, foam, or carbon dioxide be used to extinguish flames. Water may be ineffec tive  in putting out f i r e s ,  but I t  should be used to cool containers, p ro tec t personnel la  the area , flush s p i l l s  away from flar.es, aad disperse vapors i f  appropriate. The provisions of the National E lec tr ica l  Code [331] and those o f  the Sections of the National Fire Codes dealing with flammable and combustible liquids [335] and s t a t ic  e le c t r i c i ty  [333] should be complied with where applicable.
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( c )  V in y l  F lu o r id «
The Mataríais Transportation Bureau of DOT has designated vinyl f luoride 
as a hazardous a a te r la l  for purposes of transporta tion in commerce and has established requirements pertaining to I t s  labeling, packaging, and transportation  (49 CFR 172.101).
(d) VInylidene Fluoride
FDA has published regulations concerning the formulations and amount of extractable  aononer allowable in polyvinylidene fluoride resin  ccmponints of 
a r t ic le s  intended for repeated food-contact 'jse (21 CFR 177.2510).
(e) Vinyl Bromide
No other standards were located for th is  compound.
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V I I I .  RESEARCH SEEDS
The current information on biologic e ffects  of exposure to the vinyl halides is  incomplete. Vinyl chloride has been studied more extensively chan the ocher vinyl halides; however, ch? exact mechanism of i t s  toxic action is not known. Further studies are needed Co obcain additional information.
(a) Epidemiology
Since one scudy [101] has suggesced chac vinyl chloride causes increased fecal mortality in che wives of exposed workers, s t jc ie s  should be performed 
to invesr.igace tu is  po ten tia l for each of che vinyl halides.
Epidemiologic studies should be conducted to compare cohorts from the same p la r t  having various magnitudes of exposure. This can be done re la t iv e ly  easixy for Che vinyl halides since these compounds are generally produced and used in specific  units of large chemical planes. The epidemiologic studies 
should include precautions to minimize the "healthy worker" and "survivor" e ffects  usually apparent in any worker population.
(j) Toxic Effects
Exposure to vinyl chloride has been shown to induce a wide variety  of coxic e ffects  including centra l nervous, resp ira to ry , cardiovascular, 
d igestive, skin, and sk e le ta l  system e ffe c ts .  Studies should be designed to determine which of these systems are affected d ire c t ly  by vinyl chloride or 
i t s  metabolites and which e ffec ts  i f  any are secondary to the primary systemic e ffec ts .  Studies should also be conducted to determine che range of coxic effects of exposure to the other vinyl halides. These studies should be designed so that comparison of primary coxic effeccs can be made becweer. che 
compounds, ie ,  the same species, s t ra in s ,  and protocols should be used for each study.
Studies should be conducted to determine the long-term effects  of inhaled and Ingested vinyl f luorides . Because of the Increasing latency of turner induction with decreasing exposure concentrations reported in studies of 
animals exposed to vinyl chloride [135], future experiments should not be terminated u n t i l  the animals become moribund or die.
(c) Sampling and Analysis
Experiments are needed to va lidate  the lower range of the sampling ani analy tica l methods proposed for vinyl bromide, vinyl fluoride and vinylidene fluoride. Procedures and equipment should be improved to further minimize Interferences and standardize the measurement of these compounds.
Although continuous monitoring devices are conmerctally available for vinyl chloride and vinylidene chloride, such devices are needed for the other
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vinyl halides. Research should also be conducted to Increase che sen s i t iv i ty  and accuracy of che existing  equipaent so that r e l ia b le ,  continuous records of 
exposure for a l l  work areas can be obtained.
Research is  also necessary to develop techniques for biologic nonicorlr.g. 
At present, because of che rapid aetabolism of che vinyl halides , blood ar.alyses have only indicated adverse effects rather chan determining exposures, and u rina lysis  has not been developed co che extent necessary to 
define exposures. Further studies of metabolism and excrecion may develop che 
information necessary co calculate che bodv burden from che excrecion 
produces, so chat an accurate assessment of che rotal accumulated dose :an be 
t ia d e .
In addicion, resources should be expended co assess che currenc st re of concrol technology and the f e a s ib i l i ty  of implementing advances in th is area. Thought should be given to the f e a s ib i l i ty  of using less toxic substi tu tes . Finally, resp ira to rs  with end-of-serv ice-life  indicators should be developed 
for the vinyl halides for which they are not available.
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X. APPENDIX I 
FEDERAL STANDARD FOR VINYL CHLORIDE (29 CFR 1910.1017)
§ 1 9 1 0 . 1 0 1 7  Vinvl  clilori . le.
(a)  S c o p e  a n d  c p p ’i r c ! : < ' n .  (1'  Th!"> 
se r t lo n  includ-’r, r*'TUirempnt.'; for  t h"  
cont r ol  of empl oyee  exposur e to v ” ;vl 
chlor ide  ( ch lo ro e th e r . e ) , Chemica l  A b ­
s t r ac t s  Service Regi st ry  No. 75014.(2) This section applies to the m anu­facture, reaction, packaging. repaci:as- 
lng, storage, handling or use of vinyl chloride or polyvinyl chloride, but does not apply to the handling or use of fabri­cated products made of polyvinyl chlo­ride.(3) This section applies to the trans­portation of vinyl chloride or polyvinyl chloride except to the extent th a t the D epartm ent of Transportation m a- regulate the hazards covered by this sec­tion.(b) D e /in it io r .s . (1) “Action level" means a  co.icentration of 'iny l chloride of 0.5 ppm averaged over an  8-hour work day.(2) “Assistant Secretary” means the Assistant Secretary of Labor for Occupa­tional Safety and Health, U.S. D epart­m ent of Labor, or his designee.(3) “Authorized person” means any person specifically authorized by the em­ployer whose duties requlr» him to enter a  regulated area or any person entering such an  area as a designated representa­tive of employees for the purpose oi ex­ercising an opportunity to observe moni­toring ar.d measuring procedures.(4) "Director” means the Director. National Institu te  tor Occupational Safety and Health. U.S. Departm ent oi Health. Education, and Welfare, or his designee.(5) “Emergency” means any occur­rence such as, but not limited to. equip­m ent failure, or operation of a relief de­vice which is likely to. or does, result In massive release of vinyl chloride.(6) “Fabricated product" means a product made wholly or partly from polyvinyl chloride, and which does not require further processing a t  tempera­tures, and for times, sufficient to cause mass m eltins of the polyvinyl chloride resulting in the release of vinyl chloride.
7) "H.-’.. a r d ou s  n a r r a t i o n "  mean-,  any  
opera t ion .  pr' ii.ediire.  o r  act ivi ty where  a 
release of c i t h e r  vinyl chlor ide liquid or 
cas  m i j h t  be expected as a consequence 
of t he  oper at ion  or  because of an  ac ci ­
d e n t  In t he  o^^r.Ttion, v/hich wculd  resul t  
In a n  employee exposure  in excess of the  
permissible exposure  limit.(8) “ OSH A Area Director" means the 
Dire ct or  for the O ccu pa t i on al  Safety 
a n d  H e a l t h  A dmi ni s t r a t io n  Are a  Office 
havins;  j u r i sd ic t ion  over the  geographic  
a r e a  In which t he  employer ' s  e s t ab l i sh­
m e n t  is located.
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(9) "Polyvinyl chloride” means poly­vinyl chloride homopolymer or copoly- tncr before such Is converted to a fab ri­cated product.
(10)  "Vinyl chloride" m eans  vinyl 
chloride monomer.
(c) Perm issib le exposure lim it. (1) No employee m ay be exposed to vinyl cWu- rldc a t  concen tra t ions  crca ter  th a n  1 ppm  
avcrar.od over any 3-linur pericd. and
(2) No employee m ay be exposed to 
vinyl chloride a t  concen tra tions  g rea ter  
th a n  5 ppm  averaged over any period no t  exceeding 15 minutes.
(3) No employee may be expor^d to vinyl chloride by direct contact with liquid vinyl chloride.
<rt) M onitoring . Cl) A program  of Initial monitoring and  measurement shall be undertaken In each establish­m ent to determine If there Is any em­ployee exposed, without regard to the use of respirators, In excess of the action level.
(2) W here a determination conducted urider paragrapn (d)(1) of this section ihovvs any employee exposures, without regard to the use of respirators. In ex­cess of the action level, a program for de­termining exposures for each such em­ployee shall be established. Such a  pro­gram:
<1> Shall be repeated a t  least monthly where any employee Is exposed, without regard to the use of respirators. In ex­cess of the permissible exposure limit.
(11) Shall be repeated not less then  Tuarterly where any employee is exposed, without regard to the use of respirators. In excess of the action level.
(Ill) May be discontinued for any em­ployee only when a t  least two consecu­tive monitoring determinations, made not less than  5 working days apart, show ex­posures for th a t employee a t  or below the action level.
(3) W henever there h as  been a  pro­duction, process or control change which may result In an Increase In the release of vinyl chloride, or the employer has any o ther reason to suspect tha t any em ­ployee may be exposed in excess of the action level, a determ ination of employee exposure under paragraph (d) (1) of this section shall be performed.(4) The method of monitoring and measurement shall have an accuracy (with a confidence level of 95 percent) of
not less than  plus or minus 50 pcrcenfc from 0.25 through 0.5 ppm, plus or minus 35 pcrccnt from over 0.5 ppm through 1.0 ppm, nnd plus or minus 25 percent over 1.0 ppm- (Methods meeting these accuracy requirements are available In the “NIOSU M anual of Analytical 
M e th o d s” ) .(5) Employees or their designated rep­
resen ta tives  shall be afforded reasonable  
opp o rtu n ity  to observe the monitor­ing and measuring requited by this paragraph­ic) R egula ted  area. (1) A regulated area shall be established where:(1) Vinyl chloride or polyvinyl chloride is m anufactured, reacted, repackaged, stored, handled or used; and
<U) Vinyl chloride concentrations are In excess of the permissible exposure limit.
(2) Access to regulated areas shall be limited to authorized persons. A dally roster shall be made of authorized p e r ­sons who enter.
(f) M ethods o f com-pliance. Employee exposures to vinyl chloride shall be con­trolled to a t or below the permissible ex­posure limit provided in paragraph (c) of this section by engineering, w ori prac­tice. and personal protective controls as follows:(1) Feasible engineering and work practice controls shall immediately be used to reduce exposures to a t or below the permissible exposure limit.(2 W herever feasible en?ineering a id  work practice controls which cr.n be In­stituted immediately are not sufficient to reduce exposures to a t or below the per­missible exposure limit, they shall none­theless be used to reduce exposures to the lowest practicable level, and shall be supplemented by respiratory protection in  accordance with paragraph (g) of th is section. A program shall be established and implemented to reduce exposures to  a t  o r below the permissible exposure limit, or to the greatest extent lcasible, solely by means of engineering and work practice controls, as soon as feasible.




respirators shall bp a t  the discretion of each employee for exposures no t In ex­
cess of 2 j ppr.i, measured over any 15- m inute pertc,'.. Until April 1. 1976, each employee v/ho chooses no t to v/ear an  approrriate  respirator shall be In­
formed -x ¡east quarterly of the hazards of Yiny. chloride and the purpose, proper
R e q u i r e d  a p p c . r a t v .1
( t)  TTnV-ntvg-i o r above 0,500 pp=i  O p ? n -c ! rc 'j t \  siLT-contained b re a th in g  a p p a ra tu s . p re s -sur>. dem and type, T.lth full faceplece.
(11) N ot over 3.SOO ppm ___________ (A) Com bination type C supplied air respirator, pres-sura demand ty p i, 7.1th full or hair faceplece, 
end auxiliary ;? i:-contained air supply; or (!U) Not over 1,000 ppm________ (B) Com bination type, supplied air respirator contin­uous flow type, w ith full or half faceplece, »ad auxiliary self-contained air supply.Type C supplied air respirator, continuous flow type, w ith fuU c r half faceplece, helm et or hood.
(It ) N ot 07er 100 ppm  __ ___ (A) Com bination type C supplied air respirator de­m and type, vrlth fuU faceplece, an d  auxUlary Eelf-contalred air supply: or
(B) O pen-clrcult ielf-contained b reata lng  apparatusw ith fuU faceplece. in demand mode; T(C) Type C su p p llii  eLr respirator, dem and type, w ithfull faceplece.
(?) N ot over 35 ppm_______ ■ ■ (A) A powered air-purifying respirator with hood,helm et, fu ll or half faceplece, and a canister 
« b leb  provides a service Ilf« of a t  least 4 
hours for concenratlons of vinyl chloride up 
to  25 ppm. or(B) Q*s mask, fron t- or back-m ounted can ister which provides a  serrice life of a t least 4 to u rs  for 
concentrations of vinyl chloride up to 25 p p n . 
(Tl) N ot or»r 10 ppm  ____(A) Com bination type C supplled-air respirator, de­m and type, v i ta  half faceplece, an d  auxiliary 
Eslf-contalr.ed air supply; or(B) Type C suppUed-alr respirator, dem and type, vrtth
h alf faceplece; or(C) Any chemical cartridge resplratcr w ith  an  organicVapor cartridge which provides a service 11/» of a t  least 1 hour for concentratl. \s of vinyl 
cbloriao up to  10 ppm.
(g) R esp ira tory  pro tec tion . Wher<> respiratory protection Is required under 
this scctlon:(1) T ha employer shall provide a respirator which meets the requirements of this paragraph and shall assure tha t the employee uses such respirator, cxcept th a t un til April 1, 1976, wearing of
Atm ospheric concentrct'.o.t of 
vinyl chloride
use. and  lim itations of respiratory devices.(2) Respirators shall be selected from among those Jointly approved by the Mining Enforcem ent and Safety Admin­istration, Departm ent of the Interior, 
and the National Institu te for Occupa­tional Safety and H ealth under the pro­visions of 30 CFR P a rt 11.(3) A respiratory protection program m eetinc the requirements of ! 1910.134 shall established and maintained.<4> Selection of respirators fo r vinyl ch lo i.le  shall be os follows:
(5) (i) Entry Into unkoTvn concentra­
tions or concentrations greater than 
36.0C0 ppm (lower explosive lim it) may 
be made only for purposes of life rescue; 
and(II) Entry Into concentrations of less 
than  36,000 ppm, but greater than  3,600 ppm may be made only for purposes of 
life rescue, firefighting, o r securing 
equipment so as to  prevent a greater 
hazard from release of vinyl chloride.
(6) Where air-purifying respirators 
are used:
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(I) Air-purifying cannlsters o r car­tridges shall be replaced prior to the expiration of their service lire or the end of the shift in which they <Lve first used, whichever occurs first, and(II) A continuous monitoring and alarm  system shall be provided where concentrations of vinyl chloride could reasonably excccd the allowable concen­trations for the devices In use. Such sys­tem shall be used to alert employees when vinyl chloride concentrations exreed the allowable concentrations for the devices In use.
(7) Apparatus prescribed for higher concentrations may be used for any lower concentration.
(h) H azardous operations. (1) Em­ployees engaged In hazardous operations. Including entry of vessels to clean poly­vinyl chloride residue from vessel walls, shall be provided and  required to wear and use;
(1) Respiratory protection in accord­ance with paragraphs (c) and (g) of this section; and
(il) Protective garm ents to prevent skin contact with liquid vinyl chloride or with polyvinyl chloride residue from vessel walls. The protective garments shall be selected for the operation and Its possible exposure conditions.
(2) Protective garments shall be pro­vided clean and dry for each use.
(1) E m ergency s itua tion s. A written operational plan for emergency situa­tions shall be developed for each facility storing, handling, or otherwise using vinyl chloride as a liquid or compressed gas. Appropriate portions of the plan shall be Implemented In the  event of ai. emergency. The plan shall specifically provide th a t:
(1) Employees engaged in hazardous operations or correcting situations of ex­isting hazardous releases shall be equipped as required in  paragraph (h) of th is section;
(2) O ther employees not so equipped shall evacuate the area and not retu rn  until conditions are controlled by the methods required in paragraph (f) of this section and the emergency is abated.
(J) Training . Each employee engaged In vinyl chloride or polyvinyl chlor'de operations shall be provided training in a  program relating to  the hazards of vinyl chloride and  precautions for its safe use.
(1) The program shall include:
(1) The nature of the  health  hazard from chronic exposure to vinyl chloride including specifically the carcinogenic hazard:(li) The specific nature of operations which could result In exposure to vinyl chloride In c.xcess of the permissible limit and necessaiy protective steps;
(ili) The purpose for. proper use, and lim itations of respiratory protective devices;
(Iv) The fire hazard and acute toxic­ity of vinyl chloride, and the necessary protective steps;
(v) The purpose for and a description . of the monitoring program;
(vi) The purpose for, and a descrip­tion of, the medical surveillance program;
(vii) Emergency procedures;(viii) Specific Inform ation to aid the employee In recognition of conditions which may result in the release of vinyl chloride; and(lx) A review of this standard  a t the employee’s first training and Indoctrina­tion program, and annually thereafter.(2) All materials relating to the pro­gram shall be provided upon request to the Assistant Secretary and tl'?  Director.
(k) M edical surveillance. A p .csram  of medical surveillance shall be ’nstl- tuted for each employee exposed, w ith­out regard to the use of respirators, to vinyl chloride In excess of the action level. The program shall provide each such employee with an opportunity for examinations and tests in accordance with this paragraph. All medical ex­aminations and procedures shall be per­formed by or under the supervision of a licensed physician, and shall be provided without cost to the employee.(1) At the time of Initial assignment, or upon Institution of medical surveil­lance;(I) A general physical exam ination rhall be performed, with specific a tten ­tion to detecting enlargement of liver, spleen or kidneys, or dysfunction In these organs, and for abnormalties in skin, connective tissues and the pulmonary system (See Appendix A).(II) A medical history shall be taken. Including the following topics:
(A) Alcohol intake;(B) Past history of hepatitis;
(C) Work history and past exposure to  potential h"patolnxlc agents, includ­ing drugs and chemicals;
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(D) Past hls';ory of blood transfu­sions: and(E i Past history of hospitalizations.(iil) A serum specimen shall be ob­tained and determ inations made of:(A) Total bilirubin;
(B) Alkaline phosphatase;
(C) Serum clutamlc oxalacetlc trans­am inase (S C O T );
(D) Scrum glutamic pyruvic transam ­inase (S G P T ); and
(E) Gamma glustamyl transpeptidase.
(2) Examinations piovlded in accord­ance with this paragraph shall be per­formed a t least:
(i) Every 6 m onths for each employee who has been employed in vinyl chlo­ride or polyvinyl chloride m anufacturing for 10 years or longer; and(li) Annually for all other employees.
(3) Each employee exposed to an  emergency shall be afforded appropriate medical surveillance.
(4) A statem ent of each employee’.'; suitability for continued exposure to vinyl chloride Including use of protec­tive equipment and respirators, shall be obtained from the examining physician promptly a fter any examination. A copy of the physician’s statem ent shall be pro­vided each employee.
(5) If any employee's health would be materially impaired by continued ex­posure. such employee shall be w ith­drawn from possible contact with vinyl chloride.(S) Laboratory analyses for all bio­logical specimens included in medical examinations shall be performed In labo­ratories licensed under 42 CFR P art 74.
(7) If the examining physician deter­mines tha t alternative medical examina­tions to those required by paragraph <k)(l) of th is section will provide at least equal assurance of detecting med­ical conditions pertinent to the exposure to  vinyl chloride, the  employer may ac- ccpt such alternative examinations as meeting the requirements of paragraph (k)U> of this section, if the employer obtains a statem ent from the examining physician setting forth  the alternative exam inations and the  rationale for sub­stitution. This statem ent shall be avail­able upon request for examination and copying to authorized representatives of the Assistant Secretary and the Director.(1) Higns and labels. (1) Entrances to regulated areas shall be posted with leg­ible signs bearing the  legend:
C a n c e r - S u s p e c t  A c e n t  A m  A u t h o r iz e d  
P e r s o n n e l  O n l y  :
(2) Areas containing hazardous oper­ations or where an emergency currently exists shall be posted with legible signs bearing the legend:
Cancek-Suspect Acent if» THt3 Area Paorrc-
tive Equipment Requdieo AuTHORixra
PtRSONW EL O v L T
(3) Containers of polyvinyl chloride resin waste .rom reactors or other waste contaminated with vinyl chloride shall be legibly labeled:
CO.NUMINATED V/lTH VlNYL CHLORIDE Cancer-S uspect Agent
(•!' Containers of polyvinyl chloride shall be legibly labeled:
POt-TYLNTX CHLORIDE (OR TRADE N *M X ) 
C o n t a i n s  
V i n y l  C h l o r id e  
V lN T L  CKLOXQE IS  A C A N C E R -SosreC T  A c e n t
(5) Containers of vinyl chloride shall be legibly labeled either:
(1)
V u r r c .  C H L O R tterREMELT FLAMMABtt GaS UitDER PBESSCH* 
C A K c m -S o sp E C T  A c e ; «
or (11) In  accordance with 49 CFR Parts 170-189, with the additional legend:
C a n c e r - S u s p e c t  A c e n t
applied near the label or placard.(6) No statem ent shall appear on or near any required sign, label or Instruc­tion which contradicts or detracts from the effect of, any required warning. Information or instruction.
(m) Records. (1) All records main­tained in accordance with this section shall include the nam e and social secu­rity num ber of each employee where relevant.
(2) Records of required monitoring and measuring, medical records, and au­thorized personnel rosters, shall be made and shall be available upon request for exam ination and copying to authorized 
representatives of the Assistant Secre­
tary and the Director.(1) Monitoring and measuring records shall:(A) S ta te  the date  of such monitor­
ing and measuring and the concentra­
tions determined and Identify the Instru­
ments and methods used;(B) Include any additional Informa­
tion necessary to determine Individual
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employee exposures where such expo­sures are determined by means o ther than  individual monitoring oi employees; and
(C) Be maintained for no t less than  30 years.
(il) Authorized personnel rosters shall be maintained for not ¡ess than  30 years.
(iii) Medical records shall be m ain­tained for the duration of the employ­m ent of cach employee plus 20 years, or 30 years, whichever Is longer.
(3) In  the event th a t the employer ceases to do business and there is no successor to receive and retain  his rec­ords for the prescribed period, these rec­ords shall be transm itted by registered man to the Director, and each employee Individually notified in  writing o ' this transfer.
(4) Employees o r the ir designated representatives shall be provided access to examine and cop'' records of required monitoring and measuring.
(5) Former employees sha ll be pro­vided access to examine and copy re­quired monitoring and measuring records reflecting their o .?n exposures.
(6) Upon written request of any em­ployee, a copy of the medical record of th a t employee shall be furnished to any physician designated by the ;mploy>“i.
(n) R eports. (1) Not la te r than  1 m onth after the establishment of a reg­ulated area, the following information shall be reported to the OSHA Area Di­rector. Any changes to such information shall be reported within 15 days.
(i) The address and location of each establishment which has one or m a rl regulated are?s; and
(ii) The number of employees In each regulated area during normal operations. Including maintenance.
• 2) Emere<‘ncl<*<!. and the  facts ob­tainable a t th a t time, shall be reported w ithin 24 hours to the OSHA Area Di­rector. Upon request of the Area Direc­tor, the employer shall subm it additional Information In writin? relevant to the  nature and extent of employee exposures and measures taken to prevent fu ture emergencies of sim ilar nature.
(3) W ithin 10 -working days following any monitoring and m easuring which discloses th a t any emolovee has been exposed, without regard to the  use of respirators, in excess of the permissible exposure limit, each such employee shall be notified in writing of the  results of the  exposure measurement and the steps
being taken to reduce the exposure to within the permissible exposure limit.
(o) E ffective dates. (1) Until April 1, 1975, the provisions currently set forth in 5 1910.93q of this P art shall apply.
(2) Effective April 1, 1975, the pro­visions set forth in § 1910.93q of this P a rt shall apply.
A r p r v t j i x  A — S u p p l i m e n t a r t  M c s i c a I .
I n f o r m a t i o n
W hen re q u ire d  te s ts  » inder p a rn s ra p li  
( k ) ( l )  of tills  sec tion  chow  a b n o rm a litie s , 
th e  te s ts  sh o u ld  be rep ea ted  as 6oon as p ra c ­
ticab le. p re fe rab ly  w ith in  3 to  4 weeks. I i  
te s ts  rem ain  abn o rm al, ">nslcJeratlon sh o u ld  
be  given to  tv lthdraw al o i th e  em ployee from  
c o n ta c t  w ith  vinyl ch lo rld c , w h ile  a  m o rs  
com prehensive  e x am in a tio n  Is m ade.
A dd itio nal te s ts  w hich m ay  be u se fu l:A. F o r k idney  d y sfu n c tio n : u r in e  e x am in a ­
t io n  fo r a lb u m in , re d  b lood  cells, a n d  ex­fo lia tiv e  a b n o rm a l ceUa.
B. P u lm onary  system : F orced  v ita l c ap a c ­ity , Forced ex o lra to ry  vo lum e a t  1 second, 
a n d  c h es t ro en tg en o g ram  (p o s te r io r-a n te r io r , 
14 x  17 In c h e s ) .
C. A dd itio nal se ru m  te s ts :  Le.ctlc ac id  d e ­hy drog en ase , lac tic  ec ld  d ehyd rog enase  
Isoenzym e, p ro te in  d e te rm in a tio n , a n d  p ro te in  e lectrophoresis.
D. For a  m ore com prehen siv e  e x a m in a tio n  
o n  rep ea ted  a b n o rm al se ru m  t« s ts :  H e p a tit is  
B a n tig e n , a n d  liver scan n in g .
(Secs. 6 and  8, 84 S ta t . 1596. 1599 (29 V.S.C.  655, 657): S ecre ta ry  o f L ab o r’s  O rd er No. 
12-71. 35 FR 8754) |39  F R  35896, O ct. *,
1974; 39 FR  41848, Dec. 3. 1974, as am en d ed  
•  t  40 FR  33211. M ar. 25, 1975. R e d e s ig n e d  
a t  40 FR  23073, May 28, 19751
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XI. APPENDIX II
SAMPLING AND ANALYTICAL METHOD FOR VINYL CHLORIDE IN AIR
This is  NIOSH-accepted (C la s s if ic a t io n  B) a n a ly t ic a l  method No. P&CAM 178 
for determ ination of vinyl chloride in  a i r ,  issued September 3, 1974 and 
re / ise d  January 29, 1976 [245]. This method involves adsorption on activa ted  carbon, desorption with carbon d isu l f id e ,  and gas chromatography. The range 
for determ ination of v iny l cnloride using th is  method is  0.008-5.2 mg/cu m 
(0.003-2.03 ppm) in a 5 - l i t e r  a i r  sample. The p rec is ion  (c o e f f ic ie n t  of variation-CV(T)) i s  approximately 0.08 a t  leve ls  of 7 and 71 mg/cu m (2.73 and 
27.7 ppm).
P rinc ip le  of the Method
A known volume of a i r  is  drawn through two sorbent tubes in se r ie s  
containing ac tiva ted  carbon (made from coconut s h e l l s ) , which adsorbs the 
v inyl ch loride  presen t in the a i r  sample. The c o l l e c t e d  viny l ch loride  is  
then desorbed with carbon d isu l f id e ,  and the re s u l t in g  so lu tions  are analyzed 
by gas chromatography with a f lam e-ion ization  d e te c to r .  The areas under the re su l t in g  peaks are compared with areas obtained from the in je c t io n  of 
s tandards.
Range and S e n s i t iv i ty
(a) The minimum de tec tab le  amount of v iny l ch lo ride  was found to be 0.2 
n g / in jec t io n  a t  a 1 x 1 a ttenua tion  of a gas chromatograph. This corresponds 
co an estimated concentration  of 0.008 mg/cu m in  a 5 - l i t e r  a i r  sample 
analyzed by th is  method. However, the desorption e ff ic iency  from ac tiva ted  carbon of amounts of v iny l chloride as small as 40 ng (0.008 y g / l i t e r  x 5 
l i t e r s )  has not been determined. Therefore, the de tec tion  l im it  of the 
o v e ra l l  method may be somewhat higher than 0.008 mg/cu m.
(b) At a sampling flowrate of 50 ml/minute, the t o t a l  volume to be sampled should not exceed 5 l i t e r s .  T hu  value is  based on data  in d ica t ing  
th a t  more than 10 l i t e r s  of a i r  containing 2.6 ¿¿g/liter  (1 ppm) of v iny l 
ch loride  could be sampled on ac tiva ted  carbon before 52 breakthrough was 
observed. This would in d ica te  th a t  5 l i t e r s  of a i r  containing no more than 
5.2 mg/cu m may be sampled without s ig n i f ic a n t  breakthrough. I f  a p a r t ic u la r  
atmosphere Is  suspected of containing a high concentration of contaminants or 
a high humidity i s  suspected, the sampling volume should be reduced by 50%. A 
sa fe ty  fa c to r  has been included in the 5-11te r  volume, and the capacity  of the f i r s t  tube should be adequate w ithin these l im i ts  except under the most extreme conditions.
Interferences
(a) When Che amount of water in  the a i r  i s  so g rea t  th a t  condensation
a c tu a l ly  occurs in  the tube, organic vapors 'w ill  not be trapped e f fe c t iv e ly .Experiments in d ica te  th a t  high humidity severely  decreases the capacity  of
ac tiva ted  carbon fo r  organic vapors.
(b) When two or more substances are  known or suspected to be presen t in
the a i r ,  th is  information, Including th e i r  suspected id e n t i t i e .1 , should be 
transm itted with the sample, since these compounds may in te r f e re  with the 
analysis for v iny l ch loride.
(c) Any compound th a t  has the same re ten t io n  time as v iny l ch loride  under 
the operating conditions described in  th is  method is  an In te rfe rence . Hence, 
re ten t io n  time data on a s ing le  column, or even on a number of columns, may not provide proof of chemical id e n t i ty .  Often, operating conditions can be 
modified to e lim inate  In te rfe ren ces .  Samples should be analysed by an 
independent method when overlapping gas-chromatographic peaks canno: be resolved.
Precision  and Accuracy
(a) A c o e i f ic ie n t  of v a r ia t io n  of 0.0.76 was obtained from analysis  of 
each of two se ts  of sorbent tubes, one se t  of 27 tubes exposed to v inyl 
ch loride  a t  a concentration  of 7.2 mg/cu m in  a i r  and another se t  of 29 tubes 
exposed a t  a concentration  of 71.3 mg/cu m. These values r e f l e c t  t o t a l  sampling and a n a ly t ic a l  e rro r  as well as desorption e ff ic ien cy  co rrec tion  e rro rs .
(b) Experiments were performed to obtain  some in d ica t ion  of the accuracy of th is  method, although accuracy was d i f f i c u l t  to evalua te . These 
experiments generally  involved s ix  sorbent tube samples exposed to a sy n the tic  atmosphere. The ca lcu la ted  value was the concentration  expected based on the 
measured amounts of v iny l ch loride  and a i r  mixed to prepare the syn the tic  
atmosphere. The ca lcu la ted  value was not the true  value , s ince i t  was subject 
to experimental e r ro r .  The value found from analysis  of each sorbent tube, 
a f t e r  co rrec t ion  fo r  desorption e ff ic ien cy , was a lso  compared with th a t  found 
by the d i re c t  in je c t io n  of gas samples from the same sy n the tic  atmosphere used 
in  loading the tubes. The r e s u l t s  of these experiments a re  shown in  Table XI- 1. I t  should be noted th a t  average concentrations determined by ana lysis  of 
sorbent tubes were w ith in  62 of the average concentrations determined by analysis  of gas samples.
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TA3LE XI-1












I Gas samples 64 71.2 ±0.7 -2
Solvent tubes 64 69.8 ±1.5
I I II 13 14.5 ±0.5
13 13.6 ±0.4 -6
I I I II 2.6 2.88 ±0.072.6 2.91 ±0.13 +1
IV M 1.3 «
1.3 1.27 ±0.09 •
*Average of concentrations determined from so rren t tubes minus average of 
concentrations determined from gas samples, divided by average of concen­
t r a t io n s  determined from gas samples, x 100
**Mean value ±952 confidence leve l  (standard devia tion  x S tudent’s t  a t  0.05 s ign if icance  le v e l ,  divided by square root of number of samples)
Advantages and Disadvantages of the Method
(a) The sampling device i s  small, p o r tab le ,  and involves no l iq u id s .  
In te rfe rences  a re  minimal, and most of those th a t  do occur can be elim inated 
by a l te r in g  chromatographic conditions. The tubes are analyzed by a rapid  
instrum ental method. The method can a lso  be used fo r  the simultaneous 
determ ination of two or more components suspected to be present in the same 
sample by changing gas-chromatographic conditions rrom isothermal to a temperature-programmed mode of operation .
(b) One disadvantage of the method is  th a t  the amount of sample th a t  can 
be taken is  l im ited  by the amount of v iny l ch loride  th a t  the cube w i l l  hold 
before i t  becomes overloaded. When the value obtained fo r  the backup sec tion  
of the sorbent tube exceeds 20% of th a t  found on the fron t se c tio n , there  is  a 
p o s s ib i l i ty  of sample lo ss .  During storage, v o l a t i l e  compounds such as v iny l ch loride  w il l  m igrate throughout the tube u n t i l  equilibrium is  reached. At 
th is  time, 332 of these compounds w il l  be found in the backup sec tion . This
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may lead to sane confusion as to whether sample loss has occurred. This 
migration e f f e c t  can be considerably decreased by shipping and s to r in g  the
tubes a t  -20 C or by using two separa te ly  capped tubes fo r  the f ro n t and
backup sec tio n s .
(c) The p rec is ion  of the method is  lim ited  by the rep ro d u c ib il i ty  of the 
pressure  drop and, th ere fo re ,  by the flowrates across the tubes. Because the
pump is  usually  ca l ib ra ted  for one p a r t ic u la r  tube, d iffe rences in  flowrates
from tube to tube can cause sample volumes to vary.
Apparatus
(a) Personal sampling pump: The pump should be a properly c a l ib ra ted  
personal sampling pump for personal and area samples. The pump should a lso  be 
capable of accurate  performance a t the recommended flow ra tes. I t  should be 
ca l ib ra ted  with a rep re sen ta tiv e  sorbent tube in  the sampling l in e .  A dry or 
wet t e s t  meter or a g lass  rotameter th a t  w i l l  determine the flowrate to w ith in  
±52 may be used fo r  the c a l ib ra t io n .
(b) Sorbent tubes: The g lass  tubes are flame sealed a t  both >nds. Each 
is  7 cm long, 6-mm outer diameter, 4-mm inner diameter, and contains two 
sections of 20/40-mesh ac tiva ted  carbon separated  by a 3-nm portion  of 
urethane foam. The ac t iva ted  carbon is  prepared from coconut sh e l ls  and is  
f i red  a t  600 C p r io r  to packing to remove adsorbed m a te r ia ls . The primary 
adsorbing sec tion  contains 100 mg of sorbent, the backup sec tion  50 mg. A 
plug of s i la n iz ed  g lass wool i s  placed in fro n t  of the adsorbing sec tion . The 
pressure  drop across the tube must be le ss  than 2 inches of water a t  a flowrate z£ 0.2 l i te rs /m in u te .
(c) Gas chromatograph equipped with a f lam e-ion ization  d e tec to r .
(d) S ta in less  s t e e l  column (20 fe e t  x 0.125 Inch) packed with 102 SE-30 
on 80/100 mesh Chromosorb W (acid washed, s i la n iz ed  with 
d im ethy ld ich lo rosilane) . Other columns capable of performing the required separations may be used.
(e) A mechanical or e lec tro n ic  in te g ra to r  and a recorder or some method fo r  determining peak area.
(f) Vials (2 ml) th a t  can be sealed with caps containing Teflon-lined  s i l ic o n e  rubber sep ta .
(g) M icro l ite r  syringes (10 f i l  and o ther convenient s izes  fo r  making s tan d a rd s ) .
(h) Gastight syringe (1 ml, with a g as t ig h t  va lve).
(1) P ipets  (0.5-ml delivery  p ipe ts  or 1.0-ml p ipe ts  graduated in 0.1-ml increments).
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( j )  Volumetric f la sk s  (10 ml or convenient s ize s  fo r  making so lu t io n s ) ,  
p referab ly  vich p la s t ic  s toppers.
(k) Gas bags, Tedlar or equivalent.
Reagents
(a) Carbon d i s u l f id e ,  "spec troqua lity"  or b e t te r  grade.
(b) Vinyl ch lo r ide , le c tu re  b o t t l e ,  99.9% minimum p u r i ty .
(c) Toluene, chromatographic q u a li ty .
(d) Helium, Bureau of Mines grade A. '
(e) F repurified  hydrogen.
(f)  F i l te re d ,  compressed a i r .
Procedure
(a) C ollection  and Shipping of Samples
(1) Immediately before sampling, break the ends of the two tubes to
provide an opening of a t  le a s t  2 mm, one-half the in te rn a l  diameter of the
tube.
(2) P osition  the second sorbent tube next tc  the sampling pump in
tandem with the f i r s t  tube, to serve as a backup. I f  one tube i s  used,
pos it ion  the smaller sec tion  of tube nearest the sampling pump.
(3) Place the sorbent tubes in a v e r t i c a l  po s it io n  with the la rg e r  
sec tion  of sorbent pointing up during sampling to minimize channeling of the 
vinyl chloride through the sorbent.
(4) Do not allow a i r  being sampled to pass through any hose or 
tubing before entering  the sorbent tubes.
(5) Measure the flowrate  and time, or the sampling volume, as 
accurately  as possib le . Take the sample a t  a f lowrate of 50 ml/minute. The 
maximum volume to be sampled should not exceed 5 l i t e r s .
(6) Sample r e la t iv e ly  la rge  volumes (10-20 l i t e r s )  of a i r  through other sorbent tubes a t  the same time personal samples are  taken. These bulk 
a i r  samples w i l l  be used by the analyst to  id e n t ify  possib le  in te rfe rences  before the personal samples are  analyzed.
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(7) Measure and record ths temperature and pressure of the
atstosphere being sampled i f  they are  s ig n i f i c a n t ly  d i f f e re n t  from 25 C or 760
umHg.
(8) Cap the sorbent tubes with the supplied p la s t i c  caps immediately 
a f t e r  sampling. Under no circumstances should rubber caps be used.
(9) Treat one tube in  the same manner as a sample tube (break, s e a l ,  
and tra n sp o r t ) ,  but do not sample any a i r  through the tube. This tube is  
labeled as a blank.
(10) Pack capped tubes t ig h t ly  to minimize tube breakage during 
transpo rt  to the labora to ry . The use of two tubes in  s e r ie s  during sampling 
elim inates the need for cooling during shipping. However, i f  only one tuba is  
used, and i f  the samples w il l  spend a day or more in  t r a n s i t ,  then cool the 
tubes, eg, with dry ic e ,  to minimize m igration of the v iny l ch lo r ide  to the 
backup sec tion .
(11) Samples received a t  the laboratory  are logged in  and immediately 
storad  in  a f reeze r  (around -20 C) u n t i l  time fo r  an a ly s is .  Samples may be
stored in th is  manner for long periods of time witn no appreciable  loss of
vinyl ch loride  (2 months). Even.around -20 C, v inyl ch loride  w il l  e q u i l ib ra te  
between the two sec tions of ac t iva ted  carbon in  one tube, ie ,  i t  w il l  migrate 
to the backup sec tion . This phenomenon is  observable a f t e r  2 weeks and may be 
confused with sample lo ss  a f t e r  1-2 months.
(b) Analysis of Samples
(1) Cleaning of Equipment. All glassware used fo r  the laboratory  
analysis  should be washed with detergent and thoroughly rinsed with tapwater and d i s t i l l e d  water.
(2) P reparation  and Desorption of Samples. The two tubes used in  the c o l lec t io n  of a s in g le  sample a re  analyzed sepa ra te ly .  I f  only one tube 
is  used fo r  sampling, then each sec tion  of ac t iva ted  carbon should be analyzed 
separa te ly . Discard the g lass  wool from each tube. Transfer both sec tions of 
each tube to a small v i a l  containing 1 ml of the precooled carbon d isu lf id e .  
I t  i s  important to add the sorbent to carbon d isu lf id e  and not the carbon 
d isu lf id e  to the sorbent. Top v ia l  with a septum cap. Discard the separa ting  
sec tion  in  each tube. Tests in d ica te  th a t  desorption i s  complete in  30 
minutes i f  the sample i s  ag ita ted  occasionally  during th is  period . The 
samples should be analyzed w ithin  60 minutes a f t e r  add it ion  to  carbon d isu lf id e .
(3) Gas-Chromatographic Conditions. The ty p ic a l  operating conditions fo r  the gas chromatograph are:
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(A) Helium c a r r ie r  gas flow, 40 ml/minute (80 p s ig ) .
(B) Hydrogen gas flow to d e te c to r ,  65 ml/minute (20 p s ig ) .
(C) Airflow to de tec to r ,  500 ml/minute (50 p s ig ) .
(D) In je c to r  temperature, 230 C.
(E) Detector temperature, 230 C.
(F) Column temperature, 60 C.
(4) In jec t io n :  The f i r s t  step  in  the analysis  i s  the in je c t io n
of the sample in to  the gas chromatograph. To e lim inate  d i f f i c u l t i e s
a r is in g  from blowback or d i s t i l l a t i o n  w ith in  the syringe needle, use the 
solvent f lush  in je c t io n  technqiue. Flush a 10-jil syringe with solvent
several times to wet the b a r re l  and plunger. Draw 2 jil o f  so lvent in to  the
syringe to increase the accuracy and rep ro d u c ib i l i ty  of the in jec ted  sample 
volume. Remove the needle from the so lvent and p u l l  the plunger back about 
0.4 yl to separa te  the so lvent flush from the sample with a pocket of a i r  
to be used as a marker. Then immerse the needle in  the sample and withdraw 
a 5-jul a l iq uo t to the 7 .4-^1 mark (2 >¿1 of so lvent + 0.4 ¡¿1 of a i r  + 5 jul
of sample » 7 . 4  j i l ) . A fter the needle i s  removed from the sample and p r io r
to in je c t io n ,  the plunger is  pulled back a short d istance to minimize
evaporation of the sample from the t ip  of the needle. Make duplicate
in jec tio n s  of each sample and standard. No more than a 3Z d iffe rence  inarea from repeated in je c t io n s  is  to be expected. Automatic sampling 
devices may also  be used. A syringe equipped with a Chaney adapter may 
also be used in  l i e u  of the so lvent f lush  technique.
(5) Measurement of Area: Measure the area under the sample peak
using an e le c t ro n ic  in te g ra to r  or some other su i ta b le  form of area 
measurement. Area measurements are  compared with a standard curve prepared 
as discussed in  Preparation  of Standards. Preliminary r e s u l t s  are read
from a standard curve prepared as discussed below.
(c) Determination of Desorption Efficiency
(1) Importance of Determination. The e ff ic iency  of desorption of a 
p a r t ic u la r  compound can vary from one laboratory  to another and a lso  from one 
batch of sorbenc to another. Thus, i t  i s  necessary to determine a t  le a s t  once 
the percentage of v iny l  ch loride  th a t  Is  removed in  the desorption process. 
Desorption e ff ic ien cy  should be determined on the same batch of sorbent tubes 
used in  sampling. Results ind ica te  th a t  desorption e ff ic iency  varies  with 
loading ( to t a l  v iny l ch loride  on the tube), p a r t ic u la r ly  a t  lower va lues, eg,
2.5 Mg.
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(2) Procedure fo r  Determining Desorption E ffic iency . Sorbent tubes 
from the same batch as th a t  used in  obtaining samples are  used in  th is  determination. In je c t  a measured volume of v iny l ch loride  gas in to  a bag 
containing a measured volume of a i r .  The concentration  in  the bag may be 
ca lcu la ted  i f  room temperature and pressure are  known. The bag i s  made of 
Tediar (or o ther m ate r ia l  th a t  w il l  r e ta in  the v iny l ch loride  and not absorb 
i t )  and should have a gas sampling valve and a septum in je c t io n  p o r t .  Sample 
a measured volume from the bag through a sorbent tube using a ca l ib ra ted  
sampling pump. Prepare a t  le a s t  f ive  tubes in  th is  manner. These tubes are 
desorbed and analyzed in  the same nanner as the samples. Samples taken with a 
gastigh t syringe from the bag are also in jec ted  in to  the gas chromatograph. 
The concentration in the bag (standard) is  compared with the concentration 
obtained from Che tube (sample).The desorption e ff ic iency  equals the amount of vinyl ch loride  desorbed 
from the .charcoal divided by the product of the vinyl ch loride  concentration 
in  the bag times the volume of syn the tic  atmosphere sampled, or;
___________ (amount of v iny l ch loride  desorbed from sorbent)___________
(vinyl ch loride  concentration in  bag) x (volume of atmosphere sampled)
Preparations of Standards
Caution: These laboratory  operations involve carcinogens.
Vinyl chloride has been id e n t i f ie d  as a human carcinogen and appropriate 
precautions must be taken in  handling th is  compound.
A se r ie s  of standards, varying in  concentration over the range of 
in te r e s t ,  is  prepared and analyzed under the same gas-chromatographic 
conditions and during the same time period as the unknown samples. Curves are 
es tab lished  by p lo t t in g  concentration  in jug/al vs peak area or peak height. 
There are  two methods of preparing standards , and they are comparable i f  
highly pu r if ied  v iny l ch loride  i s  used. I f  no in te rn a l  standard is  used in 
the method, standard so lu tions must be analyzed a t  the same time as the 
sample. This w i l l  minimize Che e f f e c t  of day-to-day v a r ia t io n s  of the flame- io n iza t ion  response.
(a) Gravimetric Method. Slowly bubble v iny l chloride in to  a weighed 10- 
ml volumetric f la s k  containing approximately 5 ml of toluene. After 3 minutes, weigh the f la sk  again. A weight change of 100-300 mg w il l  usually  be 
observed. D ilu te  the so lu tio n  to exactly  10 ml with carbon d isu lf id e  and use 
to prepare o ther standards by removing a liq uo ts  with syringes of various 
s iz e s .  Subsequent d i lu t io n  of these a l iq u o ts  with carbon d isu lf id e  r e s u l t s  in 
a s e r ie s  of standards th a t  have l in e a r  values from the range of 0.2 
n g / ln jec t io n ,  the minimum de tec tab le  amount of v iny l ch lo r ide , to 1.5 Mg/injection.
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(b) Volumetric Method. Draw a 1-al gas sample of pure vinyl chloride
in to  a g as t ig h t  syringe and close the syringe valve. In s e r t  the t ip  of the
needle in to  a 10-al volumetric f lask  containing approximately 5 ml of carbon
d isu lf id e .  Open the syringe valve and withdraw the plunger s l ig h t ly  to allow 
the carbon d isu l f id e  to enter the s.-ringe. Return the so lu tion  in  the syringe 
to the f la sk  and r in se  the syringe with clean carbon d is u l f id e ,  adding the
washings to the volumetric f la sk . F i l l  the volumetric f la sk  to tne mark with
carbon d isu lf id e .  Other standards are then prepared from th is  stock so lu tion .
Standards are stored in a f: e e :e r  it -20 C and have been found to bestab le  at this cempenture for 3 davi. T i^ h t - fit t ing p la s t ic  tops on :he 
volumetric teem to re ta in  the vinyl chloride b e t te r  than ground-glasss toppers.
Calculations
(a) The weight, in Mg, corresponding to the area under each peak is  read 
frcm the standara curve for v inyl ch loride . Mo liqu id  volume corrections are 
needed because S ch the standards and the samples are based on the number of 
Mg in 1.0 ml c carbon d isu lf id e  and the volume in jected  in both cases is  i d e n t ic a l .
(b) Corrections £'>’• the blank are made for each sample:
Mg ■ Mg(sample) - Mg(bian>0
A sim ila r  procedure i s  followed for the backup sec tio n s .
(c) Add , the amounts presen t in  the fro n t  and backup sec tions  of the same 
sample tube to determine the to ta l  amount of vinyl chloride in the sample.
(d) The to t a l  amount i s  corrected for the desorption e ff ic iency  a t  the leve l of v iny l ch loride  measured:
Corrected amount (in Mg) * amount (in  jig)
desorption e ff ic iency
(e) The coueentration  of v inyl chloride in  a i r  may be expressed in  mg/cum:
mg/cu a ■ corrected  weight ( in  Mg)______
volume of a i r  sampled (in  l i t e r s )
(f) The concentration, may a lso  be expressed in terms of ppa by volume:
ppm “ ag/cu a  x 24.¿5 x 760 x T+273 MW P 293
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where: 24.45 ■ molar volume ( l i te rs /m o le )  a t  25 C and 760 maHg 
MW ■ molecular weight 
P * pressure  (maHg) of a i r  sampled 




SAMPLING AND ANALYTICAL METHOD FOR VINYLIDENE CHLORIDE IN AIR
This is  the NIGSH-proposed (C la s s if ic a t io n  S) a n a ly t ic a l  method No. P&CAM 
266 for determination of vinylidene ch loride  in  a i r  issued November 21, 1977
[259]. This method involves adsorption on charcoal, desorption with carbon 
d isu lf id e ,  and gas chromatography. The range for determ ination of vinylidene 
chloride using th is  method is  2-12 mg/cu m (0.5-3.02 ppm) in  7 l i t e r s  of a i r .  
The p recis ion  (pooled r e la t iv e  standard deviation) i 3 approximately 5% for 
analysis of samples containing 12-85 MS of vinylidene chloride/sam ple .
Synopsis
(a) A known volume of a i r  i s  drawn through a charcoal tube to trap the 
vinylidene ch loride  p resen t.
(b) The charcoal in the tube i s  tran sfe rred  to a small v i a l  where the
vinylidene ch loride  i s  desorbed with carbon d isu l f id e .
(c) An a liq uo t of the desorbed sample i s  in jec ted  in to  a gas
chromatograph.
(d) The area or the height of the re su l t in g  peak is  determined andcompared with e i th e r  the peak areas or heights obtained from in je c t io n  of 
standards.
Working Range. S e n s i t iv i ty ,  and Detection Limit
(a) The method was tes ted  with sample loading between 12 and 85 Mg of 
vinylidene ch lo r ide /charcoal tube. The samples were co llec ted  from 
atmospheres containing vinylidene ch loride  in the range of 7.6-10.0 mg/cu m 
and having a r e la t iv e  humidity of g rea te r  than 802.
(b) The slope of the c a l ib ra t io n  curve (response vs weight/sample) was 0.0322 area count/Mg when analysis  was done by e le c t ro n ic  in te g ra t io n .  When 
analysis  was done using peak he igh t, the slope of the c a l ib ra t io n  curve was 4.75 x lO^^ajnpg/jjg.
(c) The lowest q u a n t if ia b le  l im i t  fo r  th is  method was determined to be 7 
Mg of vinylidene chloride/sample. At th is  lev e l  the r e la t iv e  standard 
devia tion  of r e p l ic a te  samples was found to be le s s  than 102 and the
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desorption e ff ic ien cy  was g rea te r  than 802. This l im i t  could be lower i f  the 
charcoal used i s  shown to give b e t t e r  desorption c h a ra c te r i s t ic s  a t  the lower 
le v e l .
In te rfe rences
(a) When two or more substances are  known or suspected to be present in  
the a i r ,  th is  information, including th e i r  suspected i d e n t i t i e s ,  should be 
transm itted  with the sample, s ince  these compounds may in te r f e re  with the 
analysis  for v inylidene ch lo ride .
(b) Any compound tha t has the same re ten t io n  time as v inylidene chloride 
under the operating conditions described in th is  method is  an in te rfe rence . 
Therefore, re te n t io n  time data on s ing le  or m ultip le  columns cannot be 
considered proof of chemical id e n t i ty .
(c) I f  the p o s s ib i l i ty  of in te rfe re n c e  e x i s t s ,  separa tion  conditions, eg, 
column packing, temperature, c a r r i e r  flow, and d e te c to r ,  must be changed to 
circumvent the problem.
Precision  and Accuracy
(a) The pooled r e l a t iv e  standard devia tion  of the a n a ly t ic a l  method was
4 .87. fo r  the analysis  of 36 samples jv er  the range of 12-85 ^g vinylidenechloride/sample.
(b) The concentration  of the sampled a i r  was a lso  determined using a gas
phase in fra red  analyzer. The gas-chromatographic determinations averaged 57. 
lower when compared with the r e s u l t s  of the in fra red  analyzer. No desorption e ff ic iency  correc tions were used.
(c) The breakthrough volume and, th e re fo re ,  the capacity ox charcoal for
vinylidene ch loride  decreased with increasing  r e l a t iv e  humidity. At 872 
r e l a t iv e  humidity the breakthrough volume was 102 of the breakthrough volume 
a t  102 r e l a t iv e  humidity. The breakthrough volume was a lso  found to be a 
function  of concentration  of vinylidene ch loride . When high r e l a t iv e  humidity 
a i r  containing 144 mg/cu m of vinylidene ch loride  was sampled a t  0.2 
l i te r /m in u te  the breakthrough volume was 3.7 l i t e r s .  At a v inylidene ch loride  concentration of 10 mg/cu m and high r e la t iv e  humidity the breakthrough volume was 7.3 l i t e r s .
(d) Samples of v inylidene ch loride  on charcoal were found to be s tab le  a t  
25 C fo r  7 days and fo r  21 days i f  s tored  a t  5 C fo r  the remainder of the period.
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Advantages and Disadvantages of Che Method
(a) The sampling device i s  small, po rtab le ,  and involves no l iq u id s .  
Many of the in te rfe re n c es  can be e lim inated by a l te r in g  chromatographic 
conditions. The tubes are  analyzed by means of a quick instrum ental method.
(b) One disadvantage of the method is  chat the amount of sample th a t  can 
be taken is  l im ited  by the capacity  of the charcoal tube. When the sample 
value obtained for the backup sec tion  of the charcoal tube exceeds 202 of th a t  
found on Che fronc sec tion , Che p o s s ib i l i ty  of sample loss e x is t s .  During sample storage the v o la t i l e  compounds may migrate throughout the tube u n t i l  
equilibrium is  reached (33% of the sample on the backup s e c t io n ) . This can be minimized by s to r ing  the samples in a r e f r ig e ra to r  u n t i l  the ana lysis  is 
performed.
(c) The p rec is ion  of the method is  lim ited  by the rep ro d u c ib i l i ty  of the 
pressure drop across the tubes. V aria tion  in  pressure drop w il l  a f fe c t  the 
f lo v ra te .  The reported salnple volume w il l  then be imprecise because the pump 
is  usually  c a l ib ra te d  fo r  one tube only.
(d) The recommended gas-chromatographic packing w il l  not separa te  v inyl 
chloride and carbon d isu lf id e .  Other gas-chromatographic packings that 
separate  v inyl ch loride  and carbon d isu l f id e  do not separate  vinylidene 
ch loride  and carbon d isu l f id e .  I f  analysis  fo r  each of these monomers i s  to 
be performed, i t  is  necessary to use d i f f e re n t  columns to analyze the samples.
Apparatus
(a) Personal sampling pump capable of accurate  performance a t  0.2 
l i te r /m in u te  and c a l ib ra ted  with a rep re sen ta t iv e  charcoal tube in  the l in e .
(b) Charcoal tubes: Glass tubes with both ends flame-sealed, 7 cm long 
with a 6-mm outer diameter, and a ¿»-mm inner diameter, containing two sections 
of 20/40-mesh ac t iva ted  carbon separated by a 2-mm portion  of urethane foam. 
The activa ted  charcoal i s  prepared from coconut sh e l ls  and i s  f i re d  a t  600 C 
p r io r  to packing. The adsorbing sec tion  contains 100 mg of charcoal, the 
backup sec tion  50 mg. A plug of s i ly l a t e d  g lass  wool i s  placed in  f ro n t  of 
the adsorbing sec tion . The pressure drop across the tube must be le ss  than 1 
inch of mercury a t  a f lowrate of 0.2 l i te r /m in u te .
(c) Gas chromatograph equipped with a flam e-ion ization  d e tec to r .  Optional: e le c tro n ic  in te g ra to r .
(d) S ilan ized  g lass gas-chromatographic column (10 f e e t  x 1/4-inch outer 
diameter) packed with Durapak OPN 100/120 mash. Any gas-chromatographic column capable of separating  carbon d isu lf id e  and v inylidene ch loride  may be used.
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(e) V ials (2 ml) th a t  can be sealed with caps containing Teflon-lined 
s i l ic o n e  rubber sep ta .
(f) M icro l i te r  sy ringes, 10 m1 . and convenient s izes  for making
s tandards.
(g) P ipe t ,  1.0 ml.
Reagents
All reagents used should be ACS Reagent Grade or b e t t e r .
(a) Carbon d isu l f id e ,  "spectroqua lity"  or b e t t e r .
(b) Vinylidene ch loride , 99%.
(c) Cyclohexane.
(d) Helium, Bureau of Mines grade A.
(e) P repu rified  hydroger.
(f) F i l te re d ,  compressed a i r .
Procedure
(a) Cleaning of Equipment. All nondisposable glassware used for the 
laboratory analysis  should be washed with detergent and rinsed  thoroughly with 
tap water and d i s t i l l e d  water.
(b) C ollection and Shipping of Samples
(1) Immediately before sampling, the ends of the tube are  broken to 
provide an opening (2 mm) a t  l e a s t  one-half the in te rn a l  diameter of the tube.
(2) The tube is  connected to the sampling pump v ia  rubber tubing. 
The smaller sec tion  of charcoal is  the backup and is  positioned nearest the. sampling pump.
(3) .The charcoal tube should be v e r t i c a l  during sampling to prevent channeling through the tube.
(4) Air being sampled should not be passed through any hose or tubing before entering  the charcoal tubes.
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(5) Measure and report the f lo v ra te  and time, or the sampling
volume, as accura te ly  as possib le . The sample is  taken a t 0.2 l i te r /m in u te  or
le s s .  The maximum volume sampled should not exceed 7.0 l i t e r s .
(6) Measure and record the temperature and pressure of the 
atmosphere being sampled.
(7) Cap the charcoal tubes with the p l a s t i c  cap3 supplied
immediately a f t e r  sampling. Under no circumstances should rubber caps be
used.
(8) For every 10 sa*3Dles taken, one charcoal tube shculd be handled
in the same manner a s  the samples (break, s e a l ,  and tra n sp o r t ) ,  except tha t no
a i r  is  sampled through th is  tube. This should be labeled as a blank.
(9) I f  samples are  shipped to a labora to ry , they should be packed 
t ig h t ly  to minimize tube breakage during shipping.
(10) Six to twelve unopened charcoal tubes should a lso  be shipped so 
desorption e ff ic iency  stud ies  can be performed on the same type and lo t  of 
charcoal used for sampling.
(11) Samples received at the laboratory  are logged in and immediately 
stored  in a r e f r ig e ra to r .
(c) Analysis of Samples
(1) P reparation  of Samples. The charcoal tubes are  removed from the 
re f r ig e ra to r  and permitted to e q u il ib ra te  to room temperature to prevent water 
condensation on the cold charcoal. Each charcoal tube i s  scored with a f i l e  
in f ro n t  of the f i r s t  sec tion  of charcoal and broken open. The g la ts  wool is
removed and discarded. The fro n t  sec tion  ( la rger)  is  t ransfe rred  to a sm?l.".
v i a l .  The separating  foam i s  removed from the tube and discarded. The backup 
sec tion  i s  a lso  tra n sfe rred  to a small v ia l .  The contents of each indiv idual
tube are  desorbed before the next sample tube is  opened.
(2) Desorption of Samples. A fter the two sec tions  of a charcoal tube are  tra n s fe rre d  to small v i a l s ,  1.00 ml of carbon d isu lf id e  is  p ipe t ted  
in to  each of the two v ia l s .  A serum cap is  then crimped in to  place immediately a f t e r  the carbon d isu lf id e  has been added. (All work with carbon 
d isu lf id e  should be performed in  a hood because of. the high to x ic i ty  of carbon 
d i s u l f id e ) .  The capped samples are  kept a t  room temperature with occasional 
a g i ta t io n .  Desorption is  complete In 30 minutes. The samples should be analyzed the same day they a re  desorbed.
(3) Gas-Chromatographic Conditions:
(A) 70 ml/minute helium c a r r ie r  flow.
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(B) 50 ml/minute hydrogen flow to d e te c to r .
(C) 500 ml/minute a i r  flow to d e te c to r .
(D) 150 C in je c to r  temperature.
(E) 200 C manifold (de tec to r)  temperature.
(F) 65 C (isothermal) oven temperature.
Under these conditions the capacity r a t io  for v inylidene ch loride  was 5.2.
(4) In je c t io n .  In je c t  a 5-jil a liquo t in to  the i;as chromatograph. A 
syringe equipped with a Chaney adapter may be used in  l ie u  of the solvent 
f lu sh  technique.
(5) Measurement of Area: Measure the area under the sample peak 
using an e le c t ro n ic  in te g ra to r  or another s u i ta b le  form of area measurement. Area measurements are  compared with a standard curve prepared as discussed in 
P reparation  of Standards.
(6) Measurement of Peak Height. The product of peak height and
a tten u a to r  s e t t in g  is  l in e a r  over the a n a ly t ic a l  range. The peak height is  
m u ltip lied  by the a ttenua to r  s e t t in g  necessary to keep the peak on sca le . 
Preliminary re s u l t s  are  read from a standard curve prepared as discussed below.
(d) Determination of Desorption Efficiency
(1) Importance of Determination. The desorpuion e ff ic iency  of a
p a r t ic u la r  compound can vary between labo ra to r ie s  and batches of charcoal. Also, fo r  a given batch of charcoal the desorption e ff ic iency  can vary with 
the weight of contaminant adsorbed. The charcoal used for the study of th is  
method gave a desorption e ff ic iency  of 802 for a loading of 7 ^g of vinylidene chloride/LQ0 m3 bed of charcoal.
(2) Procedure fo r  Determining Desorption E ffic iency . The desorption e ff ic ien cy  should be determined a t  three leve ls  with a minimum of three 
samples a t  each le v e l .  Vinylidene ch loride  can be dissolved in  cyclohexane to 
g iva stc~k so lu tio n s .  The concentrations should be such th a t  no more than 8 
Ml of a stock so lu tion  w i l l  be in jec ted  onto the charcoal. Activated charcoal
in  an amount equivalent to  th a t  found in the la rg e r  sec tion  of the charcoal
tube (100 mg) is  placed in  a small v i a l  and capped. An a l iq u o t of the stock so lu tion  is  in jec ted  in to  the charcoal tube. Two of the lev e ls  should r e f l e c t  
the extremes of the a n a ly t ic a l  range while the th i rd  lev e l  i s  inbetween the high and low le v e ls .  Each v i a l  is  allowed to stand overnight to assure 
complete adsorption of vinylidene ch loride  onto the charcoal. Standards are
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prepared by in je c t in g  an id e n t ic a l  amount of cyclohexane stock so lu tion  in to  
1.0 ml of carbon d i s u l f id e .  The samples and standards are  analyzed as
described in  Analysis of Samples.
The desorption e ff ic iency  a t  each lev e l  i s  the r a t io  of the average amount 
found to the amount taken. A blank co rrec tion  is  not expected to benecessary. The desorption eff ic iency  curve i s  constructed by p lo t t in g  the
amount of v inylidene ch loride  found in a sample vs the desorption e ff ic iency .
C alib ra t ion  and S tandardization
CAUTION: Vinylidene ch loride  has been te n ta t iv e ly  id e n t i f ie d  as a carcinogen.
Precautions must be taken while handling th is  compound • to prevent
contamination of personnel and the working area .
I t  i s  convenient to express the concentration  of standards in  terms of 
Mg/1.0 ml of carbon d isu l f id e  or Mg/sample. The density  of vinylidene 
ch loride  i s  used to convert the volume taken to the mass taken (1.218 mg/jil). A se r ie s  of standards varying in  concentration over the range of in te r e s t  is  
prepared end analyzed under the same gas-chromatographic conditions and during the same t;ime period as the samples. I t  i s  best to a l te rn a te  standard then 
sample, during the ana ly s is .  Curves are  es tab lished  by p lo t t in g  the
concentra:ion of the standards in  Mg/1*0 ml of carbon d isu lf id e  vs peak areaor p'eak h i ig h t .
Calculations
(a) The sample weight in  Mg i3 read from the standard curve.
(b) Blank co rrec tions are  not expected bu t, i f  the analysis  shows a blank 
co rrec tion  i s  needed, the co rrec tion  i s :
WF -  Ws -  Wb
where:
WF * corrected  amount (Mg) on the f ro n t sec tion  of the charcoal tube 
Ws * amount found on the ’fro n t  sec tion  of 
the charcoal tube 
Wb ■ amount (Mg) found on the f ro n t sec tion  of the blank charcoal tube
A s im ila r  procedure i s  followed for the backup sec tion s .
\
(c) A co rrec tion  for desorption e ff ic iency  i s  made:
MF -  WF 
D
where:
MF ■ corrected  amount (pg)
WF ■ amount (¿ig) a f t e r  blank co rrec tion  
D ■ desorption e ff ic iency  corresponding to the weight WF
The corrected amount of the backup sec tion , MB, is  s im ila r ly  ca lcu la ted .
(d) The concentration , C, of vlnylidene ch loride  in the a i r  sampled is  
expressed in  mg/cu m, which i s  numerically equal to ¿¿g/liter:
C -  MF + MBV
where:
MF -  amount of v lnylidene ch loride  found on fro n t  
sec tion  in tig MB ■ amount of viny?.J.dene ch loride  found on backup 
sec tion  in  Mg V ■ volume of a i r  sampled in  l i t e r s
(e) I f  desired the r e s u l t s  nay be expressed in ppm a t 25 C (298 K) and 
760 mmHg:
C(ppm) * C (^ g / l i te r )  x 24.45 x 760 x T + 273
96.6 P 298
where:
P ■ pressure of a i r  sampled ln mmHg 
T ■ temperature of a i r  sampled in  C
24.45 * molar volume a t  25 C and 760 mmHg in l i te r s /m o l  






SAMPLING AND ANALYTICAL METHOD FOR VINYL BROMIDE IN AIR
The da ta  presented in th is  proposed sampling and a n a ly t ic a l  method for 
v inyl bromide were adapted from NIOSH method No. P&CAM 127 for Organic Solvents in Air [336] and from information provided by Bales [249] and DW 
Yeager (w ritten  communication, February 1978). This proposed method, as outlined below, has not been tes ted  by NIOSH but should allow routine  analyses in the 1-ppm range.
P rinc ip le  of the Method
(a) A known volume . of a i r  i s  drawn through a charcoal tube to trap the 
v inyl bromide presen t.
(b) The charcoal in the tube is  tran sfe rred  to a small, graduated t e s t
tube and desorbed with carbon d isu lf id e .
(c) An a liq uo t of the desorbec sample is  in jec ted  in to  a gaschromatograph.
(d) The area of the re su l t in g  peak i s  determined and compared with areas
obtained from the in je c t io n  of standards.
Range and S e n s i t iv i ty
No data are curren tly  a v a i lab le .  However, Bales [249] reported 
measurement of v iny l bromide concentrations down to 0.01 ppm using th is  general method.
In te rfe rences
(a) When the amount of water in  the a i r  i s  so g reat tha t condensation ac tu a l ly  occurs in  the tube, v iny l bromide w i l l  not be trapped. Preliminary 
experiments ind ica te  th a t  high humidity severely  decreases the breakthrough volume.
(b) I t  must be emphasized th a t  any compound which has the same re ten t io n  
time as v iny l bromide a t  the operating conditions described in  th is  method is  
an in te rfe re n c e .  Hence, re ten t io n  time data on a s ing le  column, or even on a 
number of columns, cannot be considered as proof of chemical id e n t i ty .  For 
th is  reason i t  i s  important that a sample of the so lven t(s)  be submitted at 
the same time so th a t  id e n t i ty ( ie s )  can be es tab lished  by other means.
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(c) I f  the p o s s ib i l i ty  of in te rfe ren ce  e x is t s ,  separation  conditions 
(column packing, temperatures, etc) must be changed to circumvent the problem.
P rec is ion  and Accuracy
No data  a re  cu rren tly  ava i lab le .
Advantages and Disadvantages of the Method
(a) The sampling device is  small, po rtab le ,  and involves no l iqu id s .
In te rferences  are minimal, and most of those which do occur can be eliminated
by a l te r in g  chromatographic conditions. The charcoal tubes are analyzed by 
means of a quick, instrum ental method.
(b) One disadvantage of the method is  th a t  the amount of sample which can 
be taken i s  lim ited  by the number of mg th a t  the tube w il l  hold before 
overloading. When the sample value obtained fo r  the backup sec tion  of the 
charcoal trap  exceeds approximately 20% of th a t  found on the fron t sec tion ,
the p o s s ib i l i ty  of sample loss e x is t s .  During sample storage the more
v o la t i le  compounds w il l  migrate throughout the tube u n t i l  equilibrium  is  
reached.
(c) Furthermore, the p recis ion  of the method is  lim ited by the 
rep ro d u c ib il i ty  of the pressure drop across the two sec tions of the sampling 
tube. This drop w i l l  a f fe c t  the flowrate and cause the volume to be imprecise, because the pump is  usually  ca l ib ra ted  fo r  one tube only. This 
disadvantage could be eliminated by c a l ib ra t in g  the pump with a rep resen ta t ive  charcoal tube.
Apparatus
(a) An approved and c a l ib ra ted  personal sampling pump fo r  personal 
samples. For an area sample any vacuum pump whose flow can be determined accura te ly  a t  1 l i te r /m in u te  or le s s .
(b) Charcoal tubes: glass tube with both ends flame-sealed, 7 cm long 
with a 6-tnm outer diameter and a 4-mm inner diameter, containing two sec tions 
of 20/40-mesh ac t iva ted  charcoal separated by a 2-mm portion of urethane foam. 
The ac t iva ted  charcoal is  prepared from coconut sh e l ls  and is  f i re d  a t  600 C 
p r io r  to packing. The absorbing sec tion  contains 100 mg of charcoa l, the 
backup sec tion  50 mg. A 3-mm portion  of urethane foam i s  placed between the 
o u t le t  end of the tube and the backup sec tion . A plug of s i ly la te d  g lass wool 
i s  placed in  f ro n t  of the absorbing sec tion . The pressure  drop across the 




(c) Gas chromatograph equipped with a flam e-ion iza tion  d e tec to r .
(d) Column, 20 f e e t ,  SE-30. Other columns capable of performing the
required separa tions may be used.
(e) A mechanical or e lec tro n ic  in te g ra to r  or a recorder and some method 
for determining peak area.
(f)  Glass stoppered micro tubes. The 2.5-ml graduated m icrocentrifuge 
tubes are  recommended.
(g) Hamilton syringes: 10 m1, and convenient s ize s  fo r  making standards.
(h-) P ipe ts :  0.5-ml delivery  p ipe ts  or 1.0-ml type graduated in 0.1-ml
increments.
( i)  Volumetric f la sk s :  10 ml, or convenient s izes  fo r  making standard
so lu tions .
Reagents
(a) Carbon d is u l f id e ,  "spectroqua lity"  or b e t t e r .
(b) Sample of the sp e c if ic  compound undtr study, preferably
"chromatoquality" grade.
(c) Helium, Bureau of Mines grade A.
(d) P repurified  hydrogen.
(e) F i l te r e d ,  compressed a i r .
Procedure
(a) C a l ib ra t ion  of Personal Pumps. Each personal pump must be c a l ib ra tedwith a rep resen ta tive  charcoal tube in  the l in e .  This w i l l  minimize e rro rs
associated  with u rc e r ta in t ie s  in  the sample volume co llec ted .
(b) C ollection and Shipping of Samples
(1) Immediately before sampling, the ends of the charcoal tube 
should be broken to provide an opening a t  l e a s t  one-half the in te rn a l  diameter 
of the tube (2 mm).
(2) The sm aller sec tion  of charcoal is  used as a backup and should 
be positioned nearest  the sampling pump.
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(3) The charcoal cube should be v e rc ic a l  during sampling.
(4) Air being sampled should noc be passed chrough any hose cr
Cubing before eacering Che charcoal Cube.
(5) The flowrace, Cime, and/or volume musC be measured as accuracely
as poss ib le .  The sample should be caken a t  a flowrace of 1 l i te r /m in u te  or
le s s  Co aCCain Che Cotal sample volume required .
(6) The cemperacure and pressure of the atmosphere being sampled 
should be measured and recorded.
(7) The charcoal tubes should be capped with the supplied p la s t ic
caps immediately a f t e r  sampling. Under no circumstances should' rubber caps be
used.
(8) One Cube should be handled in  Che same manner as Che sample cube
(break, s e a l ,  and Cransport), cxcept chat no a i r  i s  sampled through th is  tube.
This Cube should be labeled as a blank.
(9) Capped Cubes should be packed cighcly before they are shipped to 
minimize cube breakage during shipping.
(10) Samples received a t  the laboratory  are  logged in and immediacely 
scored in  a r e f r ig e r a c o r .
(c) Cleaning of EquipmenC. All glassware used fo r Che laboratory  
analysis  should be decergenc washed and choroughly rinsed  wlch Cap wacer and d i s c l l l e d  water.
(d) Analysis of Samples
(1) P repara tion  of Samples. In prepara tion for an a ly s is ,  each 
charcoal Cube is  scored with a f i l e  in  fronc of Che f i r s c  secCion of charcoal 
and broken open. The g lass wool i s  removed and discarded. The charcoal in  
Che f irsC  (la rger)  seccion i s  cransferred  Co a small scoppered cesc Cube. The 
separaCing seccion of foam is  removed and discarded; Che second seccion is  Cransferred Co another CesC Cube. These cwo sec tions are  analyzed separa te ly .
(2) Desorpcion of Samples. P r io r  Co an a ly s is ,  0.5 ml of carbon d isu lf id e  i s  plpecced inco each cesc cube and Che g lass sCopper is  inserCed. 
(All work wich carbon d isu lf id e  should be performed in  a hood because of ics  
high coxic icy .)  Tescs indicace chat desorpcion i s  complece in  30 minuces i f  
Che sample i s  agicaced occasionally  during chis period . The use of graduated 
glass-scoppered, microcenCrifuge cubes i s  recommended so chac one can observe 
any change in  volume during Che desorpcion process. Carbon d isu lf id e  i s  a 
very v o la c i le  solvenc, so volume changes can occur during che desorpcion 





by the charcoal plus the 0.5 ml of carbon d isu lf id e  should be noted and 
corresponding voluat adjustments should be made whenever necessary j u s t  before 
gas chromatographic ana ly s is .
(3) Gas-Chromatographic Conditions. The ty p ic a l  operating 
•'conditions fo r  the gas chromatograph are:
(A) 30 cc/minute helium c a r r ie r  gas flow.
(B) 65 cc/minute (24 n«?is;) hydrogen gas flow to d e tec to r .
(C) 500 cc/minute (50 psig) a i r  flow to d e tec to r .
(D) 200 C in je c to r  temperature.
(E) 200 C manifold temperature (detector)
(F) Column temperature, 70 C, door on instrument closed.
(4) In je c t io n .  The f i r s t  step in the analysis i s  the in je c t io n  of 
the sample in to  the gas chromatograph. To e lim inate  d i f f i c u l t i e s  a r is in g  from 
blowback or d i s t i l l a t i o n  w ith in  the syringe needle, one should employ the 
solvent f lush  in je c t io n  technique. The 10-<il syringe is  f i r s t  flushed with 
solvent severa l times to wet the b a r re l  and plunger. Three m ic ro l i te r s  of
solvent are  drawn in to  the syringe to increase the acouracy and
rep ro d u c ib il i ty  of the in jec ted  sample volume. The needle i s  removed from *he 
so lvent, and the plunger i s  pulled back about 0.2 to separate  the solvent f lush  from the sample with a pocket of a i r  to be used as a marker. The needle 
is  then immersed in the sample, and a 5-;il a l iq uo t is  withdrawn, taking in to  
consideration  the volume of rhe needle, s ince  the sample in  the needle w il l  be completely in je c te d .  A fter the needle is  removed from the sample arid p r io r  to 
in je c t io n ,  the plunger is  pulled  back a short d istance to minimize evaporation 
of the sample from the t ip  of the needle. Duplicate In jec t ion s  of each sample
and standard should be made. No more than a 31 d iffe rence  in  area i s  to he
expected.
(5) Measurement of Area. The area of the sample peak is  measured by 
an e le c tro n ic  In teg ra to r  or some other s u i ta b le  form of area measurement, and 
prelim inary r e s u l t s  are  read from a standard curve prepared as discussed below.
(a) Determination of Desorption Efficiency
(1) Importance of Dtermlnatlon. The desorption e ff ic iency  of a 
p a r t ic u la r  compound can vary from one labora tory  to another and a lso  from one 
batch of charcoal to another. Thus, i t  is  necessary to determine a t  l e a s t  
once the percentage of t:he sp ec if ic  compound th a t  is  removed in  the desorption 
process fo r a given compound, provided the same batch of charcoal is  used.
(2) Procedure for Determining Desorption E ffic iency . Activated 
charcoal equivalent to the amount In the f i r s t  sec tion  of the sampling tube 
(100 ng) i s  measured la to  a 5-cm, 4-mm inner diameter g lass  tube, flame-sealed 
a t  one end (s im ila r  to commercially ava i lab le  culcure tubes). This charcoal must be from the same batch as th a t  used in  obtaining the samples and can be 
obtained from unused charcoal cubes. The open end i s  capped with Parafilm . A 
known amount of the v inyl bromide is  in jec ted  d i re c t ly  in to  che ac t iv a ted  
charcoal with a m ic ro l i te r  syringe, and the tube is  capped with more Parafilm .
At l e a s t  f ive  tubes are prepared in th is  manner and allowed to stand for 
a t  le a s t  overnight to assure complete absorption of the v inyl bromide onto the 
charcoal. These f ive  tubes are  re fe rred  to as the samples. A p a r a l l e l  blank 
tube should be trea ted  in the same manner except tha t no sample is  added to i t .  The sample and blank tubes are  aesorbed and analyzed in  exactly  the same 
manner as the sampling tube described in Analysis of Samples.
Two or th ree  standards are  prepared by in je c t in g  the same volume of v iny l 
bromide in to  0.5 ml of carbon d isu l f id e  with the same syringe used in  the preparation of the sample. These are anal Samplingyzed «rith the samples.
The desorption e ff ic iency  equals the d iffe rence  between the average peak 
area of the samples and the peak area of the blank divided by the average peak area of the s tandards , or:
Desorption Efficiency * Area sample -  Area blank
Area standard
C alib ra tion  and Standards
I t  is  convenient to express concentration of standards in terms of mg/0.5 
ml of carbon d isu l f id e  because samples are desorbed in  th is  amount of carbon 
d isu lf id e .  To minimize e rro r  due to the v o l a t i l i t y  of carbon d is u l f id e ,  one 
can in je c t  20 times the volume of v iny l bromide in to  10 ml of carbon 
d isu lf id e .  For example, to prepare a 0.3 mg/0.5 ml of standard, one would 
in je c t  6.0 mg in to  exactly  10 ml of carbon d isu lf id e  in  a g lass-stoppered 
f la sk .  The density  of the sp ec if ic  compound is  used to convert 6.0 mg in to  yl 
for easy measurement with a m ic ro l i te r  syringe. A se r ie s  of s tandards, 
varying in  concentration over the range of i n t e r e s t ,  is  prepared and analyzed under the same gas-chromatographic conditions and during the same time period 
as the unknown samples. Curves are  es tab lished  by p lo t t in g  concentration  in  fg /0 .5  ml vs peak area.
NOTE: Since no In te rn a l  standard i s  used in  the method, standard so lu tionsmust be analyzed a t  the same time th a t  the sample analysis  is  done. This w il l  
minimize the e f f e c t  of known day-to-day v a r ia t io n s  and v a r ia t io n s  during the same day cf the f lam e-ion ization  de tec to r  response.
Calculations
(a) The weight, in  mg, corresponding to each peak area i s  read froo  the 
standard curve. No volume correc tions are  needed, because the standard curve 
i s  based on mg/0.5 ml of carbon d isu l f id e  and the volume of sample in je c te d  is  
id e n t ic a l  to the volume of the standards In jec ted .
(b) Corrections fo r  the blank must be made fo r  each sample.
Correct mg -  mg(s) -  mg(b)
where:
mg(s) -  mg found in fron t sec tion  of sample tube
mg(b) * mg found in fro n t  sec tion  of blank tube
A s im ila r  procedure i s  followed for the ba<_kup sec tion s .
(c) The corrected  amounts presen t in the f ro n t  and backup sec tions of the 
same sample tube are  added to determine the to t a l  measured amount in  the 
sample.
(d) This to t a l  weight is  divided by the determined desorption e ff ic iency  
to obtain  the t o t a l  mg/sample.
(e) The volume of a i r  sampled is  converted to standard conditions of 25 C 
and 760 mmHg:
Vs * V x _P_ x 298 760 T+273
where:
Vs ■ volume of a i r  in  l i t e r s  a t  25 C and 760 mmHg 
V -  volume of a i r  in  l i t e r s  as measured 
P -  barometric pressure in  mmHg 
T -  temperature of a i r  in  degrees C
(f) The concentration  of the v iny l bromide in  the a i r  sampled can be 
expressed in  mg/cu m, which is  numerically equal to M g/li ter of a i r :
mg/cu m -  M g/Hter -  to t a l  mg x  1,000 (jig / l i t e r )
Vs
(g) Another method of expressing concentration  i s  ppm:
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ppm » m-1 of v iny l  bromide/Vs
ppm ■ uz  of v iny l  bromide x 24.45 Vs MW
where:
24.45 * molar volume a t  25 C and 760 mmHg 
MW -  mr.lecular weight of v iny l bromide
fl* *
XIV. APPENDIX V
SAMPLING AND ANALYTICAL METHOD FOR VINYL FLUORIDE IN AIR
The data presented in th is  proposed sampling and a n a ly t ic a l  method for 
v inyl f lu o r id e  were adapted from NIOSH method No. P&CAM 127 for Organic 
Solvents in Air [336] and information provided by Bales [2.50] and DW Yeager 
(w ritten  communications, August 1977 and February 1978). The proposed method, as ou tlined  below, has not been tes ted  by NIOSH, but should allow rou tine  
analyses in the 1-ppm range.
P r in c ip le  of the Method
(a) A known volume of a i r  is  pumped in to  a Teflon bag.
(b) An a l iq u o t  of the a i r  sample in  the bag is  in jec ted  in to  a gas 
chromatograph.
(c) The area of the re su l t in g  peak i s  determined and compared with areas 
obtained from the in je c t io n  of standards.
Range and S e n s i t iv i ty
The l im i t  of de tec tion  has been reported as 1 ppm (1.88 mg/cu n) (DW 
Yeager, w r it ten  communication, February 1978).
In te rfe rences
(a) I t  must be emphasized chat any compound which has the same re ten t io n  
time as v iny l f lu o r id e  a t  the operating conditions described in  th is  method is  
an In te rfe rence . Hence, re ten t io n  time data on a s ing le  column, or even on a number of columns, cannot be considered as proof of chemical id e n t i ty .  For th is  reason i t  i s  important that a sample of the bulk so lv e n t(s '  be submitted 
a t  the same time so th a t  id e n t i ty ( ie s )  can be es tab lished  by o ther means.
(b) I f  the p o s s ib i l i ty  of in te rfe ren ce  e x i s t s ,  separa tion  conditions 
(column packing, temperatures, e tc) must be changed to circumvent the problem.
(c) I f  samples are not analyzed w ith in  3-4 days, s ig n i f ic a n t  sample 
leakage may occur (DW Yeager, w ritten  communication, August 1977).
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P recision  ar.d Accuracy
No data  on p rec is io n  and accuracy are  ava i lab le  a t  th is  time.
Advantages and Disadvantages of the Method
(a) The sampling device i s  portab le  and Involves no l iq u id s .
In te rfe rences  are  minimal, and most of those which do occur can be elim inated 
by a l te r in g  chromatographic conditions. The samples are analyzed by means of a quick, instrum ental method. No solvent desorption is  necessary.
(b) One disadvantage of the method is tha t the amount of sample which can
be taken is  lim ited  by the volume capacity of the bag. Full sample bags may
in te r f e re  with the f re e  movement of the worker.
(c) Furthermore, the p rec is ion  of the method .s lim ited  by the
rep ro d u c ib i l i ty  of th*i sampling ra te  of the pump.
Apparatus
(a) An approved and c a l ib ra ted  p e r i s t a l t i c  sampling pump, diaphragm-pump, 
or vacuum pump, with f i l t e r e d  o u t le t  to remove o i l ,  fo r personal samples. For 
an area sample any vacuum pump whose flow can be determined accurately  a t  1 l i te r /m in u te  or le s s .
(b) Teflon bag.
(c) Gas chromatograph equipped with a f lam e-ion ization  de tec to r .
(d) Column, 20 f e e t ,  SE-30. Other columns capable of performing the required separa tions may be used.
(e) A mechanical or e le c t ro n ic  in te g ra to r  or a recorder a^d some method fo r  determining peak area.
(f)  Syringes: 5 ml.
Reagents
(a) Vinyl f lu o r id e ,  99%.
(b) Helium, Bureau of Mines grade A.
(c) P repu rif ied  hydrogen.
(d) F i l te re d ,  compressed a i r .
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(a) C a lib ra t ion  of Personal Sampling Pumps. Each personal smapling pump 
must be c a l ib ra ted  with a rep re sen ta t iv e  bag In the l in e .  This w il l  minimize 
e rro rs  associa ted  with u n c e r ta in t ie s  in the sample volume c o l lec ted .
(b) C ollec tion and Shipment of Samples
(1) Tue f low rate , t in e ,  and/or volume must be measured as accurately  
as possib le . The sampling bags should be flushed before use. The sample should be taken a t  a f low rate  of 1 l i te r /m in u te  or le ss  to a t t a in  the to t a l  
sample volume required .
(2) The temperature and pressure of the atmosphere being sampled 
should be measured and recorded.
(3) Air samples are  shipped to the laboratory  for analysis  in the 
Teflon bags. Appropriate precautions should be taken to prevent damage of the 
bags while in  t r a n s i t .
(c) Analysis of Samples
(1) Gas-Chromatographic Conditions. The ty p ica l  operating 
conditions for the gas chromatograph are:
(A) 30 cc/minute helium c a r r ie r  gas flow.
(B) 65 cc/minute (24 psig) hydrogen gas flow to d e tec to r .
(C) 500 cc/minute (50 psig) a i r  flow to de tec to r .
(D) 200 C in je c to r  temperature.
(E) 200 C manifold tempertaure (d e tec to r) .
(F) Column temperature, 33 C, door of oven open and blower l e f t
on.
(2) In je c t io n
Five m i l l i l i t e r s  of a i r  from the Teflon bag i s  withdrawn with a 
syringe. Two m i l l i l i t e r s  are in jec ted  d i re c t ly  in to  the gas chromatograph.
(3) Measurement of Area. The area of the sample peak is  measured by 
an e le c t ro n ic  in te g ra to r  or some other su i ta b le  form of area measurement, and







C alib ra t ion  and Standards
Standards are prepared by f i l l i n g  seve ra l Teflon bags with known 
concentrations of v iny l f lu o r id e  which cover the range of in t e r e s t .  Five 
m i l l i l i t e r s  of a i r  from each standard bag are  withdrawn and 2 ml are  in jec ted  d i r e c t ly  in to  the instrument.
C a lib ra t ion  curves are  prepared by p lo t t in g  '■he concentration (mg of v inyl f lu o r id e /2  ml) vs peak area.
Calculations
(a) The weight, in  mg, corresponding to each peak area i s  read from the 
standard curve for the p a r t ic u la r  compound. No volume correc tions are needed, 
because the standard curve i s  based on mg/2 ml and the volume of sample 
in jec ted  i s  id e n t ic a l  to the volume of the standards in je c te d .
(b) The volume of a i r  sampled (co llec ted  i.i bag) is  converted to standard conditions of 25 C and 760 mmHg:
Vs " v x _L_ x 298 760 T+273
where:
Vs -  volume of a i r  in  l i t e r s  a t  25 C and 760 mmHg 
V ■ volume of a i r  in  l i t e r s  as measured 
P ■ barometric pressure in'mmHg 
T * temperature of a i r  in  degress centigrade
(c) The concentration  of v iny l f lu o r id e  in the a i r  sampled can be 
expressed in mg/cu m, which is  numerically equal to y g / l i t e r  of a i r :




SAMPLING AND ANALYTICAL METHOD FOR VINYLIDENE FLUORIDE IN AIR
The data presented in th is  proposed sampling and a n a ly t ic a l  method for 
vinylldene f lu o r id e  were adapted from NIOSH method No. P&CAM 127 for Organic 
Solvents in Air [336] and from information provided by the Pennwalt Corporation [251] and JL Sadenwasser (written communication, March 1978). 
This proposed method, as outlined below, has not been te s ted  by NIOSH, but i t  
should allow rou tine  analyses in the 1-ppm range.
P rinc ip le  of the Method
(a) A known volume of a i r  i s  drawn through two charcoal tubes in  se r ie s  
to trap the v inylidene f lu o r id e  p resen t.
(b) The charcoal in the tubes i s  t ra n sfe rred  to a small, graduated t e s t
tube and desorbed with carbon d isu lf id e .
(c) An a l iq u o t of the desorbed sample is  in jec ted  in to  a gas
chromatograph.
(d) The area of the re su l t in g  peak is  determined and compared with areas
obtained from the in je c t io n  of standard?
Range and S e n s i t iv i ty
No data a re  cu rren tly  ava i lab le .  However, Sadenwasser (w ritten  
communication, March 1978) reported measuring vinylidene f luo ride
concentrations down to about 2 ppm using th is  general method.
In te rferences
(a) When the amount of water in  the a i r  i s  so g rea t th a t  condensation 
ac tua l ly  occurs in  the tube, v inylidene f luo ride  w i l l  not be trapped.
Preliminary experiments in d ica te  tha t high humidity severely  decreases the breakthrough volume.
(b) I t  must be emphasized th a t  any compound which has the same re ten t io n  
time as v inylidene f lu o r id e  a t  the operating conditions described in th is  
method is  an in te rfe ren ce . Hence, re ten t io n  time data on a s in g le  column, or 
even on a number of columns, cannot be considered as proof of chemical
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id e n t i ty .  For th is  reason i t  i s  important th a t  a sample of the so lven t(s)  be 
submitted a t  the same time so th a t  id e n t i ty ( i e s )  can be estab lished  by ~cher 
means.
(c) I f  the p o s s ib i l i ty  of in te rfe ren ce  e x i s t s ,  separa tion  conditions 
(column packing, temperatures, etc) must be changed to circuuvent the problem.
(d) I f  samples are  not analyzed w ithin 5 days, s ig n i f ic a n t  sample loss 
may occur. Although no sp ec if ic  data were provided, JL Sadenwasser (w ritten  communication, March 1978) s ta ted  tha t vinylidene f lu o r id e  was re ta ined  by the 
charcoal fo r  a t  l e a s t  5 days with l i t t l e  lo ss .
P rec ision  and Accuracy
No data  are  cu rren tly  ava ilab le .
Advantages and Disadvantages of the. Method
(a) The sampling device is  small, po rtab le , and involves no l iq u id s .  
In te rfe rences  are minimal, and most of those th a t  do occur can be eliminated 
by a l te r in g  chromatographic conditions. The charcoal tubes are analyzed by 
means of a quick, instrum ental method.
(b) One disadvantage of the method is  th a t  the amount of sample which can 
be taken is  lim ited  by the number of mg th a t  the tubes w i l l  hold before 
overloading. When the sample value obtained fo r  the backup sec tion  of the 
charcoal trap  exceeds approximately 20% of th a t  found on the fro n t sec tion , 
the p o s s ib i l i ty  of sample loss e x is t s .  Sampling a t  1 l i te r /m in u te  caused a s ig n if ic a n t  breakthrough a f t e r  c o l le c t io n  of 3 l i t e r s .  Curing sample s to rage , 
v o la t i l e  compounds such as vinylidene f lu o r id e  w il l  migrate throughout the tube u n t i l  equilibrium is  reached.
(c) Furthermore, the p recis ion  of the method is  lim ited  by the 
rep ro d u c ib il i ty  of the pressure drop across the two sec tions of the sampling tubes. This drop w i l l  a f fe c t  the flowrate and cause the volume to be 
imprecise, because the pump is  usually  c a l ib ra ted  for one p a r t ic u la r  tube 
only. This disadvantage could be elim inated by c a l ib ra t in g  the pump with rep resen ta tive  charcoal tubes.
Apparatus
(a) An approved and c a l ib ra ted  personal-sampling pump fo r  personal 
samples. For an area sample any vacuum pump whose flow can be determined 
accura te ly  a t  0.5 l i te r /m in u te  or le s s .
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(b) Charcoal tubes: g lass tube with both ends flam e-sealed, 7 cm long 
with a 6-mm outer diameter and a 4-mm inner diameter, containing two sections 
of 20/40-mesh ac t iva ted  charcoal separated by a 2-mm portion  of urethane foam. The ac t iva ted  charcoal is  prepared from coconut sh e l l s  and is  f i r e d  a t  600 C 
p r io r  to packing. The absorbing sec tion  contains 100 mg of charcoal, the backup sec tion  50 mg. A 3-mm portion  of urethane foam is  placed between the 
o u t le t  end of the tube and the backup sec tion . A plug of s i ly la te d  g lass wool i s  placed in fron t of the absorbing sec tion . The pressure  drop across the 
tube must be less than 1 inch of mercury a t  a f lowrate of 1 l i te r /m in u te .
(c) Gas chromatograph equipped with a flam e-ioniza tion  d e tP c to i .
(d) Column, s ta in le s s  s t e e l ,  6 -fee t x 1/8-inch outer diameter, packed 
with Chromosorb 102, 80/100 mesh. Other columns capable of performing the 
required separations may be used.
(e) A mechanical or e le c t ro n ic  in te g ra to r  or a recorder and some method for determining pea»*. a rea . •
(f) Glass stoppered micro tubes. The 2.5-ml graduated m icrocentrifuge cubes are  recommended.
(g) Hamilton syringes: 10 yl, and convenient s izes  for making standards.
(h) P ipe ts :  0.5-ml delivery  p ipe ts  or 1.0-ml type graduated in 0.1 j 1 
increments.
( i)  Volumetric f la sk s :  10 ml or convenient s izes  fo r  making standard so lu t io n s .
Reagents
(a) Carbon d i s u l f id e ,  "spec troqua lity"  or b e t t e r .
(b) Sample of the sp e c if ic  compound under study, preferably  "chromatoquality" grade.
(c) Helium, Bureau of Mines grade A.
(d) P repu rif ied  hydrogen.
(e) F i l te re d ,  compressed a i r .
Procedure
(a) C a l ib ra t ion  of Fersonal Sampling Pumps. Each personal sampling pump
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must be c a l ib ra ted  with rep re sen ta t iv e  charcoal tubes in the l i n e .  This w il l  
minimize e rro rs  assoc ia ted  with u n c e r ta in t ie s  in tha sample volume co llec ted .
(b) C ollec tion  and Shipping of Samples
(1) Immediately before sampling, the ends of the tube should be 
broken to provide an opening a t  l e a s t  one-half the in te rn a l  diameter of the 
tube (2 mm).
(2) P osi t io n  the second charcoal tube next to the sampling pump in
tandem with the f i r s t  tube, to serve as a bickup. I f  one tube is  used the 
sm aller sec tion  of charcoal is  used ¿s a backup and should be positioned 
nearest  the sampling pump.
(3) The charcoal tube should be v e r t i c a l  during sampling.
(4) Air being sampled should not be passed through any hose or 
tubing before en tering  the charcoal tube.
(5) The f low rate , time, and/or volume must be measured as accurately  
as poss ib le .  The sample should be taken at a f lowrate of 0.5 l i te r /m in u te  or 
le ss  to a t t a in  Che to t a l  sample volume required . The s e n s i t i v i ty  of the 
method is  increased by using lover flowrates to increase the amount of sample 
co llec ted  (JL Sadenwasser, w r it ten  communication, March 1978).
(6) The temperature and pressure  of the atmosphere being sampled should be measured and recorded.
(7) The charcoal tubes should be carped with Che supplied p la s t ic
caps immediately a f t e r  sampling. Under no circumstances should rubber caps be used.
(8) One tube should be handled in the same manner as a sample tube 
(break, s e a l ,  and t ra n sp o r t ) ,  except tha t no a i r  is  sampled through th is  tube. 
This tube should be labeled as a blank.
(9) Capped tubes should be packed t ig h t ly  before they are  shipped to minimize tube breakage during shipping.
(10) Samples received a t  the labora tory  are logged in and immediately s tored  in a r e f r ig e r a to r .
(c) Cleaning of Equipment. All glassware used fo r  the laboratory
analysis  should be detergent washed and thoroughly rinsed  with tap water andd i s t i l l e d  water.
(d) Analysis of Samples
(1) Preparation  of Samples. The two tubes used in  the c o l lec t io n  of
261
a s in g le  sample are  analyzed separa te ly . I f  only one tube i s  used fo r  
sampling, then each sec tion  of ac t iva ted  carbon should be analyzed separa te ly . 
In prepara tion  fo r  a n a ly s is ,  each charcoal tube i s  scored with a f i l e  in  fron t 
of the f i r s t  sec tion  of charcoal and broken open. The g lass wool i s  removed 
and discarded. The charcoal in  the f i r s t  ( la rg e r)  sec tion  is  tra n s fe rre d  to a 
small stoppered te s t  tub«. The separa ting  sec tion  of foam is  removed and 
discarded; the second sec tion  is  t ra n sfe rred  to another t e s t  tube. These two 
sec tions are  analyzed separa te ly .
(2) Desorption of Samples. P r io r  to a n a ly s is ,  2 ml of carbon d isu lf id e  i s  p ipe tted  in to  each t e s t  tube and the g lass stopper is in se r ted . 
(All work with carbon d isu lf id e  should be performed in  a hood because of i t s  
high to x ic i ty . )  Tests in d ica te  th a t  desorption is  complete in 15 minutes i f  the sample is a g ita te d  occasionally  during th is  period. The use of graduated 
g lass-stoppered , :nicrocentrifuge tubes is  recommended so th a t  one ca:i observe 
any change in  volume during the desorption process. Carbon d isu lf id e  is  a 
very v o l a t i l e  so lvent, so volume changes can occur during the desorption 
process depending on the surrounding temperature. The i n i t i a l  volume occupied 
by the charcoal plus the 2 ml of carbon d isu lf id e  should be noted and 
corresponding volume adjustments should be made whenever necessary ju s t  before 
gas-chromatographic ana ly s is .
(3) Gas-Chromatographic Conditions. The ty p ic a l  operating 
conditions for the gas chromatograph are:
(A) 30 .c/minute helium c a r r ie r  gas flow.
(B) 50 cc/minute (24 psig) hydrogen gas flow to d e tec to r .
(C) 500 cc/minute (50 psig) a i r  flow to de tec to r .
(D) 150 C in je c to r  temperature.
(E) 200 C manifcld temperature (detecto r)
(F) Column temperature, 100 C, door on instrument closed.
(4) In je c t io n .  The f i r s t  step in  the analysis  is  the in je c t io n  of 
the sample into the gas chromatograph. To e lim inate  d i f f i c u l t i e s  a r is in g  from 
blowback or d i s t i l l a t i o n  w ithin  the syringe needle, one should employ the 
so lvent f lu sh  in je c t io n  technique. The 10-/il syringe is  f i r s t  flushed with 
so lvent severa l times to wet the b a r re l  and plunger. Three m ic ro l i te r s  of 
so lvent i s  drawn in to  the syringe to increase the accuracy and rep ro d u c ib i l i ty  
of the in jec ted  sample volume. The needle i s  removed from the so lvent, and 
the plunger is  pulled back about 0.2 atl to separa te  the solvent f lush  from the 
sample with a pocket of a i r  to be used as a marker. The needle is  then 
immersed In the sample, and a 1-^1 a l iq uo t i s  withdrawn, taking in to  
consideration  the volume of the needle, since the sample in the needle w il l  be
completely in je c te d .  A fter the needle i s  removed from the sample and p r io r  to
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in je c t io n ,  the plunger i s  pulled back a short d istance  to minimize evaporation 
of the sample from the t ip  of the needle. Duplicate in je c t io n s  of each sample 
and standard should be made. No more than a 3% d iffe rence  in area is  to be 
expected. A la rg e r  3ample in je c t io n  may be used to increase  the s e n s i t i v i ty  
of the uethpd (JL Sadenwasser, w r it ten  communication, March 1978).
(5) Measurement of Area. The area of the sample peak is  measured by 
an e le c t ro n ic  in te g ra to r  or some other su i ta b le  form of area measurement, and 
prelim inary r e s u l t s  are read from a standard curve prepared as discussed 
below.
(e) Determination of Desorption Efficiency
(1) Importance of Determination. The desorption e ff ic iency  cf a 
p a r t ic u la r  compound can vary from one laboratory  to another and a lso  from one 
batch of charcoal to another. Thus, i t  is  necessary to determine a t  le a s t  
once the percentage of the sp e c if ic  compound th a t  is  removed in  the desorption 
process fo r  a given compound, provided the same batch of charcoal i s  used.
(2) Procedure for Determining Desorption E ffic iency . Activatedcharcoal equivalent to the amount in  the f i r s t  sec tion  of the sampling tube 
(100 mg) is  measured in to  a 5-cm, 4-mm inner diameter g lass tube, flame-sealed 
a t  one end (s im ila r  to commercially ava ilab le  cu ltu re  tubes). This charcoal 
nuic be from the same batch as that used in  .obtaining the samples and can be
obtained from unused charcoal tubes. The open end i s  capped with Parafiim . A
known amount of the vinylidene f lu o r id e  i s  in jec ted  d i re c t ly  in to  theactiva ted  charcoal with a m ic ro l i te r  syringe, and the tube i s  capped with more 
Parafiim.
At le a s t  f ive  tubes are prepared in th is  manner and allowed to stand for 
a t  le a s t  overnight to assure complete absorption of the vinylidene f lu o r id e  
onto the charcoal. These f iv e  tubes are  re fe rred  to as the samples. A
p a ra l l e l  blank tube should be t rea ted  in the same manner except tha t no sample
is  added to i t .  The sample and blank tubes are desorbed and analyzed in
exactly  the same manner as the sampling tube described in  Analysis of Samples.
Two or th ree  standards **are prepared by in je c t in g  the same volume of
vinylidene f lu o r id e  in to  2 ml of carbon d isu lf id e  with the same syringe used 
in  the prepara tion  of the sample. These are analyzed with the samples.
The desorption e ff ic ien cy  equals the d iffe rence  between the average peak area of the samples and the peak area of the blank divided by the average peak area of the standards, or:




I t  i s  convenient to express concentration  of standards in terms of mg/2 ml 
of carbon d isu lf id e  because samples a re  desorbed in  th is  amount of carbon 
d isu l f id e .  To minimize e rro r  due to the v o l a t i l i t y  of carbon d i s u l f id e ,  one can in je c t  f ive  times the volume of vinylidene f lu o r id e  in to  10 ml of carbon 
d isu lf id e .  For example, to prepare 0.3 mg/2 ml of standard , one would in je c t
1.5 mg in to  exactly  10 ml of carbon d isu lf id e  in  a g lass-stoppered  f la sk .  The 
density  of the sp ec if ic  compound i s  used to convert 1.5 mg in to  ql for easy 
measurement with a m ic ro l i te r  syringe. A se r ie s  of standards , varying in 
concentration over the range of in te r e s t ,  i s  prepared and analysed under the same gas-chromatographic conditions and during the sane time period as the 
unknown samples. Curves are e s tab lished  by p lo t t in g  concentration in ng/2 ml vs peak area.
NOTE: Since no in te rn a l  standard i s  used in the method, standard so lu tions
must be analyzed a t  the same time th a t  the sample ana lysis  i s  done. This w il l  
minimize the e f fe c t  of known day-to-day v a r ia t io n s  and v a r ia t io n s  during the 
same day of the flam e-ion iza tion  de tec to r  response.
Calculations
(a) The weight, in  mg, corresponding to each peak area is  read from the 
standard curve. No volume co rrec tions are needed, because the standard curve 
is  based on mg/2 ml of carbon d isu lf id e  and the volume of sample in jec ted  is  id e n t ic a l  to the volume of the standards in je c te d .
(b) Corrections for the blank must be made for each sample:
Correct mg = mg(s) -  mg(b)
where:
mg(s) * mg found in  f ro n t  sec tion  of sample tube
mg(b) * mg found in  fro n t  sec tion  of blank tube
A s im ila r  procedure i s  followed for the backup sec tion s .
(c) The corrected amounts present in the f ro n t  and backup sec tions of the same sample tube are added to determine the to t a l  measured amount in  the sample.
(d) This t o t a l  weight i s  divided by the determined desorption e ff ic iency  to obtain  the t o t a l  mg/sample.
(e) The volume of a i r  sampled is  converted to standard conditions of 25 C and 760 mmHg:
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Vs -  V x _P_ x 298 
760 T+273
where:Vs * volume of a i r  In l i t e r s  a t 25 C and 760 mmHg 
V -  volume of a i r  in  l i t e r s  as measured 
P » barometric pressure in mmHg 
T ■ temperature of a i r  in degrees C
(f) The concentration of the vinylidene f lu o r id e  in the a i r  sampled can be expressed in mg/cu m, which is  numerically ecual to ¿¿g/liter 0f a i r :
mg/cu m * qg/liter = total x 1,000 (¿ig/mg)
Vs
(g) Another method of expressing concentration is  ppm:
ppm * y l of vinylidene fluoride/Vs
ppm » Mg of vinylidene f luo ride  x 2<*. 45 
Vs MW
where:
24.45 » molar volume a t  25 C and 760 mmHg 




MATERIAL SAFETY DATA SHEET
The following items of information which are app licab le  to a sp ec if ic  
product or m ateria l sh a l l  be provided in the appropria te  block of the M aterial 
Safety Data Sheet (MSDS).
The product designation  I s  inserted  in the block in the upper l e f t  corner 
of r.he f i r s t  page to f a c i l i t a t e  f i l i n g  and r e t r i e v a l .  P r in t  in upper case
l e t t e r s  as la rge  as possib le . I t  should be p rin ted  to read upright with the
sheet turned sideways. The product designation is  th a t  name or code 
designation  which appears on the la b e l ,  or by which the product is  sold or 
known by employees. The r e l a t iv e  numerical hazard ra t in g s  and key statements a re  those determined by the ru les  in  Chapter V, P art  B, of the NIOSH
pub lica tion , An Id e n t i f ic a t io n  System for Occupationally Hazardous M ate r ia ls . 
The company id e n t i f ic a t io n  may be p rin ted  in the upper r ig h t  corner i fdesired .
(a) Section I .  Product Id e n t i f ic a t io n
The m anufacturer 's  name, address, and regu lar  and emergency telephone 
mmbers (including area cods) are in se r ted  in the appropriate  blocks of 
Section I .  The company l i s t e d  should be a source of d e ta i le d  backup
inform ition  on the hazards of the m ate r ia l(s )  covered by the MSDS. The
l i s t i n g  of suppliers  or wholesale d i s t r ib u to r s  i s  discouraged. The trade name 
should be the product designation or common name associa ted  with the m ate r ia l .  
The synonyms are those commonly used for the product, e sp e c ia l ly  formal
chemical nomenclature. Every kr.jwn chemical designation or com petitor 's  trade name need not be l i s t e d .
(b) Section I I .  Hazardous Ingred ients
The "m aterials"  l i s t e d  in  Section I I  s h a l l  be those substances which are
part of the hazardous product covered by the MSDS and in d iv idua lly  meet any of 
the c r i t e r i a  defin ing a hazardous m a te r ia l .  Thus, one component of a
multicomponent product might be l i s t e d  because of i t s  to x ic i ty ,  another 
component because of i t s  f lam m ability , while a th ird  component could be 
included both fo r  i t s  to x ic i ty  and i t s  r e a c t iv i ty .  Note th a t  a MSDS for a 
s ing le  component product must have the name of the m ate r ia l  repeated in  th is
sec tion  to avoid giving the impression th a t  there  are  no hazardousin gred ien ts .
Chemical substances should be l i s t e d  according to th e i r  complete name 
derived from a recognized system of nomenclature. Where poss ib le ,  avoid using
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common names and general c la ss  names such as "aromatic amine," "safe ty  
so lv en t,"  or " a l ip h a t ic  hydrocarbon" when the sp e c if ic  name is  known.
The "%" may be the approximate percentage by weight or volume ( in d ica te  
basis )  which each hazardous ingred ien t of the mixture bears to the "hole mixture. This may be ind icated  as a range or maximum amount, i e ,  "10-40% vol" 
or "10% max wt" to avoid d isc losu re  of trade s e c re ts .
Toxic hazard data  sh a l l  be s ta te d  in terms of concen tra tion , mode of 
exposure or t e s t ,  and animal used, eg, "100 ppm LC50-rat," "25 mg/kg LD50- 
s k in - r a b b i t , " "75 ppm LC man," or "perm issible exposure from 29 CFR
1910.1000," or, i f  not av a i lab le ,  from ocher sources of pub lica tions such as 
Che American Conference of Governmental In d u s tr ia l  Hygienists or the American 
National Standards I n s t i t u t e  Inc. F lashpoint, shcck s e n s i t i v i ty ,  or s im ila r  
d e sc r ip tiv e  data may be used to in d ica te  f la n m a b i l i ty , r e a c t iv i ty ,  or s im ila r  
hazardous p rope r t ie s  of the m ate r ia l .
(c) Section I I I .  Physical Data
The data in Section I I I  should be fo r  the to t a l  mixture and should include 
the bo iling  point and melting point in degrees Fahrenheit (Celsius in 
parentheses); vapor p ressure , in  conventional m ill im eters  of mercury (ramHg); 
vapor density  of gas or vapor (a i r  ■ 1); s o lu b i l i t y  in water, in parts/hundred 
p a r ts  of water by weight; sp ec if ic  g rav ity  (water = 1); percent v o la t i l e s  ( ind ica ted  i f  by weight or volume) a t  70 F (21.1 C); evaporation r a te  fo r
l iqu id s  or sublimable s o l id s ,  r e l a t iv e  to butyl ace ta te ;  and appearance and 
odor. These data are  usefu l fo r  the con tro l of toxic substances. Boiling 
poin t, vapor density , percent v o l a t i l e s ,  vapor p ressure , and evaporation are usefu l fo r  designing proper v e n t i la t io n  equipment. This information i s  a lso  
usefu l fo r  design and deployment of adequate f i r e  and s p i l l  containment equipment. The appearance and odor may f a c i l i t a t e  id e n t i f ic a t io n  of 
substances s tored  in  improperly marked con ta in ers ,  or when s p i l l e d .
(d) Section IV. F ire  and Explosion Data
Section IV should contain complete f i r e  and explosion data fo r  the 
product, including f lashpo in t and au to ig n i t io n  temperature in  degrees 
Fahrenheit (Celsius in  parentheses); flammable l im i t s ,  in  percent by volume in 
a i r ;  s u i ta b le  extinguishing media or m a te r ia ls ;  sp ec ia l  f i r e f ig h t in g  procedures; and unusual f i r e  and explosion hazard information. I f  the product 
p resents no f i r e  hazard, in s e r t  "NO FIRE HAZARD" on the l in e  labeled 
"Extinguishing Media."
(e) Section V. Health Hazard Information
The "Health Hazard Data" should be a combined estim ate  of the hazard of 
the to t a l  product. This can be expressed as a TWA concen tration , as a
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perm issib le  exposure, or by some other in d ica t io n  of an acceptable  standard. 
Other data are  acceptable , such as lowest LD50 i f  m ultip le  components are 
involved.
Under "Routes of Exposure," comments in  each category should r e f l e c t  the p o te n t ia l  hazard from absorption by the route  in  question . Comments should 
in d ica te  the sev e r i ty  of the e f fe c t  and the basis fo r  the statement i f  possib le . The basis  might be animal s tu d ie s ,  analogy with s im ila r  products, 
or human experiences. Comments such as "yes" or "possib le" are not he lp fu l .  
Typical comments might be:
Skin Contact—sin g le  short contac t, no adverse e f fe c ts  l ik e ly ;
prolonged or repeated contact, possibly mild i r r i t a t i o n .
Eye Contact—some pain and mild t r a n s ie n t  i r r i t a t i o n ;  no corneal
sca rr in g .
"Emergency and F i r s t  Aid Procedures" should be w r i t ten  in  lay language and 
should prim arily  rep resen t f i r s t - a i d  treatment th a t  could be provided by 
paramedical personnel or ind iv idua ls  tra ined  in f i r s t  a id .
Information in  the "Notes to Physician" sec tion  should include any spec ia l  
medical information which would be of a ss is tan ce  to an a ttending physician 
including required or recommended preplacement and period ic  medical 
examinations, d iagn os t ic 'p rocedu res , and medical management of overexposed 
employees.
(f) Section VI. R eactiv ity  Data
The comments in  Section VI r e l a t e  to safe  storage and handling of 
hazardous, unstable  substances. I t  i s  p a r t ic u la r ly  important to h igh ligh t  
in s t a b i l i t y  or incom patib il i ty  to common substances or circumstances, such as 
water, d i r e c t  su n lig h t ,  s t e e l  or copper piping, ac id s ,  a lk a l i e s ,  e tc . 
"Hazardous Decomposition Products" s h a l l  include those products re leased  under 
f i r e  conditions. I t  must a lso include dangerous products produced by aging, 
such as peroxides in the case of some e th e rs .  Where a p p l ic a b le , she lf  l i f e  
should a lso  be ind icated .
(g) Section VII. S p i l l  or Leak Procedures
Detailed procedures fo r  cleanup and d isposal should be , l i s t e d  with 
emphasis on precautions to be taken to p ro tec t  employees assigned to cleanup 
d e ta i l .  Specific  n e u tra l iz in g  chemicals or procedures should be described in  
d e t a i l .  Disposal methods should be e x p l ic i t  including proper labe ling  of 
conta iners holding res idues and u ltim ate  d isposal methods such as " san ita ry  
l a n d f i l l "  or " in c in e ra t io n ."  Warnings such as "comply with lo c a l ,  s t a t e ,  and 
Federal a n t ip o l lu t io n  ordinances" are  proper but not s u f f i c ie n t .  Specific  
procedures s h a l l  be id e n t i f ie d .
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(h) Section V III. Special P ro tec tion  Information
Section VIII requires sp e c if ic  information. Statements such as "Yes,” 
"No," or " I f  necessary" are  not inform ative. V en ti la t ion  requirements should 
be sp e c if ic  as to type and preferred  methods. R espirators sh a l l  be spec if iedas to type and NIOSH or MSHA approval c la s s ,  i e ,  "Supplied a i r , "  "Organic
vapor c a n i s te r ,"  e tc .  P ro tec t ive  equipment must be sp ec if ied  as to type and 
m ateria ls  of construction .
( i)  Section IX. Special Precautions
"Precautionary Statements" s h a l l  consis t  of the labe l statements se lected  for use on the container or p lacard . Additional information on any aspect of 
sa fe ty  or health  not covered in other sec tions should be in se r ted  in  Section 
IX. The lower block can contain references to published guides or in-house 
procedures fo r  handling and s to rage . Department of T ransporta tion  markings 
and c la s s i f i c a t io n s  and other f r e ig h t ,  handling, or storage requirements and 
environmental contro ls  can be noted.
( j)  Signature a.id F il ing
F in a l ly ,  the name and address of the responsib le  person who completed the MSDS and the date of completion are  entered. This w il l  f a c i l i t a t e  co rrec tion  
of e rro rs  and id e n t ify  a source of add it ion a l  information.
The MSDS s h a l l  be f i le d  in a lo ca tion  read ily  accessib le  to employees
exposed to the hazardous substance. The MSDS can be used as a tra in in g  aid 
and basis  fo r  d iscussion  during sa fe ty  meetings and t ra in in g  of new employee«. I t  should a s s i s t  management by d irec t in g  a t te n t io n  to the need for sp ec if ic  
contro l engineering, work p ra c t ic e s ,  and p ro tec tiv e  measures to ensure safe  
handling and use of the m ate r ia l .  I t  w il l  aid the safe ty  and hea lth  s t a f f  in 
planning a safe  and h e a l th fu l  work environment ar.d in  suggesting appropria te  






MATER IAL  SAFETY DATA SHEET
1 PRODUCT IDENTIF ICATION
m a n u f a c t u r e r  S  N A M E
R E G U L A «  T Ç U Ê P W O N Ê  N O  
E M E R G E N C Y  T E l E P h O N é  N O
; A D O f l E S S
TRADE NAME
SY N O N Y M S
II HAZARDOU S  INGRED IENTS
1 M A T E R I A L  U R  C O M P O N E N T \ h a z a r d  O a t a
i
■
III PH YS ICAL  DATA
8 0 * U N C ,  P C î  * T  7 6 0  M M  M O m e e t i n g  p o *n t
S P £ C l i » C  G R A V I T Y  I H j O ' U V A P O R  P R E S S U R E
V A P O f l  0 6 N S I T V  I A l R . 1 l S O C U 0 I W T Y  IN  H j Q  %  8 Y  W T
%  V O l A T l t t S  B Y  V O L E V A P O R A T I O N  R A T C  < 8 U T y i  A C C T A T C  j i
A P P Ç  A R A N C I  A N O O O O M
270
«
IV FIRE AND EXPLOS ION  DATA
f l a s h  p o i m  
i T E S T  M E T H O D )
A U T O I C N I T I O N
T E M P E R A T U R E
f l a m m a b l e  l i m i t s N  A I R  \  0 Y  V O L L O W E R U P P E R
EXTINGUISHING ME DIA
S P E C I A L  F I R E
f i g h t i n g
P R O C E D U R E S
U N U S U A L  F I H É  
A N O  E x P t  O S I O N  HAZARD
V HEALTH HAZARD INFORMATION
M E A c T h  H A 2 A H O  O A T A
R O U T E S  O f  E X P O S U R E
i n h a l a t i o n
S K I N  C O N T A C T
S K I N  A B S O R P T I O N
fc Y E C O N T A C T
I N G E S T I O N
E F F E C T S  O F  O V E R E X P O S U R *  
A C U T E  O V E R E X P O S U R E
C H R O N I C  O V E R E X P O S U R E
E M E R G E N C Y  A N O  F i R S T  A i O  P R O C E O U R E S  
EYES
S K I N
i n h a l a t i o n
iNGEST'ON
N O T E S  T O  P H Y S I C I A N
271
VI REACTIVITY DATA
C O N O lT lO N S  C O N T R IB U T IN G  TO IN S T A B IL IT Y
I N C O M B A ) .  B t L l T Y
m A Z A R O O U S  D E C O M P O S I T I O N  P « O O U C T S
C O N O I T ' O N S  C O N  T R I Q  i j  T I N G  T O H A Z A f l O Û U S  P O L Y M É « l ¿ A l  i O N
V!I S P I L L  OR  L E A K  P R O C E D U R E S
S T E f * S  T O  0 t  T A K E N  I F  M A T E R I A L  IS  « « E l E A S E O  0 »  S P I L L  E O  
N E U T R A L I Z I N G  C H E M I C A L S
W A S T C  D I S P O S A L  M E T H O O
VI II  S P E C I A L  P R O T E C T I O N  I N F O R M A T I O N
V É N r I L A T i O N  R E Q U I R E M E N T S
S P E C I F I C  P E R S O N A L  P R O T E C T i V É  E Q U I P M E N T  
R E S P I P A T O A Y  ( S P E C I F Y  IN D E T A I L )
i
E Y E
g l o v e s
o t h € w c l o t h i n g  a n o  e q u i p m e n t
2 72
f
IX SP EC IA L  PR EC AU T IO NS
P R E C A U T I O N A R Y  
ST A T  { Mf cNTS
O T H E R  H A N D L I N G  A N O  
S T O R A G E  R E Q U I R E M E N T S





P H Y S ICA L  A N D  C H EM IC A L  PR O P ER T IES  OF V IN Y L  H A L ID E  CO M PO U NDS
TABLE  X V II 1
P r o p e r l y V i n y l  C h lo n d t R s f V in y l id u n e  C l i io r id f t R t l V m y l  B r o m id e R u t V i n y l  F lu o r id e R * t V in y t i d c n c  F lu o r i c « R e f
M o l? c u it r  f w m v l l C H j 'C H C l 297 C M j- C C  12 301 C “ ,  C H f lr 317 C H ^ -C H F 130 C * j - C f 2 130
6 2  5 0 3 3« 9 6  9 5 JO t lU ti % 304 4u  0 4 6 130 t>4 0  38 I X
A p p e « i* n c * C o 'o i i t u  941 2 a ; 0 >:jf c o l< ;' ic ii liq u id \  14 Cu!f»rlevi y j t 337 C u lo i im  9 >̂ 1 14 C 1 14
O d o r/T iw e th o id  (p p m ) Sweet 339 S v .e n / 5 0 0 - 1 .000 114 P u n y rn l 304 F i  n! e i f ' i ' t i i 340 Fa i> i e the»ra i 8
6 o*l*n* p o in t u s e 207 31 5 6  C 301 15 H_, C 300 72 0  C 1 J  U 8 5  7 C 130
M d tift y  p o in t 153  7 C 2 8? »22 5  C 301 1 .1 78  C 127 160 C 130 1*4  C 130
Spec>l*c 9>««ilv 0  9 9  at -2 5  C 33« 1 2 18  ¿1 2 0  C 114 1 5 2 3  at 1 1 C 341 0  8 53  a i 2»i C J 4 1
D e n i 'iy  l iq u id 0 9 1 2 1  at 2 0  C 2 9 ; ! 2132  at 2 0  C 301 1 52 2  a< 2 0  C 304 0  6 3b  «1 21 C U ii) ( i  u59  a* 21 C 2 r) l
V apo f p r t t M i*  (m m H g) 2 .5 0 0  i t  2 0  C 1 14 4 y 5  at 2 0  r . 33'_ 1 OOtJ a i 2U C 3 42 19 .1 2 9  a i 21 C " 1 10 
343
i i  763 a l 21 C * * 130
343
V apo •  dem »ty  (*»r — 1) 2 15 339 3 3 4 301 :  7 304 1 5o 1 14 2 ? 114
D fO i iiy  o* M tu fa te d  a«r - 2 6 301 -
r n t o i \  40GG at 10 C 287 1 4 2 4 6 8  at 20  C 301 1 4 110 at 2 0  C 3 43 1 35 at 20  C 340
Mo>*r (« f rv c t tv ity * 15 bb 22 9
34 4




10 65 2 IN  
344
tO 4 3 2 2 »
344
V iw o » ity 0  2734  c e n f p o i i t  a l - 2 0  C 10 0  3 3 0 2  c e n i . i t t u r  at 2 0  C 301 0  " i '6  at 0  C 300 0  15 ccDtipui^« at 15 t, C ' 30
S p e c if ic  h * a t  (c jl/^ J l> 'iu  d . 0  3 8  a l 2 0  C . gat at 
1 a im  and 2 6  C . 0  2 06
10 0 275 J 4 5 G d i a* ■ a i» r and 25  C  0  1241 337 " G *» at 25  C . 14 37  ca l/m o t* 2 S I
H eat o f vap o nta t> o n (a t b o ilin g  p o in t) 79 84  cal/g 10 6 .2 5 7  c a f 'n o l« 301 54 <j m / y 304 3 9 7  K ca i< " ’ 0 i* 3-10 i)R 0  la i/ m o lt 251
H ( i i  o f  co /n th n lio n 206  2  K c a l/m u l« 339 201 9 3  K ca l/m o le 301 -
Meat o f p a ly f lw i t i t io n 22  9  K c a l/m o lt 3-W 18 K i i i / r n u ie 3 0 1 18 K ta i/ .n o le 300 -
H eai o f fu t io n ; 8  14 c a l/9  at m a ilin g  p o in t *0 1 557  ca i'*no le 301 12 3 c di/g 304 -
f  lis h p o m t lo p t f l cup ) -7 8  C J o ' 15 C 1 14 None 304 -
tia m m a b l*  l im it !  ( in  a n ) 3  6  -33  0% 3 0 7 - 16%  ai 2 8  C 301 9 - 1 5 % 300 2 6 - 2 1  7% 130 5 5 21 3% 1 »
O 'f ie c t r .c  c o n f(» o | 6  2 6  at 17 2  C *0 4 f 7 41 10 C 301 I  n u i j  a l 5 C b  b 3 . g j i  at
100  C . 1 01
¿ 4 1 20  2  11 -8» C  100  Q O v H t 1 JO
D ip o le  m o m n |  [ m  ) 1 4 5 343 1 34 343 1 42 3 43 \  43 343 1 38 343
S o lu b il ity
W atw  1 * 0 0 0  m il U 1» at 24 C 10 0  25  a l 75  C 315 0  5G 5 «1 2 5  C .100 In iu ly N e 3 i 0 0 0 1 8  at 2 5  C 130
O rgan ic to lv ff it * - 1 14 S o 'u ii le  *n mu»« 300 ‘ -
A tco bo i S u lu b U 2 8 ? S o lu b le 2 u l So lub le 300 S u iu b lt 34 0 5uiub<e X 3
£ ih * r Ve>y id u b * * 2 u ; 300 3-10 V i f y  lul< 'lie 3^3
C C I4 2 87 V e iy  io lu b le 301 3H0 -
B e n it / w 2 87 S o lu b le 301 ■ 3*» 3 -






TA BLE  X V I I - 1 (CONTINUED)
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TABLE XVII-2
SYNONYMS FOR VINYL HALIDES


















uns-Dichloroethy!» ene 1, 1-Dichloroethene
1 ,1-Dichloroethylene 
Vinylidene d ich lo ride  alpha,alpha-Dichloroethylene 







Isc tron  1132A Genetron 1122A
Adapted from references 8,251,287,298,301,341,343,352-354
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TABLE XVII-3
OCCUPATIONS WITH POTENTIAL EXPOSURE TO VINYL HALIDES






Monomer loaders and unloaders
Monomer production workers











Adapted from references 130,279,284,287,294,300,301,355,356
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TABLE X V I 1-4
REPORTED CASES OF ANC[OSARCOMA OF THE LIVFR IN 
VINYL CHLORIDE POLYMERIZATION WORKERS*
C o u n t r y
Ca s e
No.
B i r t h
D a t e
t ' i r s r  VC
o r  PVC 
E x p o s u r e
D l a g n o s  i s  
o f  
Ang i o -  
s a r c orr.a
Age
a t
D i a e -
n o s l j
Y e a r s  f rom 
F i r s t  Ex­
p o s u r e  t o  
0 i j>;nos i s
T o t a l  
Yeai  s 
Expo­
s u r e
D a t e  o f  
De a t h
Be l g i u m 01 0 0 - 0 0 - 0 0 0 0 - 0 0 - 0 0 0 0 - 0 0 - 0 0 00 00 00 0 6 - 2 9 - 7 o
Cai .ada 01** 1 2 - 1 5 - 1 3 0 0 - 0 0 - 4 4 0 0 - 0 0 - 5 5 41 10 1 1 0 9 - 0 2 - 5 5
" 02** 0 3 - 0 6 - 1 4 0 0 - 0 0 - 4 3 0 0 - 0 0 - 5 7 43 14 14 1 2 - 2 1 - 5 7
U 03** 0 8 - 2 6 - 1 9 0 0 - 0 0 - 4 1 0 0 - 0 0 - 6 2 42 21 20 0 3 - 2 2 - o 2
" 04** 0 4 - 0 5 - 1 9 0 0 - 0 0 - 4 5 0 0 - 0 0 - 6 7 48 22 22 0 1 - 2 1 - 6 8
" 05** 0 5 - 0 7 - 1 1 0 0 - 0 0 - 4 4 0 0 - 0 0 - 6 8 57 24 05 0 7 - 0 5 - 6 8
" 06** 1 2 - 1 5 - 1 9 0 0 - 0 0 - 4 7 0 0 - 0 0 - 7 l 51 24 23 0 4 - 1 0 - 7  i
II 07** 1 1 - 0 9 - 1 9 0 0 - 0 0 - 4 6 0 0 - 0 0 - 7 2 53 26 25 1 2 - 2 4 - 7 2
" 08 0 5 - 1 3 - 2 0 0 0 - 0 0 - 6 1 0 0 - 0 0 - 7 3 53 12 05 0 6 - 1 2 - 7 3
" 09 0 7 - 1 9 - 2 1 0 0 - 0 0 - 4 6 0 0 - 0 0 - 7 4 53 28 26 0 9 - 0 4 - 7 4
I 10 0 5 - 1 6 - 1 5 0 0 - 0 0 - 5 3 0 0 - 0 0 - 7 6 61 23 14 0 4 - 0 C - 7 7
C z e c h o s l o v a k i a 01** 0 0 - 0 0 - 2 8 0 0 - 0 0 - 5 7 0 0 - 0 0 - 7 3 46 U) 16 0 0 - 0 0 - 7 4
ir 02** 0 0 - 0 0 - 2 6 C 0- 0 0- 51 0 0 - 0 0 - 6 6 40 13 15 0 0 - 0 0 - 6 6
F e d e r a l  Repub­
l i c  o f  Germany
G i * * 0 6 - 0 4 - 3 0 1 0 - 0 1 - 5 6 0 9 - 1 9 - 6 8 38 12 12 0 1 - 2 5 - 6 9
II 02** 0 7 - 2 6 - 3 1 1 0 - 1 4 - 5 7 0 9 - 2 5 - 7 0 39 13 12 1 2 - 1 4 - 7 1
04 0 9 - 0 4 - 3 0 0 4 - 1 6 - 5 7 0 0 - 0 0 - 7 4 44 17 17 1 1 - 2 5 - 7 4
11 05** 0 1 - 0 1 - 3 2 1 2 - 1 6 - 6 2 0 0 - 0 0 - 7 5 43 13 12 0 1 - 0 9 - 7 5
07** 0 9 - 2 9 - 2 6 0 4 - 1 5 - 5 4 0 0 - 0 0 - 7 5 49 21 12 1 1 - 1 3 - 7 5
»» 08** 1 0 - 1 9 - 1 7 0 4 - 1 9 - 5 4 C 0 - 0 0 - 7 5 58 22 21 1 2 - 2 5 - 7 5
• 1 )9** 1 2 - 1 3 - 3 4 1 2 - 0 2 - 5 9 0 6 - 1 6 - 7 6 42 17 15 A l i v e
TABLE XV! 1-4 (COVTINtF.D)
REPORTFD CASES OF ANCTOSAHCOMA Or THE LIVER IN 
VINYL CHLORIDE POLYMERIZATION WORKERS*
Cou-. t  rv
Cast?
No .
B i r t h  
!' i t o
F i r s t  VC
' i  r v c





Y e i r s  i r o n  
F i r s t  F x - 
? v; - i re  to
1) i 1 . ;nn;; 1 i
T o •: a 1 
Y.vir;
1 :<p o - 
s u r e
r i ' i i ' t i ' .  -:■- 
11. of  m TT.ISV
V-.i 11 1 r. . o -
r r a ^ o c 01** 0 - -  15-24 3 1 - C 0 - - 6 0 2 - 1 8 - 6 7 43 21 19
•• 02 0 6 - 0  3-11 0 7 - 0 6 - 5 9 0 1 - 0 8 - 7 5 63 15 12
03** 00-CG-19 0 0 - 0 0 - 4 6 0 1 - 0 0 - 7 5 55 29 29
" 0 - * * 0 1 - 2 7 - 2 7 10-1"«-49 0 1 - 0 4 - 7 6 49 26 26
•• 05** 0 1 - 2 9 - 3 3 2 0 - 0 0 - 6  5 0- . - 00 -  76 33 11 10
■ 06** 0 4 -  1 4-3-» 0 0 - 0 0 - 5 3 0 9 - 0 0 - 7 6 42 18 17
•• 07 0 0 - 0 0 - 2 7 0 7 - 0 1 - 5 0 0 7 - 0 0 - 7 6 49 26 23
r> a V* ̂ o ~ ^ "yi C 0 - 0 0 -  0 0 OO-CO-OO 00 00 00
G r e a t  S r - . t J i r . ?! * * " o - v ' J -   ̂1 : : - o : - 4 6 1 * ' -^0-72 71 26 -> ^
03 06-02-37 02-00-66 00-00-74 37 09 04
I t a l y 02** 11-13-29 00-00-57 12-13-72 43 15 06
•• 03** 03-14-20 00-00-53 07-10-75 55 22 21
Japan 01 08-01-22 04-00-53 OS-21-74 52 22 22
Norway 01** 12-23-15 03-00-50 12-20-71 56 22 21







United States 01** 10-17-23 12-09-48 03-0J-73 49 22 16
«« 02** 08-19-33 11-15-55 05-00-70 37 14 13
D i t e  




















REPORTED CASKS OF AV.IOSA!’.C v t \  OF THE LIVER IN 
VINYL CULOIUDE POLYMERIZATION WORKERS*
TABLE XVI1-4 (CONTINUED)
C o u n t r y
Ca se
No.
B i r t h
Da te
F i r s t  VC
o r  PVC 
E x p o s u r e
D i a g n o s i s
o f
A n g l o -
s a r c o n ;
Age
a t
D i j g -
nos  i s
Y e a r s  frora 
F i r s t  Ex­
p o s u r e  t o  
D i a g n o s i s
T o t a l
Y e a r s
Expo­
s u r e
D a t e  o f  
De a t h
U n i t e d  S t a t e s 03* 0 5 - 2 5 - 1 5 1 1 - 2 3 - 4 5 1 2 -  : Q - 7 3 53 23 28 1 2 - 1 9 - 7 3
•• 0-* 0 1 - 1 5 - 2 4 ) 7-Qt j -5 2 0 H - 1 > - l 7 43 15 15 0 1 - 0 7 - 6 3
" 05* 0 1 - 2 5 - 1 2 > - l > - ^ 5 2 20 13 C 4 - 0 9 - 6  4
i V- * o > ; o -  21 01-17--J2 ■o:- ;>74 4 5 12 12 0 7 - 2 4 - 7 5
07* 0 5 - 0 3 - 2 2 ■‘. S - 2  7-44 0 0 - 0 0 - 6 3 45 24 13 0 3 - 2 3 - 6 8
" 08* 0 5 - 0 6 - 2 0 1 C- C / - 4 6 0 8 - 0 0 - 6 1 41 15 15 0 8 - 2 9 - 6 1
09* 1 1 -0 8 - 3 1 0 9 - 0 9 - 5 4 0 3 - 0 1 - 7 4 43 17 17 0 3 - 0 0 - 7 5
•• 10* 0 8 - 1 6 - 1 3 0 6-  12-51 0 5 - 0 0 - 6 3 5 j 17 17 0 5 - 1 0 - 6 8
11* 0 5 - 2 7 - 0 9 1 0 - 1 -----6 0 3 - 0 0 - 7 0 61 23 23 0 3 - 1 6 - 7 0
•' i : * 1 1 - 1 7 - 1 3 0 9 - 1 3 - 4 9 0 5 - 0 2 - 6 9 50 20 15 0 5 - 0 2 - 6 9
•• 13* 1 2 - 0 1 - 2 1 0 3 - 1 9 - 4 4 0 5 - 0 0 - 7 4 52 30 30 0 7 - 0 4 - 7 4
16* 1 1 - 0 4 - 2 7 : 5 - 0 3 - 5 r 0 0 - 0 0 - 6 9 41 17 4 0 3 - 2 7 - 6 9
•• 17* 0 5 - 0 6 - 3 1 0 6 - 2 3 - 5 5 1 0 - 1 1 - 7 4 43 19 19 A l i v e
" 13* 0 4 - ; 2 - 2 S 0 9 - 1 5 - 5 4 0 0 - 0 0 - 7 5 46 21 13 1 1 - 0 2 - 7 5
" 19* OO-OC-15 0 0 - 0 0 - 4  3 C 6 - 1 9 - 7 5 60 32 32 Al i v e
2 0 * 0 8 - 3 1 - 1 7 0 0 - 0 0 - 5  5 0 1 - 3 0 - 7 6 53 21 18 0 1 - 2 0 - 7 6
" 21* 0 0 - 0 0 - 1 0 1 2 - 0 0 - 4 6 0 0 - 0 0 - 7 7 67 30 22 0 1 - 0 2 - 7 7
II 22* 1 0 - 0 2 - 2 3 0 0 - 0 0 - 4 9 0 1 - 0 0 - 7 6 52 27 27 1 2 - 0 4 - 7 6
" 2 3* 0 0 - 0 0 - 2  3 0 9 - 0 S - 58 0 0 - 0 0 - 0 0 50 00 14 0 4 - 0 6 - 7 3
" 24* 0 0 - 0 0 - 1 7 0 0 - 0 0 - 3 9 0 5 - 2 7 - 7 7 60 38 26 0 ' - 2 7 - 7 7
•• 25* 0 8 - 0 7 - 1 0 0 9 - 0 0 - 4 7 0 3 - 1 0 - 7 7 67 30 20 0 3 - 1 0 - 7 7
Y u g o s l a v i a 01* 0 4 - 0 5 - 1 4 0 0 - 0 0 - 5  3 0 4 - 0 8 - 7 3 59 20 20 0 4 - 0 8 - 7 3
02* U - 1 5 - 3 1 0 0 - 0 0 - 5 0 0 7 - 1 2 - 7 3 42 23 18 0 7 - 1 2 - 7 3
* ” 0 0 "  i n d i c a t e s  
♦♦Diagnosis was
unknown d a t a ,  
r c i c r o s c o p i c a l l y c o n f  i rmed
A d a p t e d  f rom r e f e r e n c e  61
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5 50 0.639 10.0 200 127.9
5 100 1.278 9.3 98 125.2
5 150 1.916 29.3 195 373.6
25 50 3.19 7.9 158 504
25 100 6.38 22.3 228 1,456
25 150 9.58 20.5 137 1,312
50 50 6.38 9.0 180 1,285
50 100 12.78 18.1 181 2,311
50 150 19.16 14.8 98.7 1,391
^Standard (150-ag charcoal) Cubes fron MSA 
**At 10" breakthrough from front sectior. of tube
Adapted fron; reference 254
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TABLE XVII-7
RELATIVE RETENTION TIMES FOR COMPOUNDS POTENTIALLY INTERFERING 
WITH GAS CINEMATOGRAPHIC ANALYSIS OF VINYL CHLORIDE*
O.i* Carbovax If00
Compound Chromosorb 102** Pcrapak 0** cr. Carbcpak A***
100 C 1-5 C 100 C Ambient Temperature
Methane 0.15 - 0.05 0.20
Ethane 0.21 -  - 0.29
Ethene 0.21 0.33 - 0.26
1. i-0Ifiuorcethvi.ene - 0.33 - 0.63
Propene - 0.62 0.^6 0.63
Propane 0.5A - 0.52 0.63
Methylacecylene - - 0.56
Methyl chloride 0.63 - 0.57 0.^5
1,1-Difluoroethane - 0.51
Chlorodifluoromethane 0.53
Cyclopropane - - 0.59
Formaldehyde - 0.62
1-Chloro-1,1-difluoroethane 0.92
Acetaidehyde 0.93 -  0.95 0.77
Freon 114 -  1.21
Isobutane 1.22 -
Isobutvlene 1.37 1.25
TABLE X V I I - 7  (CONTINUED)
RELATIVE RETENTION TIMES FOR COMPOUNDS POTENTIALLY INTERFERING 
VITH GAS CHROMATOGRAPHIC ANALYSIS OF VLNTL CHLORIDE*
O.iS Carbovax 1500
Ccnpcund Chrc-osorb Porapak. 0** on Carbcpak A***









1, 1-Dichlcroethy ler.e 2.00
»Retention /iny. chlcride * 1.0 
**6 feet x 1/3 inch, 30/100 mesh 
***6 feet x 1/8 inch












COMPARISON OF GaS CHROMATOGRAPHY DETECTORS 






Flame ionization Organic compounds 1.0 :< 10"*'
Electron capture Halides 2.0 x io'9
Elfcctrocor.ductivicy 
(Hall uetector)
ft 7.0 x 10-11




M/e 62 and 
64 ions
1-2.0 x 10~**
Adapted from reference 264
285
f!GL=?£ f . ' I I - l
T I ; v & ;c ■«[ li ver
- 1 n > l c - u o s i D t  ? c t v  M t ?  ; z a  t : c '. .,. c 3 < e w <
• Bv ance r mi e r ce  at t i re tI natn 3n late 0f ‘l3<;n«is if itili a ! ¡ve
•• ^ r e i i r i r a r v  re su its  in c lu d i*  onry ¡»tnoiaQicaìrv c c n l l f e c  cases m center for J isease  C :n t r ? l  revfa» 
1 aOditional ; j ?e  is jend inq  
AdaBtM  from reference 63
FIG URE X V I I - :
c - : 0 « *  •=•!!c 3 : s : - i : 3 „ t ; o f  ? : o  c a s e s  o f  a n c i c s a r c o w a  o f  t h e  l i v e r  i n
- S  i f ' . : 3 EMS *.CT OCCUPATIONALLY EXPOSED 1 0  VINYL CHLORIDE.  1 9 4 J - I W *
• By 31 t c t  -f r fV '& ' i c r  dt U r . t  J  leafh ;r  do late y  iian n osis. if still alive
•• 3 > » n r i 'dr. '<-■ / t s  i^ c i- jd «  :n !y M i^ i. ie ic a it v  c c n f lrn *d  cases in  Center for D isease C c rtro l review; 
e v ii- jU ' . r  1 ■, i y ‘n z n i  is j*p tfing
U z ^  r e ' e r e r c e  l i



